data_1sxl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sxl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 30.5 t0 -161.93 96.31 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.542 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 1.2 m -148.23 54.87 1.03 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.545 ' N ' ' ND2' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -78.34 164.09 25.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' CG1' ' A' ' 89' ' ' VAL . 1.8 pt? -127.25 141.44 51.72 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.641 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.682 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -83.44 110.92 18.57 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.595 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -84.78 116.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 109.248 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 88' ' ' SER . 9.8 p -91.11 163.15 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 109.713 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.69 89.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.558 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 87' ' ' LEU . 9.1 tp -157.22 96.68 2.07 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HG3' ' OE1' ' A' ' 85' ' ' GLN . 36.9 Cg_endo -69.11 168.53 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.989 1.52 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 42.63 1.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.987 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.531 HG21 ' CG2' ' A' ' 25' ' ' ILE . 9.3 t -80.19 -12.0 59.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' A' ' 24' ' ' THR . 0.2 OUTLIER -125.77 -177.73 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.5 p -110.59 153.76 24.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 6.1 p-10 -57.62 -47.35 82.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -65.53 -19.05 65.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 17.5 tt0 -71.15 -48.82 49.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 29' ' ' GLN . 0.9 OUTLIER -45.7 -26.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 108.735 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 10.3 t70 -64.65 -51.14 64.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.842 . . . . 0.0 109.109 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.7 m -54.62 -44.35 73.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.087 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.25 -36.11 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.197 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.633 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 2.0 m-30 -80.28 -83.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 109.346 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 23.01 67.09 0.02 OUTLIER Glycine 0 N--CA 1.503 3.115 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -172.88 -39.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.247 . . . . 0.0 109.922 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -94.38 -77.52 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.177 -0.952 . . . . 0.0 109.584 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 -168.15 14.94 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.32 32.58 4.36 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -1.232 . . . . 0.0 109.555 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 26.62 101.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.774 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.627 HG23 ' HD3' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -76.54 9.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.362 -1.461 . . . . 0.0 110.129 -179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.561 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -168.04 -164.65 0.56 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.638 -1.289 . . . . 0.0 110.776 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 159.02 106.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.33 -178.5 5.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.62 -1.3 . . . . 0.0 110.905 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 27' ' ' ASP . 5.3 mp -139.25 141.65 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.8 mp -127.58 130.38 48.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.476 ' O ' ' CG1' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 56' ' ' GLY . 13.6 m -157.38 143.08 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -1.101 . . . . 0.0 109.704 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . . . -100.47 -176.45 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 108.801 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.682 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -133.93 108.02 8.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 109.55 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 16' ' ' LEU . 1.7 t -85.89 160.85 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -104.71 140.85 37.46 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.67 ' CE2' ' CB ' ' A' ' 71' ' ' ALA . 9.4 m-85 -161.39 68.99 0.32 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.0 m-20 -46.86 -86.6 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.434 -0.791 . . . . 0.0 109.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 63' ' ' ASN . 6.5 ttmm -37.01 118.37 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.326 0.584 . . . . 0.0 109.672 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.494 ' HG3' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -45.74 -47.7 15.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.629 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 14.6 mt-10 -54.38 -50.02 68.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 3.1 tp10 -53.86 -42.78 68.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.548 ' CA ' ' HB3' ' A' ' 62' ' ' TYR . . . -55.43 -39.33 70.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.838 -1.164 . . . . 0.0 108.594 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.47 -44.73 76.73 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -49.2 -62.24 1.64 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.67 ' CB ' ' CE2' ' A' ' 62' ' ' TYR . . . -43.37 -40.09 3.48 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.524 -0.735 . . . . 0.0 109.152 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 40.8 mm -46.99 -60.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -68.82 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 37' ' ' TYR . . . -45.94 -50.95 14.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 111.588 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.633 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.18 -28.17 42.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.723 -1.235 . . . . 0.0 110.635 -178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.0 t30 -46.15 115.29 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.251 -1.53 . . . . 0.0 107.463 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.504 ' N ' ' OD1' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 60.81 78.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 75' ' ' LEU . 1.6 m -85.23 45.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' CD1' ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.97 145.05 25.93 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.42 -0.8 . . . . 0.0 109.234 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 81' ' ' GLU . 36.3 Cg_endo -62.47 139.21 75.19 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.91 1.479 . . . . 0.0 109.328 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -40.33 107.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 -179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.72 38.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 81.56 -139.47 20.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 1.4 t 78.77 -4.82 2.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.598 -0.942 . . . . 0.0 109.391 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 84' ' ' SER . 24.7 mt-30 57.97 117.22 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.835 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.504 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.5 Cg_endo -83.75 177.74 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.905 1.476 . . . . 0.0 110.295 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -118.09 138.73 52.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 109.574 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.475 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 19.2 m -79.04 103.81 9.24 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' HD12 ' A' ' 16' ' ' LEU . 1.2 m -83.08 144.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.731 0.776 . . . . 0.0 110.886 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.92 132.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 14' ' ' THR . 0.3 OUTLIER -61.29 116.21 4.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.12 162.26 25.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -95.15 71.45 3.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -150.31 -38.13 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 97.8 m-70 62.41 105.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.23 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.412 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -177.41 96.0 0.1 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.228 0.061 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.553 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 12.5 m-20 -157.97 -105.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.012 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -159.21 92.46 1.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.665 -1.272 . . . . 0.0 110.394 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.554 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 33.3 p-10 -83.65 168.53 16.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.324 -0.86 . . . . 0.0 109.564 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.592 ' CD1' ' CG1' ' A' ' 89' ' ' VAL . 0.7 OUTLIER -134.89 122.16 21.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.459 -1.401 . . . . 0.0 110.43 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' CD1' ' CE2' ' A' ' 59' ' ' PHE . 9.4 t80 -78.14 135.75 37.72 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.5 m -116.35 148.07 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.995 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 HG21 ' CZ ' ' A' ' 17' ' ' TYR . 28.3 p -131.54 178.34 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.377 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 57.17 91.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.432 HD12 HG22 ' A' ' 45' ' ' ILE . 23.2 mt -108.99 175.32 2.0 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 109.121 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -114.22 6.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.743 1.391 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 163.4 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -162.36 -44.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.444 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 24' ' ' THR . 1.1 mt 47.99 -174.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 108.913 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.28 143.83 30.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.976 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 1.5 m-20 -57.79 -62.02 2.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.349 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -51.06 -18.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 22.2 mt-30 -75.08 -61.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.368 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 1.3 tp -44.5 -25.2 0.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.077 -1.014 . . . . 0.0 109.719 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 1.2 m-20 -64.52 -54.49 31.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.982 -1.074 . . . . 0.0 108.878 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -62.38 -35.94 80.74 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.399 -0.813 . . . . 0.0 109.087 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 34' ' ' PHE . 4.5 tt -61.3 -27.69 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 108.67 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.581 ' CD1' HG21 ' A' ' 33' ' ' ILE . 12.3 m-85 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 36' ' ' LYS . . . 155.54 -91.69 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 169.3 50.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.812 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -93.76 -86.51 0.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.152 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.517 ' CA ' ' HG3' ' A' ' 67' ' ' GLU . . . -74.09 157.33 51.14 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 40' ' ' ILE . 28.1 t -79.35 79.57 5.78 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.115 -1.227 . . . . 0.0 107.904 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -34.83 115.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.662 0.744 . . . . 0.0 109.574 -178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.585 ' CG2' ' HB3' ' A' ' 61' ' ' ARG . 6.2 m -81.53 38.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 110.122 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 2.9 tt0 91.65 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.602 0.715 . . . . 0.0 111.035 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -99.95 151.45 21.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -145.65 175.68 10.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.59 -1.319 . . . . 0.0 110.992 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 58' ' ' ALA . 49.9 mt -143.19 134.43 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.1 151.43 31.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.978 -1.076 . . . . 0.0 109.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.165 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' CG1' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -126.33 140.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . . . -113.79 -174.34 2.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.483 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 m-85 -143.57 99.14 3.37 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' CD2' ' A' ' 16' ' ' LEU . 15.6 t -85.85 148.66 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 9.5 mtt180 -137.33 79.25 1.74 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.415 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 11.1 m-85 -78.86 160.04 27.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.553 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -103.45 -91.95 0.35 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.111 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -25.54 136.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.515 ' HD3' ' N ' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -50.93 -51.25 54.04 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 70' ' ' GLU . 16.5 mt-10 -63.43 -35.33 80.07 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -61.34 -28.12 68.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.534 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -75.82 -43.93 43.58 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -60.56 -20.77 61.4 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -70.75 -61.51 1.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.624 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . . . -68.44 -5.13 17.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.561 0.696 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.552 ' HA ' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -86.43 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.723 -1.236 . . . . 0.0 108.21 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -75.29 -1.64 24.5 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.818 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 70' ' ' GLU . . . -125.84 -47.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 110.357 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.58 HD22 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -84.09 -21.14 31.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 110.556 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.522 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 23.6 p-10 -46.95 -23.83 0.51 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.55 -1.344 . . . . 0.0 109.128 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 85' ' ' GLN . 3.4 m-80 -143.59 86.63 1.89 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.54 ' N ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -78.46 88.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 108.838 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.54 HG22 ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -147.55 -172.61 0.32 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.48 -0.762 . . . . 0.0 109.085 -179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -102.7 24.06 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.899 1.473 . . . . 0.0 109.424 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER 73.24 114.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 0.0 109.693 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.83 -18.65 1.11 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 137.44 -148.76 20.0 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.54 ' HB3' HG22 ' A' ' 79' ' ' ILE . 6.2 t 83.83 -28.11 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.799 -0.824 . . . . 0.0 109.837 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.493 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER 38.41 92.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.245 -0.909 . . . . 0.0 110.755 179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.54 ' HG2' ' N ' ' A' ' 78' ' ' VAL . 36.2 Cg_endo -121.24 -178.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.925 1.487 . . . . 0.0 110.049 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 77.3 mt 25.07 68.02 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 7.4 m -77.25 102.12 6.54 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.592 ' CG1' ' CD1' ' A' ' 16' ' ' LEU . 14.7 m -77.85 163.87 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.313 1.054 . . . . 0.0 113.153 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 91' ' ' LEU . 2.1 ttt180 171.2 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER -33.64 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.622 -0.674 . . . . 0.0 109.386 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.79 179.48 6.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.86 -1.15 . . . . 0.0 110.279 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.35 105.22 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.443 -0.785 . . . . 0.0 109.176 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.31 -163.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -108.38 30.62 6.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.431 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.01 -33.66 0.05 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.213 -1.169 . . . . 0.0 109.61 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' O ' HD12 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -145.59 -88.17 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.48 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.514 ' N ' ' HA ' ' A' ' 63' ' ' ASN . 3.2 m -79.22 71.62 5.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 110.03 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -76.89 -177.27 4.29 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.589 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER -112.28 103.79 11.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.702 -1.249 . . . . 0.0 111.407 -178.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' CZ ' ' A' ' 59' ' ' PHE . 2.8 t80 -83.11 81.92 8.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.5 m -82.47 129.68 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 111.261 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 19.6 m -131.76 172.18 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 19' ' ' THR . 20.3 t-20 79.27 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.969 . . . . 0.0 110.121 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -170.1 144.98 2.28 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.018 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -106.85 69.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.626 1.329 . . . . 0.0 111.003 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 4.2 mtm180 40.1 36.38 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 85' ' ' GLN . 89.2 m -79.82 -5.24 55.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 0.0 109.23 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -152.32 150.27 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.174 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -91.55 155.41 18.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 5.4 p-10 -62.31 -49.63 74.86 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.166 -0.959 . . . . 0.0 108.488 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 6.6 t0 -50.79 -22.5 2.18 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -77.37 -41.48 40.04 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.831 . . . . 0.0 109.777 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.58 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 6.9 mp -47.3 -44.35 23.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.006 . . . . 0.0 109.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 6.9 t70 -58.03 -41.32 82.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.818 -1.176 . . . . 0.0 108.991 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -36.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.491 -0.755 . . . . 0.0 110.476 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.585 HG21 ' CD1' ' A' ' 34' ' ' PHE . 1.2 tt -67.21 -33.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.784 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.68 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . 1.8 m-85 -84.37 -72.03 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 109.075 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 36' ' ' LYS . . . 104.09 -40.74 2.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CD ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -175.22 98.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.261 . . . . 0.0 109.437 -179.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.703 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -136.67 -21.7 1.28 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -175.5 46.0 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 40' ' ' ILE . 1.4 t -88.91 71.99 8.52 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.372 -1.075 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.635 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -37.71 134.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.636 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 3.9 m -102.21 48.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 111.788 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.716 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 1.1 tm0? 89.28 131.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.592 0.71 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 mtmp? -100.66 169.66 8.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -160.56 163.9 32.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.916 -1.115 . . . . 0.0 110.341 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 27' ' ' ASP . 1.8 mt -141.11 107.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 2.0 mm? -93.91 130.9 39.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.335 -0.853 . . . . 0.0 109.145 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.898 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 19' ' ' THR . 10.7 m -145.89 139.88 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -1.084 . . . . 0.0 109.075 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.493 ' O ' HG21 ' A' ' 18' ' ' VAL . . . -124.55 177.11 6.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 47.8 m-85 -142.84 107.97 4.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.554 ' CG1' ' CD2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -78.8 177.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.14 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.716 ' HB3' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -107.03 123.76 48.66 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.3 -177.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -163.93 158.34 19.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.92 -1.113 . . . . 0.0 109.77 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.551 ' OD1' ' CG1' ' A' ' 41' ' ' VAL . 5.2 p-10 -148.32 -64.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 0.0 110.962 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -49.55 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 108.977 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.493 ' HG2' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -30.36 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.748 -0.595 . . . . 0.0 111.379 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 64' ' ' LYS . 56.9 mt-10 -66.71 -64.61 0.82 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.894 -1.129 . . . . 0.0 109.426 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . 26.3 pt-20 -56.02 -24.13 37.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.903 -1.123 . . . . 0.0 108.711 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -65.03 -44.63 88.5 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 52.8 tt0 -48.19 -33.69 8.89 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -60.13 -53.0 62.92 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -60.97 -11.91 9.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.072 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 33.0 mm -80.17 -59.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.12 4.3 8.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.565 -0.709 . . . . 0.0 110.172 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.42 -54.31 1.02 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.101 . . . . 0.0 109.862 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -79.4 -11.27 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.322 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.587 ' HB2' HG23 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -82.86 42.42 0.79 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.405 -1.435 . . . . 0.0 109.145 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 2.0 p30 156.27 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.519 ' O ' ' CG1' ' A' ' 78' ' ' VAL . 2.1 t -79.97 87.62 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 172.58 135.74 0.1 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.473 -0.767 . . . . 0.0 109.181 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 36.6 Cg_endo -43.73 117.31 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.979 1.515 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -45.37 147.12 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 120.95 -59.64 0.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -60.81 -127.68 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -179.89 35.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 109.554 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.531 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 13.2 mt-30 -129.44 71.3 82.08 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.391 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.6 Cg_endo -100.69 -171.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.896 1.472 . . . . 0.0 110.954 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -116.47 113.62 23.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.1 t -78.53 102.65 8.0 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' CD1' ' A' ' 16' ' ' LEU . 17.0 m -78.5 153.89 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.008 0.909 . . . . 0.0 111.576 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 4.3 ttm-85 173.99 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 13' ' ' ASP . 7.4 tp -52.42 136.82 30.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.938 -1.101 . . . . 0.0 108.978 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 17' ' ' TYR . . . -133.79 145.42 49.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.31 141.47 35.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -179.81 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -159.65 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.55 -117.25 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.218 -1.166 . . . . 0.0 109.621 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.593 0.235 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.6 ' HB2' ' N ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -160.95 -99.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.474 -1.391 . . . . 0.0 111.584 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.568 ' CG2' ' HG3' ' A' ' 65' ' ' ARG . 7.7 p -107.75 -133.73 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.35 -1.469 . . . . 0.0 109.867 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.54 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -164.56 -167.6 1.31 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.243 -0.911 . . . . 0.0 108.932 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.605 ' CD2' ' CB ' ' A' ' 71' ' ' ALA . 2.8 tp -154.62 121.54 5.54 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.676 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 11.4 t80 -110.17 117.26 33.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.808 -1.182 . . . . 0.0 109.726 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.567 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 18.8 m -112.36 131.77 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 110.006 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 11.1 t -127.04 -166.53 1.61 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 108.896 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER 81.78 -65.24 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.317 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -38.3 126.45 1.08 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.954 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -106.37 64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.971 1.511 . . . . 0.0 110.639 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 65.08 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.906 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.456 ' OG1' ' OE1' ' A' ' 85' ' ' GLN . 19.7 m -124.0 -24.93 4.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 109.964 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pt -111.35 179.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -114.35 153.04 30.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.798 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 1.9 m-20 -63.35 -60.13 3.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 108.911 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -43.23 -26.39 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.305 -0.872 . . . . 0.0 109.382 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -72.23 -63.44 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.533 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -45.96 -24.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.124 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.531 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 1.6 t70 -64.86 -59.12 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.022 . . . . 0.0 109.118 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.8 m -64.28 -12.39 41.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.436 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG22 ' CG2' ' A' ' 78' ' ' VAL . 12.8 mm -77.72 -45.78 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.977 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.8 p90 -142.35 49.6 1.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.49 36.73 4.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -100.28 -44.97 5.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.618 ' CD1' ' OH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -79.42 -97.73 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.72 131.76 10.61 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 40' ' ' ILE . 53.4 p -79.03 75.26 5.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.915 -1.344 . . . . 0.0 108.48 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER 23.59 108.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.883 1.325 . . . . 0.0 110.319 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 61' ' ' ARG . 3.1 t -75.61 -4.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.968 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 170.11 99.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.544 -0.722 . . . . 0.0 110.033 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HD3' ' CB ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -87.16 87.09 7.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.965 . . . . 0.0 108.621 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.76 147.39 25.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 HG23 ' OD1' ' A' ' 27' ' ' ASP . 19.5 tt -161.5 140.1 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.042 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.46 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 3.3 pp -161.59 155.07 21.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.08 . . . . 0.0 110.141 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.389 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.539 ' CG1' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -160.95 166.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.125 . . . . 0.0 109.999 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 18' ' ' VAL . . . -129.53 150.26 50.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 93.5 m-85 -126.46 101.67 6.79 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.935 -1.103 . . . . 0.0 110.616 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -81.8 107.11 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 176.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.602 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -76.97 87.25 3.5 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 120.138 -1.601 . . . . 0.0 108.618 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.618 ' OH ' ' CD1' ' A' ' 37' ' ' TYR . 2.1 t80 -94.7 114.26 26.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' O ' ' A' ' 64' ' ' LYS . 9.1 m120 -71.32 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.817 -1.553 . . . . 0.0 111.148 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.63 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 7.32 127.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.568 ' HG3' ' CG2' ' A' ' 14' ' ' THR . 0.1 OUTLIER -62.23 -61.67 2.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.051 178.361 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -53.04 62.79 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 109.618 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.601 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 81.8 mt-10 -67.01 -10.9 54.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.555 ' CB ' ' OG1' ' A' ' 14' ' ' THR . . . -75.19 -37.89 61.03 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.562 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -69.71 -20.75 63.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 2.8 mt-10 -62.65 -75.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 62' ' ' TYR . . . -50.11 -23.08 1.92 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 69' ' ' GLN . 2.6 mm -58.36 -51.64 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.688 -1.257 . . . . 0.0 107.795 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -86.47 -59.46 2.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.083 . . . . 0.0 110.231 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.52 -44.0 62.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 110.446 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 34' ' ' PHE . 5.5 tp -79.25 -38.8 34.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.062 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.4 t-20 -40.96 116.71 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.506 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 67.29 78.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.537 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 7.4 p -86.18 52.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.078 -1.014 . . . . 0.0 109.773 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 84' ' ' SER . 0.3 OUTLIER -176.35 170.23 1.19 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.385 -0.822 . . . . 0.0 108.908 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -87.96 39.11 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.758 1.399 . . . . 0.0 109.677 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 46.88 68.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 108.771 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.8 1.97 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 85' ' ' GLN . . . 127.61 -50.96 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 120.885 -1.362 . . . . 0.0 110.332 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.541 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 73.1 m -50.93 -18.9 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 110.316 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 84' ' ' SER . 7.0 mp0 64.53 140.8 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.455 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.0 Cg_endo -84.25 -179.86 4.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.153 1.607 . . . . 0.0 111.455 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.567 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -122.06 123.87 42.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 109.098 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 0.2 OUTLIER -78.5 97.04 5.57 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' A' ' 16' ' ' LEU . 14.5 m -78.27 163.63 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 122.301 1.048 . . . . 0.0 112.049 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.533 ' CG ' ' HB3' ' A' ' 17' ' ' TYR . 5.5 ptp180 173.42 -133.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -146.73 119.46 8.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.679 -1.263 . . . . 0.0 108.217 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.498 ' HB1' ' CG ' ' A' ' 17' ' ' TYR . . . -145.68 -174.07 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.787 -1.196 . . . . 0.0 109.76 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -172.29 88.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.861 . . . . 0.0 109.185 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -46.42 -31.0 2.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -168.82 -152.63 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.49 95.27 1.57 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.416 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -155.95 87.16 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.363 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -161.44 34.26 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.549 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 39.0 p-10 -76.93 -171.78 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.623 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -156.18 119.69 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -81.58 134.07 35.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.568 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -106.23 150.38 8.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.523 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.492 HG21 ' CB ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -115.42 168.94 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.439 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' PRO . 86.1 m-20 61.26 72.95 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.19 115.27 10.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 109.408 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.76 -171.27 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.044 1.549 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -114.0 17.38 17.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -79.76 -56.84 3.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.191 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.567 ' CG1' ' N ' ' A' ' 26' ' ' THR . 2.0 tt -82.41 167.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.12 146.12 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 2.9 p30 -59.45 -44.31 92.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 6.9 t0 -58.46 -24.92 61.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 30' ' ' LEU . 7.8 mt-30 -73.76 -40.5 63.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 5.5 mp -42.77 -54.19 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.407 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -41.48 -49.22 3.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.875 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -61.26 -43.63 98.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.012 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.71 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 tp -57.04 -24.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.891 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.71 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 3.2 m-85 -97.69 -73.09 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.812 -1.18 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.54 -80.82 0.24 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.98 105.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.151 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -94.85 -83.4 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 108.976 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . -98.87 -93.18 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.571 ' O ' ' C ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -150.47 67.63 0.96 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.641 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -23.75 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.718 0.77 . . . . 0.0 109.715 -178.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.598 ' N ' ' CB ' ' A' ' 61' ' ' ARG . 5.3 m -90.04 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.624 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 82.6 120.29 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.415 -0.803 . . . . 0.0 112.191 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.587 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -124.02 132.59 53.71 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.77 146.0 30.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.638 -1.289 . . . . 0.0 110.503 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' O ' HG21 ' A' ' 45' ' ' ILE . 1.7 tt -92.02 124.07 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.584 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 1.7 mm? -106.96 138.53 42.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.102 -0.999 . . . . 0.0 110.215 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.756 . . . . 0.0 109.029 179.653 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 46' ' ' LEU . 2.1 m -96.89 171.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -1.192 . . . . 0.0 109.623 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.428 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -147.68 -179.13 6.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.291 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 m-85 -152.15 115.64 4.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.669 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.612 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.07 153.84 4.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.54 -1.35 . . . . 0.0 107.684 178.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.641 ' CD ' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -95.18 132.53 40.03 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.084 0.945 . . . . 0.0 111.299 -178.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -163.26 147.01 10.73 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' C ' ' A' ' 64' ' ' LYS . 13.0 p30 -137.88 -118.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.785 -1.197 . . . . 0.0 107.879 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.63 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 10.43 103.27 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 CA-C-N 118.626 0.648 . . . . 0.0 110.855 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.05 -59.25 0.14 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.611 -0.681 . . . . 0.0 111.069 -178.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.9 -50.6 65.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.685 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 85.3 mt-10 -49.65 -48.9 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 110.34 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.39 -46.75 47.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.333 -1.479 . . . . 0.0 108.038 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 5.4 tt0 -52.92 -42.38 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 7.5 mm-40 -50.04 -66.6 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 0.0 108.585 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.635 ' CB ' ' CE1' ' A' ' 62' ' ' TYR . . . -51.01 -29.62 13.0 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.895 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 24.6 mm -60.03 -49.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.465 -1.397 . . . . 0.0 108.407 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.4 m -84.35 -65.49 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 110.117 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.01 76.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.464 -0.773 . . . . 0.0 111.303 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.69 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -79.45 -38.96 33.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.62 -1.3 . . . . 0.0 110.597 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 23.8 t-20 -52.6 131.77 34.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.264 -1.522 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.595 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 8.7 m120 64.56 69.84 0.5 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 3.3 p -86.22 61.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.498 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.73 162.39 18.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.8 Cg_endo -87.14 41.21 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.656 1.345 . . . . 0.0 109.986 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' PRO . 9.0 mt-10 59.94 147.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.91 -76.37 0.41 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.67 -25.32 60.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.43 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER 58.27 28.75 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.115 . . . . 0.0 109.942 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.557 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 2.0 mt-30 -127.57 75.39 77.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.025 -1.047 . . . . 0.0 109.581 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.595 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -109.28 -161.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.879 1.463 . . . . 0.0 110.773 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -103.15 123.06 45.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 110.356 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -78.47 111.26 14.31 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 76' ' ' ASN . 2.9 m -78.19 155.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.428 1.109 . . . . 0.0 112.395 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.558 ' HD2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 167.53 126.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 15.0 mt -41.76 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.01 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.51 167.81 16.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.07 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.45 4.55 10.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.222 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -125.22 112.54 16.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.03 -1.044 . . . . 0.0 109.599 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.96 178.51 34.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 17.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 109.43 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.482 ' HA ' ' CA ' ' A' ' 97' ' ' LYS . 9.6 pttt . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.523 ' HB2' ' CA ' ' A' ' 63' ' ' ASN . 18.9 m-20 -111.27 -92.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 0.0 110.747 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.448 HG22 ' CB ' ' A' ' 68' ' ' ALA . 10.0 t -82.04 64.42 6.71 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.332 -0.855 . . . . 0.0 110.402 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.532 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 2.2 p-10 -76.76 160.63 29.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -137.57 125.8 23.13 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 117.621 -1.632 . . . . 0.0 111.636 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -85.12 114.82 22.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.606 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 32.5 m -88.89 139.32 17.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.99 -179.48 3.71 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.332 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER 57.58 86.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 109.269 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.456 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -163.18 132.75 3.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.546 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD3' ' OE1' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -108.66 52.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.965 1.508 . . . . 0.0 110.194 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' PRO . 77.3 mtt180 41.7 53.08 4.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -96.0 -21.5 17.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.459 ' CD1' HD12 ' A' ' 45' ' ' ILE . 1.3 pp -121.81 160.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.389 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -96.66 157.12 16.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.162 -0.961 . . . . 0.0 109.992 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -59.89 -53.67 55.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -3.0 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.896 -1.127 . . . . 0.0 109.625 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.473 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.0 OUTLIER -83.1 -63.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 110.722 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.555 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 3.2 mp -44.3 -37.22 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.52 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 30.5 t0 -49.7 -55.82 12.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.662 -1.274 . . . . 0.0 109.228 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.6 m -65.18 -21.44 66.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -83.01 -15.12 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.718 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.663 ' CD2' ' O ' ' A' ' 34' ' ' PHE . 10.5 p90 -153.4 33.86 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' ' CD1' ' A' ' 40' ' ' ILE . . . -97.57 61.56 1.01 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.134 -1.604 . . . . 0.0 109.697 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -138.54 -10.55 1.4 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.058 -1.26 . . . . 0.0 111.183 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CD2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -85.7 -50.14 7.41 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.684 -1.26 . . . . 0.0 109.875 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.49 -160.2 8.63 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' C ' ' A' ' 40' ' ' ILE . 14.5 m -95.35 72.77 3.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.275 -1.132 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.566 ' HB ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -25.65 131.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-O 121.153 0.502 . . . . 0.0 110.046 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.726 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 3.2 m -98.76 56.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 12.2 tt0 94.26 100.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.581 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -83.05 165.79 19.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.98 158.1 32.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.838 -1.164 . . . . 0.0 109.892 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -158.41 117.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.343 -0.848 . . . . 0.0 109.316 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.21 158.98 43.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.766 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 -179.723 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.71 163.61 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.145 . . . . 0.0 109.431 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -134.26 -174.1 3.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 108.941 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -149.17 104.48 3.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.55 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 t -79.54 152.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.041 -1.037 . . . . 0.0 108.461 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.726 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.27 128.4 46.35 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.402 0.62 . . . . 0.0 111.022 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -164.4 146.05 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.184 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.523 ' CA ' ' HB2' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -133.26 -48.56 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' O ' ' C ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -58.72 106.14 0.37 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.7 mpp_? -34.83 -55.63 0.57 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.178 0.513 . . . . 0.0 110.265 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -47.95 79.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 62' ' ' TYR . 39.7 tt0 -52.26 -29.4 22.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -68.79 -48.54 63.37 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.978 -1.076 . . . . 0.0 108.45 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -47.41 -32.33 4.89 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 20.4 mm-40 -67.38 -49.32 64.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.731 -0.606 . . . . 0.0 109.484 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.623 ' CB ' ' CE2' ' A' ' 62' ' ' TYR . . . -65.73 -13.54 59.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 19.3 mm -81.51 -69.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.012 -1.055 . . . . 0.0 108.596 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -77.48 8.6 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.635 -0.666 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 70' ' ' GLU . . . -130.02 -50.53 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.609 HD12 ' CD2' ' A' ' 34' ' ' PHE . 5.4 mp -78.91 -32.31 45.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.014 -1.054 . . . . 0.0 108.515 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 40.7 t-20 -55.18 125.06 19.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 4.4 m120 65.97 72.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 7.7 p -86.81 48.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.532 HG21 ' HD2' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -154.96 134.16 7.58 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HD2' HG21 ' A' ' 79' ' ' ILE . 34.7 Cg_endo -46.5 138.16 14.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.774 1.408 . . . . 0.0 109.758 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 80' ' ' PRO . 2.5 mm-40 -42.23 145.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.059 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.02 -29.49 2.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 140.31 -127.59 3.55 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 79' ' ' ILE . 1.2 m 70.7 3.46 4.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.323 -1.104 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' OE1' ' HD3' ' A' ' 22' ' ' PRO . 4.7 mt-30 64.94 122.73 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.055 -1.028 . . . . 0.0 109.203 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.536 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -108.12 152.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 110.803 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -70.17 119.62 14.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.578 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -78.59 98.45 6.16 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 33.8 m -78.83 153.47 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.02 0.915 . . . . 0.0 111.671 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 154.32 141.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -59.78 134.68 57.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.53 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 93' ' ' GLU . . . -94.1 -31.48 14.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 109.597 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 0.8 OUTLIER 76.23 63.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.187 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.0 -34.8 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.594 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -148.83 -92.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 15' ' ' ASN . . . -176.61 -44.89 0.06 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.482 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.236 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 120.954 0.407 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB3' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -131.21 -67.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.943 -1.098 . . . . 0.0 111.596 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.546 ' CA ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -161.53 102.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 46.8 p30 -98.38 -163.89 1.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.463 -0.773 . . . . 0.0 109.078 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.658 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -160.34 119.2 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.599 -1.24 . . . . 0.0 112.151 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -79.41 131.47 36.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 3.8 m -124.16 149.57 28.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.513 -1.367 . . . . 0.0 111.465 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -135.97 -153.32 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.525 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 34.77 16.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.995 . . . . 0.0 110.287 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 21' ' ' LEU . 2.9 pp -170.49 128.72 0.78 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -102.81 67.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.979 1.515 . . . . 0.0 109.934 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HG2' HD11 ' A' ' 45' ' ' ILE . 26.6 mtp180 62.11 54.64 2.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.5 p -79.8 -1.09 37.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -151.4 -160.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.6 p -122.12 151.53 40.84 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 92.6 m-20 -49.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.339 -0.851 . . . . 0.0 109.322 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.0 p30 -42.34 -26.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.095 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 26' ' ' THR . 1.7 tt0 -63.53 -57.74 9.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 110.143 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.582 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 3.0 mp -45.33 -44.44 11.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.867 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 21.2 t0 -59.5 -40.68 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 110.054 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 m -77.85 -10.94 59.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.0 -45.95 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 0.0 109.904 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 39.5 p90 -103.4 -45.89 4.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 109.449 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 34' ' ' PHE . . . 15.21 60.11 0.01 OUTLIER Glycine 0 N--CA 1.505 3.254 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' PHE . 12.4 tttt -133.36 -28.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.256 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -111.68 -100.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 110.31 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.24 152.48 36.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 40' ' ' ILE . 20.6 t -87.05 45.24 1.25 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.122 -1.223 . . . . 0.0 108.258 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 39.95 110.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.217 1.008 . . . . 0.0 110.598 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG21 ' CB ' ' A' ' 61' ' ' ARG . 4.8 m -77.64 7.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.296 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER 162.46 72.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.068 -1.02 . . . . 0.0 110.29 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 1.8 ptpp? -82.76 117.72 22.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.406 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 20.0 p30 -154.73 169.6 23.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.198 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.448 HG13 ' OD1' ' A' ' 27' ' ' ASP . 13.7 mt -114.39 171.01 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.484 -0.76 . . . . 0.0 109.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.2 mt -128.8 113.41 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 110.012 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . 23.0 ptt180 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 1.6 p -142.4 138.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.578 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' CB ' HG22 ' A' ' 18' ' ' VAL . . . -89.5 175.34 7.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -157.85 104.76 1.95 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.194 -0.941 . . . . 0.0 110.365 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.624 ' CG1' ' CE2' ' A' ' 62' ' ' TYR . 3.2 t -90.5 159.67 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.586 ' CB ' HG21 ' A' ' 41' ' ' VAL . 38.2 mmm-85 -139.51 147.3 41.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.586 -1.321 . . . . 0.0 110.169 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CE2' ' CG1' ' A' ' 60' ' ' VAL . 52.3 m-85 -159.42 149.43 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' ND2' HG13 ' A' ' 41' ' ' VAL . 3.8 p30 -119.79 71.82 0.9 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.292 -1.363 . . . . 0.0 109.875 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -171.19 96.86 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -33.4 -51.93 0.37 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.264 0.554 . . . . 0.0 110.359 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.24 -50.05 74.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 108.466 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HG2' ' CD2' ' A' ' 37' ' ' TYR . 15.2 tm-20 -52.37 -48.88 65.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.48 -0.762 . . . . 0.0 110.354 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' A' ' 14' ' ' THR . . . -46.72 -45.2 19.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.647 -1.283 . . . . 0.0 107.981 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.6 -45.78 73.68 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -52.41 -65.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 109.248 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.562 ' HB1' ' CE2' ' A' ' 62' ' ' TYR . . . -53.01 -15.65 0.85 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.838 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 68' ' ' ALA . 1.1 mm -85.21 -70.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.676 -1.265 . . . . 0.0 108.881 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 t -58.88 -9.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.737 -1.227 . . . . 0.0 110.582 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.14 -53.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.664 -1.273 . . . . 0.0 111.087 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 60' ' ' VAL . 7.1 tp -81.72 5.89 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.971 -1.081 . . . . 0.0 110.837 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -87.3 22.42 2.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.724 -1.235 . . . . 0.0 108.556 178.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 38.5 p-10 177.86 73.83 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ILE . 11.5 p -80.9 68.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.312 -0.867 . . . . 0.0 108.953 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.549 ' CG2' ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER 163.87 118.74 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -39.29 128.97 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.956 1.503 . . . . 0.0 110.835 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.75 163.98 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.97 -53.68 0.67 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.75 35.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.549 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 7.5 t -110.38 -14.19 14.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -1.218 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' SER . 46.7 mt-30 61.93 117.75 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 37.4 Cg_endo -123.61 -160.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 124.075 1.566 . . . . 0.0 109.354 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.587 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.9 115.76 27.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.958 -1.089 . . . . 0.0 110.926 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 5.8 m -79.23 113.63 17.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 16' ' ' LEU . 13.1 t -83.27 162.21 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.318 1.056 . . . . 0.0 113.17 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.519 ' N ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER 161.57 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.546 HD12 ' CA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -44.04 157.53 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.29 170.8 2.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.48 -0.763 . . . . 0.0 109.906 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 43.2 mm-40 -141.01 125.7 17.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.431 -0.793 . . . . 0.0 109.217 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 70.48 6.51 5.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 109.342 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -141.21 -170.09 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.61 134.37 3.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 61' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.163 . . . . 0.0 109.494 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.587 ' CB ' ' HB2' ' A' ' 63' ' ' ASN . 6.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.16 82.81 0.71 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 111.052 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.479 ' C ' ' O ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -161.35 52.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 0.0 109.142 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -79.16 -169.4 1.83 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.257 -0.902 . . . . 0.0 109.919 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.652 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -153.01 127.0 8.99 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.034 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' CE1' HG23 ' A' ' 19' ' ' THR . 0.1 OUTLIER -77.6 125.56 29.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.575 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 29.0 m -118.24 124.01 72.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.415 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -123.65 178.11 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER 87.79 15.19 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 111.337 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.661 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -154.59 43.17 0.21 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.343 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 21' ' ' LEU . 37.7 Cg_endo -76.14 142.82 24.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.593 1.312 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 61.05 9.76 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 110.691 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' ' 25' ' ' ILE . 43.2 p -99.84 -38.77 8.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.96 -1.088 . . . . 0.0 108.917 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.438 HG13 ' OG1' ' A' ' 24' ' ' THR . 1.3 pp -136.79 166.99 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 108.876 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -103.25 144.67 31.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.092 -1.005 . . . . 0.0 109.789 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -53.9 -66.2 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -44.91 -25.19 0.28 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.004 -1.06 . . . . 0.0 109.484 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 47.6 tt0 -64.75 -62.21 1.71 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 109.636 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 6.1 mp -43.96 -26.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.234 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' OD2' ' NH2' ' A' ' 61' ' ' ARG . 13.0 t70 -57.99 -54.11 50.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.9 m -62.76 -44.46 96.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.53 -17.2 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 108.509 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.674 ' CZ ' ' CD2' ' A' ' 75' ' ' LEU . 20.4 m-30 -100.5 -91.0 0.31 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 36.6 77.42 0.05 OUTLIER Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -173.7 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.296 . . . . 0.0 110.681 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.637 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.16 -80.68 0.31 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.827 -1.171 . . . . 0.0 109.763 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.47 -165.45 11.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -94.32 26.92 3.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.3 -1.118 . . . . 0.0 108.191 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.579 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 41.83 -173.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.629 0.728 . . . . 0.0 109.811 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 ' N ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -118.48 -61.78 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.099 -1.001 . . . . 0.0 111.114 -177.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.713 ' CA ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 tm0? -176.59 107.19 0.07 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.898 -0.501 . . . . 0.0 109.675 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -97.74 132.47 43.34 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.879 -1.138 . . . . 0.0 107.96 179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -141.58 159.17 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.633 -1.292 . . . . 0.0 110.356 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.473 HG23 HD11 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -123.31 137.18 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -120.26 123.67 43.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.658 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.444 -0.785 . . . . 0.0 109.085 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.432 ' O ' ' CG1' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -163.12 157.42 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.484 -1.01 . . . . 0.0 109.77 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.55 ' CB ' HD22 ' A' ' 21' ' ' LEU . . . -110.32 174.01 6.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 -143.47 104.21 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.784 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.559 HG11 ' CD2' ' A' ' 16' ' ' LEU . 1.1 t -82.47 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HD3' ' CA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -119.23 135.37 54.72 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.477 -177.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.1 m-85 -155.3 137.98 15.18 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.587 ' HB2' ' CB ' ' A' ' 12' ' ' LYS . 7.5 p30 -118.78 -50.28 2.41 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.468 -1.395 . . . . 0.0 110.194 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -53.88 137.08 39.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -63.12 -43.07 99.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 0.0 109.043 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.18 -43.19 67.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 108.772 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.602 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -61.76 -25.61 67.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' GLN . . . -72.89 -48.19 39.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.736 -1.227 . . . . 0.0 107.854 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 8.3 tp-100 -49.43 -32.97 12.88 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -58.89 -67.89 0.32 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 62' ' ' TYR . . . -45.8 -22.05 0.16 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.212 0.529 . . . . 0.0 109.641 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 15.6 mm -74.35 -70.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.406 -1.434 . . . . 0.0 108.657 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.11 22.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.53 -0.731 . . . . 0.0 110.334 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 70' ' ' GLU . . . -138.66 -50.57 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.674 ' CD2' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -79.44 -42.09 26.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 8.0 t-20 -39.2 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.347 -0.845 . . . . 0.0 109.139 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 2.1 m-20 80.9 80.04 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 2.8 p -85.28 53.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.791 . . . . 0.0 108.951 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 ' HB ' ' HD2' ' A' ' 80' ' ' PRO . 4.6 pt -117.22 173.93 2.83 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.213 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -90.62 20.35 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.97 1.51 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 69.54 70.53 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.38 -31.41 0.23 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.59 -140.18 0.82 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.47 38.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 109.375 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.499 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 29.7 mm-40 -130.55 82.86 63.87 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.52 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.8 Cg_endo -108.89 164.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.061 1.559 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.575 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -112.33 124.4 52.39 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.189 -0.945 . . . . 0.0 110.321 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 12.9 m -79.13 105.68 10.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 22.7 m -77.26 -167.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.986 -0.446 . . . . 0.0 111.611 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 104.27 108.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 15' ' ' ASN . 9.5 tp -36.64 145.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.523 0.677 . . . . 0.0 110.257 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -77.1 -67.68 0.69 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 0.0 109.402 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 43.5 mm-40 -116.8 -170.58 1.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.457 -0.777 . . . . 0.0 109.294 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.4 9.37 29.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 109.9 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 96' ' ' GLY . 18.9 p80 -97.6 -30.52 12.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 95' ' ' HIS . . . 49.08 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.474 179.977 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' CB ' ' C ' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -79.2 -2.21 39.91 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.984 -1.072 . . . . 0.0 110.538 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.603 ' CG2' ' CB ' ' A' ' 68' ' ' ALA . 15.7 m -162.52 93.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.891 -1.131 . . . . 0.0 110.405 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 13.9 t-20 -84.68 106.02 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.986 -1.071 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -79.13 103.57 9.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.926 -1.109 . . . . 0.0 109.149 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.85 86.86 5.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.558 HG21 ' CB ' ' A' ' 58' ' ' ALA . 2.6 m -89.52 97.43 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.306 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.512 ' CA ' HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -92.01 -165.53 1.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.575 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 53.39 84.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.107 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' CB ' HD12 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.51 132.95 9.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.5 Cg_endo -104.0 39.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.891 1.469 . . . . 0.0 109.897 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 15.2 mtt85 36.52 61.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.294 0.568 . . . . 0.0 110.338 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.519 ' CG2' HG13 ' A' ' 25' ' ' ILE . 7.4 t -97.48 -16.19 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.248 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CG2' ' A' ' 24' ' ' THR . 0.2 OUTLIER -127.2 179.25 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.3 p -105.63 158.45 16.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.202 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 43' ' ' LYS . 9.7 t0 -55.75 -62.45 1.68 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.643 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.79 -15.59 4.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -75.27 -51.76 12.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.829 -1.17 . . . . 0.0 110.354 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 4.6 mp -46.56 -32.16 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.82 -1.175 . . . . 0.0 108.476 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 4.2 t70 -48.66 -52.85 21.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 108.652 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 m -63.22 -41.51 99.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.466 -0.771 . . . . 0.0 109.042 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -64.54 -13.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 108.864 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD1' ' CD2' ' A' ' 75' ' ' LEU . 7.4 m-30 -83.91 -74.26 0.38 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 36' ' ' LYS . . . 144.3 -90.88 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 162.99 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.711 -0.876 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -79.81 -81.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.96 166.6 14.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 40' ' ' ILE . 15.5 m -78.58 94.47 5.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.834 -1.391 . . . . 0.0 108.293 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' C ' ' O ' ' A' ' 39' ' ' SER . 3.2 mp -34.67 117.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.549 ' CG2' ' HD2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -80.1 18.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 111.009 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB2' ' CB ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 163.65 138.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 177.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -145.96 76.7 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -94.85 174.1 7.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 tt -126.58 104.15 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 110.347 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.762 ' HA ' ' N ' ' A' ' 57' ' ' VAL . 8.4 mp 52.85 -141.62 0.84 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.516 -0.74 . . . . 0.0 110.011 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' N ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.888 0 O-C-N 120.966 -1.084 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' O ' ' CG2' ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.762 ' N ' ' HA ' ' A' ' 46' ' ' LEU . 44.6 t -159.02 153.16 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.114 -1.227 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.558 ' CB ' HG21 ' A' ' 18' ' ' VAL . . . -75.97 127.0 32.06 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.607 ' CE1' ' O ' ' A' ' 57' ' ' VAL . 91.6 m-85 -103.35 83.17 2.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 112.091 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG11 ' CD1' ' A' ' 62' ' ' TYR . 3.3 t -86.53 77.55 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.549 ' HD2' ' CG2' ' A' ' 41' ' ' VAL . 1.7 ttm180 -76.82 113.21 14.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.594 -1.316 . . . . 0.0 110.695 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.595 ' CD1' HG11 ' A' ' 60' ' ' VAL . 3.6 m-85 -114.36 -173.87 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -131.29 -100.78 0.29 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.097 -1.441 . . . . 0.0 110.337 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 63' ' ' ASN . 26.1 tttp -24.4 136.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.618 0.723 . . . . 0.0 111.795 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH2' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -55.95 -52.37 64.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -52.4 -39.65 61.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -49.49 -47.0 48.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.603 ' CB ' ' CG2' ' A' ' 14' ' ' THR . . . -57.72 -39.32 76.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.389 -0.819 . . . . 0.0 108.813 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -51.1 -37.08 43.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 108.205 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.59 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.4 mt-10 -74.8 -62.45 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.852 0.834 . . . . 0.0 109.751 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.591 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -52.76 -16.14 0.91 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.469 0.652 . . . . 0.0 110.931 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 5.0 mt -92.37 -60.33 2.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.418 -1.426 . . . . 0.0 109.465 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -66.69 -5.31 11.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 0.0 109.959 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.7 -53.94 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.944 -1.098 . . . . 0.0 109.961 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.666 ' CD2' ' CD1' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -81.27 -39.34 25.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.016 -1.053 . . . . 0.0 109.879 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 61.5 t-20 -43.79 111.68 0.31 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.594 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 74.8 91.03 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.993 0.901 . . . . 0.0 109.207 -178.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 3.1 p -103.7 38.48 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.606 ' CG2' ' CD ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -148.56 -175.16 0.45 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.606 ' CD ' ' CG2' ' A' ' 79' ' ' ILE . 36.2 Cg_endo -63.58 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 116.966 -1.556 . . . . 0.0 110.239 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 38.7 tt0 179.16 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.062 -1.024 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.16 55.95 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.32 -81.7 0.16 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.552 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -79.26 5.14 13.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.162 . . . . 0.0 109.749 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' SER . 36.1 mt-30 70.35 86.36 0.12 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.149 -0.969 . . . . 0.0 109.152 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.594 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 35.0 Cg_endo -58.69 -173.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.363 1.717 . . . . 0.0 111.927 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.545 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.99 152.75 18.05 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -99.69 100.45 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.647 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 2.5 m -78.11 172.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.734 -0.604 . . . . 0.0 110.715 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 10.8 ttt180 127.5 138.63 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.09 138.16 58.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.71 179.51 5.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.65 176.23 5.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' HIS . 4.0 mt-10 61.16 178.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLU . 96.8 m-70 -44.21 154.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.377 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.33 -40.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.548 ' CB ' ' HD3' ' A' ' 61' ' ' ARG . 16.0 pttt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 18.6 mmtp . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.986 0.422 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' CB ' ' CB ' ' A' ' 63' ' ' ASN . 23.5 m-20 -162.61 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.964 -1.085 . . . . 0.0 110.251 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.612 ' CG2' ' CD1' ' A' ' 91' ' ' LEU . 4.4 m -162.75 94.14 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.964 . . . . 0.0 111.134 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.606 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -102.96 165.47 11.01 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.035 -1.041 . . . . 0.0 108.891 178.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -132.05 122.07 24.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.311 -1.493 . . . . 0.0 110.356 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -79.47 117.88 20.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -97.33 146.08 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.467 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -124.03 167.29 14.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.2 m-20 72.4 18.05 4.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.412 -0.805 . . . . 0.0 109.398 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.46 HD23 ' HD2' ' A' ' 22' ' ' PRO . 2.9 tm? -53.73 109.61 1.6 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 109.998 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD2' HD23 ' A' ' 21' ' ' LEU . 36.4 Cg_endo -82.08 147.42 14.76 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.044 1.55 . . . . 0.0 109.794 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 19.63 3.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.958 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.3 t -89.19 -6.05 57.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.395 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.04 -166.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -57.78 -55.99 27.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 108.981 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' GLN . 3.1 p30 -49.36 -24.2 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.257 -0.902 . . . . 0.0 108.869 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 26' ' ' THR . 59.5 tt0 -71.89 -45.07 62.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 109.125 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 6.9 mp -46.8 -35.58 6.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.255 -0.903 . . . . 0.0 108.721 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 5.6 t0 -49.2 -50.68 37.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.977 -1.077 . . . . 0.0 109.263 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 m -80.87 -15.34 56.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.98 -47.73 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 109.805 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CD1' HD12 ' A' ' 75' ' ' LEU . 20.1 p90 -92.74 -41.63 10.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.745 -1.222 . . . . 0.0 109.423 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' LYS . . . 127.51 -78.17 0.39 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 1.6 tptp 174.74 78.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -1.088 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -79.71 -104.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' N ' ' HB3' ' A' ' 67' ' ' GLU . . . -68.89 176.34 29.62 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' VAL . 14.3 t -78.56 81.82 4.86 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.831 -1.394 . . . . 0.0 107.793 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.536 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -35.51 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.14 0.972 . . . . 0.0 108.447 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.639 ' O ' ' CB ' ' A' ' 42' ' ' GLN . 28.4 m -79.25 47.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.286 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.639 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 5.5 tt0 96.81 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.26 0.553 . . . . 0.0 111.449 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 8.4 ptpp? -92.24 132.17 36.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.525 ' N ' ' OD2' ' A' ' 27' ' ' ASP . 6.3 p30 -129.69 161.62 30.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.59 -1.318 . . . . 0.0 110.789 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.33 169.0 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.58 117.88 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.414 -0.804 . . . . 0.0 109.067 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 58' ' ' ALA . 85.1 t -130.39 145.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.117 . . . . 0.0 109.032 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.586 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -149.15 174.83 11.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.055 . . . . 0.0 109.543 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 33.6 m-85 -154.55 107.65 2.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.577 ' CG1' HD23 ' A' ' 16' ' ' LEU . 2.2 t -84.81 102.95 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.548 ' CB ' HG21 ' A' ' 41' ' ' VAL . 4.8 mtm180 -83.35 128.66 34.69 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.036 -1.04 . . . . 0.0 110.411 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -162.52 173.56 13.84 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' CB ' ' A' ' 13' ' ' ASP . 7.7 p30 -112.11 -114.84 0.32 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 117.68 -1.608 . . . . 0.0 110.861 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 10.6 mmtt 16.52 108.74 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.282 0.563 . . . . 0.0 112.343 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -57.47 -40.87 79.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.983 -1.073 . . . . 0.0 109.58 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -38.97 86.39 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB3' ' N ' ' A' ' 38' ' ' GLY . 60.8 mm-40 -59.7 -30.91 69.12 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 62' ' ' TYR . . . -67.17 -37.87 84.47 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -53.52 -35.23 60.46 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.7 mp0 -61.4 -52.48 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.586 ' CA ' ' HB2' ' A' ' 75' ' ' LEU . . . -67.01 -5.21 11.99 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.594 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.563 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 14.0 mm -84.49 -57.42 4.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -79.67 0.84 28.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.946 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.28 -44.16 1.59 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.026 -1.046 . . . . 0.0 109.906 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.614 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -89.34 -28.43 19.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 34.3 t-20 -46.67 -27.5 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.217 -1.552 . . . . 0.0 109.453 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -148.53 78.81 1.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG12 HG22 ' A' ' 33' ' ' ILE . 1.5 t -85.4 107.28 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.998 -1.064 . . . . 0.0 108.97 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 174.19 164.6 0.33 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.6 Cg_endo -86.47 37.41 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.703 1.37 . . . . 0.0 110.477 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' PRO . 4.0 mt-10 40.24 44.45 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.498 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.11 -19.95 17.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 84' ' ' SER . . . -141.65 -108.73 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 41.4 t 175.76 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -1.098 . . . . 0.0 109.456 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.6 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.0 pt20 -143.94 32.95 0.13 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.955 . . . . 0.0 110.632 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 37.8 Cg_endo -68.31 -162.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.424 1.223 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -100.19 114.57 28.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.812 -1.155 . . . . 0.0 109.657 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -79.1 116.04 19.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 177.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.531 ' CG1' HD13 ' A' ' 16' ' ' LEU . 17.4 m -94.38 171.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.982 0.896 . . . . 0.0 112.003 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER 166.47 116.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.612 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 2.3 mt -41.94 109.3 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.197 -0.94 . . . . 0.0 109.477 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . -58.55 -156.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.113 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.4 tp10 -171.7 99.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.994 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 78.69 3.51 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.557 -0.714 . . . . 0.0 110.046 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.441 ' CD2' ' C ' ' A' ' 95' ' ' HIS . 0.3 OUTLIER -73.57 174.18 8.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.47 47.8 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' OXT' ' NH1' ' A' ' 61' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.239 -1.153 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.626 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 1.8 mttt . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.473 ' N ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -156.35 98.17 1.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.894 -1.754 . . . . 0.0 112.192 -179.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.598 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 16.5 m -162.71 49.66 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 2.0 m120 -76.04 -177.46 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.66 0.743 . . . . 0.0 110.498 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.659 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -142.9 129.06 19.77 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.744 0.783 . . . . 0.0 109.741 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 57' ' ' VAL . 1.1 t80 -78.86 95.89 5.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.697 -0.627 . . . . 0.0 109.914 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.608 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 16.4 m -80.07 106.54 11.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 16.3 p -99.86 166.73 10.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.135 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.426 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 2.0 m120 62.76 75.29 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.429 -0.795 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -139.67 158.0 68.94 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 109.347 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HG2' ' CG2' ' A' ' 24' ' ' THR . 36.5 Cg_endo -94.74 -175.4 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.053 1.554 . . . . 0.0 109.994 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 6.83 47.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.52 ' CG2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 t -80.48 -6.25 57.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 25' ' ' ILE . 1.7 pp -127.96 127.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 4.6 p -99.68 170.98 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.809 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.0 -53.46 38.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.57 -11.71 37.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 30' ' ' LEU . 35.7 tt0 -78.36 -56.29 4.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.578 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 1.3 mp -44.64 -39.07 4.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.544 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 5.3 t70 -58.97 -48.29 82.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.038 -1.039 . . . . 0.0 109.829 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -23.03 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.49 -0.756 . . . . 0.0 110.065 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.67 ' CG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -80.44 -26.44 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.741 -1.224 . . . . 0.0 109.731 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.67 ' CZ ' ' CG2' ' A' ' 33' ' ' ILE . 4.3 m-85 -111.53 -73.44 0.68 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.11 -0.994 . . . . 0.0 109.153 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 34.11 78.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -171.92 28.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.952 -1.322 . . . . 0.0 111.028 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CE2' ' CZ ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -133.97 -96.72 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.706 -1.246 . . . . 0.0 109.758 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 -167.74 16.52 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.55 ' O ' ' C ' ' A' ' 40' ' ' ILE . 4.5 t -80.16 78.71 6.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.339 -1.095 . . . . 0.0 108.856 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.611 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -24.65 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.654 ' C ' ' HB3' ' A' ' 61' ' ' ARG . 5.5 m -100.14 58.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.643 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 2.5 tt0 92.47 117.96 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.101 0.953 . . . . 0.0 113.267 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -115.95 138.09 51.51 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.487 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -151.53 174.31 13.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.286 -1.509 . . . . 0.0 111.282 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 26' ' ' THR . 37.3 mt -145.64 111.08 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 18.3 mt -100.65 143.98 30.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.616 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HB ' ' CE2' ' A' ' 17' ' ' TYR . 19.8 m -144.98 165.38 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -1.127 . . . . 0.0 109.655 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.608 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -157.09 175.35 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.838 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -141.27 104.91 4.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 0.0 108.991 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 1.3 t -78.21 148.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.81 -1.181 . . . . 0.0 108.132 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.654 ' HB3' ' C ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -85.37 125.86 33.3 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.447 0.641 . . . . 0.0 110.136 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.707 ' CZ ' ' CE2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -163.63 147.21 10.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.934 -1.104 . . . . 0.0 108.472 179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.668 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.2 t-20 -135.02 -91.28 0.32 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.472 -1.392 . . . . 0.0 109.449 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.668 ' C ' ' O ' ' A' ' 63' ' ' ASN . 11.5 mptt -14.72 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.538 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.99 -47.85 0.08 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.83 -0.544 . . . . 0.0 110.238 -177.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.89 -50.88 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 42.5 mm-40 -46.86 -43.99 19.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . . . -60.14 -41.86 93.59 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.088 -1.632 . . . . 0.0 107.183 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.1 -37.47 6.88 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -62.83 -49.31 75.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.588 ' HB1' ' CE2' ' A' ' 62' ' ' TYR . . . -62.83 -11.92 21.23 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.142 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 49.7 mm -84.44 -69.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.865 -1.147 . . . . 0.0 108.35 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.95 3.71 7.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 70' ' ' GLU . . . -124.65 -51.87 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.051 . . . . 0.0 109.723 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.658 ' HG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -81.21 -35.35 31.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 0.0 110.225 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 1.7 p-10 -53.93 139.09 35.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.68 -1.263 . . . . 0.0 109.262 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER 52.9 50.55 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.23 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.645 HG22 ' HA ' ' A' ' 75' ' ' LEU . 2.5 t -88.56 82.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.596 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -141.94 -164.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -92.45 26.73 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.559 1.294 . . . . 0.0 110.448 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.492 ' CG ' ' C ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER 41.54 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 0.0 109.549 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.06 44.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 106.41 -168.86 14.97 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER 77.27 -4.0 2.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -1.186 . . . . 0.0 109.864 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' SER . 14.3 mt-30 60.85 145.76 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.66 147.55 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.065 1.561 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.76 121.53 18.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 17' ' ' TYR . 1.5 t -79.52 104.17 9.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 35.5 m -78.51 -144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 111.458 -177.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 84.79 106.52 0.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 -178.052 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -41.26 141.46 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.291 -0.88 . . . . 0.0 110.089 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -100.89 -165.85 1.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -95.55 119.31 33.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.993 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 164.85 -88.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 24.1 t-80 175.67 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 138.81 -119.45 1.75 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.072 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 120.716 0.293 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' LYS . 9.9 m-20 -137.43 12.59 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.801 -1.187 . . . . 0.0 110.603 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.58 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -160.29 70.56 0.43 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -77.0 152.71 35.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.771 -1.206 . . . . 0.0 108.869 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 1.5 tp -97.49 108.8 21.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.336 -0.853 . . . . 0.0 109.957 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CE1' ' CG2' ' A' ' 57' ' ' VAL . 33.3 t80 -79.55 87.07 5.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.525 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 58' ' ' ALA . 16.3 m -79.76 112.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.858 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 4.5 m -117.1 161.33 19.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' THR . 6.0 t-20 78.66 52.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.882 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -160.22 136.75 6.46 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -86.74 -177.48 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.897 1.472 . . . . 0.0 110.108 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 34.65 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.471 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -79.64 -54.98 5.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.915 . . . . 0.0 109.014 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 30' ' ' LEU . 1.1 pp -62.31 165.82 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.224 -0.922 . . . . 0.0 108.752 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -109.43 136.54 48.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 9.4 t0 -56.15 -60.59 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.037 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 10.0 p-10 -48.61 -21.55 0.61 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 26' ' ' THR . 38.7 tt0 -74.65 -45.91 41.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.979 -1.076 . . . . 0.0 110.2 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 33' ' ' ILE . 4.4 mp -45.59 -25.3 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.849 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 3.0 t0 -65.97 -51.46 58.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 108.764 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 m -53.49 -52.61 58.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.543 ' O ' ' CD1' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -63.29 -25.77 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 108.574 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -66.14 -89.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 108.869 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 9.92 58.56 0.01 OUTLIER Glycine 0 N--CA 1.503 3.12 0 C-N-CA 122.941 0.305 . . . . 0.0 112.807 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' PHE . 2.3 tttt -161.68 4.97 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.662 -1.493 . . . . 0.0 112.247 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.746 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.92 -83.81 0.09 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.381 -1.45 . . . . 0.0 110.18 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.04 -177.27 24.48 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' ILE . 56.5 m -92.93 19.6 7.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -1.21 . . . . 0.0 109.647 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.594 HD12 ' CG ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 51.33 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.369 0.604 . . . . 0.0 109.738 178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.643 ' H ' ' HB2' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -133.16 49.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 O-C-N 120.647 -1.283 . . . . 0.0 114.253 -177.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.632 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.4 tm0? 85.23 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.582 -1.324 . . . . 0.0 112.207 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 pttp -78.5 144.58 35.58 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.128 -0.982 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.74 120.61 3.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 109.813 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.542 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 22.8 pt -84.51 162.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.062 -1.024 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.6 110.5 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 110.496 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 9.2 tpm_? . . . . . 0 N--CA 1.491 1.578 0 O-C-N 120.495 -1.378 . . . . 0.0 110.41 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.479 ' HA2' ' HD2' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 46' ' ' LEU . 1.9 p -129.04 109.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 108.921 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' PHE . . . -109.34 178.28 4.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.751 -1.218 . . . . 0.0 110.241 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 3.6 m-85 -135.59 110.38 8.71 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG22 HD22 ' A' ' 30' ' ' LEU . 1.1 t -77.95 157.38 5.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.643 ' HB2' ' H ' ' A' ' 41' ' ' VAL . 9.2 ptt180 -95.76 108.88 21.24 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.362 0.601 . . . . 0.0 110.302 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -162.23 71.01 0.32 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.237 -0.915 . . . . 0.0 108.641 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.634 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -68.87 -104.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 109.343 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.634 ' C ' ' O ' ' A' ' 63' ' ' ASN . 3.0 mttp 9.05 90.07 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-N 118.18 0.445 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -29.39 -37.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.947 -0.471 . . . . 0.0 111.102 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' N ' ' HG2' ' A' ' 65' ' ' ARG . 43.4 tt0 -64.06 -58.24 7.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 108.235 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 60.1 mt-10 -53.6 -47.61 70.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.843 . . . . 0.0 109.406 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . . . -49.3 -39.16 29.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 108.725 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 2.9 tt0 -60.94 -41.51 96.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 3.6 mp0 -55.67 -49.21 73.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.47 -0.769 . . . . 0.0 109.956 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' CD2' ' A' ' 62' ' ' TYR . . . -71.21 -13.69 62.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.183 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 2.1 mm -74.89 -64.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 108.406 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -3.14 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.578 -0.701 . . . . 0.0 110.438 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 70' ' ' GLU . . . -117.36 -50.76 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.828 -1.17 . . . . 0.0 110.249 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.645 ' CD1' ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -79.4 -26.22 41.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 0.0 109.719 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.3 t-20 -47.37 102.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.653 -1.279 . . . . 0.0 107.978 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 7.2 m-20 72.82 92.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 2.7 p -85.94 53.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 79' ' ' ILE . 2.1 pp -133.33 140.1 36.12 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 35.9 Cg_endo -40.87 -76.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.936 1.493 . . . . 0.0 110.527 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 11.4 tp10 176.53 152.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.203 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . 115.54 3.27 20.72 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 131.72 -161.96 23.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m 84.16 -62.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.784 -0.833 . . . . 0.0 109.429 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.528 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.3 pt20 27.05 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 122.12 -0.362 . . . . 0.0 110.732 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.538 ' O ' ' CD1' ' A' ' 87' ' ' LEU . 37.3 Cg_endo -127.19 65.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.54 1.284 . . . . 0.0 111.428 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 174.5 87.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' TYR . 3.5 t -81.17 107.41 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 24.7 m -83.77 147.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.528 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 28.4 ptt180 152.96 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.63 149.45 25.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.788 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.34 -58.78 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 109.958 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.99 178.13 7.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.782 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -118.22 80.35 1.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 132.28 3.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.5 -175.43 52.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.512 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 16.5 p-10 -160.69 92.96 0.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.765 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.559 ' OG1' ' CA ' ' A' ' 63' ' ' ASN . 1.2 p -144.24 43.38 1.42 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -75.36 155.38 36.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.664 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.62 142.83 29.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.477 -1.689 . . . . 0.0 110.223 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE2' HG13 ' A' ' 57' ' ' VAL . 1.8 t80 -78.52 78.84 4.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 24.6 m -77.89 105.46 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.003 0.906 . . . . 0.0 109.699 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 53.1 p -116.85 126.1 52.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 19' ' ' THR . 10.0 t-20 159.01 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.632 . . . . 0.0 109.667 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.562 ' N ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -39.89 161.56 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.436 -179.309 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -117.95 50.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.903 1.475 . . . . 0.0 110.131 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.06 21.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.554 -0.717 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -87.53 -24.34 24.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' ' 85' ' ' GLN . 1.0 OUTLIER -107.54 -164.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 108.955 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -132.48 130.3 40.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.021 -1.049 . . . . 0.0 109.989 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.47 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -59.58 -50.0 75.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.951 -1.093 . . . . 0.0 108.627 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -49.28 -26.62 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.323 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 26' ' ' THR . 8.2 tt0 -74.84 -42.4 58.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 5.7 mp -46.67 -32.98 3.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 109.896 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.579 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -60.34 -62.59 1.75 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.866 -1.146 . . . . 0.0 109.511 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 32' ' ' THR . 12.1 m -62.42 -9.62 8.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.503 -0.748 . . . . 0.0 110.121 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.619 HG21 ' CD2' ' A' ' 34' ' ' PHE . 2.6 tt -83.96 -40.24 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.945 -1.097 . . . . 0.0 110.029 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -108.4 -54.24 2.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.512 -1.368 . . . . 0.0 110.456 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 16.55 67.32 0.01 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -141.49 -25.8 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.278 . . . . 0.0 111.601 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -96.2 -37.58 10.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.606 -1.309 . . . . 0.0 109.242 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.4 -163.96 10.91 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.668 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -109.96 35.94 3.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -1.172 . . . . 0.0 109.217 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.691 ' CG2' ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 43.27 147.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 CA-C-O 122.125 0.964 . . . . 0.0 111.418 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.543 HG13 ' CB ' ' A' ' 97' ' ' LYS . 96.8 t -109.44 -38.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 119.975 -1.703 . . . . 0.0 113.901 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.843 ' C ' ' HG2' ' A' ' 61' ' ' ARG . 1.1 tm0? 177.96 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 O-C-N 120.464 -1.397 . . . . 0.0 110.962 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.729 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -112.57 150.66 31.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.404 -0.81 . . . . 0.0 109.923 -177.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -159.47 172.95 16.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 109.156 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 tt -155.19 146.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.734 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -152.56 144.66 23.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 109.694 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' O ' ' CG1' ' A' ' 57' ' ' VAL . . . . . . . . 0 C--O 1.214 -1.149 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' CE2' ' A' ' 17' ' ' TYR . 1.2 m -165.38 176.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 121.863 -0.786 . . . . 0.0 110.048 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -147.86 159.73 43.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -131.97 116.73 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' CG1' ' CD2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -86.52 162.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.357 -1.464 . . . . 0.0 109.864 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.843 ' HG2' ' C ' ' A' ' 42' ' ' GLN . 3.6 mtm180 -79.73 107.49 12.54 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.672 ' CE2' ' CB ' ' A' ' 71' ' ' ALA . 44.2 m-85 -163.95 143.99 8.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.695 -1.253 . . . . 0.0 110.089 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.62 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -125.41 -132.69 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.62 ' C ' ' O ' ' A' ' 63' ' ' ASN . 1.8 mtpt 17.59 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.912 0.778 . . . . 0.0 110.386 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -28.87 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.922 -0.486 . . . . 0.0 110.599 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 64' ' ' LYS . 2.3 tt0 -64.0 -56.0 18.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 108.313 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -44.99 -44.68 10.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.476 ' CB ' HD22 ' A' ' 91' ' ' LEU . . . -56.12 -45.96 79.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.6 -1.313 . . . . 0.0 107.715 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 tt0 -45.35 -39.04 6.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 78.5 mm-40 -57.62 -54.93 41.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.672 ' CB ' ' CE2' ' A' ' 62' ' ' TYR . . . -61.2 -13.26 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.729 0.776 . . . . 0.0 110.025 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 6.7 mm -82.98 -62.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 O-C-N 120.621 -1.299 . . . . 0.0 108.679 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.58 6.69 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.965 . . . . 0.0 109.797 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -128.9 -52.53 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.605 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -79.31 -26.23 42.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.171 -0.955 . . . . 0.0 109.97 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.91 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.354 -1.467 . . . . 0.0 107.664 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' LEU . 3.8 m-20 74.21 58.67 0.08 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 108.684 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.605 ' CG1' ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -79.45 78.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.184 -0.947 . . . . 0.0 108.773 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -133.0 -163.51 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.4 Cg_endo -102.52 38.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.021 1.537 . . . . 0.0 109.984 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 47.68 60.14 3.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.35 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 163.2 -46.28 0.32 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -53.52 -175.61 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -128.75 75.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.262 . . . . 0.0 109.716 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.525 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -165.83 64.41 0.93 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -92.48 -170.65 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.969 1.51 . . . . 0.0 110.581 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.583 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -149.61 124.69 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 13.9 t -78.03 100.14 6.38 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 34.6 m -78.55 146.4 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.928 0.87 . . . . 0.0 111.948 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.9 tmm_? 168.41 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD22 ' CB ' ' A' ' 68' ' ' ALA . 1.1 mp -36.89 145.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.412 0.625 . . . . 0.0 110.417 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.69 -166.83 1.43 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 109.261 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 71.9 1.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.106 -0.996 . . . . 0.0 109.34 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.59 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -58.08 152.71 16.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.219 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 13' ' ' ASP . . . -130.91 -116.62 1.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' CB ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 0.0 109.725 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 25.3 t0 -145.46 84.59 1.69 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.664 -1.273 . . . . 0.0 111.948 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER -162.04 38.07 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -174.01 2.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.609 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -108.26 123.47 48.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.483 0.659 . . . . 0.0 110.712 -178.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.1 t80 -90.59 94.71 9.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.566 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 19.5 m -91.77 130.42 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 110.463 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 88' ' ' SER . 16.6 p -126.98 -175.67 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 55.04 70.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.624 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 20' ' ' ASN . 3.9 pp 178.8 151.41 0.47 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -110.15 -169.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.008 1.53 . . . . 0.0 110.037 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.51 41.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.434 HG21 ' N ' ' A' ' 25' ' ' ILE . 2.1 t -80.58 -29.43 37.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.434 ' N ' HG21 ' A' ' 24' ' ' THR . 37.2 pt -108.32 162.46 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.44 136.7 39.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 4.3 p-10 -61.94 -47.49 84.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 25.9 t0 -54.42 -19.8 6.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.182 -0.949 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' THR . 13.8 mt-30 -77.13 -53.14 8.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HA ' HG23 ' A' ' 33' ' ' ILE . 4.6 mp -44.72 -34.04 2.09 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.634 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.553 ' N ' ' HE3' ' A' ' 43' ' ' LYS . 4.8 t70 -50.52 -63.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.2 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' HG21 ' A' ' 32' ' ' THR . 6.6 m -64.23 -14.75 57.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.909 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG23 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -79.66 -23.22 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -150.22 35.36 0.65 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.8 -1.188 . . . . 0.0 110.853 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.546 ' HA2' ' CD1' ' A' ' 40' ' ' ILE . . . -88.34 57.54 4.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -131.94 -8.92 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 110.575 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -115.19 47.3 1.31 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.823 -1.173 . . . . 0.0 109.568 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . 122.77 171.9 13.85 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 40' ' ' ILE . 3.3 m -91.47 93.83 9.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.376 -1.073 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.657 HG23 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -29.38 143.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-O 121.259 0.552 . . . . 0.0 110.259 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.704 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -105.57 50.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -175.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 85.88 95.58 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 120.553 -1.342 . . . . 0.0 112.839 177.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.644 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 3.0 mttm -81.31 117.46 21.82 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.083 -1.011 . . . . 0.0 109.65 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -122.03 153.51 38.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 108.944 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 27' ' ' ASP . 11.1 pt -130.5 159.1 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD23 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -157.49 130.92 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' LEU . 2.3 m -128.53 154.43 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.147 -1.208 . . . . 0.0 110.069 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -113.84 176.69 4.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.537 ' CD1' HD23 ' A' ' 46' ' ' LEU . 6.8 m-85 -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.568 ' CG2' ' NZ ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -79.18 157.51 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.704 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -103.87 104.75 14.78 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.654 0.74 . . . . 0.0 109.895 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -161.01 80.78 0.63 Allowed 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.57 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -77.13 -115.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.814 -1.154 . . . . 0.0 108.748 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 27.53 89.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.683 0.674 . . . . 0.0 109.555 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -27.91 -41.95 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.777 -0.577 . . . . 0.0 110.544 -177.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' LYS . 3.8 mm-40 -67.1 -56.3 10.61 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.882 -1.136 . . . . 0.0 108.109 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -46.86 -49.15 20.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -52.91 -45.52 67.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.599 -1.313 . . . . 0.0 107.944 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HA ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.64 -42.82 35.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 1.0 OUTLIER -60.25 -68.81 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.678 . . . . 0.0 109.872 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB3' ' CD2' ' A' ' 62' ' ' TYR . . . -45.91 -20.05 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 110.104 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -71.41 -66.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.58 -1.325 . . . . 0.0 108.219 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -78.53 10.47 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.095 -1.003 . . . . 0.0 110.382 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.73 -56.79 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 109.921 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.661 ' CD1' ' CE2' ' A' ' 34' ' ' PHE . 51.3 mt -77.38 -33.22 55.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.14 133.29 28.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.709 -1.244 . . . . 0.0 108.259 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.626 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 68.54 55.69 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 109.682 -179.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.549 ' CG1' HD13 ' A' ' 87' ' ' LEU . 14.9 p -85.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 108.677 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -132.21 176.25 3.05 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -87.61 44.57 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.842 1.443 . . . . 0.0 109.128 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 80' ' ' PRO . 10.8 pt-20 40.9 45.67 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.5 77.51 0.3 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.08 -36.89 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 67.51 45.41 1.55 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.629 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 5.6 mm-40 -128.2 49.74 4.79 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 109.091 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 37.9 Cg_endo -88.52 -162.4 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.759 1.4 . . . . 0.0 111.389 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.549 HD13 ' CG1' ' A' ' 78' ' ' VAL . 4.8 mp -85.94 124.96 32.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.807 -0.558 . . . . 0.0 110.013 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.4 m -79.26 96.67 6.0 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.562 ' CG2' ' CD1' ' A' ' 16' ' ' LEU . 8.8 p -75.66 143.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.4 1.095 . . . . 0.0 112.012 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.524 ' N ' HG21 ' A' ' 89' ' ' VAL . 1.0 OUTLIER 175.37 -130.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.545 ' HG ' ' N ' ' A' ' 92' ' ' ALA . 12.3 tp -149.06 152.02 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.395 -1.441 . . . . 0.0 110.113 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.582 ' HB3' ' CG ' ' A' ' 17' ' ' TYR . . . -126.46 -171.05 2.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 109.559 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.86 -174.08 3.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.19 150.08 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.7 -172.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.52 -61.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.268 -1.137 . . . . 0.0 109.444 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 121.219 0.533 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.598 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 70.4 m-20 -149.11 -87.4 0.08 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.57 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.633 ' CG2' ' O ' ' A' ' 14' ' ' THR . 0.7 OUTLIER -163.26 105.13 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.906 -1.121 . . . . 0.0 109.73 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.528 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -77.85 -178.95 5.71 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.436 -1.415 . . . . 0.0 108.192 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -137.02 112.24 9.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.842 -1.161 . . . . 0.0 110.119 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CG ' ' HB1' ' A' ' 92' ' ' ALA . 8.8 t80 -93.92 101.62 13.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.922 . . . . 0.0 108.841 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.8 m -100.79 113.88 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 0.0 109.929 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -83.18 166.42 18.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.985 . . . . 0.0 109.613 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER 76.91 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.206 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER 49.53 101.24 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 110.103 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' SER . 36.8 Cg_endo -76.5 140.6 21.64 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.061 1.559 . . . . 0.0 109.631 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.8 41.91 1.05 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -0.967 . . . . 0.0 109.401 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -3.19 30.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.78 179.63 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.458 ' OG1' ' OE1' ' A' ' 29' ' ' GLN . 11.4 p -106.64 155.87 19.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 2.9 p30 -62.05 -42.82 99.59 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 2.6 m-20 -53.84 -27.11 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 108.974 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.458 ' OE1' ' OG1' ' A' ' 26' ' ' THR . 0.7 OUTLIER -81.48 -33.58 31.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.46 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -52.44 -33.56 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -60.12 -46.01 91.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.035 . . . . 0.0 108.418 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 5.9 m -61.1 -43.18 99.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' CG2' ' A' ' 78' ' ' VAL . 3.0 mm -52.71 -30.64 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.661 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 4.0 m-30 -79.15 -77.57 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.591 -0.693 . . . . 0.0 109.887 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 36' ' ' LYS . . . 141.12 -82.31 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 166.08 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -1.196 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 3.8 m-85 -78.77 -70.13 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.348 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.05 -169.4 15.5 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 40' ' ' ILE . 48.6 p -78.99 77.18 5.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 108.338 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.547 ' HB ' ' NE ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -40.46 146.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.646 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 28.8 m -111.2 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.814 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 50.2 tt0 62.53 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.13 -0.981 . . . . 0.0 112.803 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.538 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 3.2 mtmm -75.56 163.27 27.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.369 -0.832 . . . . 0.0 109.506 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -149.3 106.22 3.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.925 . . . . 0.0 109.592 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG13 ' HG ' ' A' ' 21' ' ' LEU . 12.3 tt -87.53 141.14 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -120.06 110.39 16.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.564 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 23' ' ' ARG . 2.1 ptm180 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 10.1 p -148.42 159.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.134 . . . . 0.0 109.04 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 18' ' ' VAL . . . -160.17 -175.11 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -155.18 104.66 2.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' A' ' 34' ' ' PHE . 2.7 p -79.33 157.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.271 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.814 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 3.8 ptt180 -84.1 142.35 30.45 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.934 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' OH ' ' CE2' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -161.42 164.94 29.54 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.598 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -145.04 -101.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.366 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' ASN . 5.1 mmtp -22.15 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.647 -0.658 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH2' ' HA ' ' A' ' 13' ' ' ASP . 32.2 mmt-85 -43.39 -50.59 6.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.187 -0.945 . . . . 0.0 108.558 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 67.6 mt-10 -55.06 -44.8 75.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -47.95 -60.78 2.35 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.666 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 14' ' ' THR . . . -46.31 -37.01 6.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.757 -1.215 . . . . 0.0 108.19 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -51.66 -53.7 36.02 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' ILE . 4.4 mm-40 -51.28 -67.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . . . -34.12 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.549 ' CD1' HG13 ' A' ' 89' ' ' VAL . 1.5 mm -70.4 -67.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.927 -1.108 . . . . 0.0 108.29 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -85.68 27.98 0.81 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.465 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 70' ' ' GLU . . . -140.71 -53.41 0.49 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.966 . . . . 0.0 108.486 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.661 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -78.78 -29.15 44.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 42.0 t30 -58.3 139.84 54.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 108.86 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' OD1' ' CB ' ' A' ' 86' ' ' PRO . 3.0 m120 58.88 63.5 1.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.053 -1.03 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.546 ' CG1' ' CD1' ' A' ' 87' ' ' LEU . 1.5 p -85.7 65.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.57 ' HB ' ' HD2' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -165.4 153.24 9.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 33.7 Cg_endo -43.96 -74.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.547 1.288 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 1.1 pt-20 162.38 144.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.6 -63.16 0.29 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . -132.18 -164.65 11.08 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER 79.86 -9.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -1.003 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER 62.25 154.08 0.11 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.073 -1.017 . . . . 0.0 109.462 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' CB ' ' OD1' ' A' ' 77' ' ' ASN . 36.4 Cg_endo -107.68 157.34 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.011 1.532 . . . . 0.0 110.839 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 2.9 mp -78.79 123.94 27.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -79.15 97.24 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.564 ' CG1' HD13 ' A' ' 16' ' ' LEU . 22.3 t -75.95 137.74 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.396 1.093 . . . . 0.0 111.442 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' N ' HG11 ' A' ' 89' ' ' VAL . 1.3 tpt180 -175.49 -135.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.15 135.92 9.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.67 -1.269 . . . . 0.0 109.184 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HB1' ' CG ' ' A' ' 17' ' ' TYR . . . -107.34 -162.68 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -171.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.96 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 176.8 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.98 138.2 0.25 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.32 -0.862 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.77 123.66 29.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.206 -1.173 . . . . 0.0 109.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.593 0.235 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -130.8 -74.66 0.53 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.651 -1.281 . . . . 0.0 110.707 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.608 ' CG2' ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -160.31 91.59 0.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.01 -1.056 . . . . 0.0 110.245 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 4.4 t30 -79.25 169.24 18.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -0.877 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -143.92 136.02 26.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.67 -1.269 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' ' CZ ' ' A' ' 59' ' ' PHE . 5.1 t80 -85.28 142.73 29.17 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.422 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.536 HG22 ' CB ' ' A' ' 58' ' ' ALA . 30.2 m -132.94 157.08 42.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -144.12 159.24 42.98 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.714 -179.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.6 t-20 79.51 88.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 110.299 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -159.99 150.87 15.73 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.53 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 36.7 Cg_endo -82.5 -176.8 3.1 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.819 1.431 . . . . 0.0 111.013 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -77.0 3.35 12.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.135 -0.978 . . . . 0.0 109.97 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.532 ' CG2' ' OE1' ' A' ' 29' ' ' GLN . 33.9 m -84.14 -112.94 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 30' ' ' LEU . 8.8 mm 42.23 23.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.898 -1.126 . . . . 0.0 110.311 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' THR . 49.0 p -35.94 158.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.692 0.758 . . . . 0.0 110.616 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 16.7 m-20 -60.27 -27.38 67.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.88 -13.03 34.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.532 ' OE1' ' CG2' ' A' ' 24' ' ' THR . 2.4 mt-30 -79.88 -66.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.59 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 2.1 mp -57.03 -28.77 62.8 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.248 -1.381 . . . . 0.0 107.98 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -62.44 -43.33 99.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 108.672 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 m -55.75 -56.53 19.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 30' ' ' LEU . 8.4 tp -62.13 -18.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.675 ' CD2' ' CD1' ' A' ' 40' ' ' ILE . 6.9 m-85 -86.9 -98.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 18.22 62.53 0.01 OUTLIER Glycine 0 N--CA 1.498 2.832 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER 178.15 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 111.074 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -128.19 50.39 2.07 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.416 -1.427 . . . . 0.0 111.179 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' ' CD1' ' A' ' 62' ' ' TYR . . . 26.21 43.47 0.02 OUTLIER Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.614 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -88.84 34.61 0.77 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.46 -1.024 . . . . 0.0 109.997 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.675 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER 165.34 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.568 ' CG2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 m -89.97 13.47 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER 165.93 53.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -42.65 144.54 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.123 -0.986 . . . . 0.0 109.98 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -152.86 150.91 29.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.03 . . . . 0.0 109.825 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.45 ' CG2' HD22 ' A' ' 21' ' ' LEU . 1.5 mt -101.9 -178.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HB3' HG23 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -148.78 105.13 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.378 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 HG22 ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -127.12 178.43 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -1.139 . . . . 0.0 109.394 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.536 ' CB ' HG22 ' A' ' 18' ' ' VAL . . . -139.7 177.11 8.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.639 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -146.48 111.27 5.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.657 ' CG1' HD23 ' A' ' 16' ' ' LEU . 16.9 t -95.87 148.14 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 68.3 mtt180 -118.18 65.24 0.75 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.287 -1.508 . . . . 0.0 110.187 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -78.64 91.66 4.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.592 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -47.68 -84.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.891 -1.13 . . . . 0.0 110.993 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.533 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -24.03 144.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.534 0.683 . . . . 0.0 112.103 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -51.66 9.93 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.625 -0.672 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -67.19 -39.49 86.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.848 -1.157 . . . . 0.0 108.24 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 18.1 mt-10 -69.3 -29.13 66.93 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . . . -63.21 -39.8 95.67 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.8 -28.24 69.32 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -57.68 -67.99 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.458 -0.776 . . . . 0.0 108.978 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 75' ' ' LEU . . . -55.51 -17.63 5.68 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.315 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.539 ' CD1' HG13 ' A' ' 89' ' ' VAL . 3.0 mm -69.39 -61.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.545 -1.347 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.91 4.34 41.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.604 -0.685 . . . . 0.0 111.11 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.453 ' HB1' ' OE1' ' A' ' 70' ' ' GLU . . . -131.56 -1.28 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.745 -1.222 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.579 HD12 ' CE1' ' A' ' 34' ' ' PHE . 2.0 tp -127.87 -23.63 3.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.742 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' CA ' HG22 ' A' ' 89' ' ' VAL . 9.9 t-20 -41.1 -27.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.206 -0.933 . . . . 0.0 108.888 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 75' ' ' LEU . 91.2 m-20 -122.99 76.02 1.33 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.755 -0.59 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 7.3 p -84.44 48.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.178 -0.951 . . . . 0.0 108.805 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 2.0 pt -124.05 -169.58 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.2 Cg_endo -110.92 40.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.983 1.517 . . . . 0.0 110.299 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER 76.97 160.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.48 -50.83 4.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.53 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . 155.67 -98.05 0.17 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' GLN . 11.6 m 62.75 10.32 4.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.13 . . . . 0.0 109.425 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 mt-30 53.29 107.7 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 0.0 110.222 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HG3' HG12 ' A' ' 79' ' ' ILE . 37.5 Cg_endo -115.61 164.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.939 1.494 . . . . 0.0 109.163 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -72.0 108.94 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.366 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.6 t -76.54 116.46 17.25 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.632 ' CG1' ' CD1' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -79.09 174.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.519 1.152 . . . . 0.0 113.155 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 163.7 96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.608 ' CD2' ' CG2' ' A' ' 14' ' ' THR . 0.1 OUTLIER -51.57 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.082 . . . . 0.0 109.417 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 90' ' ' ARG . . . -54.6 159.71 2.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.512 -0.742 . . . . 0.0 110.02 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -140.61 50.63 1.67 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 109.191 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -152.85 -69.03 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.385 -0.822 . . . . 0.0 109.458 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 7.4 p80 -119.62 79.99 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.27 -150.68 5.74 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CE ' ' OXT' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 109.502 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.542 ' CG ' ' HG2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 63' ' ' ASN . 3.9 p-10 -160.96 94.7 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.63 -1.294 . . . . 0.0 110.281 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -160.16 57.93 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.9 . . . . 0.0 110.036 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.501 ' N ' HD13 ' A' ' 91' ' ' LEU . 1.1 t30 -78.59 158.06 28.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.874 . . . . 0.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -138.07 125.2 21.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.865 -1.147 . . . . 0.0 109.788 178.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 1.1 t80 -77.28 105.67 8.54 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' A' ' 87' ' ' LEU . 4.0 m -87.09 103.77 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.489 ' OG1' ' HB3' ' A' ' 88' ' ' SER . 17.2 p -90.44 167.96 12.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.344 -0.847 . . . . 0.0 109.553 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER 68.15 7.55 5.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD11 ' CG2' ' A' ' 18' ' ' VAL . 9.9 tt -71.08 115.0 32.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.118 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HG ' ' A' ' 21' ' ' LEU . 36.6 Cg_endo -60.13 142.37 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.859 1.452 . . . . 0.0 110.289 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.71 28.62 1.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 12.11 37.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.928 . . . . 0.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 pp -130.33 170.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.485 HG21 ' OE1' ' A' ' 29' ' ' GLN . 1.2 p -113.62 153.91 28.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.351 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -49.88 -69.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 109.015 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -42.0 -27.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.485 ' OE1' HG21 ' A' ' 26' ' ' THR . 1.8 tt0 -62.97 -62.39 1.74 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.581 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 1.6 mp -52.93 -20.2 3.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.859 -1.15 . . . . 0.0 108.957 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 27.4 t0 -66.43 -47.13 74.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.089 -1.007 . . . . 0.0 108.966 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 m -68.02 -37.55 81.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.451 -0.781 . . . . 0.0 109.072 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -61.75 -27.2 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 108.889 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 10.7 m-85 -88.45 -81.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 38.19 82.83 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 109.654 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -107.79 -86.08 0.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.877 . . . . 0.0 109.109 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.6 179.29 16.42 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 40' ' ' ILE . 10.7 m -94.13 25.83 3.57 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.077 -1.249 . . . . 0.0 108.773 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.4 mp 56.91 142.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 61' ' ' ARG . 33.4 m -79.21 -12.9 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.528 -1.358 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 21.4 tt0 157.47 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HE2' ' CA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -74.24 144.71 44.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 108.656 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 7.0 m120 -132.68 144.46 50.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.1 . . . . 0.0 110.407 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tt -130.11 155.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' VAL . 8.5 tp -168.74 117.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.998 -1.064 . . . . 0.0 109.599 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 109.744 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' LEU . 27.4 m -117.64 160.61 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' HG21 ' A' ' 18' ' ' VAL . . . -153.4 164.31 38.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.557 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 11.1 m-85 -128.09 109.08 11.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.637 ' CG1' ' CD1' ' A' ' 62' ' ' TYR . 1.6 t -79.89 120.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB3' HG21 ' A' ' 41' ' ' VAL . 13.7 ttm-85 -88.03 99.73 12.39 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.878 -1.139 . . . . 0.0 110.35 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.637 ' CD1' ' CG1' ' A' ' 60' ' ' VAL . 3.6 m-85 -119.23 74.89 1.01 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 12' ' ' LYS . 1.4 m-20 -68.38 -4.93 16.33 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.978 -1.076 . . . . 0.0 110.882 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -87.98 146.53 25.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.954 -1.092 . . . . 0.0 109.606 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.542 ' HG2' ' CG ' ' A' ' 12' ' ' LYS . 39.3 mmm-85 -73.07 -58.84 3.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 108.793 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.21 -45.69 79.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.86 . . . . 0.0 108.846 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -52.83 -43.31 65.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.111 -0.993 . . . . 0.0 108.898 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 14' ' ' THR . . . -61.89 -40.54 95.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.936 -1.103 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -31.31 25.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.593 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -80.2 -72.18 0.42 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . . . -36.59 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.526 0.679 . . . . 0.0 110.685 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' GLU . 2.5 mt -81.02 -63.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.498 -1.376 . . . . 0.0 108.827 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 m -84.23 30.46 0.53 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.386 -0.821 . . . . 0.0 109.822 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.11 -52.88 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.634 ' CD2' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.47 -34.39 41.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.151 -0.968 . . . . 0.0 108.657 179.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 6.6 t-20 -42.71 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER 80.87 76.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -89.4 38.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.306 -0.871 . . . . 0.0 109.064 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 1.5 mt -151.7 128.32 5.34 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 35.9 Cg_endo -44.06 130.79 8.37 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.741 1.39 . . . . 0.0 110.105 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -46.57 102.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.17 21.08 0.5 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.18 75.76 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.497 ' CB ' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -88.46 16.23 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -1.181 . . . . 0.0 109.218 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . 28.2 mt-30 69.86 123.32 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.533 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.2 Cg_endo -110.46 -168.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.813 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' CG ' ' HB ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.29 113.46 27.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.642 -0.661 . . . . 0.0 109.927 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -79.73 106.22 11.59 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 12.5 m -78.21 -167.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 111.322 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.602 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 95.12 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.501 HD13 ' N ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -49.47 168.17 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.16 -156.44 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.14 -169.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.061 -1.025 . . . . 0.0 109.748 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' HIS . 9.7 mt-10 -131.76 124.27 29.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 109.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 57.33 110.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.97 -143.56 3.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.192 -1.181 . . . . 0.0 109.38 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -155.25 110.88 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -105.46 90.12 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.471 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.4 162.72 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 109.767 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 mmt-85 -117.58 -88.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.486 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 5' ' ' ARG . 35.6 Cg_endo -43.63 154.36 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.384 1.202 . . . . 0.0 110.951 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.489 ' N ' ' HB3' ' A' ' 65' ' ' ARG . . . -110.27 -111.79 3.37 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.535 ' CA ' ' HB2' ' A' ' 65' ' ' ARG . . . -159.07 144.0 9.81 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB2' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER 166.47 140.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -1.104 . . . . 0.0 109.486 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLU . 1.1 p -38.63 161.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.409 -0.807 . . . . 0.0 110.628 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.543 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -41.45 103.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.564 -0.71 . . . . 0.0 109.202 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -125.84 -87.28 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 30.5 t0 -161.93 96.31 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.542 ' CG2' ' HG ' ' A' ' 91' ' ' LEU . 1.2 m -148.23 54.87 1.03 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.545 ' ND2' ' N ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -78.34 164.09 25.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD12 ' CG1' ' A' ' 89' ' ' VAL . 1.8 pt? -127.25 141.44 51.72 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.641 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.682 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -83.44 110.92 18.57 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.595 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -84.78 116.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 109.248 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 88' ' ' SER . 9.8 p -91.11 163.15 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 109.713 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.69 89.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.558 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 87' ' ' LEU . 9.1 tp -157.22 96.68 2.07 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HG3' ' OE1' ' A' ' 85' ' ' GLN . 36.9 Cg_endo -69.11 168.53 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.989 1.52 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 42.63 1.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.987 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.531 HG21 ' CG2' ' A' ' 25' ' ' ILE . 9.3 t -80.19 -12.0 59.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.531 ' CG2' HG21 ' A' ' 24' ' ' THR . 0.2 OUTLIER -125.77 -177.73 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.5 p -110.59 153.76 24.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.483 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 6.1 p-10 -57.62 -47.35 82.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -65.53 -19.05 65.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 17.5 tt0 -71.15 -48.82 49.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 29' ' ' GLN . 0.9 OUTLIER -45.7 -26.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 108.735 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 10.3 t70 -64.65 -51.14 64.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.842 . . . . 0.0 109.109 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.7 m -54.62 -44.35 73.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.087 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.25 -36.11 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.197 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.633 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 2.0 m-30 -80.28 -83.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 109.346 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 23.01 67.09 0.02 OUTLIER Glycine 0 N--CA 1.503 3.115 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -172.88 -39.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.247 . . . . 0.0 109.922 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.595 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -94.38 -77.52 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.177 -0.952 . . . . 0.0 109.584 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 -168.15 14.94 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.32 32.58 4.36 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -1.232 . . . . 0.0 109.555 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 26.62 101.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.774 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.627 HG23 ' HD3' ' A' ' 61' ' ' ARG . 0.7 OUTLIER -76.54 9.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.362 -1.461 . . . . 0.0 110.129 -179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.561 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -168.04 -164.65 0.56 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.638 -1.289 . . . . 0.0 110.776 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 159.02 106.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.33 -178.5 5.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.62 -1.3 . . . . 0.0 110.905 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 27' ' ' ASP . 5.3 mp -139.25 141.65 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.8 mp -127.58 130.38 48.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -114.35 164.04 14.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 53' ' ' ARG . 10.9 t70 -134.99 69.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.276 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -129.73 1.1 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.566 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.84 15.9 1.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.453 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 t -142.14 -39.48 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.827 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.81 34.51 59.24 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.569 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -105.64 -56.97 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.176 . . . . 0.0 109.584 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 53' ' ' ARG . 37.4 Cg_endo -89.18 -163.31 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.595 1.313 . . . . 0.0 109.904 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.56 62.19 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.235 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.476 ' O ' ' CG1' ' A' ' 57' ' ' VAL . . . 54.75 78.87 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' CG1' ' O ' ' A' ' 56' ' ' GLY . 13.6 m -157.38 143.08 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -1.101 . . . . 0.0 109.704 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . . . -100.47 -176.45 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 108.801 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.682 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -133.93 108.02 8.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 109.55 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 16' ' ' LEU . 1.7 t -85.89 160.85 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -104.71 140.85 37.46 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.67 ' CE2' ' CB ' ' A' ' 71' ' ' ALA . 9.4 m-85 -161.39 68.99 0.32 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' O ' ' CB ' ' A' ' 14' ' ' THR . 18.0 m-20 -46.86 -86.6 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.434 -0.791 . . . . 0.0 109.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 9' ' ' GLU . 6.5 ttmm -37.01 118.37 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.326 0.584 . . . . 0.0 109.672 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' HB2' ' CA ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -45.74 -47.7 15.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.629 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 14.6 mt-10 -54.38 -50.02 68.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 3.1 tp10 -53.86 -42.78 68.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.548 ' CA ' ' HB3' ' A' ' 62' ' ' TYR . . . -55.43 -39.33 70.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.838 -1.164 . . . . 0.0 108.594 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.47 -44.73 76.73 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -49.2 -62.24 1.64 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.67 ' CB ' ' CE2' ' A' ' 62' ' ' TYR . . . -43.37 -40.09 3.48 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.524 -0.735 . . . . 0.0 109.152 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 40.8 mm -46.99 -60.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -68.82 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.595 ' CB ' ' CZ ' ' A' ' 37' ' ' TYR . . . -45.94 -50.95 14.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 111.588 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.633 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.18 -28.17 42.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.723 -1.235 . . . . 0.0 110.635 -178.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.0 t30 -46.15 115.29 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.251 -1.53 . . . . 0.0 107.463 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.504 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 60.81 78.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 75' ' ' LEU . 1.6 m -85.23 45.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' N ' ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.97 145.05 25.93 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.42 -0.8 . . . . 0.0 109.234 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 81' ' ' GLU . 36.3 Cg_endo -62.47 139.21 75.19 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.91 1.479 . . . . 0.0 109.328 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -40.33 107.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 -179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.72 38.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 81.56 -139.47 20.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 1.4 t 78.77 -4.82 2.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.598 -0.942 . . . . 0.0 109.391 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 84' ' ' SER . 24.7 mt-30 57.97 117.22 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.835 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.504 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.5 Cg_endo -83.75 177.74 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.905 1.476 . . . . 0.0 110.295 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -118.09 138.73 52.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 109.574 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.475 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 19.2 m -79.04 103.81 9.24 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' HD12 ' A' ' 16' ' ' LEU . 1.2 m -83.08 144.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.731 0.776 . . . . 0.0 110.886 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.92 132.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 14' ' ' THR . 0.3 OUTLIER -61.29 116.21 4.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.12 162.26 25.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -95.15 71.45 3.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -150.31 -38.13 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 97.8 m-70 62.41 105.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.23 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.412 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -177.41 96.0 0.1 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -100.5 177.95 4.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 109.617 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 47.2 t80 -152.32 20.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.842 . . . . 0.0 109.441 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.07 -58.29 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -68.03 144.23 96.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.503 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 37.0 Cg_endo -94.04 1.05 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.059 1.558 . . . . 0.0 110.063 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -158.37 14.97 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' OE1' ' A' ' 93' ' ' GLU . . . -127.6 -131.88 3.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.465 ' O ' ' OG ' ' A' ' 10' ' ' SER . 0.2 OUTLIER 65.07 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -1.156 . . . . 0.0 109.915 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.491 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -171.95 -162.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.589 ' CD1' ' HB3' ' A' ' 63' ' ' ASN . 1.4 pp -68.11 81.72 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.556 -0.715 . . . . 0.0 109.136 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 42.81 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 111.084 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.553 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 12.5 m-20 -157.97 -105.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.012 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -159.21 92.46 1.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.665 -1.272 . . . . 0.0 110.394 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.554 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 33.3 p-10 -83.65 168.53 16.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.324 -0.86 . . . . 0.0 109.564 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 ' CD1' ' CG1' ' A' ' 89' ' ' VAL . 0.7 OUTLIER -134.89 122.16 21.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.459 -1.401 . . . . 0.0 110.43 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' CD1' ' CE2' ' A' ' 59' ' ' PHE . 9.4 t80 -78.14 135.75 37.72 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 88' ' ' SER . 3.5 m -116.35 148.07 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.995 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 HG21 ' CZ ' ' A' ' 17' ' ' TYR . 28.3 p -131.54 178.34 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.377 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 57.17 91.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.432 HD12 HG22 ' A' ' 45' ' ' ILE . 23.2 mt -108.99 175.32 2.0 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 109.121 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -114.22 6.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.743 1.391 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 163.4 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.49 ' O ' ' CD1' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -162.36 -44.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.444 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.466 ' O ' ' O ' ' A' ' 24' ' ' THR . 1.1 mt 47.99 -174.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 108.913 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.28 143.83 30.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.976 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 1.5 m-20 -57.79 -62.02 2.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.349 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -51.06 -18.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 22.2 mt-30 -75.08 -61.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.368 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 1.3 tp -44.5 -25.2 0.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.077 -1.014 . . . . 0.0 109.719 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 1.2 m-20 -64.52 -54.49 31.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.982 -1.074 . . . . 0.0 108.878 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -62.38 -35.94 80.74 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.399 -0.813 . . . . 0.0 109.087 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.581 HG21 ' CD1' ' A' ' 34' ' ' PHE . 4.5 tt -61.3 -27.69 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 108.67 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.581 ' CD1' HG21 ' A' ' 33' ' ' ILE . 12.3 m-85 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 36' ' ' LYS . . . 155.54 -91.69 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 169.3 50.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.812 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -93.76 -86.51 0.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.152 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.517 ' CA ' ' HG3' ' A' ' 67' ' ' GLU . . . -74.09 157.33 51.14 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 40' ' ' ILE . 28.1 t -79.35 79.57 5.78 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.115 -1.227 . . . . 0.0 107.904 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -34.83 115.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.662 0.744 . . . . 0.0 109.574 -178.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.585 ' CG2' ' HB3' ' A' ' 61' ' ' ARG . 6.2 m -81.53 38.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 110.122 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 2.9 tt0 91.65 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.602 0.715 . . . . 0.0 111.035 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -99.95 151.45 21.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -145.65 175.68 10.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.59 -1.319 . . . . 0.0 110.992 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 58' ' ' ALA . 49.9 mt -143.19 134.43 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.1 151.43 31.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.978 -1.076 . . . . 0.0 109.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.88 -35.52 0.41 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.165 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -78.7 177.38 8.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.059 -1.025 . . . . 0.0 109.93 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.56 -43.56 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.08 -40.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.482 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 m -134.05 6.12 3.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.14 -0.975 . . . . 0.0 109.62 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.5 59.23 1.03 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 150.76 89.22 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -1.135 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -85.26 82.94 1.55 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.006 1.53 . . . . 0.0 110.385 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -133.74 -89.62 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 109.314 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.23 74.66 1.28 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' CG1' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -126.33 140.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 18' ' ' VAL . . . -113.79 -174.34 2.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.483 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 m-85 -143.57 99.14 3.37 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.544 ' CG1' ' CD2' ' A' ' 16' ' ' LEU . 15.6 t -85.85 148.66 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 9.5 mtt180 -137.33 79.25 1.74 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.415 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CE1' ' HB3' ' A' ' 71' ' ' ALA . 11.1 m-85 -78.86 160.04 27.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.589 ' HB3' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -103.45 -91.95 0.35 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.111 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -25.54 136.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.515 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -50.93 -51.25 54.04 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 70' ' ' GLU . 16.5 mt-10 -63.43 -35.33 80.07 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.517 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -61.34 -28.12 68.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.534 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -75.82 -43.93 43.58 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -60.56 -20.77 61.4 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.53 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -70.75 -61.51 1.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.624 ' HB3' ' CE1' ' A' ' 62' ' ' TYR . . . -68.44 -5.13 17.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.561 0.696 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.552 ' HA ' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -86.43 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.723 -1.236 . . . . 0.0 108.21 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -75.29 -1.64 24.5 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.818 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 70' ' ' GLU . . . -125.84 -47.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 110.357 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.58 HD22 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -84.09 -21.14 31.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 110.556 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 23.6 p-10 -46.95 -23.83 0.51 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.55 -1.344 . . . . 0.0 109.128 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 85' ' ' GLN . 3.4 m-80 -143.59 86.63 1.89 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.54 ' N ' ' HG2' ' A' ' 86' ' ' PRO . 2.2 p -78.46 88.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 108.838 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.54 HG22 ' HB3' ' A' ' 84' ' ' SER . 0.8 OUTLIER -147.55 -172.61 0.32 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.48 -0.762 . . . . 0.0 109.085 -179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -102.7 24.06 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.899 1.473 . . . . 0.0 109.424 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER 73.24 114.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 0.0 109.693 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.83 -18.65 1.11 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 137.44 -148.76 20.0 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.54 ' HB3' HG22 ' A' ' 79' ' ' ILE . 6.2 t 83.83 -28.11 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.799 -0.824 . . . . 0.0 109.837 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.493 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER 38.41 92.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.245 -0.909 . . . . 0.0 110.755 179.331 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.54 ' HG2' ' N ' ' A' ' 78' ' ' VAL . 36.2 Cg_endo -121.24 -178.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.925 1.487 . . . . 0.0 110.049 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 18' ' ' VAL . 77.3 mt 25.07 68.02 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 7.4 m -77.25 102.12 6.54 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.592 ' CG1' ' CD1' ' A' ' 16' ' ' LEU . 14.7 m -77.85 163.87 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.313 1.054 . . . . 0.0 113.153 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 91' ' ' LEU . 2.1 ttt180 171.2 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER -33.64 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.622 -0.674 . . . . 0.0 109.386 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.79 179.48 6.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.86 -1.15 . . . . 0.0 110.279 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 8' ' ' GLY . 1.2 mm-40 -123.35 105.22 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.443 -0.785 . . . . 0.0 109.176 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.31 -163.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -108.38 30.62 6.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.431 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.01 -33.66 0.05 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' CB ' HG21 ' A' ' 11' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.213 -1.169 . . . . 0.0 109.61 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.272 0.558 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 t -90.01 175.8 7.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.95 . . . . 0.0 109.719 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.6 m-30 -57.37 -64.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 5' ' ' ARG . . . -146.28 170.84 15.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.736 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 5' ' ' ARG . 4.3 ttp85 65.32 118.73 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.756 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.49 ' HG2' ' HB3' ' A' ' 91' ' ' LEU . 36.8 Cg_endo -118.46 159.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.868 1.457 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.497 ' HA3' ' OG1' ' A' ' 14' ' ' THR . . . 166.73 -174.48 42.12 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.628 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' O ' ' CD ' ' A' ' 65' ' ' ARG . . . -154.53 -90.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . 12.6 pt-20 -178.86 -177.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -1.23 . . . . 0.0 109.698 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.479 ' O ' ' CB ' ' A' ' 63' ' ' ASN . 1.5 m 73.95 148.01 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 109.302 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.564 HG21 ' CB ' ' A' ' 41' ' ' VAL . 11.1 mm -72.3 81.25 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER 153.02 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' O ' HD12 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -145.59 -88.17 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.48 -179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.514 ' N ' ' HA ' ' A' ' 63' ' ' ASN . 3.2 m -79.22 71.62 5.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 110.03 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -76.89 -177.27 4.29 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.589 ' CD1' ' HB ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER -112.28 103.79 11.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.702 -1.249 . . . . 0.0 111.407 -178.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' CZ ' ' A' ' 59' ' ' PHE . 2.8 t80 -83.11 81.92 8.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.5 m -82.47 129.68 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 111.261 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.548 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 19.6 m -131.76 172.18 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 19' ' ' THR . 20.3 t-20 79.27 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.969 . . . . 0.0 110.121 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -170.1 144.98 2.28 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.018 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -106.85 69.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.626 1.329 . . . . 0.0 111.003 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 4.2 mtm180 40.1 36.38 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.432 ' OG1' ' OE1' ' A' ' 85' ' ' GLN . 89.2 m -79.82 -5.24 55.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 0.0 109.23 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -152.32 150.27 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.174 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -91.55 155.41 18.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 5.4 p-10 -62.31 -49.63 74.86 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.166 -0.959 . . . . 0.0 108.488 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 6.6 t0 -50.79 -22.5 2.18 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -77.37 -41.48 40.04 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.831 . . . . 0.0 109.777 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.58 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 6.9 mp -47.3 -44.35 23.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.006 . . . . 0.0 109.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 6.9 t70 -58.03 -41.32 82.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.818 -1.176 . . . . 0.0 108.991 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -36.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.491 -0.755 . . . . 0.0 110.476 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.585 HG21 ' CD1' ' A' ' 34' ' ' PHE . 1.2 tt -67.21 -33.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.784 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.68 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . 1.8 m-85 -84.37 -72.03 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 109.075 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 36' ' ' LYS . . . 104.09 -40.74 2.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CD ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -175.22 98.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.261 . . . . 0.0 109.437 -179.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.703 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -136.67 -21.7 1.28 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.91 -175.5 46.0 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 40' ' ' ILE . 1.4 t -88.91 71.99 8.52 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.372 -1.075 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.635 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -37.71 134.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.636 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 3.9 m -102.21 48.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 111.788 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.716 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 1.1 tm0? 89.28 131.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.592 0.71 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 mtmp? -100.66 169.66 8.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -160.56 163.9 32.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.916 -1.115 . . . . 0.0 110.341 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 27' ' ' ASP . 1.8 mt -141.11 107.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.589 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 2.0 mm? -93.91 130.9 39.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.335 -0.853 . . . . 0.0 109.145 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.418 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 4.9 ptt180 -135.34 -58.66 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.898 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' OD1' ' HG3' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -140.42 -174.97 4.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.953 -1.092 . . . . 0.0 109.662 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -81.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.7 mt -120.6 -12.55 8.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 109.442 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.49 -160.51 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.95 25.7 25.53 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.07 114.83 30.57 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.201 -1.176 . . . . 0.0 109.634 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 55' ' ' ARG . 36.7 Cg_endo -74.89 -81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.976 1.514 . . . . 0.0 110.067 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 8.5 ttm180 83.86 -54.98 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.758 -0.589 . . . . 0.0 109.749 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.01 84.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.451 HG11 HG21 ' A' ' 19' ' ' THR . 10.7 m -145.89 139.88 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -1.084 . . . . 0.0 109.075 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.493 ' O ' HG21 ' A' ' 18' ' ' VAL . . . -124.55 177.11 6.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.555 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 47.8 m-85 -142.84 107.97 4.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.554 ' CG1' ' CD2' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -78.8 177.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.14 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.716 ' HB3' ' N ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -107.03 123.76 48.66 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.3 -177.194 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -163.93 158.34 19.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.92 -1.113 . . . . 0.0 109.77 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.551 ' OD1' ' CG1' ' A' ' 41' ' ' VAL . 5.2 p-10 -148.32 -64.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 0.0 110.962 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 66' ' ' GLU . 0.7 OUTLIER -49.55 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 108.977 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.493 ' HG2' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -30.36 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.748 -0.595 . . . . 0.0 111.379 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 64' ' ' LYS . 56.9 mt-10 -66.71 -64.61 0.82 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.894 -1.129 . . . . 0.0 109.426 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . 26.3 pt-20 -56.02 -24.13 37.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.903 -1.123 . . . . 0.0 108.711 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.436 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -65.03 -44.63 88.5 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.467 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 52.8 tt0 -48.19 -33.69 8.89 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -60.13 -53.0 62.92 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.521 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -60.97 -11.91 9.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.072 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 33.0 mm -80.17 -59.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.12 4.3 8.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.565 -0.709 . . . . 0.0 110.172 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.42 -54.31 1.02 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.101 . . . . 0.0 109.862 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.628 ' CG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -79.4 -11.27 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.322 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.587 ' HB2' HG23 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -82.86 42.42 0.79 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.405 -1.435 . . . . 0.0 109.145 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.556 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 2.0 p30 156.27 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.519 ' CG1' ' O ' ' A' ' 78' ' ' VAL . 2.1 t -79.97 87.62 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 172.58 135.74 0.1 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.473 -0.767 . . . . 0.0 109.181 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.486 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 36.6 Cg_endo -43.73 117.31 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.979 1.515 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -45.37 147.12 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 120.95 -59.64 0.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -60.81 -127.68 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -179.89 35.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 109.554 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.531 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 13.2 mt-30 -129.44 71.3 82.08 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.391 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.6 Cg_endo -100.69 -171.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.896 1.472 . . . . 0.0 110.954 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -116.47 113.62 23.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.24 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.1 t -78.53 102.65 8.0 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' HB ' ' CD1' ' A' ' 16' ' ' LEU . 17.0 m -78.5 153.89 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.008 0.909 . . . . 0.0 111.576 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 4.3 ttm-85 173.99 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.49 ' HB3' ' HG2' ' A' ' 6' ' ' PRO . 7.4 tp -52.42 136.82 30.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.938 -1.101 . . . . 0.0 108.978 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' A' ' 17' ' ' TYR . . . -133.79 145.42 49.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.31 141.47 35.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -179.81 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -159.65 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.55 -117.25 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.218 -1.166 . . . . 0.0 109.621 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 68.7 m -103.96 73.18 1.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 2' ' ' SER . 33.9 m-85 73.12 -80.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.481 -0.762 . . . . 0.0 109.542 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.83 -67.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.89 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 175.28 1.51 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 108.709 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.474 ' HG2' ' CB ' ' A' ' 91' ' ' LEU . 37.5 Cg_endo -109.73 164.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.683 1.359 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.91 -170.34 19.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.0 -129.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.56 179.45 5.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -1.105 . . . . 0.0 109.711 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.69 47.89 0.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.839 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.574 ' CD1' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.5 98.91 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.018 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.543 ' HB2' HD12 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 79.69 -59.31 0.35 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.891 -0.506 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.6 ' HB2' ' N ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -160.95 -99.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.474 -1.391 . . . . 0.0 111.584 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.568 ' CG2' ' HG3' ' A' ' 65' ' ' ARG . 7.7 p -107.75 -133.73 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.35 -1.469 . . . . 0.0 109.867 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.54 ' CB ' HD12 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -164.56 -167.6 1.31 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.243 -0.911 . . . . 0.0 108.932 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.605 ' CD2' ' CB ' ' A' ' 71' ' ' ALA . 2.8 tp -154.62 121.54 5.54 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.676 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 11.4 t80 -110.17 117.26 33.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.808 -1.182 . . . . 0.0 109.726 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.567 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 18.8 m -112.36 131.77 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 110.006 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.529 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 11.1 t -127.04 -166.53 1.61 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 108.896 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER 81.78 -65.24 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.317 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -38.3 126.45 1.08 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.954 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -106.37 64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.971 1.511 . . . . 0.0 110.639 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 65.08 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.906 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.456 ' OG1' ' OE1' ' A' ' 85' ' ' GLN . 19.7 m -124.0 -24.93 4.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 109.964 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pt -111.35 179.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -114.35 153.04 30.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.798 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 1.9 m-20 -63.35 -60.13 3.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 108.911 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -43.23 -26.39 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.305 -0.872 . . . . 0.0 109.382 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -72.23 -63.44 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.533 ' CB ' ' HD3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -45.96 -24.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.124 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 1.6 t70 -64.86 -59.12 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.022 . . . . 0.0 109.118 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 92.8 m -64.28 -12.39 41.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.436 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG22 ' CG2' ' A' ' 78' ' ' VAL . 12.8 mm -77.72 -45.78 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.977 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.598 ' CD1' HD12 ' A' ' 75' ' ' LEU . 7.8 p90 -142.35 49.6 1.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.49 36.73 4.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -100.28 -44.97 5.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.618 ' CD1' ' OH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -79.42 -97.73 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.72 131.76 10.61 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 40' ' ' ILE . 53.4 p -79.03 75.26 5.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.915 -1.344 . . . . 0.0 108.48 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.622 ' O ' ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER 23.59 108.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.883 1.325 . . . . 0.0 110.319 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.602 ' HB ' ' O ' ' A' ' 61' ' ' ARG . 3.1 t -75.61 -4.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.968 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 170.11 99.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.544 -0.722 . . . . 0.0 110.033 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HD3' ' CB ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -87.16 87.09 7.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.965 . . . . 0.0 108.621 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.76 147.39 25.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 HG23 ' OD1' ' A' ' 27' ' ' ASP . 19.5 tt -161.5 140.1 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.042 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.46 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 3.3 pp -161.59 155.07 21.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.08 . . . . 0.0 110.141 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.474 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -155.63 -163.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.389 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 54.2 p30 -97.88 175.13 6.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -103.59 -59.54 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -123.35 -56.66 1.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 p -140.29 150.11 43.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 53' ' ' ARG . . . 128.02 -72.99 0.46 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER 40.49 84.8 0.18 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.513 -0.992 . . . . 0.0 109.69 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.412 ' C ' ' HG3' ' A' ' 55' ' ' ARG . 36.5 Cg_endo -90.68 -37.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.43 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.412 ' HG3' ' C ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -130.85 -60.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 47' ' ' ARG . . . 51.83 86.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.539 ' CG1' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -160.95 166.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.125 . . . . 0.0 109.999 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 18' ' ' VAL . . . -129.53 150.26 50.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 93.5 m-85 -126.46 101.67 6.79 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.935 -1.103 . . . . 0.0 110.616 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.573 ' O ' ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -81.8 107.11 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 176.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.602 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -76.97 87.25 3.5 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 120.138 -1.601 . . . . 0.0 108.618 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.618 ' OH ' ' CD1' ' A' ' 37' ' ' TYR . 2.1 t80 -94.7 114.26 26.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' O ' ' A' ' 64' ' ' LYS . 9.1 m120 -71.32 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.817 -1.553 . . . . 0.0 111.148 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.63 ' O ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 7.32 127.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.568 ' HG3' ' CG2' ' A' ' 14' ' ' THR . 0.1 OUTLIER -62.23 -61.67 2.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.051 178.361 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -53.04 62.79 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 109.618 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.601 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 81.8 mt-10 -67.01 -10.9 54.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' CB ' ' OG1' ' A' ' 14' ' ' THR . . . -75.19 -37.89 61.03 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.562 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -69.71 -20.75 63.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.582 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 2.8 mt-10 -62.65 -75.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 62' ' ' TYR . . . -50.11 -23.08 1.92 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.562 ' HB ' ' O ' ' A' ' 69' ' ' GLN . 2.6 mm -58.36 -51.64 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.688 -1.257 . . . . 0.0 107.795 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -86.47 -59.46 2.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.083 . . . . 0.0 110.231 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.52 -44.0 62.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 110.446 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.598 HD12 ' CD1' ' A' ' 34' ' ' PHE . 5.5 tp -79.25 -38.8 34.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.062 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.4 t-20 -40.96 116.71 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.506 ' N ' ' ND2' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 67.29 78.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.537 ' O ' ' CG2' ' A' ' 79' ' ' ILE . 7.4 p -86.18 52.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.078 -1.014 . . . . 0.0 109.773 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.541 ' CG2' ' HB2' ' A' ' 84' ' ' SER . 0.3 OUTLIER -176.35 170.23 1.19 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.385 -0.822 . . . . 0.0 108.908 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -87.96 39.11 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.758 1.399 . . . . 0.0 109.677 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 46.88 68.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 108.771 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.8 1.97 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 85' ' ' GLN . . . 127.61 -50.96 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 120.885 -1.362 . . . . 0.0 110.332 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.541 ' HB2' ' CG2' ' A' ' 79' ' ' ILE . 73.1 m -50.93 -18.9 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 110.316 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' A' ' 84' ' ' SER . 7.0 mp0 64.53 140.8 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.455 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.0 Cg_endo -84.25 -179.86 4.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.153 1.607 . . . . 0.0 111.455 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.567 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -122.06 123.87 42.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 109.098 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB3' ' CG2' ' A' ' 19' ' ' THR . 0.2 OUTLIER -78.5 97.04 5.57 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' A' ' 16' ' ' LEU . 14.5 m -78.27 163.63 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 122.301 1.048 . . . . 0.0 112.049 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.533 ' CG ' ' HB3' ' A' ' 17' ' ' TYR . 5.5 ptp180 173.42 -133.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.54 HD12 ' CB ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -146.73 119.46 8.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.679 -1.263 . . . . 0.0 108.217 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.498 ' HB1' ' CG ' ' A' ' 17' ' ' TYR . . . -145.68 -174.07 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.787 -1.196 . . . . 0.0 109.76 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -172.29 88.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.861 . . . . 0.0 109.185 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -46.42 -31.0 2.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -168.82 -152.63 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.49 95.27 1.57 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.416 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.56 155.83 28.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -133.05 26.83 4.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.69 168.44 18.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.262 -0.899 . . . . 0.0 109.761 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.495 ' CG ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -117.77 175.39 2.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 91' ' ' LEU . 35.4 Cg_endo -65.41 -163.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.637 1.335 . . . . 0.0 109.924 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 92' ' ' ALA . . . -143.68 -158.52 7.61 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.408 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.83 -155.58 10.21 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 10' ' ' SER . 1.7 mt-10 -162.75 -172.11 2.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.154 -1.204 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' C ' ' A' ' 11' ' ' ILE . 1.3 t 64.55 133.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER 35.7 71.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.822 0.82 . . . . 0.0 109.011 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 67.28 -173.86 0.19 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' HB3' ' HA ' ' A' ' 9' ' ' GLU . 3.2 p-10 -155.95 87.16 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.363 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -161.44 34.26 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.549 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 39.0 p-10 -76.93 -171.78 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.623 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -156.18 119.69 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -81.58 134.07 35.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.568 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -106.23 150.38 8.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.523 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.492 HG21 ' CB ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -115.42 168.94 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.439 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' PRO . 86.1 m-20 61.26 72.95 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.19 115.27 10.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 109.408 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.76 -171.27 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.044 1.549 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -114.0 17.38 17.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -79.76 -56.84 3.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.191 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.567 ' CG1' ' N ' ' A' ' 26' ' ' THR . 2.0 tt -82.41 167.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.12 146.12 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 2.9 p30 -59.45 -44.31 92.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 6.9 t0 -58.46 -24.92 61.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 30' ' ' LEU . 7.8 mt-30 -73.76 -40.5 63.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 5.5 mp -42.77 -54.19 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.407 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -41.48 -49.22 3.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.875 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -61.26 -43.63 98.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.012 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.71 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 10.1 tp -57.04 -24.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.891 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.71 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 3.2 m-85 -97.69 -73.09 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.812 -1.18 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.54 -80.82 0.24 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.98 105.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.151 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -94.85 -83.4 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 108.976 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . -98.87 -93.18 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.571 ' O ' ' C ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -150.47 67.63 0.96 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.641 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -23.75 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.718 0.77 . . . . 0.0 109.715 -178.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.598 ' N ' ' CB ' ' A' ' 61' ' ' ARG . 5.3 m -90.04 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.624 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 82.6 120.29 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.415 -0.803 . . . . 0.0 112.191 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.587 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -124.02 132.59 53.71 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.77 146.0 30.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.638 -1.289 . . . . 0.0 110.503 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HG21 ' O ' ' A' ' 45' ' ' ILE . 1.7 tt -92.02 124.07 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 1.7 mm? -106.96 138.53 42.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.102 -0.999 . . . . 0.0 110.215 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 53.9 mtp180 -117.36 -61.57 1.69 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.756 . . . . 0.0 109.029 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER 172.56 142.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.189 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -120.76 -17.5 7.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.94 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.62 -46.48 5.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.78 -143.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.25 80.56 0.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -74.38 166.49 44.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -112.96 -1.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.972 1.511 . . . . 0.0 110.29 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -71.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.12 91.51 1.8 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 46' ' ' LEU . 2.1 m -96.89 171.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -1.192 . . . . 0.0 109.623 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -147.68 -179.13 6.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.291 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 m-85 -152.15 115.64 4.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.669 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.612 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.07 153.84 4.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.54 -1.35 . . . . 0.0 107.684 178.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.641 ' CD ' ' HB ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -95.18 132.53 40.03 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.084 0.945 . . . . 0.0 111.299 -178.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -163.26 147.01 10.73 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' C ' ' A' ' 64' ' ' LYS . 13.0 p30 -137.88 -118.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.785 -1.197 . . . . 0.0 107.879 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.63 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 10.43 103.27 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 CA-C-N 118.626 0.648 . . . . 0.0 110.855 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.05 -59.25 0.14 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.611 -0.681 . . . . 0.0 111.069 -178.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.9 -50.6 65.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.685 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 85.3 mt-10 -49.65 -48.9 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 110.34 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.39 -46.75 47.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.333 -1.479 . . . . 0.0 108.038 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 5.4 tt0 -52.92 -42.38 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 7.5 mm-40 -50.04 -66.6 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 0.0 108.585 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.635 ' CB ' ' CE1' ' A' ' 62' ' ' TYR . . . -51.01 -29.62 13.0 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.895 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 24.6 mm -60.03 -49.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.465 -1.397 . . . . 0.0 108.407 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.4 m -84.35 -65.49 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 110.117 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.01 76.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.464 -0.773 . . . . 0.0 111.303 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.69 ' HG ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -79.45 -38.96 33.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.62 -1.3 . . . . 0.0 110.597 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 23.8 t-20 -52.6 131.77 34.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.264 -1.522 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.595 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 8.7 m120 64.56 69.84 0.5 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 3.3 p -86.22 61.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.498 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.73 162.39 18.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.498 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.8 Cg_endo -87.14 41.21 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.656 1.345 . . . . 0.0 109.986 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' PRO . 9.0 mt-10 59.94 147.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.91 -76.37 0.41 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.67 -25.32 60.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.43 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER 58.27 28.75 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.115 . . . . 0.0 109.942 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.557 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 2.0 mt-30 -127.57 75.39 77.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.025 -1.047 . . . . 0.0 109.581 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.595 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -109.28 -161.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.879 1.463 . . . . 0.0 110.773 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -103.15 123.06 45.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 110.356 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -78.47 111.26 14.31 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 76' ' ' ASN . 2.9 m -78.19 155.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.428 1.109 . . . . 0.0 112.395 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.558 ' HD2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 167.53 126.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 15.0 mt -41.76 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.01 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' GLY . . . -84.51 167.81 16.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 7' ' ' GLY . 3.1 mt-10 -64.07 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.45 4.55 10.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.222 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -125.22 112.54 16.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.03 -1.044 . . . . 0.0 109.599 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.96 178.51 34.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 17.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 109.43 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HA ' ' CE2' ' A' ' 3' ' ' TYR . 1.6 ttt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.18 61.14 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 3' ' ' TYR . 21.6 p90 -165.09 157.02 15.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.95 -88.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.527 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 101.15 2.09 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.547 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.576 ' HG2' ' CG ' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -92.37 -165.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.887 1.467 . . . . 0.0 109.993 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.506 ' HA3' ' HG3' ' A' ' 65' ' ' ARG . . . -172.26 -145.09 4.8 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.052 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.554 ' N ' ' HB3' ' A' ' 13' ' ' ASP . . . 178.67 -108.35 0.24 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -166.72 136.5 3.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.959 -1.318 . . . . 0.0 110.646 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.478 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.3 OUTLIER 74.85 172.19 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.49 -0.756 . . . . 0.0 111.176 178.645 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 12' ' ' LYS . 13.3 mm -61.18 87.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.597 -0.689 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.6 pttt 147.88 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.554 ' HB3' ' N ' ' A' ' 8' ' ' GLY . 18.9 m-20 -111.27 -92.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 0.0 110.747 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 6' ' ' PRO . 10.0 t -82.04 64.42 6.71 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.332 -0.855 . . . . 0.0 110.402 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.532 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 2.2 p-10 -76.76 160.63 29.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -137.57 125.8 23.13 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 117.621 -1.632 . . . . 0.0 111.636 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -85.12 114.82 22.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.606 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 32.5 m -88.89 139.32 17.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.99 -179.48 3.71 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.332 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER 57.58 86.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 109.269 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.456 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -163.18 132.75 3.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.546 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD3' ' OE1' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -108.66 52.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.965 1.508 . . . . 0.0 110.194 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' PRO . 77.3 mtt180 41.7 53.08 4.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -96.0 -21.5 17.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.459 ' CD1' HD12 ' A' ' 45' ' ' ILE . 1.3 pp -121.81 160.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.389 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -96.66 157.12 16.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.162 -0.961 . . . . 0.0 109.992 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.523 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -59.89 -53.67 55.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -3.0 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.896 -1.127 . . . . 0.0 109.625 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.473 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.0 OUTLIER -83.1 -63.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 110.722 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 3.2 mp -44.3 -37.22 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.52 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 30.5 t0 -49.7 -55.82 12.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.662 -1.274 . . . . 0.0 109.228 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.6 m -65.18 -21.44 66.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -83.01 -15.12 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.718 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.663 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 10.5 p90 -153.4 33.86 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' HA2' ' CD1' ' A' ' 40' ' ' ILE . . . -97.57 61.56 1.01 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.134 -1.604 . . . . 0.0 109.697 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -138.54 -10.55 1.4 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.058 -1.26 . . . . 0.0 111.183 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CD2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -85.7 -50.14 7.41 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.684 -1.26 . . . . 0.0 109.875 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.49 -160.2 8.63 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' C ' ' A' ' 40' ' ' ILE . 14.5 m -95.35 72.77 3.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.275 -1.132 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.566 ' HB ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -25.65 131.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-O 121.153 0.502 . . . . 0.0 110.046 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.726 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 3.2 m -98.76 56.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 12.2 tt0 94.26 100.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.581 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -83.05 165.79 19.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.98 158.1 32.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.838 -1.164 . . . . 0.0 109.892 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -158.41 117.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.343 -0.848 . . . . 0.0 109.316 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.21 158.98 43.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.766 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -122.36 -81.8 0.64 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.416 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 2.6 p30 -99.3 -171.72 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.632 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -171.97 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.298 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 51' ' ' THR . 1.1 mp -128.61 -75.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.46 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 50' ' ' LEU . 25.7 p -149.68 19.2 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -87.77 -35.35 9.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.5 ptt180 37.88 55.45 4.19 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.611 -0.934 . . . . 0.0 109.934 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.31 -169.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.868 1.457 . . . . 0.0 110.358 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.36 -5.71 58.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.816 . . . . 0.0 109.619 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . 107.27 112.03 3.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.71 163.61 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.145 . . . . 0.0 109.431 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.606 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -134.26 -174.1 3.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 108.941 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -149.17 104.48 3.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG11 ' CD2' ' A' ' 16' ' ' LEU . 2.2 t -79.54 152.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.041 -1.037 . . . . 0.0 108.461 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.726 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.27 128.4 46.35 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.402 0.62 . . . . 0.0 111.022 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.623 ' CE2' ' CB ' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -164.4 146.05 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.184 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.523 ' CA ' ' HB2' ' A' ' 13' ' ' ASP . 1.0 OUTLIER -133.26 -48.56 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' O ' ' C ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -58.72 106.14 0.37 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.506 ' HG3' ' HA3' ' A' ' 7' ' ' GLY . 1.7 mpp_? -34.83 -55.63 0.57 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.178 0.513 . . . . 0.0 110.265 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -47.95 79.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 62' ' ' TYR . 39.7 tt0 -52.26 -29.4 22.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -68.79 -48.54 63.37 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.978 -1.076 . . . . 0.0 108.45 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -47.41 -32.33 4.89 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 20.4 mm-40 -67.38 -49.32 64.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.731 -0.606 . . . . 0.0 109.484 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.623 ' CB ' ' CE2' ' A' ' 62' ' ' TYR . . . -65.73 -13.54 59.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 19.3 mm -81.51 -69.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.012 -1.055 . . . . 0.0 108.596 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -77.48 8.6 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.635 -0.666 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 70' ' ' GLU . . . -130.02 -50.53 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.609 HD12 ' CD2' ' A' ' 34' ' ' PHE . 5.4 mp -78.91 -32.31 45.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.014 -1.054 . . . . 0.0 108.515 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 40.7 t-20 -55.18 125.06 19.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 4.4 m120 65.97 72.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 7.7 p -86.81 48.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -154.96 134.16 7.58 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 34.7 Cg_endo -46.5 138.16 14.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.774 1.408 . . . . 0.0 109.758 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 80' ' ' PRO . 2.5 mm-40 -42.23 145.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.059 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.02 -29.49 2.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 140.31 -127.59 3.55 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HB2' HG23 ' A' ' 79' ' ' ILE . 1.2 m 70.7 3.46 4.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.323 -1.104 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' OE1' ' HD3' ' A' ' 22' ' ' PRO . 4.7 mt-30 64.94 122.73 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.055 -1.028 . . . . 0.0 109.203 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.536 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -108.12 152.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 110.803 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -70.17 119.62 14.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.578 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -78.59 98.45 6.16 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 33.8 m -78.83 153.47 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.02 0.915 . . . . 0.0 111.671 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 154.32 141.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.576 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -59.78 134.68 57.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.53 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 93' ' ' GLU . . . -94.1 -31.48 14.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 109.597 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 0.8 OUTLIER 76.23 63.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.187 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.0 -34.8 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.594 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -148.83 -92.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 15' ' ' ASN . . . -176.61 -44.89 0.06 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.482 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.236 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -103.46 96.17 6.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.68 -30.13 70.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.294 -0.879 . . . . 0.0 109.568 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.37 118.61 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.729 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.492 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . 12.5 ptt180 -58.47 142.78 81.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 108.689 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 5' ' ' ARG . 35.6 Cg_endo -41.3 133.77 3.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.857 1.451 . . . . 0.0 111.042 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.78 92.05 0.12 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.84 -163.2 33.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -65.19 123.35 19.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -1.106 . . . . 0.0 109.727 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -179.01 -157.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' CD1' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -36.67 158.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -25.76 -41.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.954 0.407 . . . . 0.0 111.433 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB3' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -131.21 -67.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.943 -1.098 . . . . 0.0 111.596 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.546 ' CA ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -161.53 102.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.575 ' N ' HG23 ' A' ' 11' ' ' ILE . 46.8 p30 -98.38 -163.89 1.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.463 -0.773 . . . . 0.0 109.078 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.658 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -160.34 119.2 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.599 -1.24 . . . . 0.0 112.151 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -79.41 131.47 36.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.587 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 3.8 m -124.16 149.57 28.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.513 -1.367 . . . . 0.0 111.465 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 HG21 HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -135.97 -153.32 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.525 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 34.77 16.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.995 . . . . 0.0 110.287 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' O ' ' CD1' ' A' ' 21' ' ' LEU . 2.9 pp -170.49 128.72 0.78 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -102.81 67.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.979 1.515 . . . . 0.0 109.934 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' HG2' HD11 ' A' ' 45' ' ' ILE . 26.6 mtp180 62.11 54.64 2.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.5 p -79.8 -1.09 37.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -151.4 -160.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.6 p -122.12 151.53 40.84 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 92.6 m-20 -49.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.339 -0.851 . . . . 0.0 109.322 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.0 p30 -42.34 -26.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.095 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 26' ' ' THR . 1.7 tt0 -63.53 -57.74 9.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 110.143 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.582 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 3.0 mp -45.33 -44.44 11.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.867 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.469 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 21.2 t0 -59.5 -40.68 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 110.054 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 m -77.85 -10.94 59.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.0 -45.95 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 0.0 109.904 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 35' ' ' GLY . 39.5 p90 -103.4 -45.89 4.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 109.449 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 34' ' ' PHE . . . 15.21 60.11 0.01 OUTLIER Glycine 0 N--CA 1.505 3.254 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' PHE . 12.4 tttt -133.36 -28.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.256 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.603 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -111.68 -100.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 110.31 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.24 152.48 36.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 40' ' ' ILE . 20.6 t -87.05 45.24 1.25 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.122 -1.223 . . . . 0.0 108.258 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER 39.95 110.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.217 1.008 . . . . 0.0 110.598 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.613 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 4.8 m -77.64 7.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.296 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER 162.46 72.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.068 -1.02 . . . . 0.0 110.29 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 1.8 ptpp? -82.76 117.72 22.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.406 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 20.0 p30 -154.73 169.6 23.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.198 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG13 ' OD1' ' A' ' 27' ' ' ASP . 13.7 mt -114.39 171.01 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.484 -0.76 . . . . 0.0 109.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.2 mt -128.8 113.41 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 110.012 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.427 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . 23.0 ptt180 -133.38 -160.64 1.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -124.26 -171.7 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 109.719 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -47.63 -76.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.993 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.77 -78.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.076 -1.015 . . . . 0.0 110.007 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.4 p -105.95 33.37 3.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.028 -1.045 . . . . 0.0 109.905 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 48' ' ' ASP . . . -126.31 63.19 0.6 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -121.27 116.24 31.05 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.352 -1.087 . . . . 0.0 109.456 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -114.28 32.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.976 1.514 . . . . 0.0 110.468 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -154.2 -62.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 109.786 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.32 95.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 1.6 p -142.4 138.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.578 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' CB ' HG22 ' A' ' 18' ' ' VAL . . . -89.5 175.34 7.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -157.85 104.76 1.95 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.194 -0.941 . . . . 0.0 110.365 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.624 ' CG1' ' CE2' ' A' ' 62' ' ' TYR . 3.2 t -90.5 159.67 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.586 ' CB ' HG21 ' A' ' 41' ' ' VAL . 38.2 mmm-85 -139.51 147.3 41.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.586 -1.321 . . . . 0.0 110.169 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CE2' ' CG1' ' A' ' 60' ' ' VAL . 52.3 m-85 -159.42 149.43 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' ND2' HG13 ' A' ' 41' ' ' VAL . 3.8 p30 -119.79 71.82 0.9 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.292 -1.363 . . . . 0.0 109.875 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -171.19 96.86 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -33.4 -51.93 0.37 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.264 0.554 . . . . 0.0 110.359 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.24 -50.05 74.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 108.466 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HG2' ' CD2' ' A' ' 37' ' ' TYR . 15.2 tm-20 -52.37 -48.88 65.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.48 -0.762 . . . . 0.0 110.354 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' A' ' 14' ' ' THR . . . -46.72 -45.2 19.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.647 -1.283 . . . . 0.0 107.981 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.6 -45.78 73.68 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.586 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -52.41 -65.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 109.248 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.562 ' HB1' ' CE2' ' A' ' 62' ' ' TYR . . . -53.01 -15.65 0.85 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.838 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 68' ' ' ALA . 1.1 mm -85.21 -70.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.676 -1.265 . . . . 0.0 108.881 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 t -58.88 -9.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.737 -1.227 . . . . 0.0 110.582 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.14 -53.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.664 -1.273 . . . . 0.0 111.087 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 60' ' ' VAL . 7.1 tp -81.72 5.89 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.971 -1.081 . . . . 0.0 110.837 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -87.3 22.42 2.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.724 -1.235 . . . . 0.0 108.556 178.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 38.5 p-10 177.86 73.83 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.528 ' O ' ' CB ' ' A' ' 79' ' ' ILE . 11.5 p -80.9 68.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.312 -0.867 . . . . 0.0 108.953 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.549 ' CG2' ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER 163.87 118.74 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -39.29 128.97 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.956 1.503 . . . . 0.0 110.835 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.75 163.98 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.97 -53.68 0.67 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.75 35.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.549 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 7.5 t -110.38 -14.19 14.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -1.218 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' SER . 46.7 mt-30 61.93 117.75 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 37.4 Cg_endo -123.61 -160.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 124.075 1.566 . . . . 0.0 109.354 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.587 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.9 115.76 27.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.958 -1.089 . . . . 0.0 110.926 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 5.8 m -79.23 113.63 17.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.583 HG12 ' HB2' ' A' ' 16' ' ' LEU . 13.1 t -83.27 162.21 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.318 1.056 . . . . 0.0 113.17 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.519 ' N ' HG11 ' A' ' 89' ' ' VAL . 0.0 OUTLIER 161.57 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.546 HD12 ' CA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -44.04 157.53 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.29 170.8 2.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.48 -0.763 . . . . 0.0 109.906 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 43.2 mm-40 -141.01 125.7 17.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.431 -0.793 . . . . 0.0 109.217 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 70.48 6.51 5.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 109.342 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -141.21 -170.09 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.61 134.37 3.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 61' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.163 . . . . 0.0 109.494 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -54.68 99.56 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.099 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -175.42 75.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.512 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ARG . . . -158.77 86.79 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 109.809 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER 58.91 152.82 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.54 ' CG ' ' HB3' ' A' ' 91' ' ' LEU . 37.6 Cg_endo -120.88 -160.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.741 1.39 . . . . 0.0 110.27 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' HD23 ' A' ' 91' ' ' LEU . . . -124.75 -131.74 3.72 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.526 ' N ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.71 -133.08 3.19 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 1.4 mm-40 -169.43 179.93 3.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.161 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.554 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER 71.5 -163.05 0.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.474 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.621 ' CG2' ' CG1' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -41.05 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.587 ' CB ' ' HB2' ' A' ' 63' ' ' ASN . 6.9 mmtt 57.93 -167.92 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.526 ' HB2' ' N ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -160.16 82.81 0.71 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 111.052 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.479 ' C ' ' O ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -161.35 52.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 0.0 109.142 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -79.16 -169.4 1.83 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.257 -0.902 . . . . 0.0 109.919 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.652 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -153.01 127.0 8.99 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.034 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' CE1' HG23 ' A' ' 19' ' ' THR . 0.1 OUTLIER -77.6 125.56 29.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.575 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 29.0 m -118.24 124.01 72.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.415 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -123.65 178.11 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER 87.79 15.19 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 111.337 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.661 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -154.59 43.17 0.21 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.343 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 21' ' ' LEU . 37.7 Cg_endo -76.14 142.82 24.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.593 1.312 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 61.05 9.76 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 110.691 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' ' 25' ' ' ILE . 43.2 p -99.84 -38.77 8.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.96 -1.088 . . . . 0.0 108.917 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.438 HG13 ' OG1' ' A' ' 24' ' ' THR . 1.3 pp -136.79 166.99 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 108.876 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -103.25 144.67 31.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.092 -1.005 . . . . 0.0 109.789 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -53.9 -66.2 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -44.91 -25.19 0.28 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.004 -1.06 . . . . 0.0 109.484 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 47.6 tt0 -64.75 -62.21 1.71 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 109.636 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.606 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 6.1 mp -43.96 -26.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.234 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' OD2' ' NH2' ' A' ' 61' ' ' ARG . 13.0 t70 -57.99 -54.11 50.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.9 m -62.76 -44.46 96.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.53 -17.2 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 108.509 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.674 ' CZ ' ' CD2' ' A' ' 75' ' ' LEU . 20.4 m-30 -100.5 -91.0 0.31 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 36.6 77.42 0.05 OUTLIER Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -173.7 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.296 . . . . 0.0 110.681 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.637 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.16 -80.68 0.31 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.827 -1.171 . . . . 0.0 109.763 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.47 -165.45 11.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -94.32 26.92 3.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.3 -1.118 . . . . 0.0 108.191 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.579 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 41.83 -173.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.629 0.728 . . . . 0.0 109.811 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.621 ' CG1' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -118.48 -61.78 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.099 -1.001 . . . . 0.0 111.114 -177.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.713 ' CA ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 tm0? -176.59 107.19 0.07 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.898 -0.501 . . . . 0.0 109.675 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -97.74 132.47 43.34 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.879 -1.138 . . . . 0.0 107.96 179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -141.58 159.17 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.633 -1.292 . . . . 0.0 110.356 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.473 HD11 HG23 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -123.31 137.18 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -120.26 123.67 43.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.658 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -87.71 -130.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.444 -0.785 . . . . 0.0 109.085 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 53' ' ' ARG . 2.6 m-20 -141.01 125.4 17.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.758 -1.214 . . . . 0.0 109.678 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -121.48 33.86 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -0.895 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.88 -53.14 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 109.205 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.5 p -105.6 -34.75 7.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.14 45.35 2.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 5.3 ttt180 -64.9 157.99 72.54 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.321 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 36.4 Cg_endo -102.45 11.59 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.956 1.503 . . . . 0.0 110.397 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 54' ' ' PRO . 40.4 mtm-85 -161.19 85.04 0.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' O ' ' CG1' ' A' ' 57' ' ' VAL . . . -73.13 -111.61 0.06 OUTLIER Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -163.12 157.42 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.484 -1.01 . . . . 0.0 109.77 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.55 ' CB ' HD22 ' A' ' 21' ' ' LEU . . . -110.32 174.01 6.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 3.1 m-85 -143.47 104.21 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.784 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.559 HG11 ' CD2' ' A' ' 16' ' ' LEU . 1.1 t -82.47 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.713 ' HD3' ' CA ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -119.23 135.37 54.72 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.477 -177.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.653 ' CD1' ' O ' ' A' ' 61' ' ' ARG . 7.1 m-85 -155.3 137.98 15.18 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.587 ' HB2' ' CB ' ' A' ' 12' ' ' LYS . 7.5 p30 -118.78 -50.28 2.41 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.468 -1.395 . . . . 0.0 110.194 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 63' ' ' ASN . 0.2 OUTLIER -53.88 137.08 39.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.4 OUTLIER -63.12 -43.07 99.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 0.0 109.043 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.18 -43.19 67.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 108.772 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.602 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -61.76 -25.61 67.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' GLN . . . -72.89 -48.19 39.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.736 -1.227 . . . . 0.0 107.854 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.464 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 8.3 tp-100 -49.43 -32.97 12.88 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -58.89 -67.89 0.32 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.64 ' CB ' ' CE1' ' A' ' 62' ' ' TYR . . . -45.8 -22.05 0.16 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.212 0.529 . . . . 0.0 109.641 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 15.6 mm -74.35 -70.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.406 -1.434 . . . . 0.0 108.657 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.11 22.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.53 -0.731 . . . . 0.0 110.334 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' A' ' 70' ' ' GLU . . . -138.66 -50.57 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.674 ' CD2' ' CZ ' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -79.44 -42.09 26.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 8.0 t-20 -39.2 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.347 -0.845 . . . . 0.0 109.139 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.52 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 2.1 m-20 80.9 80.04 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 2.8 p -85.28 53.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.791 . . . . 0.0 108.951 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 ' HB ' ' HD2' ' A' ' 80' ' ' PRO . 4.6 pt -117.22 173.93 2.83 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.213 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -90.62 20.35 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.97 1.51 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 69.54 70.53 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.38 -31.41 0.23 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.59 -140.18 0.82 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.47 38.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 109.375 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.499 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 29.7 mm-40 -130.55 82.86 63.87 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.52 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.8 Cg_endo -108.89 164.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.061 1.559 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.575 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -112.33 124.4 52.39 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.189 -0.945 . . . . 0.0 110.321 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 12.9 m -79.13 105.68 10.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 22.7 m -77.26 -167.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.986 -0.446 . . . . 0.0 111.611 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 104.27 108.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 9.5 tp -36.64 145.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.523 0.677 . . . . 0.0 110.257 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -77.1 -67.68 0.69 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 0.0 109.402 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.5 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 43.5 mm-40 -116.8 -170.58 1.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.457 -0.777 . . . . 0.0 109.294 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.4 9.37 29.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 109.9 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 96' ' ' GLY . 18.9 p80 -97.6 -30.52 12.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 95' ' ' HIS . . . 49.08 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.554 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 8.1 tmtm? . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 3' ' ' TYR . 33.3 t -77.87 149.79 34.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.554 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-85 -45.11 -89.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.297 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 178.78 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.868 . . . . 0.0 109.345 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.544 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 1.0 OUTLIER -165.05 80.16 1.26 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.988 . . . . 0.0 110.057 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 91' ' ' LEU . 36.0 Cg_endo -111.01 166.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.752 1.396 . . . . 0.0 110.26 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.58 176.39 21.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 9' ' ' GLU . . . 171.96 172.66 38.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 8' ' ' GLY . 1.3 tp10 81.98 172.34 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.581 -0.952 . . . . 0.0 110.105 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 12' ' ' LYS . 0.4 OUTLIER -86.19 151.31 23.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.854 . . . . 0.0 109.857 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.606 ' CD1' ' CG1' ' A' ' 41' ' ' VAL . 5.8 tp 38.4 33.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.248 1.023 . . . . 0.0 109.605 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -164.16 26.73 0.07 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' CB ' ' C ' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -79.2 -2.21 39.91 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.984 -1.072 . . . . 0.0 110.538 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.603 ' CG2' ' CB ' ' A' ' 68' ' ' ALA . 15.7 m -162.52 93.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.891 -1.131 . . . . 0.0 110.405 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 13.9 t-20 -84.68 106.02 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.986 -1.071 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 60' ' ' VAL . 1.0 OUTLIER -79.13 103.57 9.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.926 -1.109 . . . . 0.0 109.149 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -93.85 86.86 5.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.558 HG21 ' CB ' ' A' ' 58' ' ' ALA . 2.6 m -89.52 97.43 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.306 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.512 ' CA ' HG12 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -92.01 -165.53 1.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.575 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 53.39 84.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.107 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' CB ' HD12 ' A' ' 46' ' ' LEU . 0.4 OUTLIER -146.51 132.95 9.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.5 Cg_endo -104.0 39.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.891 1.469 . . . . 0.0 109.897 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 15.2 mtt85 36.52 61.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.294 0.568 . . . . 0.0 110.338 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.519 ' CG2' HG13 ' A' ' 25' ' ' ILE . 7.4 t -97.48 -16.19 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.248 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CG2' ' A' ' 24' ' ' THR . 0.2 OUTLIER -127.2 179.25 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.3 p -105.63 158.45 16.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.202 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 43' ' ' LYS . 9.7 t0 -55.75 -62.45 1.68 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.643 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.79 -15.59 4.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -75.27 -51.76 12.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.829 -1.17 . . . . 0.0 110.354 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' O ' ' CD1' ' A' ' 34' ' ' PHE . 4.6 mp -46.56 -32.16 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.82 -1.175 . . . . 0.0 108.476 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 4.2 t70 -48.66 -52.85 21.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 108.652 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 m -63.22 -41.51 99.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.466 -0.771 . . . . 0.0 109.042 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -64.54 -13.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 108.864 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.666 ' CD1' ' CD2' ' A' ' 75' ' ' LEU . 7.4 m-30 -83.91 -74.26 0.38 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 36' ' ' LYS . . . 144.3 -90.88 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 162.99 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.711 -0.876 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.59 ' CD2' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -79.81 -81.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.96 166.6 14.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 40' ' ' ILE . 15.5 m -78.58 94.47 5.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.834 -1.391 . . . . 0.0 108.293 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' C ' ' O ' ' A' ' 39' ' ' SER . 3.2 mp -34.67 117.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.606 ' CG1' ' CD1' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -80.1 18.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 111.009 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HB2' ' CB ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 163.65 138.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 177.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -145.96 76.7 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -94.85 174.1 7.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.0 tt -126.58 104.15 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 110.347 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.762 ' HA ' ' N ' ' A' ' 57' ' ' VAL . 8.4 mp 52.85 -141.62 0.84 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.516 -0.74 . . . . 0.0 110.011 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' NE ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -163.32 120.74 1.88 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.966 -1.084 . . . . 0.0 109.482 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER 61.35 136.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.132 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.58 3.29 24.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.693 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.83 -46.71 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -118.66 146.43 44.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.913 . . . . 0.0 109.795 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' ARG . . . -87.19 51.91 4.29 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.584 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -40.9 -60.52 1.62 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.617 -0.931 . . . . 0.0 109.928 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 53' ' ' ARG . 35.9 Cg_endo -94.38 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 117.171 -1.419 . . . . 0.0 110.831 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -141.58 -37.58 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' O ' ' CG2' ' A' ' 57' ' ' VAL . . . 85.68 96.78 0.75 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.762 ' N ' ' HA ' ' A' ' 46' ' ' LEU . 44.6 t -159.02 153.16 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.114 -1.227 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.558 ' CB ' HG21 ' A' ' 18' ' ' VAL . . . -75.97 127.0 32.06 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.607 ' CE1' ' O ' ' A' ' 57' ' ' VAL . 91.6 m-85 -103.35 83.17 2.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 112.091 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG11 ' CD1' ' A' ' 62' ' ' TYR . 3.3 t -86.53 77.55 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.549 ' HD2' ' CG2' ' A' ' 41' ' ' VAL . 1.7 ttm180 -76.82 113.21 14.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.594 -1.316 . . . . 0.0 110.695 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.595 ' CD1' HG11 ' A' ' 60' ' ' VAL . 3.6 m-85 -114.36 -173.87 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -131.29 -100.78 0.29 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.097 -1.441 . . . . 0.0 110.337 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 63' ' ' ASN . 26.1 tttp -24.4 136.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.618 0.723 . . . . 0.0 111.795 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH2' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -55.95 -52.37 64.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -52.4 -39.65 61.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -49.49 -47.0 48.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.603 ' CB ' ' CG2' ' A' ' 14' ' ' THR . . . -57.72 -39.32 76.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.389 -0.819 . . . . 0.0 108.813 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -51.1 -37.08 43.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 108.205 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.59 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.4 mt-10 -74.8 -62.45 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.852 0.834 . . . . 0.0 109.751 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.591 ' O ' ' HG ' ' A' ' 75' ' ' LEU . . . -52.76 -16.14 0.91 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.469 0.652 . . . . 0.0 110.931 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 5.0 mt -92.37 -60.33 2.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.418 -1.426 . . . . 0.0 109.465 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -66.69 -5.31 11.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 0.0 109.959 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.7 -53.94 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.944 -1.098 . . . . 0.0 109.961 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.666 ' CD2' ' CD1' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -81.27 -39.34 25.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.016 -1.053 . . . . 0.0 109.879 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 61.5 t-20 -43.79 111.68 0.31 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.594 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 74.8 91.03 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.993 0.901 . . . . 0.0 109.207 -178.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 3.1 p -103.7 38.48 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.606 ' CG2' ' CD ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -148.56 -175.16 0.45 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.606 ' CD ' ' CG2' ' A' ' 79' ' ' ILE . 36.2 Cg_endo -63.58 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 116.966 -1.556 . . . . 0.0 110.239 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 38.7 tt0 179.16 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.062 -1.024 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.16 55.95 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.32 -81.7 0.16 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.552 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -79.26 5.14 13.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.162 . . . . 0.0 109.749 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' SER . 36.1 mt-30 70.35 86.36 0.12 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.149 -0.969 . . . . 0.0 109.152 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.594 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 35.0 Cg_endo -58.69 -173.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.363 1.717 . . . . 0.0 111.927 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.545 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -94.99 152.75 18.05 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -99.69 100.45 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.647 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 2.5 m -78.11 172.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.734 -0.604 . . . . 0.0 110.715 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 10.8 ttt180 127.5 138.63 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.546 ' CB ' ' HG2' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -65.09 138.16 58.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -93.71 179.51 5.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.65 176.23 5.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' HIS . 4.0 mt-10 61.16 178.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLU . 96.8 m-70 -44.21 154.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.377 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.33 -40.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.548 ' CB ' ' HD3' ' A' ' 61' ' ' ARG . 16.0 pttt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -126.5 43.14 3.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.982 . . . . 0.0 109.542 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -137.14 -170.68 2.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' CB ' ' O ' ' A' ' 3' ' ' TYR . . . 79.39 -73.47 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.907 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -148.02 97.33 3.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.384 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' O ' HD11 ' A' ' 91' ' ' LEU . 36.9 Cg_endo -84.29 120.12 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.895 1.471 . . . . 0.0 110.228 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 170.55 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.42 -148.02 18.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' C ' ' OG ' ' A' ' 10' ' ' SER . 3.4 tt0 -70.87 125.35 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -1.171 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.566 ' CB ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 176.97 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 10' ' ' SER . 0.0 OUTLIER 44.58 50.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.314 -0.866 . . . . 0.0 109.497 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 11' ' ' ILE . 18.6 mmtp 31.39 34.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.966 -0.459 . . . . 0.0 111.396 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.579 ' CB ' ' CB ' ' A' ' 63' ' ' ASN . 23.5 m-20 -162.61 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.964 -1.085 . . . . 0.0 110.251 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.612 ' CG2' ' CD1' ' A' ' 91' ' ' LEU . 4.4 m -162.75 94.14 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.964 . . . . 0.0 111.134 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.606 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -102.96 165.47 11.01 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.035 -1.041 . . . . 0.0 108.891 178.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 62' ' ' TYR . 1.0 OUTLIER -132.05 122.07 24.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.311 -1.493 . . . . 0.0 110.356 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -79.47 117.88 20.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 15.6 m -97.33 146.08 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.467 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -124.03 167.29 14.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.2 m-20 72.4 18.05 4.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.412 -0.805 . . . . 0.0 109.398 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.46 HD23 ' HD2' ' A' ' 22' ' ' PRO . 2.9 tm? -53.73 109.61 1.6 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 109.998 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD2' HD23 ' A' ' 21' ' ' LEU . 36.4 Cg_endo -82.08 147.42 14.76 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.044 1.55 . . . . 0.0 109.794 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 19.63 3.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.958 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.3 t -89.19 -6.05 57.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.395 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.04 -166.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.435 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -57.78 -55.99 27.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 108.981 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' GLN . 3.1 p30 -49.36 -24.2 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.257 -0.902 . . . . 0.0 108.869 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' HB3' ' O ' ' A' ' 26' ' ' THR . 59.5 tt0 -71.89 -45.07 62.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 109.125 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 6.9 mp -46.8 -35.58 6.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.255 -0.903 . . . . 0.0 108.721 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 5.6 t0 -49.2 -50.68 37.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.977 -1.077 . . . . 0.0 109.263 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 m -80.87 -15.34 56.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -67.98 -47.73 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 109.805 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.614 ' CD1' HD12 ' A' ' 75' ' ' LEU . 20.1 p90 -92.74 -41.63 10.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.745 -1.222 . . . . 0.0 109.423 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' LYS . . . 127.51 -78.17 0.39 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 1.6 tptp 174.74 78.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -1.088 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -79.71 -104.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' N ' ' HB3' ' A' ' 67' ' ' GLU . . . -68.89 176.34 29.62 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' VAL . 14.3 t -78.56 81.82 4.86 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.831 -1.394 . . . . 0.0 107.793 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.536 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -35.51 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.14 0.972 . . . . 0.0 108.447 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.639 ' O ' ' CB ' ' A' ' 42' ' ' GLN . 28.4 m -79.25 47.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.286 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.639 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 5.5 tt0 96.81 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.26 0.553 . . . . 0.0 111.449 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' NZ ' HD11 ' A' ' 40' ' ' ILE . 8.4 ptpp? -92.24 132.17 36.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.525 ' N ' ' OD2' ' A' ' 27' ' ' ASP . 6.3 p30 -129.69 161.62 30.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.59 -1.318 . . . . 0.0 110.789 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.33 169.0 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.58 117.88 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -96.23 -163.76 1.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.414 -0.804 . . . . 0.0 109.067 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.9 p30 -72.21 164.25 26.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.024 -1.047 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' ASP . 2.5 tptp 176.83 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.21 -40.02 4.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -161.82 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.601 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' C ' ' CG ' ' A' ' 53' ' ' ARG . . . -67.88 -79.85 0.23 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.57 ' CB ' ' CD ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -167.78 -81.97 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.181 -1.188 . . . . 0.0 109.371 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 53' ' ' ARG . 35.8 Cg_endo -48.29 97.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.861 1.453 . . . . 0.0 110.256 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -142.89 -50.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' CA ' ' O ' ' A' ' 21' ' ' LEU . . . 66.77 99.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.523 HG11 ' N ' ' A' ' 58' ' ' ALA . 85.1 t -130.39 145.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.117 . . . . 0.0 109.032 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.586 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -149.15 174.83 11.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.055 . . . . 0.0 109.543 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 33.6 m-85 -154.55 107.65 2.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.577 ' CG1' HD23 ' A' ' 16' ' ' LEU . 2.2 t -84.81 102.95 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.548 ' CB ' HG21 ' A' ' 41' ' ' VAL . 4.8 mtm180 -83.35 128.66 34.69 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.036 -1.04 . . . . 0.0 110.411 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CZ ' ' HA ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -162.52 173.56 13.84 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' CB ' ' A' ' 13' ' ' ASP . 7.7 p30 -112.11 -114.84 0.32 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 117.68 -1.608 . . . . 0.0 110.861 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 10.6 mmtt 16.52 108.74 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.282 0.563 . . . . 0.0 112.343 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -57.47 -40.87 79.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.983 -1.073 . . . . 0.0 109.58 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -38.97 86.39 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB3' ' N ' ' A' ' 38' ' ' GLY . 60.8 mm-40 -59.7 -30.91 69.12 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.622 ' HA ' ' CZ ' ' A' ' 62' ' ' TYR . . . -67.17 -37.87 84.47 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -53.52 -35.23 60.46 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.7 mp0 -61.4 -52.48 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.586 ' CA ' ' HB2' ' A' ' 75' ' ' LEU . . . -67.01 -5.21 11.99 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.594 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.563 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 14.0 mm -84.49 -57.42 4.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -79.67 0.84 28.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.946 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.28 -44.16 1.59 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.026 -1.046 . . . . 0.0 109.906 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.614 HD12 ' CD1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -89.34 -28.43 19.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 34.3 t-20 -46.67 -27.5 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.217 -1.552 . . . . 0.0 109.453 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -148.53 78.81 1.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG12 HG22 ' A' ' 33' ' ' ILE . 1.5 t -85.4 107.28 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.998 -1.064 . . . . 0.0 108.97 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 174.19 164.6 0.33 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.6 Cg_endo -86.47 37.41 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.703 1.37 . . . . 0.0 110.477 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' PRO . 4.0 mt-10 40.24 44.45 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.498 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.11 -19.95 17.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 84' ' ' SER . . . -141.65 -108.73 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 41.4 t 175.76 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -1.098 . . . . 0.0 109.456 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.6 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.0 pt20 -143.94 32.95 0.13 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.955 . . . . 0.0 110.632 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 37.8 Cg_endo -68.31 -162.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.424 1.223 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.595 ' CD2' ' CD2' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -100.19 114.57 28.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.812 -1.155 . . . . 0.0 109.657 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -79.1 116.04 19.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 177.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.531 ' CG1' HD13 ' A' ' 16' ' ' LEU . 17.4 m -94.38 171.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.982 0.896 . . . . 0.0 112.003 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER 166.47 116.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.612 ' CD1' ' CG2' ' A' ' 14' ' ' THR . 2.3 mt -41.94 109.3 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.197 -0.94 . . . . 0.0 109.477 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 91' ' ' LEU . . . -58.55 -156.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.113 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.4 tp10 -171.7 99.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.994 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 78.69 3.51 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.557 -0.714 . . . . 0.0 110.046 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 95' ' ' HIS . 0.3 OUTLIER -73.57 174.18 8.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.47 47.8 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' OXT' ' NH1' ' A' ' 61' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.239 -1.153 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmm? . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.6 p -102.33 -149.83 0.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.348 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.81 22.73 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.254 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.97 133.45 41.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 176.2 2.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 109.228 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 91' ' ' LEU . 36.0 Cg_endo -111.16 166.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.739 1.389 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.74 -157.55 7.5 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' HA3' ' OD2' ' A' ' 13' ' ' ASP . . . -177.46 -134.01 1.95 Allowed Glycine 0 N--CA 1.496 2.656 0 O-C-N 121.051 -1.264 . . . . 0.0 110.295 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -152.6 -169.0 3.22 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.107 -1.231 . . . . 0.0 110.289 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 1.4 p 79.6 -172.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.304 -0.872 . . . . 0.0 110.092 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.588 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -51.92 90.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 108.928 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.626 ' HB3' ' CB ' ' A' ' 63' ' ' ASN . 1.8 mttt 61.64 142.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.549 -1.344 . . . . 0.0 108.303 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.498 ' OD2' ' HA3' ' A' ' 8' ' ' GLY . 0.4 OUTLIER -156.35 98.17 1.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.894 -1.754 . . . . 0.0 112.192 -179.03 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.598 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 16.5 m -162.71 49.66 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.575 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 2.0 m120 -76.04 -177.46 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.66 0.743 . . . . 0.0 110.498 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.659 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -142.9 129.06 19.77 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.744 0.783 . . . . 0.0 109.741 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CE2' ' HB ' ' A' ' 57' ' ' VAL . 1.1 t80 -78.86 95.89 5.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.697 -0.627 . . . . 0.0 109.914 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.608 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 16.4 m -80.07 106.54 11.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 16.3 p -99.86 166.73 10.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.135 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.426 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 2.0 m120 62.76 75.29 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.429 -0.795 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -139.67 158.0 68.94 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 109.347 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.52 ' HG2' ' CG2' ' A' ' 24' ' ' THR . 36.5 Cg_endo -94.74 -175.4 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.053 1.554 . . . . 0.0 109.994 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 6.83 47.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.52 ' CG2' ' HG2' ' A' ' 22' ' ' PRO . 1.3 t -80.48 -6.25 57.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 25' ' ' ILE . 1.7 pp -127.96 127.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.526 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 4.6 p -99.68 170.98 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.809 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.0 -53.46 38.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.57 -11.71 37.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 30' ' ' LEU . 35.7 tt0 -78.36 -56.29 4.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.578 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 1.3 mp -44.64 -39.07 4.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 5.3 t70 -58.97 -48.29 82.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.038 -1.039 . . . . 0.0 109.829 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -23.03 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.49 -0.756 . . . . 0.0 110.065 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.67 ' CG2' ' CZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -80.44 -26.44 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.741 -1.224 . . . . 0.0 109.731 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.67 ' CZ ' ' CG2' ' A' ' 33' ' ' ILE . 4.3 m-85 -111.53 -73.44 0.68 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.11 -0.994 . . . . 0.0 109.153 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 34.11 78.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -171.92 28.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.952 -1.322 . . . . 0.0 111.028 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CE2' ' CZ ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -133.97 -96.72 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.706 -1.246 . . . . 0.0 109.758 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 -167.74 16.52 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.55 ' O ' ' C ' ' A' ' 40' ' ' ILE . 4.5 t -80.16 78.71 6.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.339 -1.095 . . . . 0.0 108.856 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.611 ' HB ' ' CD ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -24.65 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.654 ' C ' ' HB3' ' A' ' 61' ' ' ARG . 5.5 m -100.14 58.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.643 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 2.5 tt0 92.47 117.96 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.101 0.953 . . . . 0.0 113.267 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.544 ' HE2' ' N ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER -115.95 138.09 51.51 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.487 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -151.53 174.31 13.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.286 -1.509 . . . . 0.0 111.282 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 26' ' ' THR . 37.3 mt -145.64 111.08 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.485 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 18.3 mt -100.65 143.98 30.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.616 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.41 -90.34 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 1.0 OUTLIER -97.44 132.58 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.724 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -144.76 32.06 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.734 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.42 -65.6 0.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.453 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 29.2 m -150.75 30.19 0.66 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.492 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 48' ' ' ASP . . . 74.43 57.09 4.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -100.98 179.32 1.03 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.336 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -108.1 117.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.934 1.492 . . . . 0.0 110.471 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -64.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.76 103.5 0.18 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HB ' ' CE2' ' A' ' 17' ' ' TYR . 19.8 m -144.98 165.38 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -1.127 . . . . 0.0 109.655 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.608 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -157.09 175.35 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.838 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -141.27 104.91 4.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 0.0 108.991 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.598 ' CG2' ' CD2' ' A' ' 75' ' ' LEU . 1.3 t -78.21 148.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.81 -1.181 . . . . 0.0 108.132 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.654 ' HB3' ' C ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -85.37 125.86 33.3 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.447 0.641 . . . . 0.0 110.136 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.707 ' CZ ' ' CE2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -163.63 147.21 10.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.934 -1.104 . . . . 0.0 108.472 179.149 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.668 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.2 t-20 -135.02 -91.28 0.32 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.472 -1.392 . . . . 0.0 109.449 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.668 ' C ' ' O ' ' A' ' 63' ' ' ASN . 11.5 mptt -14.72 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.538 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.99 -47.85 0.08 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.83 -0.544 . . . . 0.0 110.238 -177.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.89 -50.88 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 42.5 mm-40 -46.86 -43.99 19.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . . . -60.14 -41.86 93.59 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.088 -1.632 . . . . 0.0 107.183 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.1 -37.47 6.88 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -62.83 -49.31 75.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.016 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.588 ' HB1' ' CE2' ' A' ' 62' ' ' TYR . . . -62.83 -11.92 21.23 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.142 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 49.7 mm -84.44 -69.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.865 -1.147 . . . . 0.0 108.35 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.95 3.71 7.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 70' ' ' GLU . . . -124.65 -51.87 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.051 . . . . 0.0 109.723 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.658 ' HG ' ' CZ ' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -81.21 -35.35 31.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 0.0 110.225 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 1.7 p-10 -53.93 139.09 35.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.68 -1.263 . . . . 0.0 109.262 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.518 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER 52.9 50.55 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.23 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.645 HG22 ' HA ' ' A' ' 75' ' ' LEU . 2.5 t -88.56 82.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.596 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -141.94 -164.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -92.45 26.73 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.559 1.294 . . . . 0.0 110.448 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.492 ' CG ' ' C ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER 41.54 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 0.0 109.549 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.06 44.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 106.41 -168.86 14.97 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER 77.27 -4.0 2.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -1.186 . . . . 0.0 109.864 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' SER . 14.3 mt-30 60.85 145.76 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.518 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.66 147.55 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.065 1.561 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.76 121.53 18.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 17' ' ' TYR . 1.5 t -79.52 104.17 9.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.575 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 35.5 m -78.51 -144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 111.458 -177.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 84.79 106.52 0.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 -178.052 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.567 ' CB ' ' HG2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -41.26 141.46 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.291 -0.88 . . . . 0.0 110.089 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -100.89 -165.85 1.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -95.55 119.31 33.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.993 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 164.85 -88.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.467 ' NE2' ' HB3' ' A' ' 10' ' ' SER . 24.1 t-80 175.67 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 138.81 -119.45 1.75 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.072 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 162.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.524 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -170.08 116.18 0.53 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 177.93 121.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.1 ttm180 -139.5 41.2 0.45 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.793 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 32.2 Cg_endo -45.53 149.83 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.976 1.514 . . . . 0.0 111.039 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.509 ' HA2' ' HB3' ' A' ' 65' ' ' ARG . . . -161.57 142.02 7.72 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' O ' ' HD2' ' A' ' 65' ' ' ARG . . . 142.9 141.69 3.89 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.063 -1.257 . . . . 0.0 110.131 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 10' ' ' SER . 3.5 pm0 -120.2 98.43 6.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.898 -1.354 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 0.4 OUTLIER 161.37 178.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.575 ' HA ' ' ND2' ' A' ' 63' ' ' ASN . 23.6 mm -90.56 55.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.853 -1.154 . . . . 0.0 109.77 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 169.9 38.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.926 -1.109 . . . . 0.0 110.864 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' LYS . 9.9 m-20 -137.43 12.59 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.801 -1.187 . . . . 0.0 110.603 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.58 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -160.29 70.56 0.43 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -77.0 152.71 35.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.771 -1.206 . . . . 0.0 108.869 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 1.5 tp -97.49 108.8 21.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.336 -0.853 . . . . 0.0 109.957 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CE1' ' CG2' ' A' ' 57' ' ' VAL . 33.3 t80 -79.55 87.07 5.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.525 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 58' ' ' ALA . 16.3 m -79.76 112.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.858 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 4.5 m -117.1 161.33 19.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' THR . 6.0 t-20 78.66 52.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.882 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 21' ' ' LEU . 1.0 OUTLIER -160.22 136.75 6.46 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -86.74 -177.48 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.897 1.472 . . . . 0.0 110.108 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 34.65 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.471 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -79.64 -54.98 5.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.915 . . . . 0.0 109.014 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.477 HD11 HD12 ' A' ' 30' ' ' LEU . 1.1 pp -62.31 165.82 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.224 -0.922 . . . . 0.0 108.752 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.49 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -109.43 136.54 48.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.484 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 9.4 t0 -56.15 -60.59 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.037 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 10.0 p-10 -48.61 -21.55 0.61 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.49 ' HB3' ' O ' ' A' ' 26' ' ' THR . 38.7 tt0 -74.65 -45.91 41.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.979 -1.076 . . . . 0.0 110.2 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 33' ' ' ILE . 4.4 mp -45.59 -25.3 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.849 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 3.0 t0 -65.97 -51.46 58.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 108.764 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 m -53.49 -52.61 58.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.543 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -63.29 -25.77 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 108.574 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -66.14 -89.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 108.869 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 9.92 58.56 0.01 OUTLIER Glycine 0 N--CA 1.503 3.12 0 C-N-CA 122.941 0.305 . . . . 0.0 112.807 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' PHE . 2.3 tttt -161.68 4.97 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.662 -1.493 . . . . 0.0 112.247 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.746 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.92 -83.81 0.09 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.381 -1.45 . . . . 0.0 110.18 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.04 -177.27 24.48 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' ILE . 56.5 m -92.93 19.6 7.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -1.21 . . . . 0.0 109.647 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.594 HD12 ' CG ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 51.33 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.369 0.604 . . . . 0.0 109.738 178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.643 ' H ' ' HB2' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -133.16 49.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 O-C-N 120.647 -1.283 . . . . 0.0 114.253 -177.131 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.632 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.4 tm0? 85.23 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.582 -1.324 . . . . 0.0 112.207 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 pttp -78.5 144.58 35.58 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.128 -0.982 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.74 120.61 3.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 109.813 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.542 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 22.8 pt -84.51 162.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.062 -1.024 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.6 110.5 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 110.496 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.488 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 9.2 tpm_? -160.84 -95.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.495 -1.378 . . . . 0.0 110.41 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.93 -170.6 1.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.878 -1.139 . . . . 0.0 109.906 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -132.98 -60.73 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 109.501 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -64.18 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -152.03 178.68 9.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.955 . . . . 0.0 109.599 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 28.24 29.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -58.5 135.95 85.77 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -105.83 -50.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.454 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -140.97 -93.37 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.855 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.479 ' HA2' ' HD2' ' A' ' 47' ' ' ARG . . . 148.64 103.65 0.31 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 46' ' ' LEU . 1.9 p -129.04 109.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 108.921 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.541 ' C ' ' CD1' ' A' ' 59' ' ' PHE . . . -109.34 178.28 4.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.751 -1.218 . . . . 0.0 110.241 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 3.6 m-85 -135.59 110.38 8.71 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG22 HD22 ' A' ' 30' ' ' LEU . 1.1 t -77.95 157.38 5.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.643 ' HB2' ' H ' ' A' ' 41' ' ' VAL . 9.2 ptt180 -95.76 108.88 21.24 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.362 0.601 . . . . 0.0 110.302 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -162.23 71.01 0.32 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.237 -0.915 . . . . 0.0 108.641 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.634 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.6 OUTLIER -68.87 -104.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 109.343 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.634 ' C ' ' O ' ' A' ' 63' ' ' ASN . 3.0 mttp 9.05 90.07 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-N 118.18 0.445 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.546 ' HG2' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -29.39 -37.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.947 -0.471 . . . . 0.0 111.102 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' N ' ' HG2' ' A' ' 65' ' ' ARG . 43.4 tt0 -64.06 -58.24 7.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 108.235 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 60.1 mt-10 -53.6 -47.61 70.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.843 . . . . 0.0 109.406 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 62' ' ' TYR . . . -49.3 -39.16 29.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 108.725 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.489 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 2.9 tt0 -60.94 -41.51 96.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 3.6 mp0 -55.67 -49.21 73.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.47 -0.769 . . . . 0.0 109.956 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' CD2' ' A' ' 62' ' ' TYR . . . -71.21 -13.69 62.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.183 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.528 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 2.1 mm -74.89 -64.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 108.406 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -3.14 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.578 -0.701 . . . . 0.0 110.438 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 70' ' ' GLU . . . -117.36 -50.76 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.828 -1.17 . . . . 0.0 110.249 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.645 ' CD1' ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -79.4 -26.22 41.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 0.0 109.719 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.3 t-20 -47.37 102.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.653 -1.279 . . . . 0.0 107.978 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 7.2 m-20 72.82 92.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 2.7 p -85.94 53.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 79' ' ' ILE . 2.1 pp -133.33 140.1 36.12 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 81' ' ' GLU . 35.9 Cg_endo -40.87 -76.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.936 1.493 . . . . 0.0 110.527 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 11.4 tp10 176.53 152.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.203 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . 115.54 3.27 20.72 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 131.72 -161.96 23.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 1.4 m 84.16 -62.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.784 -0.833 . . . . 0.0 109.429 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.528 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.3 pt20 27.05 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 122.12 -0.362 . . . . 0.0 110.732 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.538 ' O ' ' CD1' ' A' ' 87' ' ' LEU . 37.3 Cg_endo -127.19 65.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.54 1.284 . . . . 0.0 111.428 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 174.5 87.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' TYR . 3.5 t -81.17 107.41 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 24.7 m -83.77 147.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.528 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 28.4 ptt180 152.96 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.9 tt -58.63 149.45 25.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.788 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -123.34 -58.78 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 109.958 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.99 178.13 7.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.782 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -118.22 80.35 1.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 132.28 3.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.5 -175.43 52.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.222 0.534 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 38.1 m -46.85 -67.15 0.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.982 . . . . 0.0 109.149 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 2' ' ' SER . 3.0 m-85 -158.67 -57.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.96 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -48.43 137.68 11.81 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 109.2 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -123.86 164.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.707 1.372 . . . . 0.0 110.397 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.06 150.2 5.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' HD2' ' A' ' 65' ' ' ARG . . . -96.53 -169.24 34.21 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 10' ' ' SER . 13.0 mt-10 -101.05 165.25 11.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -1.228 . . . . 0.0 109.957 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' LYS . 0.9 OUTLIER 52.05 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.49 HD11 ' ND2' ' A' ' 63' ' ' ASN . 12.2 mm -58.51 88.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.93 -1.106 . . . . 0.0 108.13 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -128.02 -79.63 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.059 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.512 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 16.5 p-10 -160.69 92.96 0.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.765 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.559 ' OG1' ' CA ' ' A' ' 63' ' ' ASN . 1.2 p -144.24 43.38 1.42 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -75.36 155.38 36.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.664 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.62 142.83 29.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.477 -1.689 . . . . 0.0 110.223 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' CE2' HG13 ' A' ' 57' ' ' VAL . 1.8 t80 -78.52 78.84 4.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.587 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 24.6 m -77.89 105.46 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.003 0.906 . . . . 0.0 109.699 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 53.1 p -116.85 126.1 52.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 19' ' ' THR . 10.0 t-20 159.01 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.632 . . . . 0.0 109.667 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.562 ' N ' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -39.89 161.56 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.436 -179.309 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -117.95 50.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.903 1.475 . . . . 0.0 110.131 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.06 21.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.554 -0.717 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -87.53 -24.34 24.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.463 HG22 ' HB3' ' A' ' 85' ' ' GLN . 1.0 OUTLIER -107.54 -164.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 108.955 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.502 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -132.48 130.3 40.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.021 -1.049 . . . . 0.0 109.989 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.47 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -59.58 -50.0 75.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.951 -1.093 . . . . 0.0 108.627 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -49.28 -26.62 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.323 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 26' ' ' THR . 8.2 tt0 -74.84 -42.4 58.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 34' ' ' PHE . 5.7 mp -46.67 -32.98 3.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 109.896 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.579 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -60.34 -62.59 1.75 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.866 -1.146 . . . . 0.0 109.511 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 32' ' ' THR . 12.1 m -62.42 -9.62 8.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.503 -0.748 . . . . 0.0 110.121 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.619 HG21 ' CD2' ' A' ' 34' ' ' PHE . 2.6 tt -83.96 -40.24 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.945 -1.097 . . . . 0.0 110.029 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.619 ' CD2' HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -108.4 -54.24 2.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.512 -1.368 . . . . 0.0 110.456 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 16.55 67.32 0.01 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -141.49 -25.8 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.278 . . . . 0.0 111.601 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -96.2 -37.58 10.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.606 -1.309 . . . . 0.0 109.242 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.4 -163.96 10.91 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.668 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -109.96 35.94 3.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -1.172 . . . . 0.0 109.217 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.691 ' CG2' ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 43.27 147.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 CA-C-O 122.125 0.964 . . . . 0.0 111.418 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.543 HG13 ' CB ' ' A' ' 97' ' ' LYS . 96.8 t -109.44 -38.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 119.975 -1.703 . . . . 0.0 113.901 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.843 ' C ' ' HG2' ' A' ' 61' ' ' ARG . 1.1 tm0? 177.96 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 O-C-N 120.464 -1.397 . . . . 0.0 110.962 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.729 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -112.57 150.66 31.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.404 -0.81 . . . . 0.0 109.923 -177.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -159.47 172.95 16.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 109.156 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 tt -155.19 146.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.734 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -152.56 144.66 23.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 109.694 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -141.06 -83.32 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER 158.3 -176.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.351 -0.843 . . . . 0.0 109.214 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -174.42 -62.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -97.54 48.3 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.638 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.444 ' HB ' ' OD1' ' A' ' 48' ' ' ASP . 29.0 m -160.74 -59.25 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 166.08 106.78 0.2 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.08 96.29 33.72 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -1.137 . . . . 0.0 109.68 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -101.73 -16.79 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.025 1.54 . . . . 0.0 109.472 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 5.3 mtm-85 160.04 107.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' O ' ' CG1' ' A' ' 57' ' ' VAL . . . -92.45 -131.78 5.68 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.578 HG13 ' CE2' ' A' ' 17' ' ' TYR . 1.2 m -165.38 176.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 121.863 -0.786 . . . . 0.0 110.048 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.587 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -147.86 159.73 43.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -131.97 116.73 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' CG1' ' CD2' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -86.52 162.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.357 -1.464 . . . . 0.0 109.864 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.843 ' HG2' ' C ' ' A' ' 42' ' ' GLN . 3.6 mtm180 -79.73 107.49 12.54 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.672 ' CE2' ' CB ' ' A' ' 71' ' ' ALA . 44.2 m-85 -163.95 143.99 8.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.695 -1.253 . . . . 0.0 110.089 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.62 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -125.41 -132.69 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' C ' ' O ' ' A' ' 63' ' ' ASN . 1.8 mtpt 17.59 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.912 0.778 . . . . 0.0 110.386 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.522 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.5 OUTLIER -28.87 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.922 -0.486 . . . . 0.0 110.599 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 64' ' ' LYS . 2.3 tt0 -64.0 -56.0 18.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 108.313 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -44.99 -44.68 10.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.476 ' CB ' HD22 ' A' ' 91' ' ' LEU . . . -56.12 -45.96 79.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.6 -1.313 . . . . 0.0 107.715 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 tt0 -45.35 -39.04 6.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 78.5 mm-40 -57.62 -54.93 41.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.672 ' CB ' ' CE2' ' A' ' 62' ' ' TYR . . . -61.2 -13.26 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.729 0.776 . . . . 0.0 110.025 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 6.7 mm -82.98 -62.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 O-C-N 120.621 -1.299 . . . . 0.0 108.679 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.58 6.69 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.965 . . . . 0.0 109.797 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' O ' HG11 ' A' ' 78' ' ' VAL . . . -128.9 -52.53 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.605 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . 0.2 OUTLIER -79.31 -26.23 42.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.171 -0.955 . . . . 0.0 109.97 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.91 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.354 -1.467 . . . . 0.0 107.664 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' LEU . 3.8 m-20 74.21 58.67 0.08 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 108.684 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.605 ' CG1' ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -79.45 78.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.184 -0.947 . . . . 0.0 108.773 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -133.0 -163.51 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.4 Cg_endo -102.52 38.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.021 1.537 . . . . 0.0 109.984 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.465 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 47.68 60.14 3.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.35 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 163.2 -46.28 0.32 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -53.52 -175.61 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -128.75 75.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.262 . . . . 0.0 109.716 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -165.83 64.41 0.93 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -92.48 -170.65 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.969 1.51 . . . . 0.0 110.581 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.583 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -149.61 124.69 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 13.9 t -78.03 100.14 6.38 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 90' ' ' ARG . 34.6 m -78.55 146.4 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.928 0.87 . . . . 0.0 111.948 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.9 tmm_? 168.41 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD22 ' CB ' ' A' ' 68' ' ' ALA . 1.1 mp -36.89 145.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.412 0.625 . . . . 0.0 110.417 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.69 -166.83 1.43 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 109.261 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 71.9 1.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.106 -0.996 . . . . 0.0 109.34 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.59 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -58.08 152.71 16.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.219 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.512 ' HA2' ' CB ' ' A' ' 13' ' ' ASP . . . -130.91 -116.62 1.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' CB ' HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 0.0 109.725 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -116.7 130.63 56.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 109.32 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.8 p90 -151.8 174.58 13.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.52 152.99 18.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 109.217 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.592 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -85.95 -28.18 0.39 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.204 -0.935 . . . . 0.0 110.052 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 5' ' ' ARG . 37.1 Cg_endo -102.94 172.56 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.567 1.298 . . . . 0.0 111.48 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.8 -165.22 25.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.524 ' HA3' HG23 ' A' ' 14' ' ' THR . . . 160.45 -151.98 22.63 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -168.04 138.5 2.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.358 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER 45.64 -172.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.644 ' HA ' ' CG ' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -76.71 82.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.114 -0.991 . . . . 0.0 108.739 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' CD ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -140.02 -74.18 0.36 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.737 . . . . 0.0 110.853 -179.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 25.3 t0 -145.46 84.59 1.69 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.664 -1.273 . . . . 0.0 111.948 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.565 HG21 ' CB ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER -162.04 38.07 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.311 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -174.01 2.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.609 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.7 OUTLIER -108.26 123.47 48.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.483 0.659 . . . . 0.0 110.712 -178.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CG ' ' HB3' ' A' ' 92' ' ' ALA . 11.1 t80 -90.59 94.71 9.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.566 ' CG2' ' CB ' ' A' ' 58' ' ' ALA . 19.5 m -91.77 130.42 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 110.463 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 88' ' ' SER . 16.6 p -126.98 -175.67 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 55.04 70.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.624 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 20' ' ' ASN . 3.9 pp 178.8 151.41 0.47 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -110.15 -169.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.008 1.53 . . . . 0.0 110.037 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.51 41.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.434 HG21 ' N ' ' A' ' 25' ' ' ILE . 2.1 t -80.58 -29.43 37.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.434 ' N ' HG21 ' A' ' 24' ' ' THR . 37.2 pt -108.32 162.46 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.44 136.7 39.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 4.3 p-10 -61.94 -47.49 84.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 25.9 t0 -54.42 -19.8 6.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.182 -0.949 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 26' ' ' THR . 13.8 mt-30 -77.13 -53.14 8.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HA ' HG23 ' A' ' 33' ' ' ILE . 4.6 mp -44.72 -34.04 2.09 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.634 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.553 ' N ' ' HE3' ' A' ' 43' ' ' LYS . 4.8 t70 -50.52 -63.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.2 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' HG21 ' A' ' 32' ' ' THR . 6.6 m -64.23 -14.75 57.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.909 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 HG23 ' HA ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -79.66 -23.22 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.661 ' CE2' ' CD1' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -150.22 35.36 0.65 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.8 -1.188 . . . . 0.0 110.853 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.546 ' HA2' ' CD1' ' A' ' 40' ' ' ILE . . . -88.34 57.54 4.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -131.94 -8.92 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 110.575 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -115.19 47.3 1.31 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.823 -1.173 . . . . 0.0 109.568 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . 122.77 171.9 13.85 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 40' ' ' ILE . 3.3 m -91.47 93.83 9.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.376 -1.073 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.657 HG23 ' HG3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -29.38 143.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-O 121.259 0.552 . . . . 0.0 110.259 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.704 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -105.57 50.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -175.338 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 85.88 95.58 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 120.553 -1.342 . . . . 0.0 112.839 177.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.644 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 3.0 mttm -81.31 117.46 21.82 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.083 -1.011 . . . . 0.0 109.65 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -122.03 153.51 38.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 108.944 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 27' ' ' ASP . 11.1 pt -130.5 159.1 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.537 HD23 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -157.49 130.92 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.05 -23.47 15.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -153.28 168.54 25.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 109.068 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -175.45 34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.0 109.861 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.0 tp -160.02 -72.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -60.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.364 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 86.5 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -113.0 177.05 1.27 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.301 -1.117 . . . . 0.0 109.456 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -107.94 25.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.094 1.576 . . . . 0.0 109.967 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -54.63 11.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.489 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.13 93.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.427 ' O ' ' O ' ' A' ' 46' ' ' LEU . 2.3 m -128.53 154.43 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.147 -1.208 . . . . 0.0 110.069 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.566 ' CB ' ' CG2' ' A' ' 18' ' ' VAL . . . -113.84 176.69 4.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.537 ' CD1' HD23 ' A' ' 46' ' ' LEU . 6.8 m-85 -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.568 ' CG2' ' NZ ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -79.18 157.51 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.704 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -103.87 104.75 14.78 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.654 0.74 . . . . 0.0 109.895 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -161.01 80.78 0.63 Allowed 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.644 ' CG ' ' HA ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -77.13 -115.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.814 -1.154 . . . . 0.0 108.748 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 27.53 89.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.683 0.674 . . . . 0.0 109.555 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -27.91 -41.95 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.777 -0.577 . . . . 0.0 110.544 -177.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' LYS . 3.8 mm-40 -67.1 -56.3 10.61 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.882 -1.136 . . . . 0.0 108.109 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -46.86 -49.15 20.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -52.91 -45.52 67.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.599 -1.313 . . . . 0.0 107.944 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.504 ' HA ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.64 -42.82 35.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 1.0 OUTLIER -60.25 -68.81 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.678 . . . . 0.0 109.872 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.613 ' HB3' ' CD2' ' A' ' 62' ' ' TYR . . . -45.91 -20.05 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 110.104 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.537 ' CG1' ' O ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -71.41 -66.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.58 -1.325 . . . . 0.0 108.219 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -78.53 10.47 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.095 -1.003 . . . . 0.0 110.382 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.73 -56.79 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 109.921 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.661 ' CD1' ' CE2' ' A' ' 34' ' ' PHE . 51.3 mt -77.38 -33.22 55.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.14 133.29 28.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.709 -1.244 . . . . 0.0 108.259 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.626 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 68.54 55.69 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 109.682 -179.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.549 ' CG1' HD13 ' A' ' 87' ' ' LEU . 14.9 p -85.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 108.677 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -132.21 176.25 3.05 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -87.61 44.57 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.842 1.443 . . . . 0.0 109.128 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 80' ' ' PRO . 10.8 pt-20 40.9 45.67 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.5 77.51 0.3 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.08 -36.89 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 67.51 45.41 1.55 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.629 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 5.6 mm-40 -128.2 49.74 4.79 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 109.091 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 37.9 Cg_endo -88.52 -162.4 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.759 1.4 . . . . 0.0 111.389 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.549 HD13 ' CG1' ' A' ' 78' ' ' VAL . 4.8 mp -85.94 124.96 32.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.807 -0.558 . . . . 0.0 110.013 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.4 m -79.26 96.67 6.0 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.562 ' CG2' ' CD1' ' A' ' 16' ' ' LEU . 8.8 p -75.66 143.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.4 1.095 . . . . 0.0 112.012 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.524 ' N ' HG21 ' A' ' 89' ' ' VAL . 1.0 OUTLIER 175.37 -130.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 6' ' ' PRO . 12.3 tp -149.06 152.02 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.395 -1.441 . . . . 0.0 110.113 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.582 ' HB3' ' CG ' ' A' ' 17' ' ' TYR . . . -126.46 -171.05 2.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 109.559 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.86 -174.08 3.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.19 150.08 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.7 -172.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.52 -61.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.268 -1.137 . . . . 0.0 109.444 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -115.61 17.02 16.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 0.0 109.523 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -74.66 -174.1 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 5' ' ' ARG . . . -135.61 155.63 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 2.8 mtt180 61.05 80.84 0.25 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.744 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 91' ' ' LEU . 36.3 Cg_endo -72.01 -172.65 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.834 1.439 . . . . 0.0 110.048 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA2' ' CD2' ' A' ' 91' ' ' LEU . . . -160.72 168.55 36.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.47 1.03 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -166.93 43.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.557 ' C ' HG21 ' A' ' 11' ' ' ILE . 1.4 m -117.67 145.44 44.39 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.679 ' CG2' ' CG1' ' A' ' 41' ' ' VAL . 0.3 OUTLIER 32.63 37.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 CA-C-O 122.375 1.083 . . . . 0.0 108.465 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.575 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER 21.48 58.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.598 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 70.4 m-20 -149.11 -87.4 0.08 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.57 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.633 ' O ' ' CG2' ' A' ' 14' ' ' THR . 0.7 OUTLIER -163.26 105.13 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.906 -1.121 . . . . 0.0 109.73 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.528 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -77.85 -178.95 5.71 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.436 -1.415 . . . . 0.0 108.192 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.597 ' CD2' ' CB ' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -137.02 112.24 9.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.842 -1.161 . . . . 0.0 110.119 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' CG ' ' HB1' ' A' ' 92' ' ' ALA . 8.8 t80 -93.92 101.62 13.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.922 . . . . 0.0 108.841 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 88' ' ' SER . 2.8 m -100.79 113.88 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 0.0 109.929 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -83.18 166.42 18.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.985 . . . . 0.0 109.613 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER 76.91 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.206 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' HA ' HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER 49.53 101.24 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 110.103 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' SER . 36.8 Cg_endo -76.5 140.6 21.64 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.061 1.559 . . . . 0.0 109.631 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.8 41.91 1.05 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -0.967 . . . . 0.0 109.401 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -3.19 30.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.78 179.63 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.458 ' OG1' ' OE1' ' A' ' 29' ' ' GLN . 11.4 p -106.64 155.87 19.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 2.9 p30 -62.05 -42.82 99.59 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 2.6 m-20 -53.84 -27.11 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 108.974 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.458 ' OE1' ' OG1' ' A' ' 26' ' ' THR . 0.7 OUTLIER -81.48 -33.58 31.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.46 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -52.44 -33.56 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.57 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -60.12 -46.01 91.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.035 . . . . 0.0 108.418 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 5.9 m -61.1 -43.18 99.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 HG23 ' CG2' ' A' ' 78' ' ' VAL . 3.0 mm -52.71 -30.64 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.661 ' CZ ' ' CD1' ' A' ' 75' ' ' LEU . 4.0 m-30 -79.15 -77.57 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.591 -0.693 . . . . 0.0 109.887 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 36' ' ' LYS . . . 141.12 -82.31 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 166.08 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -1.196 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 3.8 m-85 -78.77 -70.13 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.348 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.05 -169.4 15.5 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 40' ' ' ILE . 48.6 p -78.99 77.18 5.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 108.338 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.547 ' HB ' ' NE ' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -40.46 146.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.679 ' CG1' ' CG2' ' A' ' 11' ' ' ILE . 28.8 m -111.2 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.814 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 50.2 tt0 62.53 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.13 -0.981 . . . . 0.0 112.803 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.538 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 3.2 mtmm -75.56 163.27 27.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.369 -0.832 . . . . 0.0 109.506 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -149.3 106.22 3.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.925 . . . . 0.0 109.592 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG13 ' HG ' ' A' ' 21' ' ' LEU . 12.3 tt -87.53 141.14 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -120.06 110.39 16.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.564 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' CZ ' ' HB3' ' A' ' 23' ' ' ARG . 2.1 ptm180 -157.03 24.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 109.47 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 57.86 164.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -110.61 -88.08 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.516 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.31 45.08 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 m -109.73 -21.06 12.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.99 55.01 4.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.24 172.43 3.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.156 -1.202 . . . . 0.0 109.446 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -110.46 109.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.015 1.534 . . . . 0.0 110.431 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -84.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.15 45.78 47.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 10.1 p -148.42 159.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.134 . . . . 0.0 109.04 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 18' ' ' VAL . . . -160.17 -175.11 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -155.18 104.66 2.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' A' ' 34' ' ' PHE . 2.7 p -79.33 157.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.271 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.814 ' HD3' ' N ' ' A' ' 42' ' ' GLN . 3.8 ptt180 -84.1 142.35 30.45 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.934 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' OH ' ' CE2' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -161.42 164.94 29.54 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.598 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -145.04 -101.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.366 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.598 ' C ' ' O ' ' A' ' 63' ' ' ASN . 5.1 mmtp -22.15 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.647 -0.658 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.501 ' NH2' ' HA ' ' A' ' 13' ' ' ASP . 32.2 mmt-85 -43.39 -50.59 6.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.187 -0.945 . . . . 0.0 108.558 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 67.6 mt-10 -55.06 -44.8 75.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -47.95 -60.78 2.35 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.666 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 14' ' ' THR . . . -46.31 -37.01 6.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.757 -1.215 . . . . 0.0 108.19 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -51.66 -53.7 36.02 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' ILE . 4.4 mm-40 -51.28 -67.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . . . -34.12 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.549 ' CD1' HG13 ' A' ' 89' ' ' VAL . 1.5 mm -70.4 -67.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.927 -1.108 . . . . 0.0 108.29 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -85.68 27.98 0.81 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.465 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 70' ' ' GLU . . . -140.71 -53.41 0.49 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.966 . . . . 0.0 108.486 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.661 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -78.78 -29.15 44.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 42.0 t30 -58.3 139.84 54.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 108.86 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' OD1' ' CB ' ' A' ' 86' ' ' PRO . 3.0 m120 58.88 63.5 1.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.053 -1.03 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.546 ' CG1' ' CD1' ' A' ' 87' ' ' LEU . 1.5 p -85.7 65.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.57 ' HB ' ' HD2' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -165.4 153.24 9.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 33.7 Cg_endo -43.96 -74.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.547 1.288 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 1.1 pt-20 162.38 144.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.6 -63.16 0.29 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . -132.18 -164.65 11.08 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 83' ' ' GLY . 0.2 OUTLIER 79.86 -9.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -1.003 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER 62.25 154.08 0.11 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.073 -1.017 . . . . 0.0 109.462 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' CB ' ' OD1' ' A' ' 77' ' ' ASN . 36.4 Cg_endo -107.68 157.34 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.011 1.532 . . . . 0.0 110.839 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.546 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 2.9 mp -78.79 123.94 27.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -79.15 97.24 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.564 ' CG1' HD13 ' A' ' 16' ' ' LEU . 22.3 t -75.95 137.74 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.396 1.093 . . . . 0.0 111.442 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' N ' HG11 ' A' ' 89' ' ' VAL . 1.3 tpt180 -175.49 -135.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.15 135.92 9.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.67 -1.269 . . . . 0.0 109.184 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.446 ' HB1' ' CG ' ' A' ' 17' ' ' TYR . . . -107.34 -162.68 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -171.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.96 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 176.8 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.98 138.2 0.25 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.32 -0.862 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.77 123.66 29.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.206 -1.173 . . . . 0.0 109.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.28 0.562 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 171.61 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.539 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 15.1 p90 -107.24 77.46 1.15 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 109.358 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 3' ' ' TYR . . . 73.25 149.78 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.367 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -126.54 45.42 1.52 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' HD3' ' C ' ' A' ' 4' ' ' ALA . 36.2 Cg_endo -58.39 112.84 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.856 1.451 . . . . 0.0 110.233 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 177.12 59.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 92' ' ' ALA . . . -127.66 -146.7 6.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 9' ' ' GLU . 5.4 pm0 -170.88 113.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 109.334 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -166.02 -167.32 1.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.817 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' CD1' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 41.24 32.95 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.512 0.672 . . . . 0.0 110.121 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER 76.69 -28.23 0.18 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 110.987 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.592 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -130.8 -74.66 0.53 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.651 -1.281 . . . . 0.0 110.707 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.608 ' CG2' ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -160.31 91.59 0.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.01 -1.056 . . . . 0.0 110.245 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 4.4 t30 -79.25 169.24 18.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -0.877 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.657 HD23 ' CG1' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -143.92 136.02 26.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.67 -1.269 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' ' CZ ' ' A' ' 59' ' ' PHE . 5.1 t80 -85.28 142.73 29.17 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.422 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.536 HG22 ' CB ' ' A' ' 58' ' ' ALA . 30.2 m -132.94 157.08 42.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -144.12 159.24 42.98 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.714 -179.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.6 t-20 79.51 88.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 110.299 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.611 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -159.99 150.87 15.73 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.53 ' O ' ' CD2' ' A' ' 21' ' ' LEU . 36.7 Cg_endo -82.5 -176.8 3.1 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.819 1.431 . . . . 0.0 111.013 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -77.0 3.35 12.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.135 -0.978 . . . . 0.0 109.97 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.532 ' CG2' ' OE1' ' A' ' 29' ' ' GLN . 33.9 m -84.14 -112.94 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.513 ' CG2' HD21 ' A' ' 30' ' ' LEU . 8.8 mm 42.23 23.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.898 -1.126 . . . . 0.0 110.311 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' THR . 49.0 p -35.94 158.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.692 0.758 . . . . 0.0 110.616 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 16.7 m-20 -60.27 -27.38 67.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.88 -13.03 34.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.532 ' OE1' ' CG2' ' A' ' 24' ' ' THR . 2.4 mt-30 -79.88 -66.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.59 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 2.1 mp -57.03 -28.77 62.8 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.248 -1.381 . . . . 0.0 107.98 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -62.44 -43.33 99.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 108.672 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 m -55.75 -56.53 19.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.488 HG21 ' O ' ' A' ' 30' ' ' LEU . 8.4 tp -62.13 -18.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.675 ' CD2' ' CD1' ' A' ' 40' ' ' ILE . 6.9 m-85 -86.9 -98.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 18.22 62.53 0.01 OUTLIER Glycine 0 N--CA 1.498 2.832 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER 178.15 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 111.074 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -128.19 50.39 2.07 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.416 -1.427 . . . . 0.0 111.179 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' ' CD1' ' A' ' 62' ' ' TYR . . . 26.21 43.47 0.02 OUTLIER Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.614 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -88.84 34.61 0.77 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.46 -1.024 . . . . 0.0 109.997 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.675 ' CD1' ' CD2' ' A' ' 34' ' ' PHE . 0.1 OUTLIER 165.34 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.568 ' CG2' ' HB3' ' A' ' 61' ' ' ARG . 15.3 m -89.97 13.47 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER 165.93 53.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.488 ' O ' ' HG3' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -42.65 144.54 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.123 -0.986 . . . . 0.0 109.98 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -152.86 150.91 29.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.03 . . . . 0.0 109.825 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.45 ' CG2' HD22 ' A' ' 21' ' ' LEU . 1.5 mt -101.9 -178.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HB3' HG23 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -148.78 105.13 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.378 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -111.59 -172.69 2.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -72.63 175.2 6.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -106.09 -65.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.473 ' O ' ' CG2' ' A' ' 51' ' ' THR . 0.1 OUTLIER -129.11 -41.36 1.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 34.0 p -158.15 175.74 13.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 53' ' ' ARG . . . 94.4 -57.59 1.99 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 52' ' ' GLY . 0.9 OUTLIER 54.88 87.49 0.14 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.201 -1.176 . . . . 0.0 109.518 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 36.6 Cg_endo -61.16 -54.34 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.042 1.548 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 175.39 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.166 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 21' ' ' LEU . . . 108.28 111.56 3.5 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 HG22 ' OH ' ' A' ' 17' ' ' TYR . 2.7 m -127.12 178.43 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -1.139 . . . . 0.0 109.394 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.536 ' CB ' HG22 ' A' ' 18' ' ' VAL . . . -139.7 177.11 8.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.639 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -146.48 111.27 5.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.657 ' CG1' HD23 ' A' ' 16' ' ' LEU . 16.9 t -95.87 148.14 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HB3' ' CG2' ' A' ' 41' ' ' VAL . 68.3 mtt180 -118.18 65.24 0.75 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.287 -1.508 . . . . 0.0 110.187 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -78.64 91.66 4.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.592 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -47.68 -84.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.891 -1.13 . . . . 0.0 110.993 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.533 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -24.03 144.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.534 0.683 . . . . 0.0 112.103 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -51.66 9.93 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.625 -0.672 . . . . 0.0 110.364 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -67.19 -39.49 86.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.848 -1.157 . . . . 0.0 108.24 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 18.1 mt-10 -69.3 -29.13 66.93 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' CB ' ' CD1' ' A' ' 91' ' ' LEU . . . -63.21 -39.8 95.67 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.51 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.8 -28.24 69.32 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.647 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -57.68 -67.99 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.458 -0.776 . . . . 0.0 108.978 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' O ' ' CB ' ' A' ' 75' ' ' LEU . . . -55.51 -17.63 5.68 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.315 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.539 ' CD1' HG13 ' A' ' 89' ' ' VAL . 3.0 mm -69.39 -61.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.545 -1.347 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.91 4.34 41.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.604 -0.685 . . . . 0.0 111.11 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.453 ' HB1' ' OE1' ' A' ' 70' ' ' GLU . . . -131.56 -1.28 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.745 -1.222 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.579 HD12 ' CE1' ' A' ' 34' ' ' PHE . 2.0 tp -127.87 -23.63 3.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.742 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' CA ' HG22 ' A' ' 89' ' ' VAL . 9.9 t-20 -41.1 -27.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.206 -0.933 . . . . 0.0 108.888 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 75' ' ' LEU . 91.2 m-20 -122.99 76.02 1.33 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.755 -0.59 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 7.3 p -84.44 48.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.178 -0.951 . . . . 0.0 108.805 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.53 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 2.0 pt -124.05 -169.58 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.2 Cg_endo -110.92 40.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.983 1.517 . . . . 0.0 110.299 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER 76.97 160.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.48 -50.83 4.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.53 ' O ' ' CD1' ' A' ' 79' ' ' ILE . . . 155.67 -98.05 0.17 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' GLN . 11.6 m 62.75 10.32 4.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.13 . . . . 0.0 109.425 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 mt-30 53.29 107.7 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 0.0 110.222 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HG3' HG12 ' A' ' 79' ' ' ILE . 37.5 Cg_endo -115.61 164.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.939 1.494 . . . . 0.0 109.163 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -72.0 108.94 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.366 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.6 t -76.54 116.46 17.25 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.632 ' CG1' ' CD1' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -79.09 174.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.519 1.152 . . . . 0.0 113.155 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER 163.7 96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.608 ' CD2' ' CG2' ' A' ' 14' ' ' THR . 0.1 OUTLIER -51.57 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.082 . . . . 0.0 109.417 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.6 159.71 2.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.512 -0.742 . . . . 0.0 110.02 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -140.61 50.63 1.67 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 109.191 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -152.85 -69.03 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.385 -0.822 . . . . 0.0 109.458 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 7.4 p80 -119.62 79.99 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.27 -150.68 5.74 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CE ' ' OXT' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 109.502 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.268 0.556 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 67.8 m -92.87 -32.4 14.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER 68.5 160.09 0.17 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ARG . . . -179.44 162.06 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.096 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' ALA . 7.3 mtm180 61.54 116.16 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -91.54 -176.76 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.993 1.523 . . . . 0.0 110.609 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.534 ' CA ' ' OD2' ' A' ' 13' ' ' ASP . . . -120.99 -149.75 8.24 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.535 ' N ' ' HB2' ' A' ' 13' ' ' ASP . . . 160.6 -132.89 3.05 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 12.9 pt-20 -161.99 -171.27 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.274 -1.133 . . . . 0.0 109.519 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER 66.61 111.9 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 0.0 109.009 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.56 ' O ' ' CG1' ' A' ' 11' ' ' ILE . 0.5 OUTLIER 38.17 67.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.542 ' CG ' ' HG2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 63.9 -162.89 0.27 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 108.516 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.535 ' HB2' ' N ' ' A' ' 8' ' ' GLY . 3.9 p-10 -160.96 94.7 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.63 -1.294 . . . . 0.0 110.281 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.551 ' HB ' ' CB ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -160.16 57.93 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.9 . . . . 0.0 110.036 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.501 ' N ' HD13 ' A' ' 91' ' ' LEU . 1.1 t30 -78.59 158.06 28.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.874 . . . . 0.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.572 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -138.07 125.2 21.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.865 -1.147 . . . . 0.0 109.788 178.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 1.1 t80 -77.28 105.67 8.54 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.568 ' HB ' ' CG ' ' A' ' 87' ' ' LEU . 4.0 m -87.09 103.77 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.489 ' OG1' ' HB3' ' A' ' 88' ' ' SER . 17.2 p -90.44 167.96 12.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.344 -0.847 . . . . 0.0 109.553 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER 68.15 7.55 5.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD11 ' CG2' ' A' ' 18' ' ' VAL . 9.9 tt -71.08 115.0 32.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.118 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD2' ' HG ' ' A' ' 21' ' ' LEU . 36.6 Cg_endo -60.13 142.37 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.859 1.452 . . . . 0.0 110.289 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.71 28.62 1.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 12.11 37.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.928 . . . . 0.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.1 pp -130.33 170.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.485 HG21 ' OE1' ' A' ' 29' ' ' GLN . 1.2 p -113.62 153.91 28.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.351 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -49.88 -69.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 109.015 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -42.0 -27.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.485 ' OE1' HG21 ' A' ' 26' ' ' THR . 1.8 tt0 -62.97 -62.39 1.74 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.581 ' O ' ' CD2' ' A' ' 34' ' ' PHE . 1.6 mp -52.93 -20.2 3.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.859 -1.15 . . . . 0.0 108.957 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 27.4 t0 -66.43 -47.13 74.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.089 -1.007 . . . . 0.0 108.966 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 m -68.02 -37.55 81.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.451 -0.781 . . . . 0.0 109.072 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -61.75 -27.2 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 108.889 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 33' ' ' ILE . 10.7 m-85 -88.45 -81.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 38.19 82.83 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 109.654 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -107.79 -86.08 0.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.877 . . . . 0.0 109.109 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.6 179.29 16.42 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 40' ' ' ILE . 10.7 m -94.13 25.83 3.57 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.077 -1.249 . . . . 0.0 108.773 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 39' ' ' SER . 3.4 mp 56.91 142.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 61' ' ' ARG . 33.4 m -79.21 -12.9 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.528 -1.358 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 21.4 tt0 157.47 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HE2' ' CA ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -74.24 144.71 44.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 108.656 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 7.0 m120 -132.68 144.46 50.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.1 . . . . 0.0 110.407 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tt -130.11 155.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' VAL . 8.5 tp -168.74 117.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.998 -1.064 . . . . 0.0 109.599 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -86.79 -39.25 16.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 109.744 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 47' ' ' ARG . 4.7 p30 165.98 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -148.71 31.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.66 -47.6 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -79.49 0.53 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.34 72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' CD ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -132.21 150.17 75.26 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 109.461 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -119.3 86.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.777 1.409 . . . . 0.0 110.611 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' NH2' ' CD ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -159.69 -36.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.17 -0.956 . . . . 0.0 109.807 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' N ' ' HG3' ' A' ' 55' ' ' ARG . . . 107.47 98.45 2.56 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' LEU . 27.4 m -117.64 160.61 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.511 ' O ' HG21 ' A' ' 18' ' ' VAL . . . -153.4 164.31 38.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.557 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 11.1 m-85 -128.09 109.08 11.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.637 ' CG1' ' CD1' ' A' ' 62' ' ' TYR . 1.6 t -79.89 120.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB3' HG21 ' A' ' 41' ' ' VAL . 13.7 ttm-85 -88.03 99.73 12.39 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.878 -1.139 . . . . 0.0 110.35 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.637 ' CD1' ' CG1' ' A' ' 60' ' ' VAL . 3.6 m-85 -119.23 74.89 1.01 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.54 ' CB ' HG21 ' A' ' 11' ' ' ILE . 1.4 m-20 -68.38 -4.93 16.33 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.978 -1.076 . . . . 0.0 110.882 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.541 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -87.98 146.53 25.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.954 -1.092 . . . . 0.0 109.606 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' HG2' ' CG ' ' A' ' 12' ' ' LYS . 39.3 mmm-85 -73.07 -58.84 3.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 108.793 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.21 -45.69 79.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.86 . . . . 0.0 108.846 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -52.83 -43.31 65.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.111 -0.993 . . . . 0.0 108.898 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.551 ' CB ' ' HB ' ' A' ' 14' ' ' THR . . . -61.89 -40.54 95.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.936 -1.103 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -31.31 25.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.593 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -80.2 -72.18 0.42 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 75' ' ' LEU . . . -36.59 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.526 0.679 . . . . 0.0 110.685 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' GLU . 2.5 mt -81.02 -63.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.498 -1.376 . . . . 0.0 108.827 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 m -84.23 30.46 0.53 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.386 -0.821 . . . . 0.0 109.822 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.11 -52.88 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.634 ' CD2' ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.47 -34.39 41.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.151 -0.968 . . . . 0.0 108.657 179.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 6.6 t-20 -42.71 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER 80.87 76.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -89.4 38.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.306 -0.871 . . . . 0.0 109.064 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' CG2' ' HD2' ' A' ' 80' ' ' PRO . 1.5 mt -151.7 128.32 5.34 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.552 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 35.9 Cg_endo -44.06 130.79 8.37 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.741 1.39 . . . . 0.0 110.105 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -46.57 102.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.17 21.08 0.5 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.18 75.76 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.497 ' CB ' HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -88.46 16.23 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -1.181 . . . . 0.0 109.218 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 84' ' ' SER . 28.2 mt-30 69.86 123.32 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.2 Cg_endo -110.46 -168.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.813 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' CG ' ' HB ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.29 113.46 27.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.642 -0.661 . . . . 0.0 109.927 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -79.73 106.22 11.59 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 12.5 m -78.21 -167.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 111.322 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.602 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 95.12 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.543 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -49.47 168.17 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -149.16 -156.44 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.14 -169.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.061 -1.025 . . . . 0.0 109.748 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' HIS . 9.7 mt-10 -131.76 124.27 29.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 109.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 57.33 110.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.97 -143.56 3.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.192 -1.181 . . . . 0.0 109.38 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 30.5 t0 -161.93 96.31 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 91' ' ' LEU . 1.2 m -148.23 54.87 1.03 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -78.34 164.09 25.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.865 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 pt? -127.25 141.44 51.72 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.641 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.682 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -83.44 110.92 18.57 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.605 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -84.78 116.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 109.248 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 57' ' ' VAL . 9.8 p -91.11 163.15 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 109.713 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.69 89.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.558 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 87' ' ' LEU . 9.1 tp -157.22 96.68 2.07 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HG3' ' OE1' ' A' ' 85' ' ' GLN . 36.9 Cg_endo -69.11 168.53 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.989 1.52 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 42.63 1.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.987 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.754 HG23 HG23 ' A' ' 25' ' ' ILE . 9.3 t -80.19 -12.0 59.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -125.77 -177.73 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.5 p -110.59 153.76 24.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' HD11 ' A' ' 45' ' ' ILE . 6.1 p-10 -57.62 -47.35 82.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -65.53 -19.05 65.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 17.5 tt0 -71.15 -48.82 49.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.576 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -45.7 -26.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 108.735 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 10.3 t70 -64.65 -51.14 64.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.842 . . . . 0.0 109.109 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.7 m -54.62 -44.35 73.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.087 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.89 HG21 ' HB ' ' A' ' 78' ' ' VAL . 1.8 mp -57.25 -36.11 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.197 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.699 ' CD1' HD21 ' A' ' 75' ' ' LEU . 2.0 m-30 -80.28 -83.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 109.346 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 23.01 67.09 0.02 OUTLIER Glycine 0 N--CA 1.503 3.115 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -172.88 -39.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.247 . . . . 0.0 109.922 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.889 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -94.38 -77.52 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.177 -0.952 . . . . 0.0 109.584 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 -168.15 14.94 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.32 32.58 4.36 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -1.232 . . . . 0.0 109.555 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 26.62 101.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.774 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.818 HG13 HH11 ' A' ' 61' ' ' ARG . 0.7 OUTLIER -76.54 9.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.362 -1.461 . . . . 0.0 110.129 -179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -168.04 -164.65 0.56 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.638 -1.289 . . . . 0.0 110.776 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 159.02 106.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -139.33 -178.5 5.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.62 -1.3 . . . . 0.0 110.905 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD11 ' HB3' ' A' ' 27' ' ' ASP . 5.3 mp -139.25 141.65 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.8 mp -127.58 130.38 48.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.498 ' C ' HG13 ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.498 HG13 ' C ' ' A' ' 56' ' ' GLY . 13.6 m -157.38 143.08 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -1.101 . . . . 0.0 109.704 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -100.47 -176.45 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 108.801 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.682 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -133.93 108.02 8.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 109.55 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 75' ' ' LEU . 1.7 t -85.89 160.85 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.818 HH11 HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.71 140.85 37.46 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.151 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 9.4 m-85 -161.39 68.99 0.32 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.671 ' ND2' HG11 ' A' ' 41' ' ' VAL . 18.0 m-20 -46.86 -86.6 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.434 -0.791 . . . . 0.0 109.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 63' ' ' ASN . 6.5 ttmm -37.01 118.37 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.326 0.584 . . . . 0.0 109.672 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.698 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -45.74 -47.7 15.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.629 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 14.6 mt-10 -54.38 -50.02 68.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 3.1 tp10 -53.86 -42.78 68.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CA ' ' HB3' ' A' ' 62' ' ' TYR . . . -55.43 -39.33 70.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.838 -1.164 . . . . 0.0 108.594 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.507 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.47 -44.73 76.73 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -49.2 -62.24 1.64 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.151 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -43.37 -40.09 3.48 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.524 -0.735 . . . . 0.0 109.152 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 40.8 mm -46.99 -60.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -68.82 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.889 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -45.94 -50.95 14.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 111.588 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.18 -28.17 42.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.723 -1.235 . . . . 0.0 110.635 -178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.0 t30 -46.15 115.29 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.251 -1.53 . . . . 0.0 107.463 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 60.81 78.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.941 HG13 HD11 ' A' ' 87' ' ' LEU . 1.6 m -85.23 45.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.97 145.05 25.93 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.42 -0.8 . . . . 0.0 109.234 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 81' ' ' GLU . 36.3 Cg_endo -62.47 139.21 75.19 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.91 1.479 . . . . 0.0 109.328 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -40.33 107.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 -179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.72 38.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 81.56 -139.47 20.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.667 ' OG ' HG21 ' A' ' 79' ' ' ILE . 1.4 t 78.77 -4.82 2.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.598 -0.942 . . . . 0.0 109.391 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 84' ' ' SER . 24.7 mt-30 57.97 117.22 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.835 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HA ' HD11 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -83.75 177.74 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.905 1.476 . . . . 0.0 110.295 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -118.09 138.73 52.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 109.574 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 19.2 m -79.04 103.81 9.24 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.865 HG12 HD11 ' A' ' 16' ' ' LEU . 1.2 m -83.08 144.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.731 0.776 . . . . 0.0 110.886 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' H ' ' HB2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER 171.92 132.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -61.29 116.21 4.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.12 162.26 25.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -95.15 71.45 3.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -150.31 -38.13 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 97.8 m-70 62.41 105.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.23 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.412 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -177.41 96.0 0.1 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.228 0.061 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.594 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 12.5 m-20 -157.97 -105.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.012 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -159.21 92.46 1.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.665 -1.272 . . . . 0.0 110.394 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.751 ' O ' HD22 ' A' ' 91' ' ' LEU . 33.3 p-10 -83.65 168.53 16.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.324 -0.86 . . . . 0.0 109.564 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -134.89 122.16 21.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.459 -1.401 . . . . 0.0 110.43 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' CD1' ' CE2' ' A' ' 59' ' ' PHE . 9.4 t80 -78.14 135.75 37.72 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.863 HG21 ' CD2' ' A' ' 87' ' ' LEU . 3.5 m -116.35 148.07 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.995 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.693 ' HA ' HG12 ' A' ' 57' ' ' VAL . 28.3 p -131.54 178.34 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.377 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 57.17 91.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.801 HD13 HG23 ' A' ' 45' ' ' ILE . 23.2 mt -108.99 175.32 2.0 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 109.121 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -114.22 6.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.743 1.391 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 163.4 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.648 ' HA ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -162.36 -44.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.444 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.759 HG22 ' OE1' ' A' ' 29' ' ' GLN . 1.1 mt 47.99 -174.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 108.913 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.589 ' H ' HG22 ' A' ' 25' ' ' ILE . 1.1 p -100.28 143.83 30.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.976 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 1.5 m-20 -57.79 -62.02 2.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.349 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -51.06 -18.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.759 ' OE1' HG22 ' A' ' 25' ' ' ILE . 22.2 mt-30 -75.08 -61.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.368 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.826 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 tp -44.5 -25.2 0.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.077 -1.014 . . . . 0.0 109.719 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.573 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 1.2 m-20 -64.52 -54.49 31.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.982 -1.074 . . . . 0.0 108.878 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -62.38 -35.94 80.74 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.399 -0.813 . . . . 0.0 109.087 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 30' ' ' LEU . 4.5 tt -61.3 -27.69 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 108.67 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.891 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 12.3 m-85 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 36' ' ' LYS . . . 155.54 -91.69 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 169.3 50.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.812 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -93.76 -86.51 0.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.152 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' CA ' ' HG3' ' A' ' 67' ' ' GLU . . . -74.09 157.33 51.14 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 40' ' ' ILE . 28.1 t -79.35 79.57 5.78 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.115 -1.227 . . . . 0.0 107.904 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -34.83 115.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.662 0.744 . . . . 0.0 109.574 -178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 61' ' ' ARG . 6.2 m -81.53 38.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 110.122 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 2.9 tt0 91.65 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.602 0.715 . . . . 0.0 111.035 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -99.95 151.45 21.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -145.65 175.68 10.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.59 -1.319 . . . . 0.0 110.992 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.801 HG23 HD13 ' A' ' 21' ' ' LEU . 49.9 mt -143.19 134.43 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.1 151.43 31.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.978 -1.076 . . . . 0.0 109.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.165 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -126.33 140.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.79 -174.34 2.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.483 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 m-85 -143.57 99.14 3.37 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 16' ' ' LEU . 15.6 t -85.85 148.66 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.945 ' O ' HG22 ' A' ' 41' ' ' VAL . 9.5 mtt180 -137.33 79.25 1.74 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.415 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 11.1 m-85 -78.86 160.04 27.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.594 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -103.45 -91.95 0.35 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.111 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -25.54 136.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.508 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -50.93 -51.25 54.04 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 70' ' ' GLU . 16.5 mt-10 -63.43 -35.33 80.07 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -61.34 -28.12 68.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -75.82 -43.93 43.58 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -60.56 -20.77 61.4 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -70.75 -61.51 1.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -68.44 -5.13 17.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.561 0.696 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.059 ' HA ' HG21 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -86.43 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.723 -1.236 . . . . 0.0 108.21 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -75.29 -1.64 24.5 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.818 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.84 -47.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 110.357 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -84.09 -21.14 31.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 110.556 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.683 ' HA ' HG22 ' A' ' 89' ' ' VAL . 23.6 p-10 -46.95 -23.83 0.51 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.55 -1.344 . . . . 0.0 109.128 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 85' ' ' GLN . 3.4 m-80 -143.59 86.63 1.89 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 87' ' ' LEU . 2.2 p -78.46 88.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 108.838 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.048 HG23 ' HG3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -147.55 -172.61 0.32 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.48 -0.762 . . . . 0.0 109.085 -179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -102.7 24.06 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.899 1.473 . . . . 0.0 109.424 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER 73.24 114.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 0.0 109.693 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.83 -18.65 1.11 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 137.44 -148.76 20.0 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 79' ' ' ILE . 6.2 t 83.83 -28.11 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.799 -0.824 . . . . 0.0 109.837 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.506 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.8 pt20 38.41 92.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.245 -0.909 . . . . 0.0 110.755 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 1.048 ' HG3' HG23 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -121.24 -178.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.925 1.487 . . . . 0.0 110.049 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.863 ' CD2' HG21 ' A' ' 18' ' ' VAL . 77.3 mt 25.07 68.02 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 7.4 m -77.25 102.12 6.54 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.059 HG21 ' HA ' ' A' ' 72' ' ' ILE . 14.7 m -77.85 163.87 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.313 1.054 . . . . 0.0 113.153 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 91' ' ' LEU . 2.1 ttt180 171.2 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER -33.64 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.622 -0.674 . . . . 0.0 109.386 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.79 179.48 6.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.86 -1.15 . . . . 0.0 110.279 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.35 105.22 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.443 -0.785 . . . . 0.0 109.176 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.31 -163.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -108.38 30.62 6.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.431 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.01 -33.66 0.05 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.213 -1.169 . . . . 0.0 109.61 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.59 -88.17 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.48 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.782 ' HA ' HD13 ' A' ' 91' ' ' LEU . 3.2 m -79.22 71.62 5.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 110.03 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -76.89 -177.27 4.29 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.048 HD23 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -112.28 103.79 11.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.702 -1.249 . . . . 0.0 111.407 -178.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' CZ ' ' A' ' 59' ' ' PHE . 2.8 t80 -83.11 81.92 8.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 2.5 m -82.47 129.68 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 111.261 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.753 HG23 HG12 ' A' ' 57' ' ' VAL . 19.6 m -131.76 172.18 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' H ' HG22 ' A' ' 19' ' ' THR . 20.3 t-20 79.27 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.969 . . . . 0.0 110.121 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -170.1 144.98 2.28 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.018 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -106.85 69.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.626 1.329 . . . . 0.0 111.003 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 4.2 mtm180 40.1 36.38 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 24' ' ' THR . 89.2 m -79.82 -5.24 55.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 0.0 109.23 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.532 ' CD1' HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -152.32 150.27 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.174 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -91.55 155.41 18.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' H ' HD11 ' A' ' 45' ' ' ILE . 5.4 p-10 -62.31 -49.63 74.86 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.166 -0.959 . . . . 0.0 108.488 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 6.6 t0 -50.79 -22.5 2.18 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -77.37 -41.48 40.04 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.831 . . . . 0.0 109.777 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.985 ' O ' HG22 ' A' ' 33' ' ' ILE . 6.9 mp -47.3 -44.35 23.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.006 . . . . 0.0 109.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 6.9 t70 -58.03 -41.32 82.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.818 -1.176 . . . . 0.0 108.991 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -36.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.491 -0.755 . . . . 0.0 110.476 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.988 HD13 HG13 ' A' ' 78' ' ' VAL . 1.2 tt -67.21 -33.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.784 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CD1' HG23 ' A' ' 33' ' ' ILE . 1.8 m-85 -84.37 -72.03 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 109.075 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 36' ' ' LYS . . . 104.09 -40.74 2.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CD ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -175.22 98.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.261 . . . . 0.0 109.437 -179.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.711 ' CE1' ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -136.67 -21.7 1.28 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 62' ' ' TYR . . . -178.91 -175.5 46.0 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 40' ' ' ILE . 1.4 t -88.91 71.99 8.52 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.372 -1.075 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -37.71 134.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.9 m -102.21 48.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 111.788 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.755 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 1.1 tm0? 89.28 131.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.592 0.71 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 mtmp? -100.66 169.66 8.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -160.56 163.9 32.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.916 -1.115 . . . . 0.0 110.341 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 27' ' ' ASP . 1.8 mt -141.11 107.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 57' ' ' VAL . 2.0 mm? -93.91 130.9 39.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.335 -0.853 . . . . 0.0 109.145 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.898 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.753 HG12 HG23 ' A' ' 19' ' ' THR . 10.7 m -145.89 139.88 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -1.084 . . . . 0.0 109.075 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -124.55 177.11 6.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 47.8 m-85 -142.84 107.97 4.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.048 HG12 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -78.8 177.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.14 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -107.03 123.76 48.66 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.3 -177.194 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.63 ' CE1' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -163.93 158.34 19.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.92 -1.113 . . . . 0.0 109.77 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.558 ' HA ' ' H ' ' A' ' 14' ' ' THR . 5.2 p-10 -148.32 -64.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 0.0 110.962 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -49.55 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 108.977 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.491 ' HG2' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -30.36 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.748 -0.595 . . . . 0.0 111.379 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 64' ' ' LYS . 56.9 mt-10 -66.71 -64.61 0.82 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.894 -1.129 . . . . 0.0 109.426 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . 26.3 pt-20 -56.02 -24.13 37.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.903 -1.123 . . . . 0.0 108.711 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 14' ' ' THR . . . -65.03 -44.63 88.5 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 52.8 tt0 -48.19 -33.69 8.89 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -60.13 -53.0 62.92 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -60.97 -11.91 9.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.072 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.902 ' HA ' HG21 ' A' ' 89' ' ' VAL . 33.0 mm -80.17 -59.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.12 4.3 8.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.565 -0.709 . . . . 0.0 110.172 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.42 -54.31 1.02 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.101 . . . . 0.0 109.862 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.037 HD21 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -79.4 -11.27 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.322 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.63 ' CB ' HG22 ' A' ' 89' ' ' VAL . 21.1 t-20 -82.86 42.42 0.79 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.405 -1.435 . . . . 0.0 109.145 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 p30 156.27 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.988 HG13 HD13 ' A' ' 33' ' ' ILE . 2.1 t -79.97 87.62 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.021 HD13 ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 172.58 135.74 0.1 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.473 -0.767 . . . . 0.0 109.181 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 36.6 Cg_endo -43.73 117.31 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.979 1.515 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -45.37 147.12 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 120.95 -59.64 0.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -60.81 -127.68 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.457 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -179.89 35.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 109.554 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 1.021 ' O ' HD13 ' A' ' 79' ' ' ILE . 13.2 mt-30 -129.44 71.3 82.08 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.391 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.69 -171.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.896 1.472 . . . . 0.0 110.954 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.96 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -116.47 113.62 23.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.24 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.1 t -78.53 102.65 8.0 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.902 HG21 ' HA ' ' A' ' 72' ' ' ILE . 17.0 m -78.5 153.89 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.008 0.909 . . . . 0.0 111.576 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 4.3 ttm-85 173.99 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 14' ' ' THR . 7.4 tp -52.42 136.82 30.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.938 -1.101 . . . . 0.0 108.978 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.615 ' N ' HD12 ' A' ' 91' ' ' LEU . . . -133.79 145.42 49.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.31 141.47 35.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -179.81 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -159.65 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.55 -117.25 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.218 -1.166 . . . . 0.0 109.621 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.648 ' HB2' ' ND2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.593 0.235 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' ' N ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -160.95 -99.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.474 -1.391 . . . . 0.0 111.584 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 68' ' ' ALA . 7.7 p -107.75 -133.73 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.35 -1.469 . . . . 0.0 109.867 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.543 ' CB ' HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -164.56 -167.6 1.31 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.243 -0.911 . . . . 0.0 108.932 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.933 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.8 tp -154.62 121.54 5.54 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.85 ' OH ' HG11 ' A' ' 57' ' ' VAL . 11.4 t80 -110.17 117.26 33.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.808 -1.182 . . . . 0.0 109.726 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 89' ' ' VAL . 18.8 m -112.36 131.77 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 110.006 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.689 ' OG1' HG12 ' A' ' 57' ' ' VAL . 11.1 t -127.04 -166.53 1.61 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 108.896 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER 81.78 -65.24 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.317 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -38.3 126.45 1.08 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.954 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -106.37 64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.971 1.511 . . . . 0.0 110.639 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 65.08 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.906 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 m -124.0 -24.93 4.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 109.964 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.726 HD12 ' CD1' ' A' ' 30' ' ' LEU . 1.1 pt -111.35 179.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -114.35 153.04 30.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.798 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 1.9 m-20 -63.35 -60.13 3.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 108.911 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -43.23 -26.39 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.305 -0.872 . . . . 0.0 109.382 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -72.23 -63.44 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.726 ' CD1' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -45.96 -24.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.124 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 1.6 t70 -64.86 -59.12 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.022 . . . . 0.0 109.118 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' THR . 92.8 m -64.28 -12.39 41.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.436 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.639 HG21 HG23 ' A' ' 78' ' ' VAL . 12.8 mm -77.72 -45.78 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.977 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.867 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 7.8 p90 -142.35 49.6 1.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.49 36.73 4.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -100.28 -44.97 5.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD1' ' OH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -79.42 -97.73 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.72 131.76 10.61 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 40' ' ' ILE . 53.4 p -79.03 75.26 5.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.915 -1.344 . . . . 0.0 108.48 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 23.59 108.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.883 1.325 . . . . 0.0 110.319 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 63' ' ' ASN . 3.1 t -75.61 -4.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.968 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 170.11 99.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.544 -0.722 . . . . 0.0 110.033 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' HG3' HG21 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -87.16 87.09 7.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.965 . . . . 0.0 108.621 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.76 147.39 25.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 58' ' ' ALA . 19.5 tt -161.5 140.1 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.042 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 3.3 pp -161.59 155.07 21.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.08 . . . . 0.0 110.141 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.389 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.85 HG11 ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -160.95 166.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.125 . . . . 0.0 109.999 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -129.53 150.26 50.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 93.5 m-85 -126.46 101.67 6.79 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.935 -1.103 . . . . 0.0 110.616 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.933 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -81.8 107.11 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 176.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.599 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -76.97 87.25 3.5 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 120.138 -1.601 . . . . 0.0 108.618 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.723 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 2.1 t80 -94.7 114.26 26.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.841 ' CG ' HG21 ' A' ' 41' ' ' VAL . 46.9 m-20 -71.32 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.817 -1.553 . . . . 0.0 111.148 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER 7.32 127.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -62.23 -61.67 2.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.051 178.361 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -53.04 62.79 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 109.618 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 81.8 mt-10 -67.01 -10.9 54.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -75.19 -37.89 61.03 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -69.71 -20.75 63.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.8 mt-10 -62.65 -75.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.752 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . . . -50.11 -23.08 1.92 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.612 ' O ' HG21 ' A' ' 89' ' ' VAL . 2.6 mm -58.36 -51.64 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.688 -1.257 . . . . 0.0 107.795 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -86.47 -59.46 2.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.083 . . . . 0.0 110.231 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.52 -44.0 62.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 110.446 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.873 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.5 tp -79.25 -38.8 34.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.062 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.634 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 2.4 t-20 -40.96 116.71 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.634 ' ND2' ' OD1' ' A' ' 76' ' ' ASN . 0.9 OUTLIER 67.29 78.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.922 ' O ' HG23 ' A' ' 79' ' ' ILE . 7.4 p -86.18 52.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.078 -1.014 . . . . 0.0 109.773 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.08 HG21 ' CB ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -176.35 170.23 1.19 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.385 -0.822 . . . . 0.0 108.908 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -87.96 39.11 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.758 1.399 . . . . 0.0 109.677 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 46.88 68.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 108.771 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.8 1.97 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 85' ' ' GLN . . . 127.61 -50.96 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 120.885 -1.362 . . . . 0.0 110.332 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 1.08 ' CB ' HG21 ' A' ' 79' ' ' ILE . 73.1 m -50.93 -18.9 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 110.316 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' SER . 7.0 mp0 64.53 140.8 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.0 Cg_endo -84.25 -179.86 4.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.153 1.607 . . . . 0.0 111.455 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.873 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -122.06 123.87 42.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 109.098 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.626 ' HB3' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -78.5 97.04 5.57 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 18' ' ' VAL . 14.5 m -78.27 163.63 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 122.301 1.048 . . . . 0.0 112.049 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 17' ' ' TYR . 5.5 ptp180 173.42 -133.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD11 ' CB ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -146.73 119.46 8.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.679 -1.263 . . . . 0.0 108.217 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -145.68 -174.07 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.787 -1.196 . . . . 0.0 109.76 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -172.29 88.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.861 . . . . 0.0 109.185 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -46.42 -31.0 2.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -168.82 -152.63 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.49 95.27 1.57 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.588 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.416 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -155.95 87.16 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.363 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -161.44 34.26 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.619 ' HB3' HG21 ' A' ' 41' ' ' VAL . 39.0 p-10 -76.93 -171.78 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -156.18 119.69 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -81.58 134.07 35.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.975 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 5.3 m -106.23 150.38 8.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.523 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.491 HG23 ' OG ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -115.42 168.94 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.439 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' THR . 86.1 m-20 61.26 72.95 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -136.19 115.27 10.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 109.408 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.76 -171.27 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.044 1.549 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -114.0 17.38 17.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -79.76 -56.84 3.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.191 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.848 HD11 HD12 ' A' ' 30' ' ' LEU . 2.0 tt -82.41 167.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.12 146.12 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 2.9 p30 -59.45 -44.31 92.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 6.9 t0 -58.46 -24.92 61.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.524 ' OE1' HG23 ' A' ' 26' ' ' THR . 7.8 mt-30 -73.76 -40.5 63.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.055 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.5 mp -42.77 -54.19 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.407 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -41.48 -49.22 3.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.875 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -61.26 -43.63 98.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.012 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.055 HG22 ' O ' ' A' ' 30' ' ' LEU . 10.1 tp -57.04 -24.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.891 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.803 ' CD1' HG23 ' A' ' 33' ' ' ILE . 3.2 m-85 -97.69 -73.09 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.812 -1.18 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.54 -80.82 0.24 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.98 105.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.151 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -94.85 -83.4 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 108.976 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . -98.87 -93.18 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.571 ' O ' ' C ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -150.47 67.63 0.96 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -23.75 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.718 0.77 . . . . 0.0 109.715 -178.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.626 ' C ' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m -90.04 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.733 ' H ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 82.6 120.29 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.415 -0.803 . . . . 0.0 112.191 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.889 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -124.02 132.59 53.71 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.77 146.0 30.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.638 -1.289 . . . . 0.0 110.503 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.606 ' C ' HD22 ' A' ' 46' ' ' LEU . 1.7 tt -92.02 124.07 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 45' ' ' ILE . 1.7 mm? -106.96 138.53 42.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.102 -0.999 . . . . 0.0 110.215 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.756 . . . . 0.0 109.029 179.653 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 46' ' ' LEU . 2.1 m -96.89 171.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -1.192 . . . . 0.0 109.623 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.975 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -147.68 -179.13 6.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.291 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 m-85 -152.15 115.64 4.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.669 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.073 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.07 153.84 4.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.54 -1.35 . . . . 0.0 107.684 178.135 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.771 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -95.18 132.53 40.03 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.084 0.945 . . . . 0.0 111.299 -178.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.166 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -163.26 147.01 10.73 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' C ' ' A' ' 64' ' ' LYS . 13.0 p30 -137.88 -118.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.785 -1.197 . . . . 0.0 107.879 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.63 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 10.43 103.27 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 CA-C-N 118.626 0.648 . . . . 0.0 110.855 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.746 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.05 -59.25 0.14 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.611 -0.681 . . . . 0.0 111.069 -178.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.9 -50.6 65.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.685 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 85.3 mt-10 -49.65 -48.9 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 110.34 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.39 -46.75 47.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.333 -1.479 . . . . 0.0 108.038 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 5.4 tt0 -52.92 -42.38 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 7.5 mm-40 -50.04 -66.6 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 0.0 108.585 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.166 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -51.01 -29.62 13.0 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.895 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 24.6 mm -60.03 -49.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.465 -1.397 . . . . 0.0 108.407 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.4 m -84.35 -65.49 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 110.117 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.01 76.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.464 -0.773 . . . . 0.0 111.303 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.073 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.45 -38.96 33.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.62 -1.3 . . . . 0.0 110.597 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 23.8 t-20 -52.6 131.77 34.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.264 -1.522 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 8.7 m120 64.56 69.84 0.5 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 78' ' ' VAL . 3.3 p -86.22 61.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.73 162.39 18.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.8 Cg_endo -87.14 41.21 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.656 1.345 . . . . 0.0 109.986 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' PRO . 9.0 mt-10 59.94 147.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.91 -76.37 0.41 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.67 -25.32 60.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.462 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER 58.27 28.75 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.115 . . . . 0.0 109.942 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.58 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 2.0 mt-30 -127.57 75.39 77.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.025 -1.047 . . . . 0.0 109.581 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -109.28 -161.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.879 1.463 . . . . 0.0 110.773 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.846 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -103.15 123.06 45.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 110.356 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -78.47 111.26 14.31 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.538 ' HB ' HD13 ' A' ' 72' ' ' ILE . 2.9 m -78.19 155.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.428 1.109 . . . . 0.0 112.395 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.572 ' HD2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 167.53 126.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 15.0 mt -41.76 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.01 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.51 167.81 16.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.07 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.45 4.55 10.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.222 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -125.22 112.54 16.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.03 -1.044 . . . . 0.0 109.599 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.96 178.51 34.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 17.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 109.43 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HA ' ' CA ' ' A' ' 97' ' ' LYS . 9.6 pttt . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 63' ' ' ASN . 18.9 m-20 -111.27 -92.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 0.0 110.747 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.777 ' HA ' HD21 ' A' ' 91' ' ' LEU . 10.0 t -82.04 64.42 6.71 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.332 -0.855 . . . . 0.0 110.402 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.799 ' O ' HD22 ' A' ' 91' ' ' LEU . 2.2 p-10 -76.76 160.63 29.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.061 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -137.57 125.8 23.13 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 117.621 -1.632 . . . . 0.0 111.636 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -85.12 114.82 22.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.067 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 32.5 m -88.89 139.32 17.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -116.99 -179.48 3.71 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.332 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.448 ' H ' HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER 57.58 86.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 109.269 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -163.18 132.75 3.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.546 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' OE1' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -108.66 52.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.965 1.508 . . . . 0.0 110.194 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' PRO . 77.3 mtt180 41.7 53.08 4.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -96.0 -21.5 17.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.3 pp -121.81 160.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.389 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -96.66 157.12 16.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.162 -0.961 . . . . 0.0 109.992 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -59.89 -53.67 55.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -3.0 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.896 -1.127 . . . . 0.0 109.625 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.0 OUTLIER -83.1 -63.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 110.722 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 3.2 mp -44.3 -37.22 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.52 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.545 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 30.5 t0 -49.7 -55.82 12.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.662 -1.274 . . . . 0.0 109.228 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.6 m -65.18 -21.44 66.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -83.01 -15.12 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.718 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.94 ' CG ' HD11 ' A' ' 75' ' ' LEU . 10.5 p90 -153.4 33.86 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.914 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -97.57 61.56 1.01 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.134 -1.604 . . . . 0.0 109.697 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -138.54 -10.55 1.4 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.058 -1.26 . . . . 0.0 111.183 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CD2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -85.7 -50.14 7.41 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.684 -1.26 . . . . 0.0 109.875 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.49 -160.2 8.63 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' C ' ' A' ' 40' ' ' ILE . 14.5 m -95.35 72.77 3.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.275 -1.132 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.914 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -25.65 131.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-O 121.153 0.502 . . . . 0.0 110.046 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 41' ' ' VAL . 3.2 m -98.76 56.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 12.2 tt0 94.26 100.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.599 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -83.05 165.79 19.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 1.9 t-20 -158.98 158.1 32.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.838 -1.164 . . . . 0.0 109.892 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 45' ' ' ILE . 0.5 OUTLIER -158.41 117.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.343 -0.848 . . . . 0.0 109.316 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.21 158.98 43.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.766 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 -179.723 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.71 163.61 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.145 . . . . 0.0 109.431 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -134.26 -174.1 3.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 108.941 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -149.17 104.48 3.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.061 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.2 t -79.54 152.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.041 -1.037 . . . . 0.0 108.461 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.757 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.27 128.4 46.35 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.402 0.62 . . . . 0.0 111.022 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.069 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -164.4 146.05 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.184 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.686 ' C ' HG22 ' A' ' 14' ' ' THR . 12.0 p-10 -133.26 -48.56 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.72 106.14 0.37 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.7 mpp_? -34.83 -55.63 0.57 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.178 0.513 . . . . 0.0 110.265 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -47.95 79.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 62' ' ' TYR . 39.7 tt0 -52.26 -29.4 22.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -68.79 -48.54 63.37 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.978 -1.076 . . . . 0.0 108.45 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -47.41 -32.33 4.89 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 20.4 mm-40 -67.38 -49.32 64.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.731 -0.606 . . . . 0.0 109.484 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -65.73 -13.54 59.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.802 ' HA ' HG21 ' A' ' 89' ' ' VAL . 19.3 mm -81.51 -69.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.012 -1.055 . . . . 0.0 108.596 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -77.48 8.6 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.635 -0.666 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -130.02 -50.53 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.941 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.4 mp -78.91 -32.31 45.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.014 -1.054 . . . . 0.0 108.515 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 40.7 t-20 -55.18 125.06 19.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 4.6 m-80 65.97 72.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.7 p -86.81 48.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -154.96 134.16 7.58 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 79' ' ' ILE . 34.7 Cg_endo -46.5 138.16 14.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.774 1.408 . . . . 0.0 109.758 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 80' ' ' PRO . 2.5 mm-40 -42.23 145.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.059 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.02 -29.49 2.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 140.31 -127.59 3.55 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.2 m 70.7 3.46 4.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.323 -1.104 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.425 ' OE1' ' HD3' ' A' ' 22' ' ' PRO . 4.7 mt-30 64.94 122.73 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.055 -1.028 . . . . 0.0 109.203 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -108.12 152.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 110.803 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -70.17 119.62 14.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.578 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -78.59 98.45 6.16 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HA ' ' A' ' 72' ' ' ILE . 33.8 m -78.83 153.47 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.02 0.915 . . . . 0.0 111.671 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 154.32 141.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.799 HD22 ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -59.78 134.68 57.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.53 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -94.1 -31.48 14.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 109.597 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 0.8 OUTLIER 76.23 63.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.187 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.0 -34.8 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.594 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -148.83 -92.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 15' ' ' ASN . . . -176.61 -44.89 0.06 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.236 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 120.954 0.407 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -131.21 -67.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.943 -1.098 . . . . 0.0 111.596 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -161.53 102.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 46.8 p30 -98.38 -163.89 1.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.463 -0.773 . . . . 0.0 109.078 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.058 HD21 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -160.34 119.2 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.599 -1.24 . . . . 0.0 112.151 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -79.41 131.47 36.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.8 m -124.16 149.57 28.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.513 -1.367 . . . . 0.0 111.465 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -135.97 -153.32 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.525 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 34.77 16.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.995 . . . . 0.0 110.287 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.869 HD11 ' HB2' ' A' ' 58' ' ' ALA . 2.9 pp -170.49 128.72 0.78 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -102.81 67.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.979 1.515 . . . . 0.0 109.934 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.68 ' CG ' HG21 ' A' ' 45' ' ' ILE . 26.6 mtp180 62.11 54.64 2.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.5 p -79.8 -1.09 37.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -151.4 -160.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.6 p -122.12 151.53 40.84 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 92.6 m-20 -49.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.339 -0.851 . . . . 0.0 109.322 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.0 p30 -42.34 -26.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.095 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.523 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.7 tt0 -63.53 -57.74 9.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 110.143 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.935 HD21 ' CD2' ' A' ' 87' ' ' LEU . 3.0 mp -45.33 -44.44 11.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.867 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.944 ' OD1' HD11 ' A' ' 40' ' ' ILE . 21.2 t0 -59.5 -40.68 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 110.054 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 m -77.85 -10.94 59.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.0 -45.95 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 0.0 109.904 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 1.006 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 39.5 p90 -103.4 -45.89 4.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 109.449 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 34' ' ' PHE . . . 15.21 60.11 0.01 OUTLIER Glycine 0 N--CA 1.505 3.254 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' PHE . 12.4 tttt -133.36 -28.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.256 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -111.68 -100.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 110.31 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 67' ' ' GLU . . . -79.24 152.48 36.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 40' ' ' ILE . 20.6 t -87.05 45.24 1.25 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.122 -1.223 . . . . 0.0 108.258 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.006 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 39.95 110.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.217 1.008 . . . . 0.0 110.598 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 61' ' ' ARG . 4.8 m -77.64 7.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.296 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER 162.46 72.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.068 -1.02 . . . . 0.0 110.29 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 1.8 ptpp? -82.76 117.72 22.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 20.0 p30 -154.73 169.6 23.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.198 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.68 HG21 ' CG ' ' A' ' 23' ' ' ARG . 13.7 mt -114.39 171.01 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.484 -0.76 . . . . 0.0 109.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.547 ' HB2' HG13 ' A' ' 57' ' ' VAL . 1.2 mt -128.8 113.41 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 110.012 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . 23.0 ptt180 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG23 HG23 ' A' ' 19' ' ' THR . 1.6 p -142.4 138.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.578 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -89.5 175.34 7.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -157.85 104.76 1.95 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.194 -0.941 . . . . 0.0 110.365 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.063 HG21 HD21 ' A' ' 75' ' ' LEU . 3.2 t -90.5 159.67 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.76 ' HB3' HG23 ' A' ' 41' ' ' VAL . 38.2 mmm-85 -139.51 147.3 41.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.586 -1.321 . . . . 0.0 110.169 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 52.3 m-85 -159.42 149.43 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.533 ' ND2' HG11 ' A' ' 41' ' ' VAL . 3.8 p30 -119.79 71.82 0.9 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.292 -1.363 . . . . 0.0 109.875 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.574 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -171.19 96.86 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -33.4 -51.93 0.37 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.264 0.554 . . . . 0.0 110.359 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.24 -50.05 74.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 108.466 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.629 ' HG2' ' CD2' ' A' ' 37' ' ' TYR . 15.2 tm-20 -52.37 -48.88 65.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.48 -0.762 . . . . 0.0 110.354 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -46.72 -45.2 19.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.647 -1.283 . . . . 0.0 107.981 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.6 -45.78 73.68 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -52.41 -65.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 109.248 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -53.01 -15.65 0.85 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.838 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.824 HD13 HG12 ' A' ' 89' ' ' VAL . 1.1 mm -85.21 -70.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.676 -1.265 . . . . 0.0 108.881 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 t -58.88 -9.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.737 -1.227 . . . . 0.0 110.582 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.14 -53.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.664 -1.273 . . . . 0.0 111.087 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.063 HD21 HG21 ' A' ' 60' ' ' VAL . 7.1 tp -81.72 5.89 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.971 -1.081 . . . . 0.0 110.837 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HA ' HG23 ' A' ' 89' ' ' VAL . 16.8 p-10 -87.3 22.42 2.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.724 -1.235 . . . . 0.0 108.556 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 38.5 p-10 177.86 73.83 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.708 ' O ' HG13 ' A' ' 78' ' ' VAL . 11.5 p -80.9 68.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.312 -0.867 . . . . 0.0 108.953 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.738 HD13 ' OG ' ' A' ' 84' ' ' SER . 0.1 OUTLIER 163.87 118.74 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -39.29 128.97 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.956 1.503 . . . . 0.0 110.835 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.75 163.98 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.97 -53.68 0.67 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.75 35.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.738 ' OG ' HD13 ' A' ' 79' ' ' ILE . 7.5 t -110.38 -14.19 14.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -1.218 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' SER . 46.7 mt-30 61.93 117.75 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 37.4 Cg_endo -123.61 -160.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 124.075 1.566 . . . . 0.0 109.354 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.935 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.9 115.76 27.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.958 -1.089 . . . . 0.0 110.926 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 5.8 m -79.23 113.63 17.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 72' ' ' ILE . 13.1 t -83.27 162.21 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.318 1.056 . . . . 0.0 113.17 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 161.57 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.558 HD11 ' CA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -44.04 157.53 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.29 170.8 2.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.48 -0.763 . . . . 0.0 109.906 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 43.2 mm-40 -141.01 125.7 17.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.431 -0.793 . . . . 0.0 109.217 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 70.48 6.51 5.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 109.342 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -141.21 -170.09 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.61 134.37 3.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 61' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.163 . . . . 0.0 109.494 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.588 ' CB ' ' HB2' ' A' ' 63' ' ' ASN . 6.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.16 82.81 0.71 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 111.052 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.603 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -161.35 52.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 0.0 109.142 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.58 HD22 HG21 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.16 -169.4 1.83 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.257 -0.902 . . . . 0.0 109.919 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.05 HD21 HG12 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -153.01 127.0 8.99 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.034 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.877 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -77.6 125.56 29.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 58' ' ' ALA . 29.0 m -118.24 124.01 72.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.415 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -123.65 178.11 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' THR . 5.0 t-20 87.79 15.19 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 111.337 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -154.59 43.17 0.21 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.343 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 21' ' ' LEU . 37.7 Cg_endo -76.14 142.82 24.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.593 1.312 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 61.05 9.76 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 110.691 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 22' ' ' PRO . 43.2 p -99.84 -38.77 8.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.96 -1.088 . . . . 0.0 108.917 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.875 HD11 HD23 ' A' ' 21' ' ' LEU . 1.3 pp -136.79 166.99 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 108.876 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -103.25 144.67 31.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.092 -1.005 . . . . 0.0 109.789 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -53.9 -66.2 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -44.91 -25.19 0.28 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.004 -1.06 . . . . 0.0 109.484 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 26' ' ' THR . 47.6 tt0 -64.75 -62.21 1.71 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 109.636 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 6.1 mp -43.96 -26.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.234 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' OD2' ' NH2' ' A' ' 61' ' ' ARG . 13.0 t70 -57.99 -54.11 50.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.9 m -62.76 -44.46 96.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.53 -17.2 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 108.509 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.912 ' CE2' HD21 ' A' ' 75' ' ' LEU . 20.4 m-30 -100.5 -91.0 0.31 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 36.6 77.42 0.05 OUTLIER Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -173.7 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.296 . . . . 0.0 110.681 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.625 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.16 -80.68 0.31 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.827 -1.171 . . . . 0.0 109.763 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.47 -165.45 11.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -94.32 26.92 3.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.3 -1.118 . . . . 0.0 108.191 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 41.83 -173.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.629 0.728 . . . . 0.0 109.811 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.58 HG21 HD22 ' A' ' 15' ' ' ASN . 0.0 OUTLIER -118.48 -61.78 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.099 -1.001 . . . . 0.0 111.114 -177.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.772 ' H ' ' CB ' ' A' ' 61' ' ' ARG . 1.3 tm0? -176.59 107.19 0.07 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.898 -0.501 . . . . 0.0 109.675 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -97.74 132.47 43.34 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.879 -1.138 . . . . 0.0 107.96 179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -141.58 159.17 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.633 -1.292 . . . . 0.0 110.356 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.31 137.18 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -120.26 123.67 43.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.658 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.444 -0.785 . . . . 0.0 109.085 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.758 ' O ' HG13 ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -163.12 157.42 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.484 -1.01 . . . . 0.0 109.77 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.641 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -110.32 174.01 6.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HD21 ' A' ' 46' ' ' LEU . 3.1 m-85 -143.47 104.21 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.784 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.064 HG21 HD23 ' A' ' 75' ' ' LEU . 1.1 t -82.47 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.941 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -119.23 135.37 54.72 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.477 -177.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 1.019 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 7.1 m-85 -155.3 137.98 15.18 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' A' ' 12' ' ' LYS . 7.5 p30 -118.78 -50.28 2.41 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.468 -1.395 . . . . 0.0 110.194 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -53.88 137.08 39.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.4 OUTLIER -63.12 -43.07 99.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 0.0 109.043 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.18 -43.19 67.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 108.772 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.602 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -61.76 -25.61 67.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' GLN . . . -72.89 -48.19 39.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.736 -1.227 . . . . 0.0 107.854 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 42.7 tp60 -49.43 -32.97 12.88 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -58.89 -67.89 0.32 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.019 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -45.8 -22.05 0.16 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.212 0.529 . . . . 0.0 109.641 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 15.6 mm -74.35 -70.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.406 -1.434 . . . . 0.0 108.657 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.11 22.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.53 -0.731 . . . . 0.0 110.334 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -138.66 -50.57 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.064 HD23 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -79.44 -42.09 26.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.1 t30 -39.2 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.347 -0.845 . . . . 0.0 109.139 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.537 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 2.1 m-20 80.9 80.04 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.8 p -85.28 53.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.791 . . . . 0.0 108.951 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' GLN . 4.6 pt -117.22 173.93 2.83 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.213 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -90.62 20.35 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.97 1.51 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 69.54 70.53 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.38 -31.41 0.23 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.59 -140.18 0.82 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.47 38.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 109.375 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.509 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 29.7 mm-40 -130.55 82.86 63.87 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' O ' HD12 ' A' ' 21' ' ' LEU . 36.8 Cg_endo -108.89 164.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.061 1.559 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -112.33 124.4 52.39 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.189 -0.945 . . . . 0.0 110.321 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 12.9 m -79.13 105.68 10.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 22.7 m -77.26 -167.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.986 -0.446 . . . . 0.0 111.611 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 104.27 108.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 93' ' ' GLU . 9.5 tp -36.64 145.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.523 0.677 . . . . 0.0 110.257 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -77.1 -67.68 0.69 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 0.0 109.402 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.654 ' O ' HD23 ' A' ' 91' ' ' LEU . 43.5 mm-40 -116.8 -170.58 1.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.457 -0.777 . . . . 0.0 109.294 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.4 9.37 29.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 109.9 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 96' ' ' GLY . 18.9 p80 -97.6 -30.52 12.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 95' ' ' HIS . . . 49.08 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 8.1 tmtm? . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' CB ' ' C ' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -79.2 -2.21 39.91 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.984 -1.072 . . . . 0.0 110.538 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.096 HG21 ' HB2' ' A' ' 68' ' ' ALA . 15.7 m -162.52 93.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.891 -1.131 . . . . 0.0 110.405 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.648 ' N ' HD11 ' A' ' 91' ' ' LEU . 13.9 t-20 -84.68 106.02 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.986 -1.071 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -79.13 103.57 9.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.926 -1.109 . . . . 0.0 109.149 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -93.85 86.86 5.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.015 HG23 ' HB3' ' A' ' 58' ' ' ALA . 2.6 m -89.52 97.43 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.306 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 1.007 HG23 HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -92.01 -165.53 1.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.575 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.68 ' H ' HG22 ' A' ' 19' ' ' THR . 1.7 t30 53.39 84.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.107 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -146.51 132.95 9.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.5 Cg_endo -104.0 39.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.891 1.469 . . . . 0.0 109.897 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 15.2 mtt85 36.52 61.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.294 0.568 . . . . 0.0 110.338 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.997 HG23 HG13 ' A' ' 25' ' ' ILE . 7.4 t -97.48 -16.19 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.248 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.997 HG13 HG23 ' A' ' 24' ' ' THR . 0.2 OUTLIER -127.2 179.25 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.3 p -105.63 158.45 16.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.202 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 43' ' ' LYS . 9.7 t0 -55.75 -62.45 1.68 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.643 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.79 -15.59 4.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.757 ' OE1' HG22 ' A' ' 25' ' ' ILE . 1.7 tt0 -75.27 -51.76 12.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.829 -1.17 . . . . 0.0 110.354 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.629 HD11 HD13 ' A' ' 25' ' ' ILE . 4.6 mp -46.56 -32.16 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.82 -1.175 . . . . 0.0 108.476 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 4.2 t70 -48.66 -52.85 21.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 108.652 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 m -63.22 -41.51 99.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.466 -0.771 . . . . 0.0 109.042 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.54 -13.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 108.864 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 1.047 ' CZ ' HD13 ' A' ' 75' ' ' LEU . 7.4 m-30 -83.91 -74.26 0.38 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' LYS . . . 144.3 -90.88 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 162.99 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.711 -0.876 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -79.81 -81.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.96 166.6 14.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 40' ' ' ILE . 15.5 m -78.58 94.47 5.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.834 -1.391 . . . . 0.0 108.293 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.2 mp -34.67 117.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -80.1 18.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 111.009 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.659 ' H ' HG22 ' A' ' 40' ' ' ILE . 1.5 tm0? 163.65 138.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -145.96 76.7 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -94.85 174.1 7.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 45' ' ' ILE . 3.0 tt -126.58 104.15 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 110.347 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HA ' ' N ' ' A' ' 57' ' ' VAL . 8.4 mp 52.85 -141.62 0.84 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.516 -0.74 . . . . 0.0 110.011 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' N ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.888 0 O-C-N 120.966 -1.084 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 1.007 HG22 HG23 ' A' ' 19' ' ' THR . 44.6 t -159.02 153.16 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.114 -1.227 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.015 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -75.97 127.0 32.06 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.607 ' CE1' ' O ' ' A' ' 57' ' ' VAL . 91.6 m-85 -103.35 83.17 2.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 112.091 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 16' ' ' LEU . 3.3 t -86.53 77.55 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.66 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.7 ttm180 -76.82 113.21 14.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.594 -1.316 . . . . 0.0 110.695 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.731 ' CE1' HG13 ' A' ' 60' ' ' VAL . 3.6 m-85 -114.36 -173.87 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -131.29 -100.78 0.29 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.097 -1.441 . . . . 0.0 110.337 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 63' ' ' ASN . 26.1 tttp -24.4 136.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.618 0.723 . . . . 0.0 111.795 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' NH2' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -55.95 -52.37 64.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -52.4 -39.65 61.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -49.49 -47.0 48.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.096 ' HB2' HG21 ' A' ' 14' ' ' THR . . . -57.72 -39.32 76.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.389 -0.819 . . . . 0.0 108.813 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 1.8 mm-40 -51.1 -37.08 43.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 108.205 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.4 mt-10 -74.8 -62.45 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.852 0.834 . . . . 0.0 109.751 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.706 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -52.76 -16.14 0.91 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.469 0.652 . . . . 0.0 110.931 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 5.0 mt -92.37 -60.33 2.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.418 -1.426 . . . . 0.0 109.465 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -66.69 -5.31 11.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 0.0 109.959 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' C ' HD23 ' A' ' 75' ' ' LEU . . . -112.7 -53.94 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.944 -1.098 . . . . 0.0 109.961 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -81.27 -39.34 25.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.016 -1.053 . . . . 0.0 109.879 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' HG21 ' A' ' 89' ' ' VAL . 61.5 t-20 -43.79 111.68 0.31 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.616 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 74.8 91.03 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.993 0.901 . . . . 0.0 109.207 -178.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.899 HG23 HG12 ' A' ' 33' ' ' ILE . 3.1 p -103.7 38.48 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -148.56 -175.16 0.45 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.926 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -63.58 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 116.966 -1.556 . . . . 0.0 110.239 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 38.7 tt0 179.16 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.062 -1.024 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.16 55.95 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.32 -81.7 0.16 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 1.021 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -79.26 5.14 13.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.162 . . . . 0.0 109.749 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 84' ' ' SER . 36.1 mt-30 70.35 86.36 0.12 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.149 -0.969 . . . . 0.0 109.152 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.679 ' HA ' HD11 ' A' ' 79' ' ' ILE . 35.0 Cg_endo -58.69 -173.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.363 1.717 . . . . 0.0 111.927 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.793 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.99 152.75 18.05 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -99.69 100.45 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 76' ' ' ASN . 2.5 m -78.11 172.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.734 -0.604 . . . . 0.0 110.715 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 10.8 ttt180 127.5 138.63 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.648 HD11 ' N ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.09 138.16 58.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -93.71 179.51 5.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.65 176.23 5.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' HIS . 4.0 mt-10 61.16 178.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLU . 96.8 m-70 -44.21 154.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.377 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.33 -40.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' A' ' 61' ' ' ARG . 16.0 pttt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 18.6 mmtp . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.986 0.422 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' CB ' ' CB ' ' A' ' 63' ' ' ASN . 23.5 m-20 -162.61 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.964 -1.085 . . . . 0.0 110.251 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.137 ' CG2' HD11 ' A' ' 91' ' ' LEU . 4.4 m -162.75 94.14 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.964 . . . . 0.0 111.134 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.791 ' O ' HD23 ' A' ' 91' ' ' LEU . 21.2 p30 -102.96 165.47 11.01 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.035 -1.041 . . . . 0.0 108.891 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HB ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -132.05 122.07 24.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.311 -1.493 . . . . 0.0 110.356 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -79.47 117.88 20.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 89' ' ' VAL . 15.6 m -97.33 146.08 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.477 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -124.03 167.29 14.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.2 m-20 72.4 18.05 4.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.412 -0.805 . . . . 0.0 109.398 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.9 tm? -53.73 109.61 1.6 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 109.998 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.4 Cg_endo -82.08 147.42 14.76 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.044 1.55 . . . . 0.0 109.794 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 19.63 3.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.958 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 22' ' ' PRO . 11.3 t -89.19 -6.05 57.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.395 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.04 -166.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -57.78 -55.99 27.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 108.981 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' GLN . 3.1 p30 -49.36 -24.2 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.257 -0.902 . . . . 0.0 108.869 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 26' ' ' THR . 59.5 tt0 -71.89 -45.07 62.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 109.125 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 87' ' ' LEU . 6.9 mp -46.8 -35.58 6.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.255 -0.903 . . . . 0.0 108.721 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 5.6 t0 -49.2 -50.68 37.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.977 -1.077 . . . . 0.0 109.263 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 m -80.87 -15.34 56.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.647 HG12 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -67.98 -47.73 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 109.805 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.87 ' CD1' HD11 ' A' ' 75' ' ' LEU . 20.1 p90 -92.74 -41.63 10.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.745 -1.222 . . . . 0.0 109.423 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' LYS . . . 127.51 -78.17 0.39 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 1.6 tptp 174.74 78.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -1.088 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.875 ' HE2' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -79.71 -104.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' N ' ' HB3' ' A' ' 67' ' ' GLU . . . -68.89 176.34 29.62 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' VAL . 14.3 t -78.56 81.82 4.86 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.831 -1.394 . . . . 0.0 107.793 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.82 HD13 ' HZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -35.51 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.14 0.972 . . . . 0.0 108.447 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 61' ' ' ARG . 28.4 m -79.25 47.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.286 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.639 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 5.5 tt0 96.81 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.26 0.553 . . . . 0.0 111.449 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' CD ' ' O ' ' A' ' 27' ' ' ASP . 8.4 ptpp? -92.24 132.17 36.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.525 ' N ' ' OD2' ' A' ' 27' ' ' ASP . 6.3 p30 -129.69 161.62 30.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.59 -1.318 . . . . 0.0 110.789 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.72 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.33 169.0 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.58 117.88 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.414 -0.804 . . . . 0.0 109.067 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' CE1' ' A' ' 59' ' ' PHE . 85.1 t -130.39 145.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.117 . . . . 0.0 109.032 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.89 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -149.15 174.83 11.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.055 . . . . 0.0 109.543 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 33.6 m-85 -154.55 107.65 2.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 75' ' ' LEU . 2.2 t -84.81 102.95 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.776 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.8 mtm180 -83.35 128.66 34.69 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.036 -1.04 . . . . 0.0 110.411 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.825 ' CZ ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -162.52 173.56 13.84 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' CB ' ' A' ' 13' ' ' ASP . 7.7 p30 -112.11 -114.84 0.32 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 117.68 -1.608 . . . . 0.0 110.861 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 10.6 mmtt 16.52 108.74 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.282 0.563 . . . . 0.0 112.343 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.691 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -57.47 -40.87 79.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.983 -1.073 . . . . 0.0 109.58 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -38.97 86.39 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' N ' ' A' ' 38' ' ' GLY . 60.8 mm-40 -59.7 -30.91 69.12 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 62' ' ' TYR . . . -67.17 -37.87 84.47 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -53.52 -35.23 60.46 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.7 mp0 -61.4 -52.48 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' CA ' ' HB2' ' A' ' 75' ' ' LEU . . . -67.01 -5.21 11.99 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.594 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.608 HD13 HG23 ' A' ' 89' ' ' VAL . 14.0 mm -84.49 -57.42 4.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -79.67 0.84 28.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.946 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.28 -44.16 1.59 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.026 -1.046 . . . . 0.0 109.906 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -89.34 -28.43 19.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.74 ' HA ' HG22 ' A' ' 89' ' ' VAL . 34.3 t-20 -46.67 -27.5 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.217 -1.552 . . . . 0.0 109.453 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -148.53 78.81 1.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 87' ' ' LEU . 1.5 t -85.4 107.28 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.998 -1.064 . . . . 0.0 108.97 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.53 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 174.19 164.6 0.33 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.6 Cg_endo -86.47 37.41 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.703 1.37 . . . . 0.0 110.477 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' PRO . 4.0 mt-10 40.24 44.45 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.498 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.11 -19.95 17.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 84' ' ' SER . . . -141.65 -108.73 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 41.4 t 175.76 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -1.098 . . . . 0.0 109.456 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.6 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.0 pt20 -143.94 32.95 0.13 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.955 . . . . 0.0 110.632 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 37.8 Cg_endo -68.31 -162.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.424 1.223 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -100.19 114.57 28.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.812 -1.155 . . . . 0.0 109.657 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -79.1 116.04 19.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 177.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 18' ' ' VAL . 17.4 m -94.38 171.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.982 0.896 . . . . 0.0 112.003 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER 166.47 116.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.137 HD11 ' CG2' ' A' ' 14' ' ' THR . 2.3 mt -41.94 109.3 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.197 -0.94 . . . . 0.0 109.477 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 17' ' ' TYR . . . -58.55 -156.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.113 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.4 tp10 -171.7 99.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.994 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 78.69 3.51 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.557 -0.714 . . . . 0.0 110.046 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 174.18 8.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.47 47.8 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' OXT' ' NH1' ' A' ' 61' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.239 -1.153 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 1.8 mttt . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' N ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -156.35 98.17 1.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.894 -1.754 . . . . 0.0 112.192 -179.03 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.595 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 16.5 m -162.71 49.66 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.76 HD21 HG23 ' A' ' 41' ' ' VAL . 2.0 m120 -76.04 -177.46 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.66 0.743 . . . . 0.0 110.498 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.942 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -142.9 129.06 19.77 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.744 0.783 . . . . 0.0 109.741 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.72 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 1.1 t80 -78.86 95.89 5.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.697 -0.627 . . . . 0.0 109.914 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 1.094 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 16.4 m -80.07 106.54 11.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 16.3 p -99.86 166.73 10.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.135 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.431 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 2.0 m120 62.76 75.29 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.429 -0.795 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.67 158.0 68.94 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 109.347 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' HG2' ' CG2' ' A' ' 24' ' ' THR . 36.5 Cg_endo -94.74 -175.4 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.053 1.554 . . . . 0.0 109.994 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 6.83 47.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 25' ' ' ILE . 1.3 t -80.48 -6.25 57.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.678 HG23 HG23 ' A' ' 24' ' ' THR . 1.7 pp -127.96 127.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.556 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.6 p -99.68 170.98 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.809 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.0 -53.46 38.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.57 -11.71 37.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 30' ' ' LEU . 35.7 tt0 -78.36 -56.29 4.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.987 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 mp -44.64 -39.07 4.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 5.3 t70 -58.97 -48.29 82.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.038 -1.039 . . . . 0.0 109.829 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -23.03 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.49 -0.756 . . . . 0.0 110.065 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.44 -26.44 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.741 -1.224 . . . . 0.0 109.731 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 33' ' ' ILE . 4.3 m-85 -111.53 -73.44 0.68 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.11 -0.994 . . . . 0.0 109.153 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 34.11 78.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -171.92 28.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.952 -1.322 . . . . 0.0 111.028 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CE2' ' CZ ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -133.97 -96.72 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.706 -1.246 . . . . 0.0 109.758 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 -167.74 16.52 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.55 ' O ' ' C ' ' A' ' 40' ' ' ILE . 4.5 t -80.16 78.71 6.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.339 -1.095 . . . . 0.0 108.856 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -24.65 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 HD21 ' A' ' 15' ' ' ASN . 5.5 m -100.14 58.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.674 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 2.5 tt0 92.47 117.96 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.101 0.953 . . . . 0.0 113.267 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.788 ' HE3' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -115.95 138.09 51.51 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -151.53 174.31 13.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.286 -1.509 . . . . 0.0 111.282 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 26' ' ' THR . 37.3 mt -145.64 111.08 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 18.3 mt -100.65 143.98 30.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.616 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 17' ' ' TYR . 19.8 m -144.98 165.38 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -1.127 . . . . 0.0 109.655 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.094 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -157.09 175.35 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.838 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -141.27 104.91 4.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 0.0 108.991 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.3 t -78.21 148.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.81 -1.181 . . . . 0.0 108.132 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.874 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -85.37 125.86 33.3 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.447 0.641 . . . . 0.0 110.136 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.857 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -163.63 147.21 10.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.934 -1.104 . . . . 0.0 108.472 179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.668 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.2 t-20 -135.02 -91.28 0.32 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.472 -1.392 . . . . 0.0 109.449 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.668 ' C ' ' O ' ' A' ' 63' ' ' ASN . 11.5 mptt -14.72 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.538 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.99 -47.85 0.08 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.83 -0.544 . . . . 0.0 110.238 -177.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.89 -50.88 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 42.5 mm-40 -46.86 -43.99 19.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . . . -60.14 -41.86 93.59 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.088 -1.632 . . . . 0.0 107.183 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.1 -37.47 6.88 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.776 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -62.83 -49.31 75.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.016 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -62.83 -11.92 21.23 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.142 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 68' ' ' ALA . 49.7 mm -84.44 -69.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.865 -1.147 . . . . 0.0 108.35 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.95 3.71 7.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -124.65 -51.87 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.051 . . . . 0.0 109.723 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.017 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -81.21 -35.35 31.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 0.0 110.225 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 1.7 p-10 -53.93 139.09 35.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.68 -1.263 . . . . 0.0 109.262 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER 52.9 50.55 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.23 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 ' CE1' ' A' ' 34' ' ' PHE . 2.5 t -88.56 82.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -141.94 -164.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -92.45 26.73 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.559 1.294 . . . . 0.0 110.448 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.492 ' CG ' ' C ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER 41.54 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 0.0 109.549 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.06 44.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 106.41 -168.86 14.97 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 77.27 -4.0 2.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -1.186 . . . . 0.0 109.864 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' SER . 14.3 mt-30 60.85 145.76 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.66 147.55 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.065 1.561 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.946 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.76 121.53 18.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 17' ' ' TYR . 1.5 t -79.52 104.17 9.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.907 ' HB ' HD12 ' A' ' 16' ' ' LEU . 35.5 m -78.51 -144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 111.458 -177.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 84.79 106.52 0.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 -178.052 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -41.26 141.46 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.291 -0.88 . . . . 0.0 110.089 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -100.89 -165.85 1.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -95.55 119.31 33.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.993 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 164.85 -88.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 24.1 t-80 175.67 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 138.81 -119.45 1.75 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.072 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 120.716 0.293 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' LYS . 9.9 m-20 -137.43 12.59 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.801 -1.187 . . . . 0.0 110.603 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.589 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -160.29 70.56 0.43 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -77.0 152.71 35.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.771 -1.206 . . . . 0.0 108.869 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.586 HD23 HG11 ' A' ' 60' ' ' VAL . 1.5 tp -97.49 108.8 21.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.336 -0.853 . . . . 0.0 109.957 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 33.3 t80 -79.55 87.07 5.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.525 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 58' ' ' ALA . 16.3 m -79.76 112.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.858 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 4.5 m -117.1 161.33 19.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' THR . 6.0 t-20 78.66 52.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.882 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -160.22 136.75 6.46 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -86.74 -177.48 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.897 1.472 . . . . 0.0 110.108 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 34.65 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.471 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -79.64 -54.98 5.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.915 . . . . 0.0 109.014 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.31 165.82 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.224 -0.922 . . . . 0.0 108.752 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -109.43 136.54 48.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 9.4 t0 -56.15 -60.59 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.037 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 10.0 p-10 -48.61 -21.55 0.61 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' THR . 38.7 tt0 -74.65 -45.91 41.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.979 -1.076 . . . . 0.0 110.2 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.798 HD23 ' CG2' ' A' ' 60' ' ' VAL . 4.4 mp -45.59 -25.3 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.849 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 3.0 t0 -65.97 -51.46 58.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 108.764 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 m -53.49 -52.61 58.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.757 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -63.29 -25.77 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 108.574 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -66.14 -89.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 108.869 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 9.92 58.56 0.01 OUTLIER Glycine 0 N--CA 1.503 3.12 0 C-N-CA 122.941 0.305 . . . . 0.0 112.807 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' PHE . 2.3 tttt -161.68 4.97 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.662 -1.493 . . . . 0.0 112.247 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.746 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.92 -83.81 0.09 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.381 -1.45 . . . . 0.0 110.18 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.04 -177.27 24.48 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' ILE . 56.5 m -92.93 19.6 7.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -1.21 . . . . 0.0 109.647 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.798 HD12 ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 51.33 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.369 0.604 . . . . 0.0 109.738 178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.86 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -133.16 49.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 O-C-N 120.647 -1.283 . . . . 0.0 114.253 -177.131 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.664 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.4 tm0? 85.23 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.582 -1.324 . . . . 0.0 112.207 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.568 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 pttp -78.5 144.58 35.58 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.128 -0.982 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.74 120.61 3.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 109.813 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.66 ' O ' HD22 ' A' ' 46' ' ' LEU . 22.8 pt -84.51 162.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.062 -1.024 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.6 110.5 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 110.496 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 9.2 tpm_? . . . . . 0 N--CA 1.491 1.578 0 O-C-N 120.495 -1.378 . . . . 0.0 110.41 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 46' ' ' LEU . 1.9 p -129.04 109.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 108.921 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.579 ' HB1' ' HA ' ' A' ' 45' ' ' ILE . . . -109.34 178.28 4.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.751 -1.218 . . . . 0.0 110.241 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 3.6 m-85 -135.59 110.38 8.71 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.798 ' CG2' HD23 ' A' ' 30' ' ' LEU . 1.1 t -77.95 157.38 5.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.798 ' NH2' HD12 ' A' ' 40' ' ' ILE . 9.2 ptt180 -95.76 108.88 21.24 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.362 0.601 . . . . 0.0 110.302 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.726 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -162.23 71.01 0.32 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.237 -0.915 . . . . 0.0 108.641 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.655 ' CG ' HG11 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -68.87 -104.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 109.343 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.648 ' H ' HD21 ' A' ' 63' ' ' ASN . 3.0 mttp 9.05 90.07 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-N 118.18 0.445 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.39 -37.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.947 -0.471 . . . . 0.0 111.102 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 65' ' ' ARG . 43.4 tt0 -64.06 -58.24 7.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 108.235 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 60.1 mt-10 -53.6 -47.61 70.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.843 . . . . 0.0 109.406 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.3 -39.16 29.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 108.725 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 2.9 tt0 -60.94 -41.51 96.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.719 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 mp0 -55.67 -49.21 73.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.47 -0.769 . . . . 0.0 109.956 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -71.21 -13.69 62.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.183 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 89' ' ' VAL . 2.1 mm -74.89 -64.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 108.406 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -3.14 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.578 -0.701 . . . . 0.0 110.438 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -117.36 -50.76 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.828 -1.17 . . . . 0.0 110.249 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.726 HD11 ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -79.4 -26.22 41.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 0.0 109.719 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.3 t-20 -47.37 102.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.653 -1.279 . . . . 0.0 107.978 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 7.2 m-20 72.82 92.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.7 p -85.94 53.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.008 ' O ' HD12 ' A' ' 79' ' ' ILE . 2.1 pp -133.33 140.1 36.12 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 35.9 Cg_endo -40.87 -76.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.936 1.493 . . . . 0.0 110.527 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 11.4 tp10 176.53 152.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.203 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . 115.54 3.27 20.72 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 131.72 -161.96 23.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.663 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.4 m 84.16 -62.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.784 -0.833 . . . . 0.0 109.429 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.534 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.3 pt20 27.05 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 122.12 -0.362 . . . . 0.0 110.732 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.922 ' O ' HD12 ' A' ' 87' ' ' LEU . 37.3 Cg_endo -127.19 65.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.54 1.284 . . . . 0.0 111.428 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 174.5 87.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.5 t -81.17 107.41 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 72' ' ' ILE . 24.7 m -83.77 147.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.528 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 28.4 ptt180 152.96 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 92' ' ' ALA . 8.9 tt -58.63 149.45 25.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.788 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.795 ' N ' HD23 ' A' ' 91' ' ' LEU . . . -123.34 -58.78 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 109.958 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.99 178.13 7.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.782 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -118.22 80.35 1.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 132.28 3.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.5 -175.43 52.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 16.5 p-10 -160.69 92.96 0.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.765 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.697 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 p -144.24 43.38 1.42 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 4.6 p30 -75.36 155.38 36.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.62 142.83 29.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.477 -1.689 . . . . 0.0 110.223 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 88' ' ' SER . 1.8 t80 -78.52 78.84 4.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.957 HG23 ' HB3' ' A' ' 58' ' ' ALA . 24.6 m -77.89 105.46 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.003 0.906 . . . . 0.0 109.699 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.851 HG22 HG12 ' A' ' 57' ' ' VAL . 53.1 p -116.85 126.1 52.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' THR . 10.0 t-20 159.01 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.632 . . . . 0.0 109.667 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.849 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -39.89 161.56 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.436 -179.309 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -117.95 50.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.903 1.475 . . . . 0.0 110.131 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.06 21.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.554 -0.717 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.602 HG23 HG23 ' A' ' 25' ' ' ILE . 12.5 t -87.53 -24.34 24.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.29 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.602 HG23 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -107.54 -164.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 108.955 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.688 HG23 ' CB ' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -132.48 130.3 40.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.021 -1.049 . . . . 0.0 109.989 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.504 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -59.58 -50.0 75.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.951 -1.093 . . . . 0.0 108.627 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -49.28 -26.62 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.323 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.688 ' CB ' HG23 ' A' ' 26' ' ' THR . 8.2 tt0 -74.84 -42.4 58.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.7 mp -46.67 -32.98 3.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 109.896 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.605 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -60.34 -62.59 1.75 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.866 -1.146 . . . . 0.0 109.511 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 32' ' ' THR . 12.1 m -62.42 -9.62 8.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.503 -0.748 . . . . 0.0 110.121 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 30' ' ' LEU . 2.6 tt -83.96 -40.24 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.945 -1.097 . . . . 0.0 110.029 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.822 ' CE2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.4 -54.24 2.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.512 -1.368 . . . . 0.0 110.456 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 16.55 67.32 0.01 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -141.49 -25.8 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.278 . . . . 0.0 111.601 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -96.2 -37.58 10.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.606 -1.309 . . . . 0.0 109.242 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.4 -163.96 10.91 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.668 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -109.96 35.94 3.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -1.172 . . . . 0.0 109.217 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.782 HG22 ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 43.27 147.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 CA-C-O 122.125 0.964 . . . . 0.0 111.418 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 63' ' ' ASN . 96.8 t -109.44 -38.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 119.975 -1.703 . . . . 0.0 113.901 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.901 ' C ' ' HG2' ' A' ' 61' ' ' ARG . 1.1 tm0? 177.96 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 O-C-N 120.464 -1.397 . . . . 0.0 110.962 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.798 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -112.57 150.66 31.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.404 -0.81 . . . . 0.0 109.923 -177.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -159.47 172.95 16.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 109.156 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 tt -155.19 146.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.734 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.513 HD21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -152.56 144.66 23.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 109.694 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.845 ' O ' HG13 ' A' ' 57' ' ' VAL . . . . . . . . 0 C--O 1.214 -1.149 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 19' ' ' THR . 1.2 m -165.38 176.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 121.863 -0.786 . . . . 0.0 110.048 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.957 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -147.86 159.73 43.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -131.97 116.73 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.851 HG21 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.52 162.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.357 -1.464 . . . . 0.0 109.864 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.901 ' HG2' ' C ' ' A' ' 42' ' ' GLN . 3.6 mtm180 -79.73 107.49 12.54 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.982 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 44.2 m-85 -163.95 143.99 8.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.695 -1.253 . . . . 0.0 110.089 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.756 ' HB3' HG21 ' A' ' 41' ' ' VAL . 16.4 p-10 -125.41 -132.69 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.66 ' HG2' ' ND2' ' A' ' 63' ' ' ASN . 1.8 mtpt 17.59 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.912 0.778 . . . . 0.0 110.386 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.575 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -28.87 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.922 -0.486 . . . . 0.0 110.599 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 64' ' ' LYS . 2.3 tt0 -64.0 -56.0 18.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 108.313 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -44.99 -44.68 10.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.005 ' CB ' HD21 ' A' ' 91' ' ' LEU . . . -56.12 -45.96 79.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.6 -1.313 . . . . 0.0 107.715 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 tt0 -45.35 -39.04 6.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 78.5 mm-40 -57.62 -54.93 41.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -61.2 -13.26 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.729 0.776 . . . . 0.0 110.025 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 6.7 mm -82.98 -62.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 O-C-N 120.621 -1.299 . . . . 0.0 108.679 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.58 6.69 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.965 . . . . 0.0 109.797 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -128.9 -52.53 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.851 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.31 -26.23 42.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.171 -0.955 . . . . 0.0 109.97 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 13.4 p-10 -48.91 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.354 -1.467 . . . . 0.0 107.664 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' LEU . 3.8 m-20 74.21 58.67 0.08 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 108.684 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.973 HG23 HD21 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -79.45 78.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.184 -0.947 . . . . 0.0 108.773 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -133.0 -163.51 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.4 Cg_endo -102.52 38.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.021 1.537 . . . . 0.0 109.984 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 47.68 60.14 3.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.35 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 163.2 -46.28 0.32 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -53.52 -175.61 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -128.75 75.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.262 . . . . 0.0 109.716 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.539 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -165.83 64.41 0.93 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -92.48 -170.65 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.969 1.51 . . . . 0.0 110.581 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.973 HD21 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -149.61 124.69 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 13.9 t -78.03 100.14 6.38 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 16' ' ' LEU . 34.6 m -78.55 146.4 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.928 0.87 . . . . 0.0 111.948 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.9 tmm_? 168.41 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.005 HD21 ' CB ' ' A' ' 68' ' ' ALA . 1.1 mp -36.89 145.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.412 0.625 . . . . 0.0 110.417 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.69 -166.83 1.43 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 109.261 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 71.9 1.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.106 -0.996 . . . . 0.0 109.34 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.59 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -58.08 152.71 16.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.219 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 13' ' ' ASP . . . -130.91 -116.62 1.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 0.0 109.725 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' C ' ' OD1' ' A' ' 13' ' ' ASP . 25.3 t0 -145.46 84.59 1.69 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.664 -1.273 . . . . 0.0 111.948 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.051 HG23 ' CB ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER -162.04 38.07 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.311 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -174.01 2.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.863 ' CG ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -108.26 123.47 48.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.483 0.659 . . . . 0.0 110.712 -178.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 11.1 t80 -90.59 94.71 9.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.964 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 19.5 m -91.77 130.42 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 110.463 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.75 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.6 p -126.98 -175.67 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 4.6 t-20 55.04 70.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.624 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.58 ' C ' HD12 ' A' ' 21' ' ' LEU . 3.9 pp 178.8 151.41 0.47 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 36.8 Cg_endo -110.15 -169.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.008 1.53 . . . . 0.0 110.037 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.51 41.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.662 HG23 HG23 ' A' ' 25' ' ' ILE . 2.1 t -80.58 -29.43 37.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 24' ' ' THR . 37.2 pt -108.32 162.46 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.44 136.7 39.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 4.3 p-10 -61.94 -47.49 84.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 25.9 t0 -54.42 -19.8 6.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.182 -0.949 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 26' ' ' THR . 13.8 mt-30 -77.13 -53.14 8.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.67 ' O ' HG22 ' A' ' 33' ' ' ILE . 4.6 mp -44.72 -34.04 2.09 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.634 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.578 ' N ' ' HE3' ' A' ' 43' ' ' LYS . 4.8 t70 -50.52 -63.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.2 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -64.23 -14.75 57.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.909 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -79.66 -23.22 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.973 ' CE2' HD11 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -150.22 35.36 0.65 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.8 -1.188 . . . . 0.0 110.853 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.981 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -88.34 57.54 4.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -131.94 -8.92 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 110.575 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -115.19 47.3 1.31 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.823 -1.173 . . . . 0.0 109.568 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . 122.77 171.9 13.85 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 40' ' ' ILE . 3.3 m -91.47 93.83 9.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.376 -1.073 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.981 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -29.38 143.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-O 121.259 0.552 . . . . 0.0 110.259 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -105.57 50.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -175.338 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.676 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 85.88 95.58 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 120.553 -1.342 . . . . 0.0 112.839 177.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 1.072 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 3.0 mttm -81.31 117.46 21.82 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.083 -1.011 . . . . 0.0 109.65 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -122.03 153.51 38.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 108.944 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' A' ' 27' ' ' ASP . 11.1 pt -130.5 159.1 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -157.49 130.92 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 19' ' ' THR . 2.3 m -128.53 154.43 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.147 -1.208 . . . . 0.0 110.069 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.84 176.69 4.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.683 ' CD1' HD21 ' A' ' 46' ' ' LEU . 6.8 m-85 -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.072 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -79.18 157.51 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.729 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -103.87 104.75 14.78 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.654 0.74 . . . . 0.0 109.895 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -161.01 80.78 0.63 Allowed 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 1.051 ' CB ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -77.13 -115.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.814 -1.154 . . . . 0.0 108.748 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 27.53 89.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.683 0.674 . . . . 0.0 109.555 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -27.91 -41.95 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.777 -0.577 . . . . 0.0 110.544 -177.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' LYS . 3.8 mm-40 -67.1 -56.3 10.61 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.882 -1.136 . . . . 0.0 108.109 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -46.86 -49.15 20.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -52.91 -45.52 67.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.599 -1.313 . . . . 0.0 107.944 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HA ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.64 -42.82 35.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 1.0 OUTLIER -60.25 -68.81 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.678 . . . . 0.0 109.872 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 75' ' ' LEU . . . -45.91 -20.05 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 110.104 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.81 ' HA ' HG21 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -71.41 -66.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.58 -1.325 . . . . 0.0 108.219 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -78.53 10.47 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.095 -1.003 . . . . 0.0 110.382 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.73 -56.79 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 109.921 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.973 HD11 ' CE2' ' A' ' 34' ' ' PHE . 51.3 mt -77.38 -33.22 55.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 11.2 p-10 -51.14 133.29 28.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.709 -1.244 . . . . 0.0 108.259 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.642 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 68.54 55.69 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 109.682 -179.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 87' ' ' LEU . 14.9 p -85.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 108.677 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -132.21 176.25 3.05 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -87.61 44.57 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.842 1.443 . . . . 0.0 109.128 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 80' ' ' PRO . 10.8 pt-20 40.9 45.67 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.5 77.51 0.3 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.08 -36.89 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.488 ' H ' HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER 67.51 45.41 1.55 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.153 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.661 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 5.6 mm-40 -128.2 49.74 4.79 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 109.091 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 37.9 Cg_endo -88.52 -162.4 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.759 1.4 . . . . 0.0 111.389 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.666 HD23 HG11 ' A' ' 18' ' ' VAL . 4.8 mp -85.94 124.96 32.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.807 -0.558 . . . . 0.0 110.013 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.4 m -79.26 96.67 6.0 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.863 HG23 ' CG ' ' A' ' 16' ' ' LEU . 8.8 p -75.66 143.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.4 1.095 . . . . 0.0 112.012 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER 175.37 -130.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 92' ' ' ALA . 12.3 tp -149.06 152.02 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.395 -1.441 . . . . 0.0 110.113 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.759 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -126.46 -171.05 2.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 109.559 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.86 -174.08 3.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.19 150.08 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -74.7 -172.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.52 -61.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' C ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.268 -1.137 . . . . 0.0 109.444 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 121.219 0.533 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 70.4 m-20 -149.11 -87.4 0.08 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.57 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.033 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -163.26 105.13 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.906 -1.121 . . . . 0.0 109.73 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.843 ' H ' HD21 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -77.85 -178.95 5.71 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.436 -1.415 . . . . 0.0 108.192 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.117 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -137.02 112.24 9.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.842 -1.161 . . . . 0.0 110.119 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 8.8 t80 -93.92 101.62 13.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.922 . . . . 0.0 108.841 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.825 HG11 HD23 ' A' ' 87' ' ' LEU . 2.8 m -100.79 113.88 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 0.0 109.929 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -83.18 166.42 18.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.985 . . . . 0.0 109.613 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 76.91 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.206 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.972 HD22 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER 49.53 101.24 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 110.103 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 84' ' ' SER . 36.8 Cg_endo -76.5 140.6 21.64 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.061 1.559 . . . . 0.0 109.631 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.8 41.91 1.05 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -0.967 . . . . 0.0 109.401 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -3.19 30.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.78 179.63 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 p -106.64 155.87 19.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 2.9 p30 -62.05 -42.82 99.59 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 2.6 m-20 -53.84 -27.11 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 108.974 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -33.58 31.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -52.44 -33.56 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -60.12 -46.01 91.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.035 . . . . 0.0 108.418 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 5.9 m -61.1 -43.18 99.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 78' ' ' VAL . 3.0 mm -52.71 -30.64 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 1.158 ' CE1' HD13 ' A' ' 75' ' ' LEU . 4.0 m-30 -79.15 -77.57 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.591 -0.693 . . . . 0.0 109.887 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 36' ' ' LYS . . . 141.12 -82.31 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 166.08 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -1.196 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 3.8 m-85 -78.77 -70.13 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.348 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.05 -169.4 15.5 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 40' ' ' ILE . 48.6 p -78.99 77.18 5.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 108.338 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.934 HD12 HH21 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -40.46 146.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.672 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 28.8 m -111.2 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.857 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 50.2 tt0 62.53 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.13 -0.981 . . . . 0.0 112.803 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 3.2 mtmm -75.56 163.27 27.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.369 -0.832 . . . . 0.0 109.506 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 1.1 m-80 -149.3 106.22 3.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.925 . . . . 0.0 109.592 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.497 HD13 ' HD3' ' A' ' 47' ' ' ARG . 12.3 tt -87.53 141.14 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -120.06 110.39 16.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.564 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 23' ' ' ARG . 2.1 ptm180 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 10.1 p -148.42 159.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.134 . . . . 0.0 109.04 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -160.17 -175.11 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -155.18 104.66 2.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 16' ' ' LEU . 2.7 p -79.33 157.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.271 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.934 HH21 HD12 ' A' ' 40' ' ' ILE . 3.8 ptt180 -84.1 142.35 30.45 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.934 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.808 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -161.42 164.94 29.54 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -145.04 -101.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.366 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 5.1 mmtp -22.15 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.647 -0.658 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.54 ' NH2' ' HA ' ' A' ' 13' ' ' ASP . 32.2 mmt-85 -43.39 -50.59 6.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.187 -0.945 . . . . 0.0 108.558 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 67.6 mt-10 -55.06 -44.8 75.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -47.95 -60.78 2.35 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.666 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.033 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -46.31 -37.01 6.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.757 -1.215 . . . . 0.0 108.19 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -51.66 -53.7 36.02 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' ILE . 4.4 mm-40 -51.28 -67.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.117 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -34.12 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.826 ' HA ' HG11 ' A' ' 89' ' ' VAL . 1.5 mm -70.4 -67.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.927 -1.108 . . . . 0.0 108.29 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -85.68 27.98 0.81 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.465 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.71 -53.41 0.49 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.966 . . . . 0.0 108.486 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.158 HD13 ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -78.78 -29.15 44.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 14.5 t-20 -58.3 139.84 54.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 108.86 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' OD1' ' CB ' ' A' ' 86' ' ' PRO . 3.0 m120 58.88 63.5 1.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.053 -1.03 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.068 ' CG1' HD13 ' A' ' 87' ' ' LEU . 1.5 p -85.7 65.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.769 HG21 ' HB3' ' A' ' 84' ' ' SER . 1.0 OUTLIER -165.4 153.24 9.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 33.7 Cg_endo -43.96 -74.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.547 1.288 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 1.1 pt-20 162.38 144.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.6 -63.16 0.29 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . -132.18 -164.65 11.08 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.769 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 79.86 -9.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -1.003 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 2.8 mm-40 62.25 154.08 0.11 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.073 -1.017 . . . . 0.0 109.462 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' CB ' ' OD1' ' A' ' 77' ' ' ASN . 36.4 Cg_endo -107.68 157.34 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.011 1.532 . . . . 0.0 110.839 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 1.068 HD13 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mp -78.79 123.94 27.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -79.15 97.24 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 1.106 HG13 HD11 ' A' ' 16' ' ' LEU . 22.3 t -75.95 137.74 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.396 1.093 . . . . 0.0 111.442 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' H ' ' CD1' ' A' ' 16' ' ' LEU . 1.3 tpt180 -175.49 -135.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.843 HD21 ' H ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.15 135.92 9.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.67 -1.269 . . . . 0.0 109.184 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -107.34 -162.68 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -171.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.96 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 176.8 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.98 138.2 0.25 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.32 -0.862 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.77 123.66 29.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.206 -1.173 . . . . 0.0 109.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.593 0.235 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -130.8 -74.66 0.53 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.651 -1.281 . . . . 0.0 110.707 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 1.132 HG22 ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -160.31 91.59 0.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.01 -1.056 . . . . 0.0 110.245 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 4.4 t30 -79.25 169.24 18.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -0.877 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.906 HD12 HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -143.92 136.02 26.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.67 -1.269 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' ' CZ ' ' A' ' 59' ' ' PHE . 5.1 t80 -85.28 142.73 29.17 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.422 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.893 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 30.2 m -132.94 157.08 42.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -144.12 159.24 42.98 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.714 -179.589 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.6 t-20 79.51 88.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 110.299 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.741 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -159.99 150.87 15.73 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.543 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.7 Cg_endo -82.5 -176.8 3.1 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.819 1.431 . . . . 0.0 111.013 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -77.0 3.35 12.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.135 -0.978 . . . . 0.0 109.97 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.849 HG22 ' OE1' ' A' ' 29' ' ' GLN . 33.9 m -84.14 -112.94 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.802 ' CG2' HD22 ' A' ' 30' ' ' LEU . 8.8 mm 42.23 23.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.898 -1.126 . . . . 0.0 110.311 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' THR . 49.0 p -35.94 158.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.692 0.758 . . . . 0.0 110.616 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 16.7 m-20 -60.27 -27.38 67.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.88 -13.03 34.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.849 ' OE1' HG22 ' A' ' 24' ' ' THR . 2.4 mt-30 -79.88 -66.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 25' ' ' ILE . 2.1 mp -57.03 -28.77 62.8 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.248 -1.381 . . . . 0.0 107.98 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -62.44 -43.33 99.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 108.672 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 m -55.75 -56.53 19.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 30' ' ' LEU . 8.4 tp -62.13 -18.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.701 ' HZ ' HD21 ' A' ' 75' ' ' LEU . 6.9 m-85 -86.9 -98.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 18.22 62.53 0.01 OUTLIER Glycine 0 N--CA 1.498 2.832 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER 178.15 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 111.074 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -128.19 50.39 2.07 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.416 -1.427 . . . . 0.0 111.179 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' ' CD1' ' A' ' 62' ' ' TYR . . . 26.21 43.47 0.02 OUTLIER Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -88.84 34.61 0.77 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.46 -1.024 . . . . 0.0 109.997 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.008 HG23 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 165.34 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 61' ' ' ARG . 15.3 m -89.97 13.47 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER 165.93 53.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -42.65 144.54 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.123 -0.986 . . . . 0.0 109.98 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.86 150.91 29.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.03 . . . . 0.0 109.825 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 46' ' ' LEU . 1.5 mt -101.9 -178.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -148.78 105.13 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.378 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.503 ' C ' HD11 ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 46' ' ' LEU . 2.7 m -127.12 178.43 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -1.139 . . . . 0.0 109.394 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.893 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -139.7 177.11 8.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.639 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -146.48 111.27 5.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.008 HG13 HG23 ' A' ' 40' ' ' ILE . 16.9 t -95.87 148.14 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 41' ' ' VAL . 68.3 mtt180 -118.18 65.24 0.75 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.287 -1.508 . . . . 0.0 110.187 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -78.64 91.66 4.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.617 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -47.68 -84.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.891 -1.13 . . . . 0.0 110.993 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -24.03 144.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.534 0.683 . . . . 0.0 112.103 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -78.11 -51.66 9.93 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.625 -0.672 . . . . 0.0 110.364 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -67.19 -39.49 86.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.848 -1.157 . . . . 0.0 108.24 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 18.1 mt-10 -69.3 -29.13 66.93 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.979 ' HB1' HD11 ' A' ' 91' ' ' LEU . . . -63.21 -39.8 95.67 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.8 -28.24 69.32 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.647 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -57.68 -67.99 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.458 -0.776 . . . . 0.0 108.978 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -55.51 -17.63 5.68 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.315 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.538 HD13 ' CG1' ' A' ' 89' ' ' VAL . 3.0 mm -69.39 -61.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.545 -1.347 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.91 4.34 41.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.604 -0.685 . . . . 0.0 111.11 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . -131.56 -1.28 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.745 -1.222 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.701 HD21 ' HZ ' ' A' ' 34' ' ' PHE . 2.0 tp -127.87 -23.63 3.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.742 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.816 ' CA ' HG23 ' A' ' 89' ' ' VAL . 9.9 t-20 -41.1 -27.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.206 -0.933 . . . . 0.0 108.888 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 75' ' ' LEU . 91.2 m-20 -122.99 76.02 1.33 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.755 -0.59 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.3 p -84.44 48.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.178 -0.951 . . . . 0.0 108.805 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 83' ' ' GLY . 2.0 pt -124.05 -169.58 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.2 Cg_endo -110.92 40.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.983 1.517 . . . . 0.0 110.299 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER 76.97 160.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.48 -50.83 4.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 79' ' ' ILE . . . 155.67 -98.05 0.17 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' GLN . 11.6 m 62.75 10.32 4.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.13 . . . . 0.0 109.425 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 mt-30 53.29 107.7 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 0.0 110.222 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.712 ' HB3' HG23 ' A' ' 79' ' ' ILE . 37.5 Cg_endo -115.61 164.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.939 1.494 . . . . 0.0 109.163 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -72.0 108.94 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.366 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.6 t -76.54 116.46 17.25 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.906 HG11 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -79.09 174.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.519 1.152 . . . . 0.0 113.155 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.629 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.1 OUTLIER 163.7 96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.132 ' CD2' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -51.57 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.082 . . . . 0.0 109.417 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 90' ' ' ARG . . . -54.6 159.71 2.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.512 -0.742 . . . . 0.0 110.02 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -140.61 50.63 1.67 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 109.191 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -152.85 -69.03 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.385 -0.822 . . . . 0.0 109.458 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 30.3 p-80 -119.62 79.99 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.27 -150.68 5.74 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CE ' ' OXT' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 109.502 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CG ' ' HG2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 63' ' ' ASN . 3.9 p-10 -160.96 94.7 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.63 -1.294 . . . . 0.0 110.281 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -160.16 57.93 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.9 . . . . 0.0 110.036 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 1.1 t30 -78.59 158.06 28.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.874 . . . . 0.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.978 HD21 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -138.07 125.2 21.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.865 -1.147 . . . . 0.0 109.788 178.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 1.1 t80 -77.28 105.67 8.54 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.967 ' CG1' HD23 ' A' ' 87' ' ' LEU . 4.0 m -87.09 103.77 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 88' ' ' SER . 17.2 p -90.44 167.96 12.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.344 -0.847 . . . . 0.0 109.553 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER 68.15 7.55 5.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 25' ' ' ILE . 9.9 tt -71.08 115.0 32.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.118 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' HD23 ' A' ' 21' ' ' LEU . 36.6 Cg_endo -60.13 142.37 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.859 1.452 . . . . 0.0 110.289 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.71 28.62 1.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 12.11 37.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.928 . . . . 0.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.943 HD11 HD21 ' A' ' 21' ' ' LEU . 2.1 pp -130.33 170.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.498 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.2 p -113.62 153.91 28.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.351 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -49.88 -69.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 109.015 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -42.0 -27.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.498 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -62.97 -62.39 1.74 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.6 mp -52.93 -20.2 3.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.859 -1.15 . . . . 0.0 108.957 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 27.4 t0 -66.43 -47.13 74.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.089 -1.007 . . . . 0.0 108.966 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 m -68.02 -37.55 81.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.451 -0.781 . . . . 0.0 109.072 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -61.75 -27.2 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 108.889 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 10.7 m-85 -88.45 -81.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 38.19 82.83 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -173.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 109.654 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -107.79 -86.08 0.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.877 . . . . 0.0 109.109 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.6 179.29 16.42 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 40' ' ' ILE . 10.7 m -94.13 25.83 3.57 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.077 -1.249 . . . . 0.0 108.773 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.848 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.4 mp 56.91 142.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.887 HG23 ' HD2' ' A' ' 61' ' ' ARG . 33.4 m -79.21 -12.9 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.528 -1.358 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.848 ' H ' HG22 ' A' ' 40' ' ' ILE . 21.4 tt0 157.47 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.79 ' CE ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.24 144.71 44.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 108.656 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 7.0 m120 -132.68 144.46 50.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.1 . . . . 0.0 110.407 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tt -130.11 155.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' VAL . 8.5 tp -168.74 117.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.998 -1.064 . . . . 0.0 109.599 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 109.744 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' LEU . 27.4 m -117.64 160.61 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.679 ' CB ' HD13 ' A' ' 21' ' ' LEU . . . -153.4 164.31 38.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.557 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 11.1 m-85 -128.09 109.08 11.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.978 HG12 HD21 ' A' ' 16' ' ' LEU . 1.6 t -79.89 120.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.887 ' HD2' HG23 ' A' ' 41' ' ' VAL . 13.7 ttm-85 -88.03 99.73 12.39 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.878 -1.139 . . . . 0.0 110.35 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 3.6 m-85 -119.23 74.89 1.01 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.748 ' OD1' HG21 ' A' ' 41' ' ' VAL . 1.4 m-20 -68.38 -4.93 16.33 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.978 -1.076 . . . . 0.0 110.882 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -87.98 146.53 25.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.954 -1.092 . . . . 0.0 109.606 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.561 ' HG2' ' CG ' ' A' ' 12' ' ' LYS . 39.3 mmm-85 -73.07 -58.84 3.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 108.793 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.21 -45.69 79.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.86 . . . . 0.0 108.846 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -52.83 -43.31 65.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.111 -0.993 . . . . 0.0 108.898 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.947 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -61.89 -40.54 95.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.936 -1.103 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -31.31 25.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -80.2 -72.18 0.42 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -36.59 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.526 0.679 . . . . 0.0 110.685 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' GLU . 2.5 mt -81.02 -63.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.498 -1.376 . . . . 0.0 108.827 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 m -84.23 30.46 0.53 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.386 -0.821 . . . . 0.0 109.822 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.11 -52.88 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.877 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.47 -34.39 41.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.151 -0.968 . . . . 0.0 108.657 179.029 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 12.1 t30 -42.71 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' LEU . 1.8 m-20 80.87 76.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.792 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -89.4 38.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.306 -0.871 . . . . 0.0 109.064 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 ' OG ' ' A' ' 84' ' ' SER . 1.5 mt -151.7 128.32 5.34 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.81 ' HD2' HG23 ' A' ' 79' ' ' ILE . 35.9 Cg_endo -44.06 130.79 8.37 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.741 1.39 . . . . 0.0 110.105 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -46.57 102.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.17 21.08 0.5 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.18 75.76 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.881 ' OG ' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -88.46 16.23 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -1.181 . . . . 0.0 109.218 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.511 ' O ' HD13 ' A' ' 79' ' ' ILE . 28.2 mt-30 69.86 123.32 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.56 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.2 Cg_endo -110.46 -168.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.813 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.967 HD23 ' CG1' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.29 113.46 27.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.642 -0.661 . . . . 0.0 109.927 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -79.73 106.22 11.59 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.776 HG12 HD12 ' A' ' 16' ' ' LEU . 12.5 m -78.21 -167.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 111.322 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.602 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 95.12 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -49.47 168.17 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 91' ' ' LEU . . . -149.16 -156.44 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.14 -169.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.061 -1.025 . . . . 0.0 109.748 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' HIS . 9.7 mt-10 -131.76 124.27 29.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 109.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 57.33 110.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.97 -143.56 3.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.192 -1.181 . . . . 0.0 109.38 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -155.25 110.88 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 7.3 m-85 -105.46 90.12 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.471 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 3' ' ' TYR . . . 63.4 162.72 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 109.767 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 mmt-85 -117.58 -88.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.486 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 5' ' ' ARG . 35.6 Cg_endo -43.63 154.36 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.384 1.202 . . . . 0.0 110.951 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 65' ' ' ARG . . . -110.27 -111.79 3.37 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 65' ' ' ARG . . . -159.07 144.0 9.81 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HB2' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER 166.47 140.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -1.104 . . . . 0.0 109.486 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLU . 1.1 p -38.63 161.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.409 -0.807 . . . . 0.0 110.628 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -41.45 103.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.564 -0.71 . . . . 0.0 109.202 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -125.84 -87.28 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 30.5 t0 -161.93 96.31 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 91' ' ' LEU . 1.2 m -148.23 54.87 1.03 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -78.34 164.09 25.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.865 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 pt? -127.25 141.44 51.72 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.641 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.682 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -83.44 110.92 18.57 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.605 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -84.78 116.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 109.248 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 57' ' ' VAL . 9.8 p -91.11 163.15 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 109.713 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.69 89.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.558 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 87' ' ' LEU . 9.1 tp -157.22 96.68 2.07 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HG3' ' OE1' ' A' ' 85' ' ' GLN . 36.9 Cg_endo -69.11 168.53 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.989 1.52 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 42.63 1.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.987 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.754 HG23 HG23 ' A' ' 25' ' ' ILE . 9.3 t -80.19 -12.0 59.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.786 ' H ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -125.77 -177.73 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.5 p -110.59 153.76 24.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' HD11 ' A' ' 45' ' ' ILE . 6.1 p-10 -57.62 -47.35 82.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -65.53 -19.05 65.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 17.5 tt0 -71.15 -48.82 49.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.576 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -45.7 -26.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 108.735 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 10.3 t70 -64.65 -51.14 64.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.842 . . . . 0.0 109.109 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.7 m -54.62 -44.35 73.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.087 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.89 HG21 ' HB ' ' A' ' 78' ' ' VAL . 1.8 mp -57.25 -36.11 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.197 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.699 ' CD1' HD21 ' A' ' 75' ' ' LEU . 2.0 m-30 -80.28 -83.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 109.346 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 23.01 67.09 0.02 OUTLIER Glycine 0 N--CA 1.503 3.115 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -172.88 -39.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.247 . . . . 0.0 109.922 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.889 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -94.38 -77.52 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.177 -0.952 . . . . 0.0 109.584 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 -168.15 14.94 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.32 32.58 4.36 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -1.232 . . . . 0.0 109.555 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 26.62 101.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.774 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.818 HG13 HH11 ' A' ' 61' ' ' ARG . 0.7 OUTLIER -76.54 9.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.362 -1.461 . . . . 0.0 110.129 -179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -168.04 -164.65 0.56 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.638 -1.289 . . . . 0.0 110.776 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 159.02 106.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -139.33 -178.5 5.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.62 -1.3 . . . . 0.0 110.905 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD11 ' HB3' ' A' ' 27' ' ' ASP . 5.3 mp -139.25 141.65 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.8 mp -127.58 130.38 48.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -114.35 164.04 14.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 53' ' ' ARG . 10.9 t70 -134.99 69.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.276 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -129.73 1.1 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.566 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.84 15.9 1.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.453 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 t -142.14 -39.48 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.827 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.81 34.51 59.24 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.582 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -105.64 -56.97 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.176 . . . . 0.0 109.584 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 53' ' ' ARG . 37.4 Cg_endo -89.18 -163.31 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.595 1.313 . . . . 0.0 109.904 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.56 62.19 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.235 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.498 ' C ' HG13 ' A' ' 57' ' ' VAL . . . 54.75 78.87 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.498 HG13 ' C ' ' A' ' 56' ' ' GLY . 13.6 m -157.38 143.08 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -1.101 . . . . 0.0 109.704 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -100.47 -176.45 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 108.801 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.682 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -133.93 108.02 8.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 109.55 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 75' ' ' LEU . 1.7 t -85.89 160.85 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.818 HH11 HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.71 140.85 37.46 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.151 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 9.4 m-85 -161.39 68.99 0.32 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.671 ' ND2' HG11 ' A' ' 41' ' ' VAL . 18.0 m-20 -46.86 -86.6 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.434 -0.791 . . . . 0.0 109.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HB2' HD12 ' A' ' 11' ' ' ILE . 6.5 ttmm -37.01 118.37 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.326 0.584 . . . . 0.0 109.672 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.698 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -45.74 -47.7 15.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.629 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 14.6 mt-10 -54.38 -50.02 68.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 3.1 tp10 -53.86 -42.78 68.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CA ' ' HB3' ' A' ' 62' ' ' TYR . . . -55.43 -39.33 70.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.838 -1.164 . . . . 0.0 108.594 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.507 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.47 -44.73 76.73 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -49.2 -62.24 1.64 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.151 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -43.37 -40.09 3.48 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.524 -0.735 . . . . 0.0 109.152 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 40.8 mm -46.99 -60.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -68.82 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.889 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -45.94 -50.95 14.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 111.588 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.18 -28.17 42.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.723 -1.235 . . . . 0.0 110.635 -178.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.0 t30 -46.15 115.29 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.251 -1.53 . . . . 0.0 107.463 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 60.81 78.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.941 HG13 HD11 ' A' ' 87' ' ' LEU . 1.6 m -85.23 45.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.97 145.05 25.93 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.42 -0.8 . . . . 0.0 109.234 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 81' ' ' GLU . 36.3 Cg_endo -62.47 139.21 75.19 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.91 1.479 . . . . 0.0 109.328 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -40.33 107.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 -179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.72 38.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 81.56 -139.47 20.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.667 ' OG ' HG21 ' A' ' 79' ' ' ILE . 1.4 t 78.77 -4.82 2.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.598 -0.942 . . . . 0.0 109.391 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 84' ' ' SER . 24.7 mt-30 57.97 117.22 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.835 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HA ' HD11 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -83.75 177.74 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.905 1.476 . . . . 0.0 110.295 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -118.09 138.73 52.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 109.574 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 19.2 m -79.04 103.81 9.24 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.865 HG12 HD11 ' A' ' 16' ' ' LEU . 1.2 m -83.08 144.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.731 0.776 . . . . 0.0 110.886 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' H ' ' HB2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER 171.92 132.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -61.29 116.21 4.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.12 162.26 25.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -95.15 71.45 3.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -150.31 -38.13 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 97.8 m-70 62.41 105.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.23 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.412 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -177.41 96.0 0.1 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -100.5 177.95 4.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 109.617 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 47.2 t80 -152.32 20.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.842 . . . . 0.0 109.441 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.07 -58.29 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -68.03 144.23 96.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 37.0 Cg_endo -94.04 1.05 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.059 1.558 . . . . 0.0 110.063 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -158.37 14.97 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' OE1' ' A' ' 93' ' ' GLU . . . -127.6 -131.88 3.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 10' ' ' SER . 0.2 OUTLIER 65.07 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -1.156 . . . . 0.0 109.915 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -171.95 -162.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.038 HG12 HG21 ' A' ' 41' ' ' VAL . 1.4 pp -68.11 81.72 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.556 -0.715 . . . . 0.0 109.136 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 42.81 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 111.084 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.594 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 12.5 m-20 -157.97 -105.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.012 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -159.21 92.46 1.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.665 -1.272 . . . . 0.0 110.394 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.751 ' O ' HD22 ' A' ' 91' ' ' LEU . 33.3 p-10 -83.65 168.53 16.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.324 -0.86 . . . . 0.0 109.564 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -134.89 122.16 21.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.459 -1.401 . . . . 0.0 110.43 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' CD1' ' CE2' ' A' ' 59' ' ' PHE . 9.4 t80 -78.14 135.75 37.72 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.863 HG21 ' CD2' ' A' ' 87' ' ' LEU . 3.5 m -116.35 148.07 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.995 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.693 ' HA ' HG12 ' A' ' 57' ' ' VAL . 28.3 p -131.54 178.34 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.377 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 57.17 91.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.801 HD13 HG23 ' A' ' 45' ' ' ILE . 23.2 mt -108.99 175.32 2.0 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 109.121 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -114.22 6.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.743 1.391 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 163.4 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.648 ' HA ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -162.36 -44.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.444 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.759 HG22 ' OE1' ' A' ' 29' ' ' GLN . 1.1 mt 47.99 -174.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 108.913 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.589 ' H ' HG22 ' A' ' 25' ' ' ILE . 1.1 p -100.28 143.83 30.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.976 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 1.5 m-20 -57.79 -62.02 2.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.349 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -51.06 -18.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.759 ' OE1' HG22 ' A' ' 25' ' ' ILE . 22.2 mt-30 -75.08 -61.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.368 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.826 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 tp -44.5 -25.2 0.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.077 -1.014 . . . . 0.0 109.719 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.573 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 1.2 m-20 -64.52 -54.49 31.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.982 -1.074 . . . . 0.0 108.878 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -62.38 -35.94 80.74 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.399 -0.813 . . . . 0.0 109.087 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 30' ' ' LEU . 4.5 tt -61.3 -27.69 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 108.67 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.891 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 12.3 m-85 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 36' ' ' LYS . . . 155.54 -91.69 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 169.3 50.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.812 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -93.76 -86.51 0.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.152 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' CA ' ' HG3' ' A' ' 67' ' ' GLU . . . -74.09 157.33 51.14 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 40' ' ' ILE . 28.1 t -79.35 79.57 5.78 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.115 -1.227 . . . . 0.0 107.904 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -34.83 115.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.662 0.744 . . . . 0.0 109.574 -178.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.038 HG21 HG12 ' A' ' 11' ' ' ILE . 6.2 m -81.53 38.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 110.122 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 2.9 tt0 91.65 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.602 0.715 . . . . 0.0 111.035 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -99.95 151.45 21.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -145.65 175.68 10.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.59 -1.319 . . . . 0.0 110.992 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.801 HG23 HD13 ' A' ' 21' ' ' LEU . 49.9 mt -143.19 134.43 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.1 151.43 31.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.978 -1.076 . . . . 0.0 109.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.88 -35.52 0.41 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.165 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -78.7 177.38 8.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.059 -1.025 . . . . 0.0 109.93 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.56 -43.56 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.08 -40.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.482 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 m -134.05 6.12 3.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.14 -0.975 . . . . 0.0 109.62 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.5 59.23 1.03 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 150.76 89.22 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -1.135 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -85.26 82.94 1.55 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.006 1.53 . . . . 0.0 110.385 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -133.74 -89.62 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 109.314 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.23 74.66 1.28 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -126.33 140.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.79 -174.34 2.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.483 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 m-85 -143.57 99.14 3.37 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 16' ' ' LEU . 15.6 t -85.85 148.66 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.945 ' O ' HG22 ' A' ' 41' ' ' VAL . 9.5 mtt180 -137.33 79.25 1.74 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.415 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 11.1 m-85 -78.86 160.04 27.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.594 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -103.45 -91.95 0.35 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.111 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -25.54 136.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.508 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -50.93 -51.25 54.04 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 70' ' ' GLU . 16.5 mt-10 -63.43 -35.33 80.07 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -61.34 -28.12 68.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -75.82 -43.93 43.58 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -60.56 -20.77 61.4 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -70.75 -61.51 1.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -68.44 -5.13 17.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.561 0.696 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.059 ' HA ' HG21 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -86.43 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.723 -1.236 . . . . 0.0 108.21 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -75.29 -1.64 24.5 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.818 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.84 -47.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 110.357 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -84.09 -21.14 31.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 110.556 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.683 ' HA ' HG22 ' A' ' 89' ' ' VAL . 23.6 p-10 -46.95 -23.83 0.51 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.55 -1.344 . . . . 0.0 109.128 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 85' ' ' GLN . 3.4 m-80 -143.59 86.63 1.89 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 87' ' ' LEU . 2.2 p -78.46 88.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 108.838 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.048 HG23 ' HG3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -147.55 -172.61 0.32 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.48 -0.762 . . . . 0.0 109.085 -179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -102.7 24.06 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.899 1.473 . . . . 0.0 109.424 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER 73.24 114.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 0.0 109.693 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.83 -18.65 1.11 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 137.44 -148.76 20.0 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 79' ' ' ILE . 6.2 t 83.83 -28.11 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.799 -0.824 . . . . 0.0 109.837 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.8 pt20 38.41 92.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.245 -0.909 . . . . 0.0 110.755 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 1.048 ' HG3' HG23 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -121.24 -178.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.925 1.487 . . . . 0.0 110.049 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.863 ' CD2' HG21 ' A' ' 18' ' ' VAL . 77.3 mt 25.07 68.02 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 7.4 m -77.25 102.12 6.54 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.059 HG21 ' HA ' ' A' ' 72' ' ' ILE . 14.7 m -77.85 163.87 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.313 1.054 . . . . 0.0 113.153 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 91' ' ' LEU . 2.1 ttt180 171.2 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER -33.64 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.622 -0.674 . . . . 0.0 109.386 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.79 179.48 6.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.86 -1.15 . . . . 0.0 110.279 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 8' ' ' GLY . 1.2 mm-40 -123.35 105.22 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.443 -0.785 . . . . 0.0 109.176 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.31 -163.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -108.38 30.62 6.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.431 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.01 -33.66 0.05 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.643 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.213 -1.169 . . . . 0.0 109.61 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.272 0.558 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 t -90.01 175.8 7.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.95 . . . . 0.0 109.719 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.6 m-30 -57.37 -64.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 5' ' ' ARG . . . -146.28 170.84 15.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.736 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 5' ' ' ARG . 4.3 ttp85 65.32 118.73 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.756 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 14' ' ' THR . 36.8 Cg_endo -118.46 159.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.868 1.457 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA3' ' OG1' ' A' ' 14' ' ' THR . . . 166.73 -174.48 42.12 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.628 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' O ' ' CD ' ' A' ' 65' ' ' ARG . . . -154.53 -90.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . 12.6 pt-20 -178.86 -177.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -1.23 . . . . 0.0 109.698 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 63' ' ' ASN . 1.5 m 73.95 148.01 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 109.302 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.771 HD13 HG12 ' A' ' 41' ' ' VAL . 11.1 mm -72.3 81.25 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER 153.02 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.59 -88.17 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.48 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.782 ' HA ' HD13 ' A' ' 91' ' ' LEU . 3.2 m -79.22 71.62 5.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 110.03 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -76.89 -177.27 4.29 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.048 HD23 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -112.28 103.79 11.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.702 -1.249 . . . . 0.0 111.407 -178.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' CZ ' ' A' ' 59' ' ' PHE . 2.8 t80 -83.11 81.92 8.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 2.5 m -82.47 129.68 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 111.261 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.753 HG23 HG12 ' A' ' 57' ' ' VAL . 19.6 m -131.76 172.18 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' H ' HG22 ' A' ' 19' ' ' THR . 20.3 t-20 79.27 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.969 . . . . 0.0 110.121 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -170.1 144.98 2.28 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.018 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -106.85 69.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.626 1.329 . . . . 0.0 111.003 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 4.2 mtm180 40.1 36.38 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 24' ' ' THR . 89.2 m -79.82 -5.24 55.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 0.0 109.23 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.532 ' CD1' HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -152.32 150.27 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.174 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -91.55 155.41 18.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' H ' HD11 ' A' ' 45' ' ' ILE . 5.4 p-10 -62.31 -49.63 74.86 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.166 -0.959 . . . . 0.0 108.488 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 6.6 t0 -50.79 -22.5 2.18 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -77.37 -41.48 40.04 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.831 . . . . 0.0 109.777 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.985 ' O ' HG22 ' A' ' 33' ' ' ILE . 6.9 mp -47.3 -44.35 23.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.006 . . . . 0.0 109.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 6.9 t70 -58.03 -41.32 82.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.818 -1.176 . . . . 0.0 108.991 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -36.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.491 -0.755 . . . . 0.0 110.476 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.988 HD13 HG13 ' A' ' 78' ' ' VAL . 1.2 tt -67.21 -33.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.784 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CD1' HG23 ' A' ' 33' ' ' ILE . 1.8 m-85 -84.37 -72.03 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 109.075 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 36' ' ' LYS . . . 104.09 -40.74 2.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CD ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -175.22 98.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.261 . . . . 0.0 109.437 -179.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.711 ' CE1' ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -136.67 -21.7 1.28 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 62' ' ' TYR . . . -178.91 -175.5 46.0 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.53 ' HB3' HD11 ' A' ' 11' ' ' ILE . 1.4 t -88.91 71.99 8.52 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.372 -1.075 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -37.71 134.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.771 HG12 HD13 ' A' ' 11' ' ' ILE . 3.9 m -102.21 48.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 111.788 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.755 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 1.1 tm0? 89.28 131.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.592 0.71 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 mtmp? -100.66 169.66 8.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -160.56 163.9 32.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.916 -1.115 . . . . 0.0 110.341 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 27' ' ' ASP . 1.8 mt -141.11 107.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 57' ' ' VAL . 2.0 mm? -93.91 130.9 39.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.335 -0.853 . . . . 0.0 109.145 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 4.9 ptt180 -135.34 -58.66 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.898 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -140.42 -174.97 4.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.953 -1.092 . . . . 0.0 109.662 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' C ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -145.35 -81.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 49' ' ' LYS . 2.7 mt -120.6 -12.55 8.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 109.442 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.536 HG22 ' H ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -116.49 -160.51 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' HG22 ' A' ' 51' ' ' THR . . . -103.95 25.7 25.53 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.07 114.83 30.57 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.201 -1.176 . . . . 0.0 109.634 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 55' ' ' ARG . 36.7 Cg_endo -74.89 -81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.976 1.514 . . . . 0.0 110.067 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 8.5 ttm180 83.86 -54.98 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.758 -0.589 . . . . 0.0 109.749 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.01 84.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.753 HG12 HG23 ' A' ' 19' ' ' THR . 10.7 m -145.89 139.88 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -1.084 . . . . 0.0 109.075 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -124.55 177.11 6.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 47.8 m-85 -142.84 107.97 4.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.048 HG12 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -78.8 177.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.14 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -107.03 123.76 48.66 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.3 -177.194 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.63 ' CE1' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -163.93 158.34 19.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.92 -1.113 . . . . 0.0 109.77 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.558 ' HA ' ' H ' ' A' ' 14' ' ' THR . 5.2 p-10 -148.32 -64.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 0.0 110.962 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -49.55 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 108.977 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.491 ' CD ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -30.36 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.748 -0.595 . . . . 0.0 111.379 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 64' ' ' LYS . 56.9 mt-10 -66.71 -64.61 0.82 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.894 -1.129 . . . . 0.0 109.426 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . 26.3 pt-20 -56.02 -24.13 37.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.903 -1.123 . . . . 0.0 108.711 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 14' ' ' THR . . . -65.03 -44.63 88.5 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 52.8 tt0 -48.19 -33.69 8.89 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -60.13 -53.0 62.92 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -60.97 -11.91 9.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.072 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.902 ' HA ' HG21 ' A' ' 89' ' ' VAL . 33.0 mm -80.17 -59.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.12 4.3 8.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.565 -0.709 . . . . 0.0 110.172 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.42 -54.31 1.02 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.101 . . . . 0.0 109.862 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.037 HD21 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -79.4 -11.27 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.322 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.63 ' CB ' HG22 ' A' ' 89' ' ' VAL . 21.1 t-20 -82.86 42.42 0.79 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.405 -1.435 . . . . 0.0 109.145 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 p30 156.27 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.988 HG13 HD13 ' A' ' 33' ' ' ILE . 2.1 t -79.97 87.62 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.021 HD13 ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 172.58 135.74 0.1 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.473 -0.767 . . . . 0.0 109.181 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 36.6 Cg_endo -43.73 117.31 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.979 1.515 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -45.37 147.12 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 120.95 -59.64 0.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -60.81 -127.68 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.457 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -179.89 35.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 109.554 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 1.021 ' O ' HD13 ' A' ' 79' ' ' ILE . 13.2 mt-30 -129.44 71.3 82.08 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.391 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.69 -171.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.896 1.472 . . . . 0.0 110.954 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.96 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -116.47 113.62 23.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.24 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.1 t -78.53 102.65 8.0 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.902 HG21 ' HA ' ' A' ' 72' ' ' ILE . 17.0 m -78.5 153.89 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.008 0.909 . . . . 0.0 111.576 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 4.3 ttm-85 173.99 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 14' ' ' THR . 7.4 tp -52.42 136.82 30.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.938 -1.101 . . . . 0.0 108.978 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.615 ' N ' HD12 ' A' ' 91' ' ' LEU . . . -133.79 145.42 49.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.31 141.47 35.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -179.81 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -159.65 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.55 -117.25 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.218 -1.166 . . . . 0.0 109.621 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 68.7 m -103.96 73.18 1.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 2' ' ' SER . 33.9 m-85 73.12 -80.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.481 -0.762 . . . . 0.0 109.542 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.83 -67.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.89 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 175.28 1.51 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 108.709 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 37.5 Cg_endo -109.73 164.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.683 1.359 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.91 -170.34 19.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.0 -129.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.56 179.45 5.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -1.105 . . . . 0.0 109.711 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.69 47.89 0.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.839 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.856 HD12 HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.5 98.91 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.018 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.689 ' HB2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 79.69 -59.31 0.35 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.891 -0.506 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' ' N ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -160.95 -99.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.474 -1.391 . . . . 0.0 111.584 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 68' ' ' ALA . 7.7 p -107.75 -133.73 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.35 -1.469 . . . . 0.0 109.867 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.543 ' CB ' HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -164.56 -167.6 1.31 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.243 -0.911 . . . . 0.0 108.932 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.933 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.8 tp -154.62 121.54 5.54 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.85 ' OH ' HG11 ' A' ' 57' ' ' VAL . 11.4 t80 -110.17 117.26 33.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.808 -1.182 . . . . 0.0 109.726 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 89' ' ' VAL . 18.8 m -112.36 131.77 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 110.006 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.689 ' OG1' HG12 ' A' ' 57' ' ' VAL . 11.1 t -127.04 -166.53 1.61 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 108.896 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER 81.78 -65.24 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.317 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.6 OUTLIER -38.3 126.45 1.08 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.954 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -106.37 64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.971 1.511 . . . . 0.0 110.639 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 65.08 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.906 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 m -124.0 -24.93 4.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 109.964 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.726 HD12 ' CD1' ' A' ' 30' ' ' LEU . 1.1 pt -111.35 179.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -114.35 153.04 30.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.798 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 1.9 m-20 -63.35 -60.13 3.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 108.911 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -43.23 -26.39 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.305 -0.872 . . . . 0.0 109.382 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -72.23 -63.44 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' CD1' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -45.96 -24.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.124 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 1.6 t70 -64.86 -59.12 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.022 . . . . 0.0 109.118 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' THR . 92.8 m -64.28 -12.39 41.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.436 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.639 HG21 HG23 ' A' ' 78' ' ' VAL . 12.8 mm -77.72 -45.78 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.977 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.867 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 7.8 p90 -142.35 49.6 1.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.49 36.73 4.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -100.28 -44.97 5.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD1' ' OH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -79.42 -97.73 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.72 131.76 10.61 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 40' ' ' ILE . 53.4 p -79.03 75.26 5.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.915 -1.344 . . . . 0.0 108.48 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 23.59 108.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.883 1.325 . . . . 0.0 110.319 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.856 HG11 HD12 ' A' ' 11' ' ' ILE . 3.1 t -75.61 -4.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.968 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 170.11 99.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.544 -0.722 . . . . 0.0 110.033 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' HG3' HG21 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -87.16 87.09 7.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.965 . . . . 0.0 108.621 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.76 147.39 25.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 58' ' ' ALA . 19.5 tt -161.5 140.1 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.042 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 3.3 pp -161.59 155.07 21.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.08 . . . . 0.0 110.141 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -155.63 -163.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.389 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 54.2 p30 -97.88 175.13 6.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -103.59 -59.54 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -123.35 -56.66 1.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 p -140.29 150.11 43.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 53' ' ' ARG . . . 128.02 -72.99 0.46 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER 40.49 84.8 0.18 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.513 -0.992 . . . . 0.0 109.69 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' C ' ' HG3' ' A' ' 55' ' ' ARG . 36.5 Cg_endo -90.68 -37.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.43 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HG3' ' C ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -130.85 -60.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 47' ' ' ARG . . . 51.83 86.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.85 HG11 ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -160.95 166.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.125 . . . . 0.0 109.999 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -129.53 150.26 50.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 93.5 m-85 -126.46 101.67 6.79 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.935 -1.103 . . . . 0.0 110.616 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.933 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -81.8 107.11 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 176.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.801 ' NH2' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -76.97 87.25 3.5 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 120.138 -1.601 . . . . 0.0 108.618 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.723 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 2.1 t80 -94.7 114.26 26.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.841 ' CG ' HG21 ' A' ' 41' ' ' VAL . 46.9 m-20 -71.32 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.817 -1.553 . . . . 0.0 111.148 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER 7.32 127.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -62.23 -61.67 2.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.051 178.361 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -53.04 62.79 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 109.618 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 81.8 mt-10 -67.01 -10.9 54.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -75.19 -37.89 61.03 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -69.71 -20.75 63.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.8 mt-10 -62.65 -75.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.752 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . . . -50.11 -23.08 1.92 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.612 ' O ' HG21 ' A' ' 89' ' ' VAL . 2.6 mm -58.36 -51.64 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.688 -1.257 . . . . 0.0 107.795 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -86.47 -59.46 2.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.083 . . . . 0.0 110.231 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.52 -44.0 62.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 110.446 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.873 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.5 tp -79.25 -38.8 34.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.062 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.634 ' OD1' ' ND2' ' A' ' 77' ' ' ASN . 2.4 t-20 -40.96 116.71 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.634 ' ND2' ' OD1' ' A' ' 76' ' ' ASN . 0.9 OUTLIER 67.29 78.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.922 ' O ' HG23 ' A' ' 79' ' ' ILE . 7.4 p -86.18 52.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.078 -1.014 . . . . 0.0 109.773 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.08 HG21 ' CB ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -176.35 170.23 1.19 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.385 -0.822 . . . . 0.0 108.908 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -87.96 39.11 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.758 1.399 . . . . 0.0 109.677 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 46.88 68.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 108.771 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.8 1.97 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 85' ' ' GLN . . . 127.61 -50.96 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 120.885 -1.362 . . . . 0.0 110.332 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.08 ' CB ' HG21 ' A' ' 79' ' ' ILE . 73.1 m -50.93 -18.9 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 110.316 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' SER . 7.0 mp0 64.53 140.8 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.0 Cg_endo -84.25 -179.86 4.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.153 1.607 . . . . 0.0 111.455 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.873 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -122.06 123.87 42.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 109.098 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.626 ' HB3' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -78.5 97.04 5.57 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 18' ' ' VAL . 14.5 m -78.27 163.63 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 122.301 1.048 . . . . 0.0 112.049 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 17' ' ' TYR . 5.5 ptp180 173.42 -133.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD11 ' CB ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -146.73 119.46 8.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.679 -1.263 . . . . 0.0 108.217 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -145.68 -174.07 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.787 -1.196 . . . . 0.0 109.76 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -172.29 88.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.861 . . . . 0.0 109.185 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -46.42 -31.0 2.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -168.82 -152.63 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.49 95.27 1.57 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.588 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.416 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.56 155.83 28.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -133.05 26.83 4.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.69 168.44 18.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.262 -0.899 . . . . 0.0 109.761 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' CG ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -117.77 175.39 2.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 5' ' ' ARG . 35.4 Cg_endo -65.41 -163.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.637 1.335 . . . . 0.0 109.924 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 92' ' ' ALA . . . -143.68 -158.52 7.61 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.408 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.83 -155.58 10.21 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mt-10 -162.75 -172.11 2.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.154 -1.204 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' LYS . 1.3 t 64.55 133.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.928 HD12 HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 35.7 71.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.822 0.82 . . . . 0.0 109.011 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 67.28 -173.86 0.19 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 9' ' ' GLU . 3.2 p-10 -155.95 87.16 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.363 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -161.44 34.26 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.619 ' HB3' HG21 ' A' ' 41' ' ' VAL . 39.0 p-10 -76.93 -171.78 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -156.18 119.69 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -81.58 134.07 35.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.975 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 5.3 m -106.23 150.38 8.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.523 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.491 HG23 ' OG ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -115.42 168.94 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.439 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' THR . 86.1 m-20 61.26 72.95 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -136.19 115.27 10.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 109.408 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.76 -171.27 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.044 1.549 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -114.0 17.38 17.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -79.76 -56.84 3.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.191 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.848 HD11 HD12 ' A' ' 30' ' ' LEU . 2.0 tt -82.41 167.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.12 146.12 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 2.9 p30 -59.45 -44.31 92.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 6.9 t0 -58.46 -24.92 61.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.524 ' OE1' HG23 ' A' ' 26' ' ' THR . 7.8 mt-30 -73.76 -40.5 63.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.055 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.5 mp -42.77 -54.19 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.407 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -41.48 -49.22 3.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.875 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -61.26 -43.63 98.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.012 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.055 HG22 ' O ' ' A' ' 30' ' ' LEU . 10.1 tp -57.04 -24.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.891 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.803 ' CD1' HG23 ' A' ' 33' ' ' ILE . 3.2 m-85 -97.69 -73.09 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.812 -1.18 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.54 -80.82 0.24 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.98 105.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.151 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -94.85 -83.4 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 108.976 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . -98.87 -93.18 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.571 ' O ' ' C ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -150.47 67.63 0.96 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -23.75 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.718 0.77 . . . . 0.0 109.715 -178.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 11' ' ' ILE . 5.3 m -90.04 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.733 ' H ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 82.6 120.29 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.415 -0.803 . . . . 0.0 112.191 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.889 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -124.02 132.59 53.71 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.77 146.0 30.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.638 -1.289 . . . . 0.0 110.503 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.606 ' C ' HD22 ' A' ' 46' ' ' LEU . 1.7 tt -92.02 124.07 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 45' ' ' ILE . 1.7 mm? -106.96 138.53 42.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.102 -0.999 . . . . 0.0 110.215 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 53.9 mtp180 -117.36 -61.57 1.69 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.756 . . . . 0.0 109.029 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER 172.56 142.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.189 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -120.76 -17.5 7.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.94 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.62 -46.48 5.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.78 -143.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.25 80.56 0.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -74.38 166.49 44.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -112.96 -1.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.972 1.511 . . . . 0.0 110.29 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -71.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.12 91.51 1.8 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 46' ' ' LEU . 2.1 m -96.89 171.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -1.192 . . . . 0.0 109.623 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.975 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -147.68 -179.13 6.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.291 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 m-85 -152.15 115.64 4.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.669 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.073 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.07 153.84 4.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.54 -1.35 . . . . 0.0 107.684 178.135 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.771 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -95.18 132.53 40.03 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.084 0.945 . . . . 0.0 111.299 -178.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.166 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -163.26 147.01 10.73 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' C ' ' A' ' 64' ' ' LYS . 13.0 p30 -137.88 -118.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.785 -1.197 . . . . 0.0 107.879 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.63 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 10.43 103.27 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 CA-C-N 118.626 0.648 . . . . 0.0 110.855 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.746 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.05 -59.25 0.14 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.611 -0.681 . . . . 0.0 111.069 -178.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.9 -50.6 65.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.685 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 85.3 mt-10 -49.65 -48.9 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 110.34 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.39 -46.75 47.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.333 -1.479 . . . . 0.0 108.038 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 5.4 tt0 -52.92 -42.38 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 7.5 mm-40 -50.04 -66.6 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 0.0 108.585 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.166 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -51.01 -29.62 13.0 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.895 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 24.6 mm -60.03 -49.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.465 -1.397 . . . . 0.0 108.407 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.4 m -84.35 -65.49 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 110.117 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.01 76.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.464 -0.773 . . . . 0.0 111.303 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.073 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.45 -38.96 33.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.62 -1.3 . . . . 0.0 110.597 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 23.8 t-20 -52.6 131.77 34.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.264 -1.522 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 8.7 m120 64.56 69.84 0.5 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 78' ' ' VAL . 3.3 p -86.22 61.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.73 162.39 18.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.8 Cg_endo -87.14 41.21 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.656 1.345 . . . . 0.0 109.986 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' PRO . 9.0 mt-10 59.94 147.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.91 -76.37 0.41 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.67 -25.32 60.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.462 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER 58.27 28.75 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.115 . . . . 0.0 109.942 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.58 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 2.0 mt-30 -127.57 75.39 77.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.025 -1.047 . . . . 0.0 109.581 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -109.28 -161.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.879 1.463 . . . . 0.0 110.773 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.846 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -103.15 123.06 45.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 110.356 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -78.47 111.26 14.31 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.538 ' HB ' HD13 ' A' ' 72' ' ' ILE . 2.9 m -78.19 155.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.428 1.109 . . . . 0.0 112.395 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.572 ' HD2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 167.53 126.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 15.0 mt -41.76 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.01 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' GLY . . . -84.51 167.81 16.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 7' ' ' GLY . 3.1 mt-10 -64.07 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.45 4.55 10.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.222 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -125.22 112.54 16.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.03 -1.044 . . . . 0.0 109.599 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.96 178.51 34.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 17.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 109.43 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HA ' ' CE2' ' A' ' 3' ' ' TYR . 1.6 ttt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.18 61.14 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 3' ' ' TYR . 21.6 p90 -165.09 157.02 15.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.95 -88.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.527 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 101.15 2.09 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.547 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.593 ' HG2' ' CG ' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -92.37 -165.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.887 1.467 . . . . 0.0 109.993 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' A' ' 65' ' ' ARG . . . -172.26 -145.09 4.8 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.052 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.56 ' N ' ' HB3' ' A' ' 13' ' ' ASP . . . 178.67 -108.35 0.24 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -166.72 136.5 3.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.959 -1.318 . . . . 0.0 110.646 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER 74.85 172.19 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.49 -0.756 . . . . 0.0 111.176 178.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.837 ' CD1' HG12 ' A' ' 41' ' ' VAL . 13.3 mm -61.18 87.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.597 -0.689 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.6 pttt 147.88 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' HB3' ' N ' ' A' ' 8' ' ' GLY . 18.9 m-20 -111.27 -92.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 0.0 110.747 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.777 ' HA ' HD21 ' A' ' 91' ' ' LEU . 10.0 t -82.04 64.42 6.71 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.332 -0.855 . . . . 0.0 110.402 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.799 ' O ' HD22 ' A' ' 91' ' ' LEU . 2.2 p-10 -76.76 160.63 29.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.061 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -137.57 125.8 23.13 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 117.621 -1.632 . . . . 0.0 111.636 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -85.12 114.82 22.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.067 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 32.5 m -88.89 139.32 17.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -116.99 -179.48 3.71 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.332 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.448 ' H ' HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER 57.58 86.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 109.269 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -163.18 132.75 3.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.546 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' OE1' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -108.66 52.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.965 1.508 . . . . 0.0 110.194 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' PRO . 77.3 mtt180 41.7 53.08 4.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -96.0 -21.5 17.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.3 pp -121.81 160.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.389 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -96.66 157.12 16.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.162 -0.961 . . . . 0.0 109.992 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -59.89 -53.67 55.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -3.0 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.896 -1.127 . . . . 0.0 109.625 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.0 OUTLIER -83.1 -63.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 110.722 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 3.2 mp -44.3 -37.22 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.52 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.545 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 30.5 t0 -49.7 -55.82 12.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.662 -1.274 . . . . 0.0 109.228 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.6 m -65.18 -21.44 66.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -83.01 -15.12 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.718 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.94 ' CG ' HD11 ' A' ' 75' ' ' LEU . 10.5 p90 -153.4 33.86 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.914 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -97.57 61.56 1.01 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.134 -1.604 . . . . 0.0 109.697 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -138.54 -10.55 1.4 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.058 -1.26 . . . . 0.0 111.183 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CD2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -85.7 -50.14 7.41 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.684 -1.26 . . . . 0.0 109.875 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.49 -160.2 8.63 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' C ' ' A' ' 40' ' ' ILE . 14.5 m -95.35 72.77 3.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.275 -1.132 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.914 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -25.65 131.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-O 121.153 0.502 . . . . 0.0 110.046 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.837 HG12 ' CD1' ' A' ' 11' ' ' ILE . 3.2 m -98.76 56.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 12.2 tt0 94.26 100.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.599 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -83.05 165.79 19.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 1.9 t-20 -158.98 158.1 32.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.838 -1.164 . . . . 0.0 109.892 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -158.41 117.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.343 -0.848 . . . . 0.0 109.316 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.21 158.98 43.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.766 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -122.36 -81.8 0.64 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 2.6 p30 -99.3 -171.72 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.632 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -171.97 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.298 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.61 -75.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 p -149.68 19.2 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -87.77 -35.35 9.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.5 ptt180 37.88 55.45 4.19 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.611 -0.934 . . . . 0.0 109.934 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.31 -169.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.868 1.457 . . . . 0.0 110.358 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.36 -5.71 58.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.816 . . . . 0.0 109.619 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . 107.27 112.03 3.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.71 163.61 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.145 . . . . 0.0 109.431 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -134.26 -174.1 3.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 108.941 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -149.17 104.48 3.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.061 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.2 t -79.54 152.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.041 -1.037 . . . . 0.0 108.461 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.757 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.27 128.4 46.35 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.402 0.62 . . . . 0.0 111.022 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.069 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -164.4 146.05 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.184 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.686 ' C ' HG22 ' A' ' 14' ' ' THR . 12.0 p-10 -133.26 -48.56 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.72 106.14 0.37 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HG3' ' HA3' ' A' ' 7' ' ' GLY . 1.7 mpp_? -34.83 -55.63 0.57 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.178 0.513 . . . . 0.0 110.265 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -47.95 79.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 62' ' ' TYR . 39.7 tt0 -52.26 -29.4 22.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -68.79 -48.54 63.37 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.978 -1.076 . . . . 0.0 108.45 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -47.41 -32.33 4.89 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 20.4 mm-40 -67.38 -49.32 64.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.731 -0.606 . . . . 0.0 109.484 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -65.73 -13.54 59.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.802 ' HA ' HG21 ' A' ' 89' ' ' VAL . 19.3 mm -81.51 -69.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.012 -1.055 . . . . 0.0 108.596 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -77.48 8.6 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.635 -0.666 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -130.02 -50.53 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.941 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.4 mp -78.91 -32.31 45.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.014 -1.054 . . . . 0.0 108.515 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 40.7 t-20 -55.18 125.06 19.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 4.6 m-80 65.97 72.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.7 p -86.81 48.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -154.96 134.16 7.58 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 79' ' ' ILE . 34.7 Cg_endo -46.5 138.16 14.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.774 1.408 . . . . 0.0 109.758 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 80' ' ' PRO . 2.5 mm-40 -42.23 145.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.059 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.02 -29.49 2.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 140.31 -127.59 3.55 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.2 m 70.7 3.46 4.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.323 -1.104 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.425 ' OE1' ' HD3' ' A' ' 22' ' ' PRO . 4.7 mt-30 64.94 122.73 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.055 -1.028 . . . . 0.0 109.203 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -108.12 152.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 110.803 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -70.17 119.62 14.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.578 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -78.59 98.45 6.16 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HA ' ' A' ' 72' ' ' ILE . 33.8 m -78.83 153.47 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.02 0.915 . . . . 0.0 111.671 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 154.32 141.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.799 HD22 ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -59.78 134.68 57.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.53 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -94.1 -31.48 14.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 109.597 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 0.8 OUTLIER 76.23 63.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.187 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.0 -34.8 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.594 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -148.83 -92.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 15' ' ' ASN . . . -176.61 -44.89 0.06 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.236 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -103.46 96.17 6.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.68 -30.13 70.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.294 -0.879 . . . . 0.0 109.568 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.37 118.61 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.729 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.5 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . 12.5 ptt180 -58.47 142.78 81.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 108.689 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 91' ' ' LEU . 35.6 Cg_endo -41.3 133.77 3.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.857 1.451 . . . . 0.0 111.042 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.78 92.05 0.12 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.84 -163.2 33.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -65.19 123.35 19.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -1.106 . . . . 0.0 109.727 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -179.01 -157.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.155 ' CD1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -36.67 158.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -25.76 -41.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.954 0.407 . . . . 0.0 111.433 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -131.21 -67.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.943 -1.098 . . . . 0.0 111.596 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -161.53 102.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.574 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 46.8 p30 -98.38 -163.89 1.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.463 -0.773 . . . . 0.0 109.078 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.058 HD21 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -160.34 119.2 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.599 -1.24 . . . . 0.0 112.151 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -79.41 131.47 36.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.8 m -124.16 149.57 28.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.513 -1.367 . . . . 0.0 111.465 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -135.97 -153.32 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.525 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 34.77 16.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.995 . . . . 0.0 110.287 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.869 HD11 ' HB2' ' A' ' 58' ' ' ALA . 2.9 pp -170.49 128.72 0.78 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -102.81 67.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.979 1.515 . . . . 0.0 109.934 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.68 ' CG ' HG21 ' A' ' 45' ' ' ILE . 26.6 mtp180 62.11 54.64 2.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.5 p -79.8 -1.09 37.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.837 ' N ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -151.4 -160.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.6 p -122.12 151.53 40.84 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 92.6 m-20 -49.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.339 -0.851 . . . . 0.0 109.322 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.0 p30 -42.34 -26.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.095 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.523 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.7 tt0 -63.53 -57.74 9.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 110.143 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.935 HD21 ' CD2' ' A' ' 87' ' ' LEU . 3.0 mp -45.33 -44.44 11.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.867 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.944 ' OD1' HD11 ' A' ' 40' ' ' ILE . 21.2 t0 -59.5 -40.68 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 110.054 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 m -77.85 -10.94 59.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.0 -45.95 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 0.0 109.904 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 1.006 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 39.5 p90 -103.4 -45.89 4.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 109.449 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 34' ' ' PHE . . . 15.21 60.11 0.01 OUTLIER Glycine 0 N--CA 1.505 3.254 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' PHE . 12.4 tttt -133.36 -28.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.256 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -111.68 -100.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 110.31 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 67' ' ' GLU . . . -79.24 152.48 36.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 40' ' ' ILE . 20.6 t -87.05 45.24 1.25 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.122 -1.223 . . . . 0.0 108.258 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.006 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 39.95 110.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.217 1.008 . . . . 0.0 110.598 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.155 HG21 ' CD1' ' A' ' 11' ' ' ILE . 4.8 m -77.64 7.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.296 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER 162.46 72.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.068 -1.02 . . . . 0.0 110.29 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 1.8 ptpp? -82.76 117.72 22.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 20.0 p30 -154.73 169.6 23.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.198 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.68 HG21 ' CG ' ' A' ' 23' ' ' ARG . 13.7 mt -114.39 171.01 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.484 -0.76 . . . . 0.0 109.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.547 ' HB2' HG13 ' A' ' 57' ' ' VAL . 1.2 mt -128.8 113.41 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 110.012 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . 23.0 ptt180 -133.38 -160.64 1.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -124.26 -171.7 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 109.719 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -47.63 -76.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.993 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.77 -78.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.076 -1.015 . . . . 0.0 110.007 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.4 p -105.95 33.37 3.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.028 -1.045 . . . . 0.0 109.905 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 48' ' ' ASP . . . -126.31 63.19 0.6 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -121.27 116.24 31.05 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.352 -1.087 . . . . 0.0 109.456 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -114.28 32.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.976 1.514 . . . . 0.0 110.468 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -154.2 -62.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 109.786 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.32 95.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG23 HG23 ' A' ' 19' ' ' THR . 1.6 p -142.4 138.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.578 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -89.5 175.34 7.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -157.85 104.76 1.95 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.194 -0.941 . . . . 0.0 110.365 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.063 HG21 HD21 ' A' ' 75' ' ' LEU . 3.2 t -90.5 159.67 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.76 ' HB3' HG23 ' A' ' 41' ' ' VAL . 38.2 mmm-85 -139.51 147.3 41.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.586 -1.321 . . . . 0.0 110.169 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 52.3 m-85 -159.42 149.43 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.599 ' HB3' HD13 ' A' ' 11' ' ' ILE . 3.8 p30 -119.79 71.82 0.9 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.292 -1.363 . . . . 0.0 109.875 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.574 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -171.19 96.86 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -33.4 -51.93 0.37 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.264 0.554 . . . . 0.0 110.359 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.24 -50.05 74.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 108.466 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.629 ' HG2' ' CD2' ' A' ' 37' ' ' TYR . 15.2 tm-20 -52.37 -48.88 65.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.48 -0.762 . . . . 0.0 110.354 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -46.72 -45.2 19.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.647 -1.283 . . . . 0.0 107.981 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.6 -45.78 73.68 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -52.41 -65.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 109.248 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -53.01 -15.65 0.85 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.838 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.824 HD13 HG12 ' A' ' 89' ' ' VAL . 1.1 mm -85.21 -70.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.676 -1.265 . . . . 0.0 108.881 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 t -58.88 -9.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.737 -1.227 . . . . 0.0 110.582 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.14 -53.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.664 -1.273 . . . . 0.0 111.087 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.063 HD21 HG21 ' A' ' 60' ' ' VAL . 7.1 tp -81.72 5.89 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.971 -1.081 . . . . 0.0 110.837 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HA ' HG23 ' A' ' 89' ' ' VAL . 16.8 p-10 -87.3 22.42 2.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.724 -1.235 . . . . 0.0 108.556 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 38.5 p-10 177.86 73.83 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.708 ' O ' HG13 ' A' ' 78' ' ' VAL . 11.5 p -80.9 68.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.312 -0.867 . . . . 0.0 108.953 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.738 HD13 ' OG ' ' A' ' 84' ' ' SER . 0.1 OUTLIER 163.87 118.74 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -39.29 128.97 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.956 1.503 . . . . 0.0 110.835 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.75 163.98 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.97 -53.68 0.67 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.75 35.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.738 ' OG ' HD13 ' A' ' 79' ' ' ILE . 7.5 t -110.38 -14.19 14.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -1.218 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' SER . 46.7 mt-30 61.93 117.75 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 37.4 Cg_endo -123.61 -160.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 124.075 1.566 . . . . 0.0 109.354 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.935 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.9 115.76 27.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.958 -1.089 . . . . 0.0 110.926 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 5.8 m -79.23 113.63 17.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 72' ' ' ILE . 13.1 t -83.27 162.21 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.318 1.056 . . . . 0.0 113.17 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 161.57 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.558 HD11 ' CA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -44.04 157.53 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.29 170.8 2.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.48 -0.763 . . . . 0.0 109.906 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 43.2 mm-40 -141.01 125.7 17.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.431 -0.793 . . . . 0.0 109.217 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 70.48 6.51 5.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 109.342 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -141.21 -170.09 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.61 134.37 3.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 61' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.163 . . . . 0.0 109.494 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -54.68 99.56 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.099 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -175.42 75.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.512 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ARG . . . -158.77 86.79 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 109.809 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER 58.91 152.82 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.571 ' CG ' ' HB3' ' A' ' 91' ' ' LEU . 37.6 Cg_endo -120.88 -160.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.741 1.39 . . . . 0.0 110.27 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.75 -131.74 3.72 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.548 ' N ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.71 -133.08 3.19 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 1.4 mm-40 -169.43 179.93 3.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.161 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.582 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER 71.5 -163.05 0.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.474 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.949 HG23 ' CG1' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -41.05 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.588 ' CB ' ' HB2' ' A' ' 63' ' ' ASN . 6.9 mmtt 57.93 -167.92 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.548 ' HB2' ' N ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -160.16 82.81 0.71 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 111.052 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.603 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -161.35 52.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 0.0 109.142 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.58 HD22 HG21 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.16 -169.4 1.83 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.257 -0.902 . . . . 0.0 109.919 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.05 HD21 HG12 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -153.01 127.0 8.99 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.034 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.877 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -77.6 125.56 29.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 58' ' ' ALA . 29.0 m -118.24 124.01 72.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.415 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -123.65 178.11 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' THR . 5.0 t-20 87.79 15.19 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 111.337 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.916 HD13 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -154.59 43.17 0.21 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.343 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 21' ' ' LEU . 37.7 Cg_endo -76.14 142.82 24.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.593 1.312 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 61.05 9.76 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 110.691 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 22' ' ' PRO . 43.2 p -99.84 -38.77 8.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.96 -1.088 . . . . 0.0 108.917 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.875 HD11 HD23 ' A' ' 21' ' ' LEU . 1.3 pp -136.79 166.99 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 108.876 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -103.25 144.67 31.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.092 -1.005 . . . . 0.0 109.789 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -53.9 -66.2 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -44.91 -25.19 0.28 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.004 -1.06 . . . . 0.0 109.484 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 26' ' ' THR . 47.6 tt0 -64.75 -62.21 1.71 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 109.636 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 6.1 mp -43.96 -26.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.234 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' OD2' ' NH2' ' A' ' 61' ' ' ARG . 13.0 t70 -57.99 -54.11 50.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.9 m -62.76 -44.46 96.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.53 -17.2 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 108.509 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.912 ' CE2' HD21 ' A' ' 75' ' ' LEU . 20.4 m-30 -100.5 -91.0 0.31 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 36.6 77.42 0.05 OUTLIER Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -173.7 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.296 . . . . 0.0 110.681 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.625 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.16 -80.68 0.31 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.827 -1.171 . . . . 0.0 109.763 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.47 -165.45 11.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -94.32 26.92 3.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.3 -1.118 . . . . 0.0 108.191 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 41.83 -173.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.629 0.728 . . . . 0.0 109.811 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.949 ' CG1' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -118.48 -61.78 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.099 -1.001 . . . . 0.0 111.114 -177.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.772 ' H ' ' CB ' ' A' ' 61' ' ' ARG . 1.3 tm0? -176.59 107.19 0.07 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.898 -0.501 . . . . 0.0 109.675 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -97.74 132.47 43.34 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.879 -1.138 . . . . 0.0 107.96 179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -141.58 159.17 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.633 -1.292 . . . . 0.0 110.356 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.31 137.18 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -120.26 123.67 43.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.658 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -87.71 -130.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.444 -0.785 . . . . 0.0 109.085 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 53' ' ' ARG . 2.6 m-20 -141.01 125.4 17.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.758 -1.214 . . . . 0.0 109.678 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.769 ' C ' HD23 ' A' ' 50' ' ' LEU . 5.5 mtmp? -121.48 33.86 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -0.895 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -138.88 -53.14 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 109.205 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.5 p -105.6 -34.75 7.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.14 45.35 2.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 5.3 ttt180 -64.9 157.99 72.54 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.321 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 36.4 Cg_endo -102.45 11.59 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.956 1.503 . . . . 0.0 110.397 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 54' ' ' PRO . 40.4 mtm-85 -161.19 85.04 0.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.758 ' O ' HG13 ' A' ' 57' ' ' VAL . . . -73.13 -111.61 0.06 OUTLIER Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -163.12 157.42 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.484 -1.01 . . . . 0.0 109.77 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.641 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -110.32 174.01 6.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HD21 ' A' ' 46' ' ' LEU . 3.1 m-85 -143.47 104.21 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.784 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.064 HG21 HD23 ' A' ' 75' ' ' LEU . 1.1 t -82.47 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.941 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -119.23 135.37 54.72 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.477 -177.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 1.019 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 7.1 m-85 -155.3 137.98 15.18 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' A' ' 12' ' ' LYS . 7.5 p30 -118.78 -50.28 2.41 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.468 -1.395 . . . . 0.0 110.194 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -53.88 137.08 39.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.4 OUTLIER -63.12 -43.07 99.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 0.0 109.043 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.18 -43.19 67.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 108.772 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.602 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -61.76 -25.61 67.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' GLN . . . -72.89 -48.19 39.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.736 -1.227 . . . . 0.0 107.854 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 42.7 tp60 -49.43 -32.97 12.88 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -58.89 -67.89 0.32 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.019 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -45.8 -22.05 0.16 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.212 0.529 . . . . 0.0 109.641 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 15.6 mm -74.35 -70.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.406 -1.434 . . . . 0.0 108.657 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.11 22.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.53 -0.731 . . . . 0.0 110.334 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -138.66 -50.57 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.064 HD23 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -79.44 -42.09 26.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.1 t30 -39.2 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.347 -0.845 . . . . 0.0 109.139 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.537 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 2.1 m-20 80.9 80.04 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.8 p -85.28 53.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.791 . . . . 0.0 108.951 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' GLN . 4.6 pt -117.22 173.93 2.83 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.213 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -90.62 20.35 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.97 1.51 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 69.54 70.53 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.38 -31.41 0.23 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.59 -140.18 0.82 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.47 38.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 109.375 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.509 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 29.7 mm-40 -130.55 82.86 63.87 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' O ' HD12 ' A' ' 21' ' ' LEU . 36.8 Cg_endo -108.89 164.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.061 1.559 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -112.33 124.4 52.39 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.189 -0.945 . . . . 0.0 110.321 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 12.9 m -79.13 105.68 10.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 22.7 m -77.26 -167.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.986 -0.446 . . . . 0.0 111.611 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 104.27 108.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 93' ' ' GLU . 9.5 tp -36.64 145.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.523 0.677 . . . . 0.0 110.257 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -77.1 -67.68 0.69 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 0.0 109.402 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.654 ' O ' HD23 ' A' ' 91' ' ' LEU . 43.5 mm-40 -116.8 -170.58 1.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.457 -0.777 . . . . 0.0 109.294 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.4 9.37 29.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 109.9 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 96' ' ' GLY . 18.9 p80 -97.6 -30.52 12.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 95' ' ' HIS . . . 49.08 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.582 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 8.1 tmtm? . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 3' ' ' TYR . 33.3 t -77.87 149.79 34.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.554 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 1.4 m-85 -45.11 -89.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.297 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 3' ' ' TYR . . . 178.78 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.868 . . . . 0.0 109.345 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 1.0 OUTLIER -165.05 80.16 1.26 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.988 . . . . 0.0 110.057 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.953 ' O ' HD22 ' A' ' 91' ' ' LEU . 36.0 Cg_endo -111.01 166.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.752 1.396 . . . . 0.0 110.26 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.58 176.39 21.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 9' ' ' GLU . . . 171.96 172.66 38.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 8' ' ' GLY . 1.3 tp10 81.98 172.34 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.581 -0.952 . . . . 0.0 110.105 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -86.19 151.31 23.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.854 . . . . 0.0 109.857 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.677 HD11 HG12 ' A' ' 41' ' ' VAL . 5.8 tp 38.4 33.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.248 1.023 . . . . 0.0 109.605 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -164.16 26.73 0.07 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' CB ' ' C ' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -79.2 -2.21 39.91 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.984 -1.072 . . . . 0.0 110.538 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.096 HG21 ' HB2' ' A' ' 68' ' ' ALA . 15.7 m -162.52 93.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.891 -1.131 . . . . 0.0 110.405 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.648 ' N ' HD11 ' A' ' 91' ' ' LEU . 13.9 t-20 -84.68 106.02 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.986 -1.071 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -79.13 103.57 9.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.926 -1.109 . . . . 0.0 109.149 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -93.85 86.86 5.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.015 HG23 ' HB3' ' A' ' 58' ' ' ALA . 2.6 m -89.52 97.43 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.306 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 1.007 HG23 HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -92.01 -165.53 1.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.575 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.68 ' H ' HG22 ' A' ' 19' ' ' THR . 1.7 t30 53.39 84.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.107 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -146.51 132.95 9.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.5 Cg_endo -104.0 39.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.891 1.469 . . . . 0.0 109.897 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 15.2 mtt85 36.52 61.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.294 0.568 . . . . 0.0 110.338 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.997 HG23 HG13 ' A' ' 25' ' ' ILE . 7.4 t -97.48 -16.19 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.248 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.997 HG13 HG23 ' A' ' 24' ' ' THR . 0.2 OUTLIER -127.2 179.25 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.3 p -105.63 158.45 16.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.202 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 43' ' ' LYS . 9.7 t0 -55.75 -62.45 1.68 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.643 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.79 -15.59 4.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.757 ' OE1' HG22 ' A' ' 25' ' ' ILE . 1.7 tt0 -75.27 -51.76 12.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.829 -1.17 . . . . 0.0 110.354 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.629 HD11 HD13 ' A' ' 25' ' ' ILE . 4.6 mp -46.56 -32.16 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.82 -1.175 . . . . 0.0 108.476 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 4.2 t70 -48.66 -52.85 21.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 108.652 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 m -63.22 -41.51 99.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.466 -0.771 . . . . 0.0 109.042 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.54 -13.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 108.864 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 1.047 ' CZ ' HD13 ' A' ' 75' ' ' LEU . 7.4 m-30 -83.91 -74.26 0.38 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' LYS . . . 144.3 -90.88 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 162.99 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.711 -0.876 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -79.81 -81.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.96 166.6 14.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 40' ' ' ILE . 15.5 m -78.58 94.47 5.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.834 -1.391 . . . . 0.0 108.293 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.2 mp -34.67 117.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -80.1 18.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 111.009 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.659 ' H ' HG22 ' A' ' 40' ' ' ILE . 1.5 tm0? 163.65 138.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -145.96 76.7 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -94.85 174.1 7.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.0 tt -126.58 104.15 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 110.347 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HA ' ' N ' ' A' ' 57' ' ' VAL . 8.4 mp 52.85 -141.62 0.84 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.516 -0.74 . . . . 0.0 110.011 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' NE ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -163.32 120.74 1.88 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.966 -1.084 . . . . 0.0 109.482 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 61.35 136.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.132 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.58 3.29 24.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.693 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.83 -46.71 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -118.66 146.43 44.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.913 . . . . 0.0 109.795 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' ARG . . . -87.19 51.91 4.29 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.625 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -40.9 -60.52 1.62 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.617 -0.931 . . . . 0.0 109.928 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 53' ' ' ARG . 35.9 Cg_endo -94.38 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 117.171 -1.419 . . . . 0.0 110.831 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -141.58 -37.58 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 47' ' ' ARG . . . 85.68 96.78 0.75 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.007 HG22 HG23 ' A' ' 19' ' ' THR . 44.6 t -159.02 153.16 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.114 -1.227 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.015 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -75.97 127.0 32.06 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.607 ' CE1' ' O ' ' A' ' 57' ' ' VAL . 91.6 m-85 -103.35 83.17 2.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 112.091 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 16' ' ' LEU . 3.3 t -86.53 77.55 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.66 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.7 ttm180 -76.82 113.21 14.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.594 -1.316 . . . . 0.0 110.695 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.731 ' CE1' HG13 ' A' ' 60' ' ' VAL . 3.6 m-85 -114.36 -173.87 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -131.29 -100.78 0.29 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.097 -1.441 . . . . 0.0 110.337 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 63' ' ' ASN . 26.1 tttp -24.4 136.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.618 0.723 . . . . 0.0 111.795 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' NH2' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -55.95 -52.37 64.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -52.4 -39.65 61.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -49.49 -47.0 48.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.096 ' HB2' HG21 ' A' ' 14' ' ' THR . . . -57.72 -39.32 76.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.389 -0.819 . . . . 0.0 108.813 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 1.8 mm-40 -51.1 -37.08 43.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 108.205 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.4 mt-10 -74.8 -62.45 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.852 0.834 . . . . 0.0 109.751 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.706 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -52.76 -16.14 0.91 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.469 0.652 . . . . 0.0 110.931 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 5.0 mt -92.37 -60.33 2.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.418 -1.426 . . . . 0.0 109.465 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -66.69 -5.31 11.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 0.0 109.959 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' C ' HD23 ' A' ' 75' ' ' LEU . . . -112.7 -53.94 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.944 -1.098 . . . . 0.0 109.961 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -81.27 -39.34 25.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.016 -1.053 . . . . 0.0 109.879 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' HG21 ' A' ' 89' ' ' VAL . 61.5 t-20 -43.79 111.68 0.31 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.616 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 74.8 91.03 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.993 0.901 . . . . 0.0 109.207 -178.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.899 HG23 HG12 ' A' ' 33' ' ' ILE . 3.1 p -103.7 38.48 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -148.56 -175.16 0.45 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.926 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -63.58 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 116.966 -1.556 . . . . 0.0 110.239 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 38.7 tt0 179.16 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.062 -1.024 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.16 55.95 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.32 -81.7 0.16 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 1.021 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -79.26 5.14 13.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.162 . . . . 0.0 109.749 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 84' ' ' SER . 36.1 mt-30 70.35 86.36 0.12 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.149 -0.969 . . . . 0.0 109.152 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.679 ' HA ' HD11 ' A' ' 79' ' ' ILE . 35.0 Cg_endo -58.69 -173.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.363 1.717 . . . . 0.0 111.927 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.793 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.99 152.75 18.05 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -99.69 100.45 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 76' ' ' ASN . 2.5 m -78.11 172.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.734 -0.604 . . . . 0.0 110.715 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 10.8 ttt180 127.5 138.63 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -65.09 138.16 58.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -93.71 179.51 5.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.65 176.23 5.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' HIS . 4.0 mt-10 61.16 178.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLU . 96.8 m-70 -44.21 154.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.377 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.33 -40.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' A' ' 61' ' ' ARG . 16.0 pttt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -126.5 43.14 3.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.982 . . . . 0.0 109.542 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.707 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -137.14 -170.68 2.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 3' ' ' TYR . . . 79.39 -73.47 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.907 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -148.02 97.33 3.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.384 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -84.29 120.12 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.895 1.471 . . . . 0.0 110.228 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 170.55 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.42 -148.02 18.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' C ' ' OG ' ' A' ' 10' ' ' SER . 3.4 tt0 -70.87 125.35 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -1.171 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.566 ' CB ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 176.97 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.7 HD13 ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 44.58 50.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.314 -0.866 . . . . 0.0 109.497 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 11' ' ' ILE . 18.6 mmtp 31.39 34.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.966 -0.459 . . . . 0.0 111.396 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.7 ' HB2' HD13 ' A' ' 11' ' ' ILE . 23.5 m-20 -162.61 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.964 -1.085 . . . . 0.0 110.251 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.137 ' CG2' HD11 ' A' ' 91' ' ' LEU . 4.4 m -162.75 94.14 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.964 . . . . 0.0 111.134 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.791 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -102.96 165.47 11.01 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.035 -1.041 . . . . 0.0 108.891 178.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HB ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -132.05 122.07 24.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.311 -1.493 . . . . 0.0 110.356 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -79.47 117.88 20.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 89' ' ' VAL . 15.6 m -97.33 146.08 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.477 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -124.03 167.29 14.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.2 m-20 72.4 18.05 4.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.412 -0.805 . . . . 0.0 109.398 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.9 tm? -53.73 109.61 1.6 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 109.998 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.4 Cg_endo -82.08 147.42 14.76 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.044 1.55 . . . . 0.0 109.794 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 19.63 3.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.958 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 22' ' ' PRO . 11.3 t -89.19 -6.05 57.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.395 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.04 -166.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -57.78 -55.99 27.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 108.981 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' GLN . 3.1 p30 -49.36 -24.2 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.257 -0.902 . . . . 0.0 108.869 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 26' ' ' THR . 59.5 tt0 -71.89 -45.07 62.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 109.125 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 87' ' ' LEU . 6.9 mp -46.8 -35.58 6.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.255 -0.903 . . . . 0.0 108.721 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 5.6 t0 -49.2 -50.68 37.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.977 -1.077 . . . . 0.0 109.263 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 m -80.87 -15.34 56.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.647 HG12 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -67.98 -47.73 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 109.805 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.87 ' CD1' HD11 ' A' ' 75' ' ' LEU . 20.1 p90 -92.74 -41.63 10.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.745 -1.222 . . . . 0.0 109.423 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' LYS . . . 127.51 -78.17 0.39 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 1.6 tptp 174.74 78.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -1.088 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.875 ' HE2' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -79.71 -104.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' N ' ' HB3' ' A' ' 67' ' ' GLU . . . -68.89 176.34 29.62 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' VAL . 14.3 t -78.56 81.82 4.86 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.831 -1.394 . . . . 0.0 107.793 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.82 HD13 ' HZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -35.51 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.14 0.972 . . . . 0.0 108.447 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 61' ' ' ARG . 28.4 m -79.25 47.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.286 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.639 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 5.5 tt0 96.81 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.26 0.553 . . . . 0.0 111.449 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' CD ' ' O ' ' A' ' 27' ' ' ASP . 8.4 ptpp? -92.24 132.17 36.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.525 ' N ' ' OD2' ' A' ' 27' ' ' ASP . 6.3 p30 -129.69 161.62 30.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.59 -1.318 . . . . 0.0 110.789 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.72 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.33 169.0 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.58 117.88 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -96.23 -163.76 1.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.414 -0.804 . . . . 0.0 109.067 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.9 p30 -72.21 164.25 26.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.024 -1.047 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 2.5 tptp 176.83 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.21 -40.02 4.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -161.82 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.601 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' C ' ' CG ' ' A' ' 53' ' ' ARG . . . -67.88 -79.85 0.23 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.57 ' CB ' ' CD ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -167.78 -81.97 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.181 -1.188 . . . . 0.0 109.371 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 53' ' ' ARG . 35.8 Cg_endo -48.29 97.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.861 1.453 . . . . 0.0 110.256 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -142.89 -50.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . 66.77 99.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' CE1' ' A' ' 59' ' ' PHE . 85.1 t -130.39 145.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.117 . . . . 0.0 109.032 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.89 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -149.15 174.83 11.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.055 . . . . 0.0 109.543 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 33.6 m-85 -154.55 107.65 2.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 75' ' ' LEU . 2.2 t -84.81 102.95 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.776 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.8 mtm180 -83.35 128.66 34.69 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.036 -1.04 . . . . 0.0 110.411 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.825 ' CZ ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -162.52 173.56 13.84 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' CB ' ' A' ' 13' ' ' ASP . 7.7 p30 -112.11 -114.84 0.32 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 117.68 -1.608 . . . . 0.0 110.861 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 10.6 mmtt 16.52 108.74 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.282 0.563 . . . . 0.0 112.343 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.691 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -57.47 -40.87 79.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.983 -1.073 . . . . 0.0 109.58 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -38.97 86.39 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' N ' ' A' ' 38' ' ' GLY . 60.8 mm-40 -59.7 -30.91 69.12 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 62' ' ' TYR . . . -67.17 -37.87 84.47 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -53.52 -35.23 60.46 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.7 mp0 -61.4 -52.48 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' CA ' ' HB2' ' A' ' 75' ' ' LEU . . . -67.01 -5.21 11.99 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.594 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.608 HD13 HG23 ' A' ' 89' ' ' VAL . 14.0 mm -84.49 -57.42 4.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -79.67 0.84 28.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.946 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.28 -44.16 1.59 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.026 -1.046 . . . . 0.0 109.906 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -89.34 -28.43 19.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.74 ' HA ' HG22 ' A' ' 89' ' ' VAL . 34.3 t-20 -46.67 -27.5 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.217 -1.552 . . . . 0.0 109.453 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -148.53 78.81 1.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 87' ' ' LEU . 1.5 t -85.4 107.28 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.998 -1.064 . . . . 0.0 108.97 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.53 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 174.19 164.6 0.33 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.6 Cg_endo -86.47 37.41 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.703 1.37 . . . . 0.0 110.477 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' PRO . 4.0 mt-10 40.24 44.45 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.498 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.11 -19.95 17.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 84' ' ' SER . . . -141.65 -108.73 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 41.4 t 175.76 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -1.098 . . . . 0.0 109.456 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.6 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.0 pt20 -143.94 32.95 0.13 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.955 . . . . 0.0 110.632 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 37.8 Cg_endo -68.31 -162.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.424 1.223 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -100.19 114.57 28.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.812 -1.155 . . . . 0.0 109.657 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -79.1 116.04 19.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 177.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 18' ' ' VAL . 17.4 m -94.38 171.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.982 0.896 . . . . 0.0 112.003 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER 166.47 116.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.137 HD11 ' CG2' ' A' ' 14' ' ' THR . 2.3 mt -41.94 109.3 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.197 -0.94 . . . . 0.0 109.477 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 17' ' ' TYR . . . -58.55 -156.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.113 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.4 tp10 -171.7 99.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.994 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 78.69 3.51 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.557 -0.714 . . . . 0.0 110.046 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 174.18 8.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.47 47.8 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' OXT' ' NH1' ' A' ' 61' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.239 -1.153 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmm? . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.6 p -102.33 -149.83 0.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.348 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.81 22.73 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.254 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.97 133.45 41.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -148.75 176.2 2.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 109.228 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' HG2' ' CB ' ' A' ' 91' ' ' LEU . 36.0 Cg_endo -111.16 166.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.739 1.389 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.74 -157.55 7.5 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' OD2' ' A' ' 13' ' ' ASP . . . -177.46 -134.01 1.95 Allowed Glycine 0 N--CA 1.496 2.656 0 O-C-N 121.051 -1.264 . . . . 0.0 110.295 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -152.6 -169.0 3.22 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.107 -1.231 . . . . 0.0 110.289 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 1.4 p 79.6 -172.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.304 -0.872 . . . . 0.0 110.092 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.788 HG23 ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -51.92 90.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 108.928 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 1.8 mttt 61.64 142.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.549 -1.344 . . . . 0.0 108.303 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD2' ' HA3' ' A' ' 8' ' ' GLY . 0.4 OUTLIER -156.35 98.17 1.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.894 -1.754 . . . . 0.0 112.192 -179.03 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.595 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 16.5 m -162.71 49.66 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.76 HD21 HG23 ' A' ' 41' ' ' VAL . 2.0 m120 -76.04 -177.46 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.66 0.743 . . . . 0.0 110.498 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.942 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -142.9 129.06 19.77 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.744 0.783 . . . . 0.0 109.741 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.72 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 1.1 t80 -78.86 95.89 5.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.697 -0.627 . . . . 0.0 109.914 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 1.094 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 16.4 m -80.07 106.54 11.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 16.3 p -99.86 166.73 10.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.135 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.431 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 2.0 m120 62.76 75.29 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.429 -0.795 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.67 158.0 68.94 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 109.347 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' HG2' ' CG2' ' A' ' 24' ' ' THR . 36.5 Cg_endo -94.74 -175.4 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.053 1.554 . . . . 0.0 109.994 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 6.83 47.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 25' ' ' ILE . 1.3 t -80.48 -6.25 57.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.678 HG23 HG23 ' A' ' 24' ' ' THR . 1.7 pp -127.96 127.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.556 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.6 p -99.68 170.98 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.809 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.0 -53.46 38.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.57 -11.71 37.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 30' ' ' LEU . 35.7 tt0 -78.36 -56.29 4.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.987 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 mp -44.64 -39.07 4.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 5.3 t70 -58.97 -48.29 82.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.038 -1.039 . . . . 0.0 109.829 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -23.03 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.49 -0.756 . . . . 0.0 110.065 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.44 -26.44 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.741 -1.224 . . . . 0.0 109.731 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 33' ' ' ILE . 4.3 m-85 -111.53 -73.44 0.68 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.11 -0.994 . . . . 0.0 109.153 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 34.11 78.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -171.92 28.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.952 -1.322 . . . . 0.0 111.028 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CE2' ' CZ ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -133.97 -96.72 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.706 -1.246 . . . . 0.0 109.758 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 -167.74 16.52 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.55 ' O ' ' C ' ' A' ' 40' ' ' ILE . 4.5 t -80.16 78.71 6.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.339 -1.095 . . . . 0.0 108.856 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -24.65 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 HD21 ' A' ' 15' ' ' ASN . 5.5 m -100.14 58.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.674 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 2.5 tt0 92.47 117.96 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.101 0.953 . . . . 0.0 113.267 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.788 ' HE3' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -115.95 138.09 51.51 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -151.53 174.31 13.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.286 -1.509 . . . . 0.0 111.282 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 26' ' ' THR . 37.3 mt -145.64 111.08 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 18.3 mt -100.65 143.98 30.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.616 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.41 -90.34 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 1.0 OUTLIER -97.44 132.58 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.724 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -144.76 32.06 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.734 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.42 -65.6 0.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.453 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 51' ' ' THR . 29.2 m -150.75 30.19 0.66 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.492 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 48' ' ' ASP . . . 74.43 57.09 4.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -100.98 179.32 1.03 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.336 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -108.1 117.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.934 1.492 . . . . 0.0 110.471 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -64.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.76 103.5 0.18 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 17' ' ' TYR . 19.8 m -144.98 165.38 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -1.127 . . . . 0.0 109.655 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.094 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -157.09 175.35 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.838 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -141.27 104.91 4.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 0.0 108.991 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.3 t -78.21 148.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.81 -1.181 . . . . 0.0 108.132 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.874 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -85.37 125.86 33.3 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.447 0.641 . . . . 0.0 110.136 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.857 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -163.63 147.21 10.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.934 -1.104 . . . . 0.0 108.472 179.149 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.668 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.2 t-20 -135.02 -91.28 0.32 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.472 -1.392 . . . . 0.0 109.449 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.668 ' C ' ' O ' ' A' ' 63' ' ' ASN . 11.5 mptt -14.72 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.538 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.99 -47.85 0.08 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.83 -0.544 . . . . 0.0 110.238 -177.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.89 -50.88 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 42.5 mm-40 -46.86 -43.99 19.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . . . -60.14 -41.86 93.59 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.088 -1.632 . . . . 0.0 107.183 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.1 -37.47 6.88 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.776 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -62.83 -49.31 75.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.016 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -62.83 -11.92 21.23 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.142 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 68' ' ' ALA . 49.7 mm -84.44 -69.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.865 -1.147 . . . . 0.0 108.35 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.95 3.71 7.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -124.65 -51.87 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.051 . . . . 0.0 109.723 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.017 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -81.21 -35.35 31.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 0.0 110.225 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 1.7 p-10 -53.93 139.09 35.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.68 -1.263 . . . . 0.0 109.262 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER 52.9 50.55 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.23 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 ' CE1' ' A' ' 34' ' ' PHE . 2.5 t -88.56 82.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -141.94 -164.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -92.45 26.73 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.559 1.294 . . . . 0.0 110.448 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.492 ' CG ' ' C ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER 41.54 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 0.0 109.549 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.06 44.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 106.41 -168.86 14.97 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 77.27 -4.0 2.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -1.186 . . . . 0.0 109.864 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' SER . 14.3 mt-30 60.85 145.76 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.66 147.55 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.065 1.561 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.946 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.76 121.53 18.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 17' ' ' TYR . 1.5 t -79.52 104.17 9.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.907 ' HB ' HD12 ' A' ' 16' ' ' LEU . 35.5 m -78.51 -144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 111.458 -177.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 84.79 106.52 0.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 -178.052 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.59 ' CB ' ' HG2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -41.26 141.46 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.291 -0.88 . . . . 0.0 110.089 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -100.89 -165.85 1.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -95.55 119.31 33.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.993 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 164.85 -88.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.472 ' NE2' ' HB3' ' A' ' 10' ' ' SER . 24.1 t-80 175.67 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 138.81 -119.45 1.75 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.072 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 162.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.524 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -170.08 116.18 0.53 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' TYR . . . 177.93 121.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.1 ttm180 -139.5 41.2 0.45 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.793 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.579 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 32.2 Cg_endo -45.53 149.83 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.976 1.514 . . . . 0.0 111.039 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 65' ' ' ARG . . . -161.57 142.02 7.72 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 65' ' ' ARG . . . 142.9 141.69 3.89 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.063 -1.257 . . . . 0.0 110.131 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 10' ' ' SER . 3.5 pm0 -120.2 98.43 6.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.898 -1.354 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 0.4 OUTLIER 161.37 178.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.868 HG23 ' HB ' ' A' ' 41' ' ' VAL . 23.6 mm -90.56 55.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.853 -1.154 . . . . 0.0 109.77 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 169.9 38.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.926 -1.109 . . . . 0.0 110.864 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 10' ' ' SER . 9.9 m-20 -137.43 12.59 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.801 -1.187 . . . . 0.0 110.603 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.589 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -160.29 70.56 0.43 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -77.0 152.71 35.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.771 -1.206 . . . . 0.0 108.869 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.586 HD23 HG11 ' A' ' 60' ' ' VAL . 1.5 tp -97.49 108.8 21.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.336 -0.853 . . . . 0.0 109.957 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 33.3 t80 -79.55 87.07 5.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.525 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 58' ' ' ALA . 16.3 m -79.76 112.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.858 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 4.5 m -117.1 161.33 19.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' THR . 6.0 t-20 78.66 52.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.882 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -160.22 136.75 6.46 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -86.74 -177.48 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.897 1.472 . . . . 0.0 110.108 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 34.65 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.471 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -79.64 -54.98 5.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.915 . . . . 0.0 109.014 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.31 165.82 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.224 -0.922 . . . . 0.0 108.752 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -109.43 136.54 48.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 9.4 t0 -56.15 -60.59 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.037 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 10.0 p-10 -48.61 -21.55 0.61 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' THR . 38.7 tt0 -74.65 -45.91 41.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.979 -1.076 . . . . 0.0 110.2 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.798 HD23 ' CG2' ' A' ' 60' ' ' VAL . 4.4 mp -45.59 -25.3 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.849 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 3.0 t0 -65.97 -51.46 58.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 108.764 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 m -53.49 -52.61 58.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.757 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -63.29 -25.77 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 108.574 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -66.14 -89.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 108.869 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 9.92 58.56 0.01 OUTLIER Glycine 0 N--CA 1.503 3.12 0 C-N-CA 122.941 0.305 . . . . 0.0 112.807 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' PHE . 2.3 tttt -161.68 4.97 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.662 -1.493 . . . . 0.0 112.247 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.746 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.92 -83.81 0.09 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.381 -1.45 . . . . 0.0 110.18 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.04 -177.27 24.48 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' ILE . 56.5 m -92.93 19.6 7.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -1.21 . . . . 0.0 109.647 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.798 HD12 ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 51.33 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.369 0.604 . . . . 0.0 109.738 178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.868 ' HB ' HG23 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -133.16 49.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 O-C-N 120.647 -1.283 . . . . 0.0 114.253 -177.131 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.664 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.4 tm0? 85.23 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.582 -1.324 . . . . 0.0 112.207 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.568 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 pttp -78.5 144.58 35.58 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.128 -0.982 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.74 120.61 3.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 109.813 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.66 ' O ' HD22 ' A' ' 46' ' ' LEU . 22.8 pt -84.51 162.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.062 -1.024 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.6 110.5 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 110.496 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 9.2 tpm_? -160.84 -95.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.495 -1.378 . . . . 0.0 110.41 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.93 -170.6 1.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.878 -1.139 . . . . 0.0 109.906 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -132.98 -60.73 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 109.501 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -64.18 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -152.03 178.68 9.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.955 . . . . 0.0 109.599 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 28.24 29.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -58.5 135.95 85.77 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -105.83 -50.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.454 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -140.97 -93.37 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.855 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 47' ' ' ARG . . . 148.64 103.65 0.31 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 46' ' ' LEU . 1.9 p -129.04 109.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 108.921 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.579 ' HB1' ' HA ' ' A' ' 45' ' ' ILE . . . -109.34 178.28 4.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.751 -1.218 . . . . 0.0 110.241 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 3.6 m-85 -135.59 110.38 8.71 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.798 ' CG2' HD23 ' A' ' 30' ' ' LEU . 1.1 t -77.95 157.38 5.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.798 ' NH2' HD12 ' A' ' 40' ' ' ILE . 9.2 ptt180 -95.76 108.88 21.24 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.362 0.601 . . . . 0.0 110.302 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.726 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -162.23 71.01 0.32 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.237 -0.915 . . . . 0.0 108.641 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.741 ' ND2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -68.87 -104.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 109.343 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.634 ' C ' ' O ' ' A' ' 63' ' ' ASN . 3.0 mttp 9.05 90.07 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-N 118.18 0.445 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.39 -37.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.947 -0.471 . . . . 0.0 111.102 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 65' ' ' ARG . 43.4 tt0 -64.06 -58.24 7.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 108.235 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 60.1 mt-10 -53.6 -47.61 70.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.843 . . . . 0.0 109.406 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.3 -39.16 29.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 108.725 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 2.9 tt0 -60.94 -41.51 96.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.719 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 mp0 -55.67 -49.21 73.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.47 -0.769 . . . . 0.0 109.956 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -71.21 -13.69 62.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.183 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 89' ' ' VAL . 2.1 mm -74.89 -64.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 108.406 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -3.14 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.578 -0.701 . . . . 0.0 110.438 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -117.36 -50.76 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.828 -1.17 . . . . 0.0 110.249 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.726 HD11 ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -79.4 -26.22 41.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 0.0 109.719 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.3 t-20 -47.37 102.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.653 -1.279 . . . . 0.0 107.978 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 7.2 m-20 72.82 92.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.7 p -85.94 53.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.008 ' O ' HD12 ' A' ' 79' ' ' ILE . 2.1 pp -133.33 140.1 36.12 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 35.9 Cg_endo -40.87 -76.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.936 1.493 . . . . 0.0 110.527 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 11.4 tp10 176.53 152.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.203 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . 115.54 3.27 20.72 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 131.72 -161.96 23.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.663 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.4 m 84.16 -62.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.784 -0.833 . . . . 0.0 109.429 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.534 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.3 pt20 27.05 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 122.12 -0.362 . . . . 0.0 110.732 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.922 ' O ' HD12 ' A' ' 87' ' ' LEU . 37.3 Cg_endo -127.19 65.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.54 1.284 . . . . 0.0 111.428 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 174.5 87.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.5 t -81.17 107.41 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 72' ' ' ILE . 24.7 m -83.77 147.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.528 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 28.4 ptt180 152.96 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 92' ' ' ALA . 8.9 tt -58.63 149.45 25.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.788 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.795 ' N ' HD23 ' A' ' 91' ' ' LEU . . . -123.34 -58.78 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 109.958 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.99 178.13 7.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.782 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -118.22 80.35 1.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 132.28 3.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.5 -175.43 52.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.222 0.534 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 38.1 m -46.85 -67.15 0.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.982 . . . . 0.0 109.149 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 2' ' ' SER . 3.0 m-85 -158.67 -57.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.96 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -48.43 137.68 11.81 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 109.2 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -123.86 164.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.707 1.372 . . . . 0.0 110.397 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 13' ' ' ASP . . . 141.06 150.2 5.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' O ' ' HD2' ' A' ' 65' ' ' ARG . . . -96.53 -169.24 34.21 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 10' ' ' SER . 13.0 mt-10 -101.05 165.25 11.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -1.228 . . . . 0.0 109.957 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' LYS . 0.9 OUTLIER 52.05 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 41' ' ' VAL . 12.2 mm -58.51 88.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.93 -1.106 . . . . 0.0 108.13 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -128.02 -79.63 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.059 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 16.5 p-10 -160.69 92.96 0.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.765 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.697 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 p -144.24 43.38 1.42 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 4.6 p30 -75.36 155.38 36.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.62 142.83 29.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.477 -1.689 . . . . 0.0 110.223 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 88' ' ' SER . 1.8 t80 -78.52 78.84 4.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.957 HG23 ' HB3' ' A' ' 58' ' ' ALA . 24.6 m -77.89 105.46 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.003 0.906 . . . . 0.0 109.699 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.851 HG22 HG12 ' A' ' 57' ' ' VAL . 53.1 p -116.85 126.1 52.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' THR . 10.0 t-20 159.01 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.632 . . . . 0.0 109.667 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.849 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -39.89 161.56 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.436 -179.309 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -117.95 50.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.903 1.475 . . . . 0.0 110.131 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.06 21.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.554 -0.717 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.602 HG23 HG23 ' A' ' 25' ' ' ILE . 12.5 t -87.53 -24.34 24.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.29 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.602 HG23 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -107.54 -164.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 108.955 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.688 HG23 ' CB ' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -132.48 130.3 40.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.021 -1.049 . . . . 0.0 109.989 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.504 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -59.58 -50.0 75.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.951 -1.093 . . . . 0.0 108.627 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -49.28 -26.62 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.323 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.688 ' CB ' HG23 ' A' ' 26' ' ' THR . 8.2 tt0 -74.84 -42.4 58.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.7 mp -46.67 -32.98 3.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 109.896 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.605 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -60.34 -62.59 1.75 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.866 -1.146 . . . . 0.0 109.511 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 32' ' ' THR . 12.1 m -62.42 -9.62 8.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.503 -0.748 . . . . 0.0 110.121 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 30' ' ' LEU . 2.6 tt -83.96 -40.24 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.945 -1.097 . . . . 0.0 110.029 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.822 ' CE2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.4 -54.24 2.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.512 -1.368 . . . . 0.0 110.456 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 16.55 67.32 0.01 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -141.49 -25.8 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.278 . . . . 0.0 111.601 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -96.2 -37.58 10.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.606 -1.309 . . . . 0.0 109.242 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.4 -163.96 10.91 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.668 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -109.96 35.94 3.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -1.172 . . . . 0.0 109.217 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.782 HG22 ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 43.27 147.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 CA-C-O 122.125 0.964 . . . . 0.0 111.418 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 63' ' ' ASN . 96.8 t -109.44 -38.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 119.975 -1.703 . . . . 0.0 113.901 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.901 ' C ' ' HG2' ' A' ' 61' ' ' ARG . 1.1 tm0? 177.96 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 O-C-N 120.464 -1.397 . . . . 0.0 110.962 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.798 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -112.57 150.66 31.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.404 -0.81 . . . . 0.0 109.923 -177.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -159.47 172.95 16.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 109.156 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 tt -155.19 146.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.734 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.513 HD21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -152.56 144.66 23.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 109.694 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -141.06 -83.32 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER 158.3 -176.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.351 -0.843 . . . . 0.0 109.214 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HB3' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -174.42 -62.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -97.54 48.3 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.638 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.456 ' HB ' ' OD1' ' A' ' 48' ' ' ASP . 29.0 m -160.74 -59.25 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 166.08 106.78 0.2 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.08 96.29 33.72 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -1.137 . . . . 0.0 109.68 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -101.73 -16.79 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.025 1.54 . . . . 0.0 109.472 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 5.3 mtm-85 160.04 107.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.845 ' O ' HG13 ' A' ' 57' ' ' VAL . . . -92.45 -131.78 5.68 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 19' ' ' THR . 1.2 m -165.38 176.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 121.863 -0.786 . . . . 0.0 110.048 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.957 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -147.86 159.73 43.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -131.97 116.73 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.851 HG21 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.52 162.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.357 -1.464 . . . . 0.0 109.864 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.901 ' HG2' ' C ' ' A' ' 42' ' ' GLN . 3.6 mtm180 -79.73 107.49 12.54 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.982 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 44.2 m-85 -163.95 143.99 8.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.695 -1.253 . . . . 0.0 110.089 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.756 ' HB3' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -125.41 -132.69 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' C ' ' O ' ' A' ' 63' ' ' ASN . 1.8 mtpt 17.59 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.912 0.778 . . . . 0.0 110.386 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.575 ' HD3' ' H ' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -28.87 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.922 -0.486 . . . . 0.0 110.599 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 64' ' ' LYS . 2.3 tt0 -64.0 -56.0 18.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 108.313 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -44.99 -44.68 10.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.005 ' CB ' HD21 ' A' ' 91' ' ' LEU . . . -56.12 -45.96 79.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.6 -1.313 . . . . 0.0 107.715 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 tt0 -45.35 -39.04 6.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 78.5 mm-40 -57.62 -54.93 41.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -61.2 -13.26 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.729 0.776 . . . . 0.0 110.025 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 6.7 mm -82.98 -62.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 O-C-N 120.621 -1.299 . . . . 0.0 108.679 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.58 6.69 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.965 . . . . 0.0 109.797 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -128.9 -52.53 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.851 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.31 -26.23 42.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.171 -0.955 . . . . 0.0 109.97 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 13.4 p-10 -48.91 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.354 -1.467 . . . . 0.0 107.664 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' LEU . 3.8 m-20 74.21 58.67 0.08 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 108.684 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.973 HG23 HD21 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -79.45 78.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.184 -0.947 . . . . 0.0 108.773 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -133.0 -163.51 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.4 Cg_endo -102.52 38.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.021 1.537 . . . . 0.0 109.984 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 47.68 60.14 3.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.35 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 163.2 -46.28 0.32 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -53.52 -175.61 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -128.75 75.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.262 . . . . 0.0 109.716 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -165.83 64.41 0.93 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -92.48 -170.65 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.969 1.51 . . . . 0.0 110.581 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.973 HD21 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -149.61 124.69 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 13.9 t -78.03 100.14 6.38 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 16' ' ' LEU . 34.6 m -78.55 146.4 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.928 0.87 . . . . 0.0 111.948 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.9 tmm_? 168.41 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.005 HD21 ' CB ' ' A' ' 68' ' ' ALA . 1.1 mp -36.89 145.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.412 0.625 . . . . 0.0 110.417 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.69 -166.83 1.43 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 109.261 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 71.9 1.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.106 -0.996 . . . . 0.0 109.34 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.59 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -58.08 152.71 16.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.219 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 13' ' ' ASP . . . -130.91 -116.62 1.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 0.0 109.725 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -116.7 130.63 56.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 109.32 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 7.8 p90 -151.8 174.58 13.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.52 152.99 18.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 109.217 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.592 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -85.95 -28.18 0.39 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.204 -0.935 . . . . 0.0 110.052 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.64 ' CB ' HD22 ' A' ' 91' ' ' LEU . 37.1 Cg_endo -102.94 172.56 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.567 1.298 . . . . 0.0 111.48 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.8 -165.22 25.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . . . 160.45 -151.98 22.63 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -168.04 138.5 2.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.358 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER 45.64 -172.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.673 ' HA ' ' CG ' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -76.71 82.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.114 -0.991 . . . . 0.0 108.739 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' CD ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -140.02 -74.18 0.36 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.737 . . . . 0.0 110.853 -179.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 13' ' ' ASP . 25.3 t0 -145.46 84.59 1.69 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.664 -1.273 . . . . 0.0 111.948 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.051 HG23 ' CB ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER -162.04 38.07 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.311 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -174.01 2.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.863 ' CG ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -108.26 123.47 48.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.483 0.659 . . . . 0.0 110.712 -178.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 11.1 t80 -90.59 94.71 9.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.964 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 19.5 m -91.77 130.42 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 110.463 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.75 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.6 p -126.98 -175.67 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 4.6 t-20 55.04 70.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.624 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 21' ' ' LEU . 3.9 pp 178.8 151.41 0.47 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 36.8 Cg_endo -110.15 -169.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.008 1.53 . . . . 0.0 110.037 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.51 41.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.662 HG23 HG23 ' A' ' 25' ' ' ILE . 2.1 t -80.58 -29.43 37.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 24' ' ' THR . 37.2 pt -108.32 162.46 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.44 136.7 39.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 4.3 p-10 -61.94 -47.49 84.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 25.9 t0 -54.42 -19.8 6.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.182 -0.949 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 26' ' ' THR . 13.8 mt-30 -77.13 -53.14 8.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.67 ' O ' HG22 ' A' ' 33' ' ' ILE . 4.6 mp -44.72 -34.04 2.09 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.634 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.578 ' N ' ' HE3' ' A' ' 43' ' ' LYS . 4.8 t70 -50.52 -63.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.2 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -64.23 -14.75 57.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.909 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -79.66 -23.22 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.973 ' CE2' HD11 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -150.22 35.36 0.65 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.8 -1.188 . . . . 0.0 110.853 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.981 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -88.34 57.54 4.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -131.94 -8.92 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 110.575 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -115.19 47.3 1.31 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.823 -1.173 . . . . 0.0 109.568 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . 122.77 171.9 13.85 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 40' ' ' ILE . 3.3 m -91.47 93.83 9.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.376 -1.073 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.981 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -29.38 143.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-O 121.259 0.552 . . . . 0.0 110.259 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -105.57 50.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -175.338 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.676 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 85.88 95.58 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 120.553 -1.342 . . . . 0.0 112.839 177.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 1.072 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 3.0 mttm -81.31 117.46 21.82 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.083 -1.011 . . . . 0.0 109.65 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -122.03 153.51 38.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 108.944 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' A' ' 27' ' ' ASP . 11.1 pt -130.5 159.1 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -157.49 130.92 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.05 -23.47 15.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -153.28 168.54 25.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 109.068 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -175.45 34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.0 109.861 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 50' ' ' LEU . 18.0 tp -160.02 -72.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -60.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.364 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 86.5 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -113.0 177.05 1.27 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.301 -1.117 . . . . 0.0 109.456 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -107.94 25.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.094 1.576 . . . . 0.0 109.967 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -54.63 11.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.489 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.13 93.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 19' ' ' THR . 2.3 m -128.53 154.43 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.147 -1.208 . . . . 0.0 110.069 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.84 176.69 4.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.683 ' CD1' HD21 ' A' ' 46' ' ' LEU . 6.8 m-85 -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.072 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -79.18 157.51 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.729 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -103.87 104.75 14.78 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.654 0.74 . . . . 0.0 109.895 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -161.01 80.78 0.63 Allowed 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 1.051 ' CB ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -77.13 -115.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.814 -1.154 . . . . 0.0 108.748 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 27.53 89.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.683 0.674 . . . . 0.0 109.555 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -27.91 -41.95 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.777 -0.577 . . . . 0.0 110.544 -177.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' LYS . 3.8 mm-40 -67.1 -56.3 10.61 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.882 -1.136 . . . . 0.0 108.109 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -46.86 -49.15 20.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -52.91 -45.52 67.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.599 -1.313 . . . . 0.0 107.944 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HA ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.64 -42.82 35.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 1.0 OUTLIER -60.25 -68.81 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.678 . . . . 0.0 109.872 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 75' ' ' LEU . . . -45.91 -20.05 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 110.104 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.81 ' HA ' HG21 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -71.41 -66.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.58 -1.325 . . . . 0.0 108.219 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -78.53 10.47 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.095 -1.003 . . . . 0.0 110.382 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.73 -56.79 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 109.921 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.973 HD11 ' CE2' ' A' ' 34' ' ' PHE . 51.3 mt -77.38 -33.22 55.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 11.2 p-10 -51.14 133.29 28.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.709 -1.244 . . . . 0.0 108.259 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.642 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 68.54 55.69 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 109.682 -179.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 87' ' ' LEU . 14.9 p -85.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 108.677 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -132.21 176.25 3.05 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -87.61 44.57 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.842 1.443 . . . . 0.0 109.128 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 80' ' ' PRO . 10.8 pt-20 40.9 45.67 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.5 77.51 0.3 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.08 -36.89 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.488 ' H ' HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER 67.51 45.41 1.55 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.153 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.661 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 5.6 mm-40 -128.2 49.74 4.79 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 109.091 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 37.9 Cg_endo -88.52 -162.4 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.759 1.4 . . . . 0.0 111.389 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.666 HD23 HG11 ' A' ' 18' ' ' VAL . 4.8 mp -85.94 124.96 32.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.807 -0.558 . . . . 0.0 110.013 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.4 m -79.26 96.67 6.0 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.863 HG23 ' CG ' ' A' ' 16' ' ' LEU . 8.8 p -75.66 143.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.4 1.095 . . . . 0.0 112.012 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER 175.37 -130.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.64 HD22 ' CB ' ' A' ' 6' ' ' PRO . 12.3 tp -149.06 152.02 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.395 -1.441 . . . . 0.0 110.113 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.759 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -126.46 -171.05 2.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 109.559 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.86 -174.08 3.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.19 150.08 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -74.7 -172.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.52 -61.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.268 -1.137 . . . . 0.0 109.444 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -115.61 17.02 16.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 0.0 109.523 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -74.66 -174.1 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ARG . . . -135.61 155.63 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 2.8 mtt180 61.05 80.84 0.25 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.744 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 91' ' ' LEU . 36.3 Cg_endo -72.01 -172.65 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.834 1.439 . . . . 0.0 110.048 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.935 ' HA2' HD22 ' A' ' 91' ' ' LEU . . . -160.72 168.55 36.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.47 1.03 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -166.93 43.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 12' ' ' LYS . 1.4 m -117.67 145.44 44.39 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 1.157 ' CG2' HG11 ' A' ' 41' ' ' VAL . 0.3 OUTLIER 32.63 37.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 CA-C-O 122.375 1.083 . . . . 0.0 108.465 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.575 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER 21.48 58.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 70.4 m-20 -149.11 -87.4 0.08 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.57 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.033 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -163.26 105.13 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.906 -1.121 . . . . 0.0 109.73 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.843 ' H ' HD21 ' A' ' 91' ' ' LEU . 0.3 OUTLIER -77.85 -178.95 5.71 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.436 -1.415 . . . . 0.0 108.192 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.117 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -137.02 112.24 9.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.842 -1.161 . . . . 0.0 110.119 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 8.8 t80 -93.92 101.62 13.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.922 . . . . 0.0 108.841 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.825 HG11 HD23 ' A' ' 87' ' ' LEU . 2.8 m -100.79 113.88 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 0.0 109.929 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -83.18 166.42 18.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.985 . . . . 0.0 109.613 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 76.91 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.206 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.972 HD22 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER 49.53 101.24 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 110.103 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 84' ' ' SER . 36.8 Cg_endo -76.5 140.6 21.64 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.061 1.559 . . . . 0.0 109.631 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.8 41.91 1.05 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -0.967 . . . . 0.0 109.401 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -3.19 30.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.78 179.63 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 p -106.64 155.87 19.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 2.9 p30 -62.05 -42.82 99.59 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 2.6 m-20 -53.84 -27.11 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 108.974 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -33.58 31.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -52.44 -33.56 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -60.12 -46.01 91.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.035 . . . . 0.0 108.418 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 5.9 m -61.1 -43.18 99.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 78' ' ' VAL . 3.0 mm -52.71 -30.64 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 1.158 ' CE1' HD13 ' A' ' 75' ' ' LEU . 4.0 m-30 -79.15 -77.57 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.591 -0.693 . . . . 0.0 109.887 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 36' ' ' LYS . . . 141.12 -82.31 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 166.08 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -1.196 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 3.8 m-85 -78.77 -70.13 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.348 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.05 -169.4 15.5 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 40' ' ' ILE . 48.6 p -78.99 77.18 5.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 108.338 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.934 HD12 HH21 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -40.46 146.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.157 HG11 ' CG2' ' A' ' 11' ' ' ILE . 28.8 m -111.2 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.857 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 50.2 tt0 62.53 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.13 -0.981 . . . . 0.0 112.803 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 3.2 mtmm -75.56 163.27 27.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.369 -0.832 . . . . 0.0 109.506 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 1.1 m-80 -149.3 106.22 3.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.925 . . . . 0.0 109.592 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.497 HD13 ' HD3' ' A' ' 47' ' ' ARG . 12.3 tt -87.53 141.14 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -120.06 110.39 16.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.564 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 23' ' ' ARG . 2.1 ptm180 -157.03 24.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 109.47 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 57.86 164.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' N ' ' HD3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -110.61 -88.08 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.516 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -120.31 45.08 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 m -109.73 -21.06 12.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.99 55.01 4.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -114.24 172.43 3.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.156 -1.202 . . . . 0.0 109.446 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 53' ' ' ARG . 36.7 Cg_endo -110.46 109.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.015 1.534 . . . . 0.0 110.431 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -84.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.15 45.78 47.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 10.1 p -148.42 159.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.134 . . . . 0.0 109.04 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -160.17 -175.11 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -155.18 104.66 2.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 16' ' ' LEU . 2.7 p -79.33 157.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.271 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.934 HH21 HD12 ' A' ' 40' ' ' ILE . 3.8 ptt180 -84.1 142.35 30.45 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.934 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.808 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -161.42 164.94 29.54 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -145.04 -101.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.366 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 5.1 mmtp -22.15 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.647 -0.658 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.54 ' NH2' ' HA ' ' A' ' 13' ' ' ASP . 32.2 mmt-85 -43.39 -50.59 6.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.187 -0.945 . . . . 0.0 108.558 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 67.6 mt-10 -55.06 -44.8 75.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -47.95 -60.78 2.35 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.666 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.033 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -46.31 -37.01 6.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.757 -1.215 . . . . 0.0 108.19 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -51.66 -53.7 36.02 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' ILE . 4.4 mm-40 -51.28 -67.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.117 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -34.12 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.826 ' HA ' HG11 ' A' ' 89' ' ' VAL . 1.5 mm -70.4 -67.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.927 -1.108 . . . . 0.0 108.29 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -85.68 27.98 0.81 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.465 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.71 -53.41 0.49 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.966 . . . . 0.0 108.486 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.158 HD13 ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -78.78 -29.15 44.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 14.5 t-20 -58.3 139.84 54.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 108.86 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' OD1' ' CB ' ' A' ' 86' ' ' PRO . 3.0 m120 58.88 63.5 1.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.053 -1.03 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.068 ' CG1' HD13 ' A' ' 87' ' ' LEU . 1.5 p -85.7 65.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.769 HG21 ' HB3' ' A' ' 84' ' ' SER . 1.0 OUTLIER -165.4 153.24 9.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 33.7 Cg_endo -43.96 -74.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.547 1.288 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 1.1 pt-20 162.38 144.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.6 -63.16 0.29 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . -132.18 -164.65 11.08 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.769 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 79.86 -9.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -1.003 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 2.8 mm-40 62.25 154.08 0.11 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.073 -1.017 . . . . 0.0 109.462 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' CB ' ' OD1' ' A' ' 77' ' ' ASN . 36.4 Cg_endo -107.68 157.34 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.011 1.532 . . . . 0.0 110.839 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 1.068 HD13 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mp -78.79 123.94 27.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -79.15 97.24 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 1.106 HG13 HD11 ' A' ' 16' ' ' LEU . 22.3 t -75.95 137.74 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.396 1.093 . . . . 0.0 111.442 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' H ' ' CD1' ' A' ' 16' ' ' LEU . 1.3 tpt180 -175.49 -135.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.935 HD22 ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -159.15 135.92 9.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.67 -1.269 . . . . 0.0 109.184 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -107.34 -162.68 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -171.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.96 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 176.8 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.98 138.2 0.25 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.32 -0.862 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.77 123.66 29.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.206 -1.173 . . . . 0.0 109.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.28 0.562 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 171.61 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.667 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 15.1 p90 -107.24 77.46 1.15 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 109.358 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 3' ' ' TYR . . . 73.25 149.78 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.367 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -126.54 45.42 1.52 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 4' ' ' ALA . 36.2 Cg_endo -58.39 112.84 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.856 1.451 . . . . 0.0 110.233 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 93' ' ' GLU . . . 177.12 59.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 92' ' ' ALA . . . -127.66 -146.7 6.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 9' ' ' GLU . 5.4 pm0 -170.88 113.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 109.334 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -166.02 -167.32 1.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.817 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.684 ' CG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 41.24 32.95 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.512 0.672 . . . . 0.0 110.121 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER 76.69 -28.23 0.18 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 110.987 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -130.8 -74.66 0.53 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.651 -1.281 . . . . 0.0 110.707 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.132 HG22 ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -160.31 91.59 0.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.01 -1.056 . . . . 0.0 110.245 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 4.4 t30 -79.25 169.24 18.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -0.877 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.906 HD12 HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -143.92 136.02 26.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.67 -1.269 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' ' CZ ' ' A' ' 59' ' ' PHE . 5.1 t80 -85.28 142.73 29.17 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.422 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.893 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 30.2 m -132.94 157.08 42.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -144.12 159.24 42.98 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.714 -179.589 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.6 t-20 79.51 88.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 110.299 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.741 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -159.99 150.87 15.73 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.543 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.7 Cg_endo -82.5 -176.8 3.1 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.819 1.431 . . . . 0.0 111.013 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -77.0 3.35 12.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.135 -0.978 . . . . 0.0 109.97 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.849 HG22 ' OE1' ' A' ' 29' ' ' GLN . 33.9 m -84.14 -112.94 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.802 ' CG2' HD22 ' A' ' 30' ' ' LEU . 8.8 mm 42.23 23.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.898 -1.126 . . . . 0.0 110.311 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' THR . 49.0 p -35.94 158.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.692 0.758 . . . . 0.0 110.616 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 16.7 m-20 -60.27 -27.38 67.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.88 -13.03 34.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.849 ' OE1' HG22 ' A' ' 24' ' ' THR . 2.4 mt-30 -79.88 -66.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 25' ' ' ILE . 2.1 mp -57.03 -28.77 62.8 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.248 -1.381 . . . . 0.0 107.98 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -62.44 -43.33 99.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 108.672 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 m -55.75 -56.53 19.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 30' ' ' LEU . 8.4 tp -62.13 -18.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.701 ' HZ ' HD21 ' A' ' 75' ' ' LEU . 6.9 m-85 -86.9 -98.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 18.22 62.53 0.01 OUTLIER Glycine 0 N--CA 1.498 2.832 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER 178.15 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 111.074 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -128.19 50.39 2.07 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.416 -1.427 . . . . 0.0 111.179 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' ' CD1' ' A' ' 62' ' ' TYR . . . 26.21 43.47 0.02 OUTLIER Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -88.84 34.61 0.77 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.46 -1.024 . . . . 0.0 109.997 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.008 HG23 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 165.34 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 61' ' ' ARG . 15.3 m -89.97 13.47 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER 165.93 53.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -42.65 144.54 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.123 -0.986 . . . . 0.0 109.98 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.86 150.91 29.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.03 . . . . 0.0 109.825 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 46' ' ' LEU . 1.5 mt -101.9 -178.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -148.78 105.13 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.378 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -111.59 -172.69 2.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -72.63 175.2 6.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -106.09 -65.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -129.11 -41.36 1.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 50' ' ' LEU . 34.0 p -158.15 175.74 13.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.419 ' C ' ' HG3' ' A' ' 53' ' ' ARG . . . 94.4 -57.59 1.99 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 52' ' ' GLY . 0.9 OUTLIER 54.88 87.49 0.14 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.201 -1.176 . . . . 0.0 109.518 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 36.6 Cg_endo -61.16 -54.34 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.042 1.548 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 175.39 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.166 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' C ' HD11 ' A' ' 21' ' ' LEU . . . 108.28 111.56 3.5 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 46' ' ' LEU . 2.7 m -127.12 178.43 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -1.139 . . . . 0.0 109.394 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.893 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -139.7 177.11 8.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.639 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -146.48 111.27 5.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.008 HG13 HG23 ' A' ' 40' ' ' ILE . 16.9 t -95.87 148.14 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 41' ' ' VAL . 68.3 mtt180 -118.18 65.24 0.75 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.287 -1.508 . . . . 0.0 110.187 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -78.64 91.66 4.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.617 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -47.68 -84.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.891 -1.13 . . . . 0.0 110.993 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -24.03 144.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.534 0.683 . . . . 0.0 112.103 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -78.11 -51.66 9.93 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.625 -0.672 . . . . 0.0 110.364 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -67.19 -39.49 86.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.848 -1.157 . . . . 0.0 108.24 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 18.1 mt-10 -69.3 -29.13 66.93 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.979 ' HB1' HD11 ' A' ' 91' ' ' LEU . . . -63.21 -39.8 95.67 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.8 -28.24 69.32 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.647 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -57.68 -67.99 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.458 -0.776 . . . . 0.0 108.978 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -55.51 -17.63 5.68 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.315 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.538 HD13 ' CG1' ' A' ' 89' ' ' VAL . 3.0 mm -69.39 -61.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.545 -1.347 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.91 4.34 41.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.604 -0.685 . . . . 0.0 111.11 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . -131.56 -1.28 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.745 -1.222 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.701 HD21 ' HZ ' ' A' ' 34' ' ' PHE . 2.0 tp -127.87 -23.63 3.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.742 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.816 ' CA ' HG23 ' A' ' 89' ' ' VAL . 9.9 t-20 -41.1 -27.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.206 -0.933 . . . . 0.0 108.888 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 75' ' ' LEU . 91.2 m-20 -122.99 76.02 1.33 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.755 -0.59 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.3 p -84.44 48.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.178 -0.951 . . . . 0.0 108.805 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 83' ' ' GLY . 2.0 pt -124.05 -169.58 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.2 Cg_endo -110.92 40.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.983 1.517 . . . . 0.0 110.299 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER 76.97 160.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.48 -50.83 4.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 79' ' ' ILE . . . 155.67 -98.05 0.17 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' GLN . 11.6 m 62.75 10.32 4.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.13 . . . . 0.0 109.425 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 mt-30 53.29 107.7 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 0.0 110.222 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.712 ' HB3' HG23 ' A' ' 79' ' ' ILE . 37.5 Cg_endo -115.61 164.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.939 1.494 . . . . 0.0 109.163 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -72.0 108.94 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.366 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.6 t -76.54 116.46 17.25 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.906 HG11 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -79.09 174.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.519 1.152 . . . . 0.0 113.155 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.629 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.1 OUTLIER 163.7 96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.132 ' CD2' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -51.57 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.082 . . . . 0.0 109.417 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' O ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.6 159.71 2.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.512 -0.742 . . . . 0.0 110.02 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 3.6 pt-20 -140.61 50.63 1.67 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 109.191 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -152.85 -69.03 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.385 -0.822 . . . . 0.0 109.458 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.439 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 30.3 p-80 -119.62 79.99 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.27 -150.68 5.74 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' CE ' ' OXT' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 109.502 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.268 0.556 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 67.8 m -92.87 -32.4 14.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER 68.5 160.09 0.17 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ARG . . . -179.44 162.06 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.096 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' ALA . 7.3 mtm180 61.54 116.16 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CG ' ' HB3' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -91.54 -176.76 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.993 1.523 . . . . 0.0 110.609 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.534 ' CA ' ' OD2' ' A' ' 13' ' ' ASP . . . -120.99 -149.75 8.24 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.549 ' N ' ' HB2' ' A' ' 13' ' ' ASP . . . 160.6 -132.89 3.05 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 12.9 pt-20 -161.99 -171.27 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.274 -1.133 . . . . 0.0 109.519 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER 66.61 111.9 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 0.0 109.009 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.567 HG23 ' CB ' ' A' ' 63' ' ' ASN . 0.5 OUTLIER 38.17 67.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CG ' ' HG2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 63.9 -162.89 0.27 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 108.516 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB2' ' N ' ' A' ' 8' ' ' GLY . 3.9 p-10 -160.96 94.7 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.63 -1.294 . . . . 0.0 110.281 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -160.16 57.93 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.9 . . . . 0.0 110.036 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 1.1 t30 -78.59 158.06 28.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.874 . . . . 0.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.978 HD21 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -138.07 125.2 21.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.865 -1.147 . . . . 0.0 109.788 178.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 1.1 t80 -77.28 105.67 8.54 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.967 ' CG1' HD23 ' A' ' 87' ' ' LEU . 4.0 m -87.09 103.77 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 88' ' ' SER . 17.2 p -90.44 167.96 12.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.344 -0.847 . . . . 0.0 109.553 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER 68.15 7.55 5.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 25' ' ' ILE . 9.9 tt -71.08 115.0 32.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.118 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' HD23 ' A' ' 21' ' ' LEU . 36.6 Cg_endo -60.13 142.37 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.859 1.452 . . . . 0.0 110.289 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.71 28.62 1.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 12.11 37.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.928 . . . . 0.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.943 HD11 HD21 ' A' ' 21' ' ' LEU . 2.1 pp -130.33 170.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.498 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.2 p -113.62 153.91 28.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.351 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -49.88 -69.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 109.015 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -42.0 -27.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.498 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -62.97 -62.39 1.74 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.6 mp -52.93 -20.2 3.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.859 -1.15 . . . . 0.0 108.957 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 27.4 t0 -66.43 -47.13 74.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.089 -1.007 . . . . 0.0 108.966 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 m -68.02 -37.55 81.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.451 -0.781 . . . . 0.0 109.072 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -61.75 -27.2 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 108.889 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 10.7 m-85 -88.45 -81.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 38.19 82.83 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -173.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 109.654 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -107.79 -86.08 0.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.877 . . . . 0.0 109.109 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.6 179.29 16.42 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 40' ' ' ILE . 10.7 m -94.13 25.83 3.57 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.077 -1.249 . . . . 0.0 108.773 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.848 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.4 mp 56.91 142.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.887 HG23 ' HD2' ' A' ' 61' ' ' ARG . 33.4 m -79.21 -12.9 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.528 -1.358 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.848 ' H ' HG22 ' A' ' 40' ' ' ILE . 21.4 tt0 157.47 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.79 ' CE ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.24 144.71 44.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 108.656 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 7.0 m120 -132.68 144.46 50.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.1 . . . . 0.0 110.407 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tt -130.11 155.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' VAL . 8.5 tp -168.74 117.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.998 -1.064 . . . . 0.0 109.599 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -86.79 -39.25 16.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 109.744 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 4.7 p30 165.98 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -148.71 31.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.66 -47.6 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -79.49 0.53 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.34 72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' CD ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -132.21 150.17 75.26 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 109.461 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -119.3 86.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.777 1.409 . . . . 0.0 110.611 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' NH2' ' CD ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -159.69 -36.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.17 -0.956 . . . . 0.0 109.807 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' N ' ' HG3' ' A' ' 55' ' ' ARG . . . 107.47 98.45 2.56 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' LEU . 27.4 m -117.64 160.61 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.679 ' CB ' HD13 ' A' ' 21' ' ' LEU . . . -153.4 164.31 38.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.557 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 11.1 m-85 -128.09 109.08 11.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.978 HG12 HD21 ' A' ' 16' ' ' LEU . 1.6 t -79.89 120.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.887 ' HD2' HG23 ' A' ' 41' ' ' VAL . 13.7 ttm-85 -88.03 99.73 12.39 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.878 -1.139 . . . . 0.0 110.35 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 3.6 m-85 -119.23 74.89 1.01 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.748 ' OD1' HG21 ' A' ' 41' ' ' VAL . 1.4 m-20 -68.38 -4.93 16.33 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.978 -1.076 . . . . 0.0 110.882 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -87.98 146.53 25.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.954 -1.092 . . . . 0.0 109.606 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.561 ' HG2' ' CG ' ' A' ' 12' ' ' LYS . 39.3 mmm-85 -73.07 -58.84 3.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 108.793 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.21 -45.69 79.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.86 . . . . 0.0 108.846 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -52.83 -43.31 65.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.111 -0.993 . . . . 0.0 108.898 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.947 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -61.89 -40.54 95.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.936 -1.103 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -31.31 25.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -80.2 -72.18 0.42 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -36.59 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.526 0.679 . . . . 0.0 110.685 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' GLU . 2.5 mt -81.02 -63.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.498 -1.376 . . . . 0.0 108.827 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 m -84.23 30.46 0.53 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.386 -0.821 . . . . 0.0 109.822 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.11 -52.88 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.877 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.47 -34.39 41.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.151 -0.968 . . . . 0.0 108.657 179.029 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 12.1 t30 -42.71 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' LEU . 1.8 m-20 80.87 76.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.792 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -89.4 38.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.306 -0.871 . . . . 0.0 109.064 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 ' OG ' ' A' ' 84' ' ' SER . 1.5 mt -151.7 128.32 5.34 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.81 ' HD2' HG23 ' A' ' 79' ' ' ILE . 35.9 Cg_endo -44.06 130.79 8.37 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.741 1.39 . . . . 0.0 110.105 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -46.57 102.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.17 21.08 0.5 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.18 75.76 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.881 ' OG ' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -88.46 16.23 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -1.181 . . . . 0.0 109.218 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.511 ' O ' HD13 ' A' ' 79' ' ' ILE . 28.2 mt-30 69.86 123.32 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.56 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.2 Cg_endo -110.46 -168.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.813 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.967 HD23 ' CG1' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.29 113.46 27.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.642 -0.661 . . . . 0.0 109.927 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -79.73 106.22 11.59 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.776 HG12 HD12 ' A' ' 16' ' ' LEU . 12.5 m -78.21 -167.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 111.322 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.602 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 95.12 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.574 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -49.47 168.17 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 91' ' ' LEU . . . -149.16 -156.44 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.14 -169.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.061 -1.025 . . . . 0.0 109.748 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' HIS . 9.7 mt-10 -131.76 124.27 29.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 109.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 57.33 110.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.97 -143.56 3.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.192 -1.181 . . . . 0.0 109.38 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 30.5 t0 -161.93 96.31 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 91' ' ' LEU . 1.2 m -148.23 54.87 1.03 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -78.34 164.09 25.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.865 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 pt? -127.25 141.44 51.72 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.641 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.682 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -83.44 110.92 18.57 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.605 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -84.78 116.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 109.248 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 57' ' ' VAL . 9.8 p -91.11 163.15 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 109.713 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.69 89.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.558 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 87' ' ' LEU . 9.1 tp -157.22 96.68 2.07 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HG3' ' OE1' ' A' ' 85' ' ' GLN . 36.9 Cg_endo -69.11 168.53 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.989 1.52 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 42.63 1.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.987 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.754 HG23 HG23 ' A' ' 25' ' ' ILE . 9.3 t -80.19 -12.0 59.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -125.77 -177.73 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.5 p -110.59 153.76 24.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' HD11 ' A' ' 45' ' ' ILE . 6.1 p-10 -57.62 -47.35 82.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -65.53 -19.05 65.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 17.5 tt0 -71.15 -48.82 49.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.576 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -45.7 -26.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 108.735 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 10.3 t70 -64.65 -51.14 64.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.842 . . . . 0.0 109.109 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.7 m -54.62 -44.35 73.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.087 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.89 HG21 ' HB ' ' A' ' 78' ' ' VAL . 1.8 mp -57.25 -36.11 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.197 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.699 ' CD1' HD21 ' A' ' 75' ' ' LEU . 2.0 m-30 -80.28 -83.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 109.346 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 23.01 67.09 0.02 OUTLIER Glycine 0 N--CA 1.503 3.115 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -172.88 -39.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.247 . . . . 0.0 109.922 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.889 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -94.38 -77.52 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.177 -0.952 . . . . 0.0 109.584 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 -168.15 14.94 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.32 32.58 4.36 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -1.232 . . . . 0.0 109.555 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 26.62 101.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.774 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.818 HG13 HH11 ' A' ' 61' ' ' ARG . 0.7 OUTLIER -76.54 9.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.362 -1.461 . . . . 0.0 110.129 -179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -168.04 -164.65 0.56 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.638 -1.289 . . . . 0.0 110.776 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 159.02 106.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -139.33 -178.5 5.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.62 -1.3 . . . . 0.0 110.905 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD11 ' HB3' ' A' ' 27' ' ' ASP . 5.3 mp -139.25 141.65 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.8 mp -127.58 130.38 48.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.498 ' C ' HG13 ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.498 HG13 ' C ' ' A' ' 56' ' ' GLY . 13.6 m -157.38 143.08 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -1.101 . . . . 0.0 109.704 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -100.47 -176.45 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 108.801 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.682 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -133.93 108.02 8.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 109.55 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 75' ' ' LEU . 1.7 t -85.89 160.85 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.818 HH11 HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.71 140.85 37.46 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.151 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 9.4 m-85 -161.39 68.99 0.32 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.671 ' ND2' HG11 ' A' ' 41' ' ' VAL . 18.0 m-20 -46.86 -86.6 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.434 -0.791 . . . . 0.0 109.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 63' ' ' ASN . 6.5 ttmm -37.01 118.37 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.326 0.584 . . . . 0.0 109.672 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.698 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -45.74 -47.7 15.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.629 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 14.6 mt-10 -54.38 -50.02 68.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 3.1 tp10 -53.86 -42.78 68.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CA ' ' HB3' ' A' ' 62' ' ' TYR . . . -55.43 -39.33 70.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.838 -1.164 . . . . 0.0 108.594 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.507 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.47 -44.73 76.73 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -49.2 -62.24 1.64 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.151 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -43.37 -40.09 3.48 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.524 -0.735 . . . . 0.0 109.152 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 40.8 mm -46.99 -60.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -68.82 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.889 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -45.94 -50.95 14.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 111.588 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.18 -28.17 42.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.723 -1.235 . . . . 0.0 110.635 -178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.0 t30 -46.15 115.29 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.251 -1.53 . . . . 0.0 107.463 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 60.81 78.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.941 HG13 HD11 ' A' ' 87' ' ' LEU . 1.6 m -85.23 45.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.781 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.97 145.05 25.93 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.42 -0.8 . . . . 0.0 109.234 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 81' ' ' GLU . 36.3 Cg_endo -62.47 139.21 75.19 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.91 1.479 . . . . 0.0 109.328 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -40.33 107.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 -179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.72 38.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 81.56 -139.47 20.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.667 ' OG ' HG21 ' A' ' 79' ' ' ILE . 1.4 t 78.77 -4.82 2.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.598 -0.942 . . . . 0.0 109.391 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 84' ' ' SER . 24.7 mt-30 57.97 117.22 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.835 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HA ' HD11 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -83.75 177.74 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.905 1.476 . . . . 0.0 110.295 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -118.09 138.73 52.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 109.574 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 19.2 m -79.04 103.81 9.24 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.865 HG12 HD11 ' A' ' 16' ' ' LEU . 1.2 m -83.08 144.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.731 0.776 . . . . 0.0 110.886 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' H ' ' HB2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER 171.92 132.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -61.29 116.21 4.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.12 162.26 25.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -95.15 71.45 3.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -150.31 -38.13 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 97.8 m-70 62.41 105.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.23 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.412 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -177.41 96.0 0.1 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 120.228 0.061 . . . . 0.0 111.084 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.594 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 12.5 m-20 -157.97 -105.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.012 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -159.21 92.46 1.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.665 -1.272 . . . . 0.0 110.394 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.751 ' O ' HD22 ' A' ' 91' ' ' LEU . 33.3 p-10 -83.65 168.53 16.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.324 -0.86 . . . . 0.0 109.564 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -134.89 122.16 21.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.459 -1.401 . . . . 0.0 110.43 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' CD1' ' CE2' ' A' ' 59' ' ' PHE . 9.4 t80 -78.14 135.75 37.72 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.863 HG21 ' CD2' ' A' ' 87' ' ' LEU . 3.5 m -116.35 148.07 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.995 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.693 ' HA ' HG12 ' A' ' 57' ' ' VAL . 28.3 p -131.54 178.34 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.377 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 57.17 91.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.801 HD13 HG23 ' A' ' 45' ' ' ILE . 23.2 mt -108.99 175.32 2.0 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 109.121 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -114.22 6.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.743 1.391 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 163.4 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.648 ' HA ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -162.36 -44.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.444 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.759 HG22 ' OE1' ' A' ' 29' ' ' GLN . 1.1 mt 47.99 -174.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 108.913 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.589 ' H ' HG22 ' A' ' 25' ' ' ILE . 1.1 p -100.28 143.83 30.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.976 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 1.5 m-20 -57.79 -62.02 2.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.349 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -51.06 -18.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.759 ' OE1' HG22 ' A' ' 25' ' ' ILE . 22.2 mt-30 -75.08 -61.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.368 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.826 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 tp -44.5 -25.2 0.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.077 -1.014 . . . . 0.0 109.719 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.573 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 1.2 m-20 -64.52 -54.49 31.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.982 -1.074 . . . . 0.0 108.878 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -62.38 -35.94 80.74 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.399 -0.813 . . . . 0.0 109.087 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 30' ' ' LEU . 4.5 tt -61.3 -27.69 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 108.67 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.891 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 12.3 m-85 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 36' ' ' LYS . . . 155.54 -91.69 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 169.3 50.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.812 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -93.76 -86.51 0.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.152 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.545 ' CA ' ' HG3' ' A' ' 67' ' ' GLU . . . -74.09 157.33 51.14 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 40' ' ' ILE . 28.1 t -79.35 79.57 5.78 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.115 -1.227 . . . . 0.0 107.904 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -34.83 115.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.662 0.744 . . . . 0.0 109.574 -178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.945 HG22 ' O ' ' A' ' 61' ' ' ARG . 6.2 m -81.53 38.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 110.122 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 2.9 tt0 91.65 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.602 0.715 . . . . 0.0 111.035 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -99.95 151.45 21.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -145.65 175.68 10.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.59 -1.319 . . . . 0.0 110.992 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.801 HG23 HD13 ' A' ' 21' ' ' LEU . 49.9 mt -143.19 134.43 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.1 151.43 31.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.978 -1.076 . . . . 0.0 109.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.165 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -126.33 140.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.79 -174.34 2.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.483 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 m-85 -143.57 99.14 3.37 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 16' ' ' LEU . 15.6 t -85.85 148.66 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.945 ' O ' HG22 ' A' ' 41' ' ' VAL . 9.5 mtt180 -137.33 79.25 1.74 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.415 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 11.1 m-85 -78.86 160.04 27.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.594 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -103.45 -91.95 0.35 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.111 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -25.54 136.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.508 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -50.93 -51.25 54.04 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 70' ' ' GLU . 16.5 mt-10 -63.43 -35.33 80.07 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -61.34 -28.12 68.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -75.82 -43.93 43.58 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -60.56 -20.77 61.4 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -70.75 -61.51 1.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -68.44 -5.13 17.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.561 0.696 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.059 ' HA ' HG21 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -86.43 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.723 -1.236 . . . . 0.0 108.21 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -75.29 -1.64 24.5 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.818 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.84 -47.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 110.357 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -84.09 -21.14 31.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 110.556 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.683 ' HA ' HG22 ' A' ' 89' ' ' VAL . 23.6 p-10 -46.95 -23.83 0.51 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.55 -1.344 . . . . 0.0 109.128 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 85' ' ' GLN . 3.4 m-80 -143.59 86.63 1.89 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 87' ' ' LEU . 2.2 p -78.46 88.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 108.838 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.048 HG23 ' HG3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -147.55 -172.61 0.32 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.48 -0.762 . . . . 0.0 109.085 -179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -102.7 24.06 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.899 1.473 . . . . 0.0 109.424 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER 73.24 114.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 0.0 109.693 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.83 -18.65 1.11 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 137.44 -148.76 20.0 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 79' ' ' ILE . 6.2 t 83.83 -28.11 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.799 -0.824 . . . . 0.0 109.837 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.506 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER 38.41 92.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.245 -0.909 . . . . 0.0 110.755 179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 1.048 ' HG3' HG23 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -121.24 -178.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.925 1.487 . . . . 0.0 110.049 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.863 ' CD2' HG21 ' A' ' 18' ' ' VAL . 77.3 mt 25.07 68.02 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 7.4 m -77.25 102.12 6.54 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.059 HG21 ' HA ' ' A' ' 72' ' ' ILE . 14.7 m -77.85 163.87 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.313 1.054 . . . . 0.0 113.153 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 91' ' ' LEU . 2.1 ttt180 171.2 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER -33.64 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.622 -0.674 . . . . 0.0 109.386 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.79 179.48 6.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.86 -1.15 . . . . 0.0 110.279 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.35 105.22 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.443 -0.785 . . . . 0.0 109.176 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.31 -163.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -108.38 30.62 6.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.431 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.01 -33.66 0.05 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.489 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.213 -1.169 . . . . 0.0 109.61 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.927 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.59 -88.17 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.48 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.782 ' HA ' HD13 ' A' ' 91' ' ' LEU . 3.2 m -79.22 71.62 5.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 110.03 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -76.89 -177.27 4.29 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.048 HD23 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -112.28 103.79 11.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.702 -1.249 . . . . 0.0 111.407 -178.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' CZ ' ' A' ' 59' ' ' PHE . 2.8 t80 -83.11 81.92 8.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 2.5 m -82.47 129.68 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 111.261 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.753 HG23 HG12 ' A' ' 57' ' ' VAL . 19.6 m -131.76 172.18 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.562 ' H ' HG22 ' A' ' 19' ' ' THR . 20.3 t-20 79.27 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.969 . . . . 0.0 110.121 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -170.1 144.98 2.28 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.018 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -106.85 69.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.626 1.329 . . . . 0.0 111.003 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 4.2 mtm180 40.1 36.38 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 24' ' ' THR . 89.2 m -79.82 -5.24 55.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 0.0 109.23 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.532 ' CD1' HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -152.32 150.27 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.174 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -91.55 155.41 18.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' H ' HD11 ' A' ' 45' ' ' ILE . 5.4 p-10 -62.31 -49.63 74.86 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.166 -0.959 . . . . 0.0 108.488 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 6.6 t0 -50.79 -22.5 2.18 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -77.37 -41.48 40.04 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.831 . . . . 0.0 109.777 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.985 ' O ' HG22 ' A' ' 33' ' ' ILE . 6.9 mp -47.3 -44.35 23.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.006 . . . . 0.0 109.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 6.9 t70 -58.03 -41.32 82.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.818 -1.176 . . . . 0.0 108.991 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -36.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.491 -0.755 . . . . 0.0 110.476 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.988 HD13 HG13 ' A' ' 78' ' ' VAL . 1.2 tt -67.21 -33.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.784 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CD1' HG23 ' A' ' 33' ' ' ILE . 1.8 m-85 -84.37 -72.03 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 109.075 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 36' ' ' LYS . . . 104.09 -40.74 2.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CD ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -175.22 98.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.261 . . . . 0.0 109.437 -179.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.711 ' CE1' ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -136.67 -21.7 1.28 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 62' ' ' TYR . . . -178.91 -175.5 46.0 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.482 ' O ' ' C ' ' A' ' 40' ' ' ILE . 1.4 t -88.91 71.99 8.52 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.372 -1.075 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -37.71 134.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 41' ' ' VAL . 3.9 m -102.21 48.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 111.788 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.755 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 1.1 tm0? 89.28 131.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.592 0.71 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 mtmp? -100.66 169.66 8.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -160.56 163.9 32.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.916 -1.115 . . . . 0.0 110.341 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 27' ' ' ASP . 1.8 mt -141.11 107.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 57' ' ' VAL . 2.0 mm? -93.91 130.9 39.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.335 -0.853 . . . . 0.0 109.145 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.898 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.753 HG12 HG23 ' A' ' 19' ' ' THR . 10.7 m -145.89 139.88 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -1.084 . . . . 0.0 109.075 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -124.55 177.11 6.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 47.8 m-85 -142.84 107.97 4.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.048 HG12 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -78.8 177.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.14 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -107.03 123.76 48.66 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.3 -177.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.63 ' CE1' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -163.93 158.34 19.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.92 -1.113 . . . . 0.0 109.77 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.558 ' HA ' ' H ' ' A' ' 14' ' ' THR . 5.2 p-10 -148.32 -64.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 0.0 110.962 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -49.55 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 108.977 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.491 ' HG2' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -30.36 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.748 -0.595 . . . . 0.0 111.379 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 64' ' ' LYS . 56.9 mt-10 -66.71 -64.61 0.82 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.894 -1.129 . . . . 0.0 109.426 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . 26.3 pt-20 -56.02 -24.13 37.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.903 -1.123 . . . . 0.0 108.711 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 14' ' ' THR . . . -65.03 -44.63 88.5 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 52.8 tt0 -48.19 -33.69 8.89 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -60.13 -53.0 62.92 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -60.97 -11.91 9.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.072 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.902 ' HA ' HG21 ' A' ' 89' ' ' VAL . 33.0 mm -80.17 -59.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.12 4.3 8.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.565 -0.709 . . . . 0.0 110.172 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.42 -54.31 1.02 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.101 . . . . 0.0 109.862 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.037 HD21 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -79.4 -11.27 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.322 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.63 ' CB ' HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -82.86 42.42 0.79 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.405 -1.435 . . . . 0.0 109.145 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 p30 156.27 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.988 HG13 HD13 ' A' ' 33' ' ' ILE . 2.1 t -79.97 87.62 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.021 HD13 ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 172.58 135.74 0.1 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.473 -0.767 . . . . 0.0 109.181 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 36.6 Cg_endo -43.73 117.31 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.979 1.515 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -45.37 147.12 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 120.95 -59.64 0.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -60.81 -127.68 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.457 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -179.89 35.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 109.554 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 1.021 ' O ' HD13 ' A' ' 79' ' ' ILE . 13.2 mt-30 -129.44 71.3 82.08 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.391 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.69 -171.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.896 1.472 . . . . 0.0 110.954 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.96 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -116.47 113.62 23.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.1 t -78.53 102.65 8.0 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.902 HG21 ' HA ' ' A' ' 72' ' ' ILE . 17.0 m -78.5 153.89 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.008 0.909 . . . . 0.0 111.576 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 4.3 ttm-85 173.99 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 14' ' ' THR . 7.4 tp -52.42 136.82 30.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.938 -1.101 . . . . 0.0 108.978 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.615 ' N ' HD12 ' A' ' 91' ' ' LEU . . . -133.79 145.42 49.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.31 141.47 35.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -179.81 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -159.65 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.55 -117.25 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.218 -1.166 . . . . 0.0 109.621 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 63' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 CA-C-O 120.593 0.235 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' ' N ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -160.95 -99.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.474 -1.391 . . . . 0.0 111.584 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 68' ' ' ALA . 7.7 p -107.75 -133.73 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.35 -1.469 . . . . 0.0 109.867 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.543 ' CB ' HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -164.56 -167.6 1.31 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.243 -0.911 . . . . 0.0 108.932 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.933 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.8 tp -154.62 121.54 5.54 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.85 ' OH ' HG11 ' A' ' 57' ' ' VAL . 11.4 t80 -110.17 117.26 33.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.808 -1.182 . . . . 0.0 109.726 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 89' ' ' VAL . 18.8 m -112.36 131.77 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 110.006 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.689 ' OG1' HG12 ' A' ' 57' ' ' VAL . 11.1 t -127.04 -166.53 1.61 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 108.896 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER 81.78 -65.24 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.317 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -38.3 126.45 1.08 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.954 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -106.37 64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.971 1.511 . . . . 0.0 110.639 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 65.08 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.906 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 m -124.0 -24.93 4.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 109.964 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.726 HD12 ' CD1' ' A' ' 30' ' ' LEU . 1.1 pt -111.35 179.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -114.35 153.04 30.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.798 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 1.9 m-20 -63.35 -60.13 3.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 108.911 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -43.23 -26.39 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.305 -0.872 . . . . 0.0 109.382 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -72.23 -63.44 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.726 ' CD1' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -45.96 -24.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.124 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 1.6 t70 -64.86 -59.12 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.022 . . . . 0.0 109.118 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' THR . 92.8 m -64.28 -12.39 41.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.436 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.639 HG21 HG23 ' A' ' 78' ' ' VAL . 12.8 mm -77.72 -45.78 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.977 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.867 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 7.8 p90 -142.35 49.6 1.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.49 36.73 4.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -100.28 -44.97 5.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD1' ' OH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -79.42 -97.73 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.72 131.76 10.61 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 40' ' ' ILE . 53.4 p -79.03 75.26 5.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.915 -1.344 . . . . 0.0 108.48 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 23.59 108.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.883 1.325 . . . . 0.0 110.319 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.926 HG11 HD21 ' A' ' 63' ' ' ASN . 3.1 t -75.61 -4.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.968 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 170.11 99.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.544 -0.722 . . . . 0.0 110.033 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.597 ' HG3' HG21 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -87.16 87.09 7.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.965 . . . . 0.0 108.621 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.76 147.39 25.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 58' ' ' ALA . 19.5 tt -161.5 140.1 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.042 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 3.3 pp -161.59 155.07 21.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.08 . . . . 0.0 110.141 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.389 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.85 HG11 ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -160.95 166.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.125 . . . . 0.0 109.999 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -129.53 150.26 50.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 93.5 m-85 -126.46 101.67 6.79 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.935 -1.103 . . . . 0.0 110.616 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.933 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -81.8 107.11 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 176.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.599 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 0.2 OUTLIER -76.97 87.25 3.5 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 120.138 -1.601 . . . . 0.0 108.618 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.723 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 2.1 t80 -94.7 114.26 26.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.926 HD21 HG11 ' A' ' 41' ' ' VAL . 9.1 m120 -71.32 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.817 -1.553 . . . . 0.0 111.148 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER 7.32 127.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -62.23 -61.67 2.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.051 178.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -53.04 62.79 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 109.618 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 81.8 mt-10 -67.01 -10.9 54.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -75.19 -37.89 61.03 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -69.71 -20.75 63.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.8 mt-10 -62.65 -75.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.752 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . . . -50.11 -23.08 1.92 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.612 ' O ' HG21 ' A' ' 89' ' ' VAL . 2.6 mm -58.36 -51.64 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.688 -1.257 . . . . 0.0 107.795 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -86.47 -59.46 2.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.083 . . . . 0.0 110.231 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.52 -44.0 62.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 110.446 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.873 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.5 tp -79.25 -38.8 34.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.062 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.4 t-20 -40.96 116.71 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.506 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 67.29 78.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.922 ' O ' HG23 ' A' ' 79' ' ' ILE . 7.4 p -86.18 52.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.078 -1.014 . . . . 0.0 109.773 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.08 HG21 ' CB ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -176.35 170.23 1.19 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.385 -0.822 . . . . 0.0 108.908 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -87.96 39.11 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.758 1.399 . . . . 0.0 109.677 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 46.88 68.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 108.771 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.8 1.97 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 85' ' ' GLN . . . 127.61 -50.96 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 120.885 -1.362 . . . . 0.0 110.332 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 1.08 ' CB ' HG21 ' A' ' 79' ' ' ILE . 73.1 m -50.93 -18.9 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 110.316 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' SER . 7.0 mp0 64.53 140.8 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.0 Cg_endo -84.25 -179.86 4.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.153 1.607 . . . . 0.0 111.455 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.873 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -122.06 123.87 42.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 109.098 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.626 ' HB3' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -78.5 97.04 5.57 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 18' ' ' VAL . 14.5 m -78.27 163.63 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 122.301 1.048 . . . . 0.0 112.049 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 17' ' ' TYR . 5.5 ptp180 173.42 -133.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.543 HD11 ' CB ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -146.73 119.46 8.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.679 -1.263 . . . . 0.0 108.217 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -145.68 -174.07 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.787 -1.196 . . . . 0.0 109.76 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -172.29 88.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.861 . . . . 0.0 109.185 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -46.42 -31.0 2.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -168.82 -152.63 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.49 95.27 1.57 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.588 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.416 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -155.95 87.16 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.363 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -161.44 34.26 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.619 ' HB3' HG21 ' A' ' 41' ' ' VAL . 39.0 p-10 -76.93 -171.78 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -156.18 119.69 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -81.58 134.07 35.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.975 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 5.3 m -106.23 150.38 8.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.523 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.491 HG23 ' OG ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -115.42 168.94 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.439 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' THR . 86.1 m-20 61.26 72.95 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -136.19 115.27 10.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 109.408 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.76 -171.27 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.044 1.549 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -114.0 17.38 17.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -79.76 -56.84 3.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.191 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.848 HD11 HD12 ' A' ' 30' ' ' LEU . 2.0 tt -82.41 167.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.12 146.12 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 2.9 p30 -59.45 -44.31 92.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 6.9 t0 -58.46 -24.92 61.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.524 ' OE1' HG23 ' A' ' 26' ' ' THR . 7.8 mt-30 -73.76 -40.5 63.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.055 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.5 mp -42.77 -54.19 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.407 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -41.48 -49.22 3.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.875 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -61.26 -43.63 98.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.012 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.055 HG22 ' O ' ' A' ' 30' ' ' LEU . 10.1 tp -57.04 -24.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.891 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.803 ' CD1' HG23 ' A' ' 33' ' ' ILE . 3.2 m-85 -97.69 -73.09 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.812 -1.18 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.54 -80.82 0.24 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.98 105.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.151 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -94.85 -83.4 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 108.976 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . -98.87 -93.18 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.571 ' O ' ' C ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -150.47 67.63 0.96 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -23.75 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.718 0.77 . . . . 0.0 109.715 -178.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.626 ' C ' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m -90.04 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.733 ' H ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 82.6 120.29 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.415 -0.803 . . . . 0.0 112.191 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.889 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -124.02 132.59 53.71 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.77 146.0 30.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.638 -1.289 . . . . 0.0 110.503 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.606 ' C ' HD22 ' A' ' 46' ' ' LEU . 1.7 tt -92.02 124.07 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 45' ' ' ILE . 1.7 mm? -106.96 138.53 42.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.102 -0.999 . . . . 0.0 110.215 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.756 . . . . 0.0 109.029 179.653 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 46' ' ' LEU . 2.1 m -96.89 171.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -1.192 . . . . 0.0 109.623 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.975 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -147.68 -179.13 6.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.291 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 m-85 -152.15 115.64 4.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.669 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.073 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.07 153.84 4.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.54 -1.35 . . . . 0.0 107.684 178.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.771 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -95.18 132.53 40.03 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.084 0.945 . . . . 0.0 111.299 -178.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.166 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -163.26 147.01 10.73 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' C ' ' A' ' 64' ' ' LYS . 13.0 p30 -137.88 -118.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.785 -1.197 . . . . 0.0 107.879 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.63 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 10.43 103.27 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 CA-C-N 118.626 0.648 . . . . 0.0 110.855 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.746 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.05 -59.25 0.14 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.611 -0.681 . . . . 0.0 111.069 -178.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.9 -50.6 65.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.685 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 85.3 mt-10 -49.65 -48.9 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 110.34 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.39 -46.75 47.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.333 -1.479 . . . . 0.0 108.038 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 5.4 tt0 -52.92 -42.38 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 7.5 mm-40 -50.04 -66.6 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 0.0 108.585 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.166 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -51.01 -29.62 13.0 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.895 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 24.6 mm -60.03 -49.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.465 -1.397 . . . . 0.0 108.407 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.4 m -84.35 -65.49 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 110.117 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.01 76.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.464 -0.773 . . . . 0.0 111.303 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.073 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.45 -38.96 33.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.62 -1.3 . . . . 0.0 110.597 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 23.8 t-20 -52.6 131.77 34.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.264 -1.522 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 8.7 m120 64.56 69.84 0.5 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 78' ' ' VAL . 3.3 p -86.22 61.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.73 162.39 18.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.8 Cg_endo -87.14 41.21 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.656 1.345 . . . . 0.0 109.986 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' PRO . 9.0 mt-10 59.94 147.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.91 -76.37 0.41 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.67 -25.32 60.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.462 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER 58.27 28.75 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.115 . . . . 0.0 109.942 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.58 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 2.0 mt-30 -127.57 75.39 77.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.025 -1.047 . . . . 0.0 109.581 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -109.28 -161.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.879 1.463 . . . . 0.0 110.773 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.846 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -103.15 123.06 45.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 110.356 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -78.47 111.26 14.31 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.538 ' HB ' HD13 ' A' ' 72' ' ' ILE . 2.9 m -78.19 155.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.428 1.109 . . . . 0.0 112.395 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.572 ' HD2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 167.53 126.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 15.0 mt -41.76 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.01 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -84.51 167.81 16.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -64.07 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.45 4.55 10.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.222 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -125.22 112.54 16.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.03 -1.044 . . . . 0.0 109.599 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.96 178.51 34.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 17.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 109.43 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HA ' ' CA ' ' A' ' 97' ' ' LYS . 9.6 pttt . . . . . 0 N--CA 1.498 1.937 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 63' ' ' ASN . 18.9 m-20 -111.27 -92.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 0.0 110.747 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.777 ' HA ' HD21 ' A' ' 91' ' ' LEU . 10.0 t -82.04 64.42 6.71 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.332 -0.855 . . . . 0.0 110.402 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.799 ' O ' HD22 ' A' ' 91' ' ' LEU . 2.2 p-10 -76.76 160.63 29.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.061 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -137.57 125.8 23.13 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 117.621 -1.632 . . . . 0.0 111.636 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -85.12 114.82 22.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.067 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 32.5 m -88.89 139.32 17.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -116.99 -179.48 3.71 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.332 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.448 ' H ' HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER 57.58 86.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 109.269 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -163.18 132.75 3.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.546 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' OE1' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -108.66 52.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.965 1.508 . . . . 0.0 110.194 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' PRO . 77.3 mtt180 41.7 53.08 4.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -96.0 -21.5 17.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 25' ' ' ILE . 1.3 pp -121.81 160.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.389 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -96.66 157.12 16.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.162 -0.961 . . . . 0.0 109.992 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -59.89 -53.67 55.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -3.0 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.896 -1.127 . . . . 0.0 109.625 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.0 OUTLIER -83.1 -63.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 110.722 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.556 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 3.2 mp -44.3 -37.22 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.52 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.545 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 30.5 t0 -49.7 -55.82 12.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.662 -1.274 . . . . 0.0 109.228 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.6 m -65.18 -21.44 66.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -83.01 -15.12 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.718 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.94 ' CG ' HD11 ' A' ' 75' ' ' LEU . 10.5 p90 -153.4 33.86 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.914 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -97.57 61.56 1.01 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.134 -1.604 . . . . 0.0 109.697 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -138.54 -10.55 1.4 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.058 -1.26 . . . . 0.0 111.183 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CD2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -85.7 -50.14 7.41 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.684 -1.26 . . . . 0.0 109.875 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.49 -160.2 8.63 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' C ' ' A' ' 40' ' ' ILE . 14.5 m -95.35 72.77 3.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.275 -1.132 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.914 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -25.65 131.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-O 121.153 0.502 . . . . 0.0 110.046 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 41' ' ' VAL . 3.2 m -98.76 56.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 12.2 tt0 94.26 100.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.599 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -83.05 165.79 19.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 1.9 t-20 -158.98 158.1 32.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.838 -1.164 . . . . 0.0 109.892 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -158.41 117.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.343 -0.848 . . . . 0.0 109.316 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.21 158.98 43.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.766 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 -179.723 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.71 163.61 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.145 . . . . 0.0 109.431 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -134.26 -174.1 3.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 108.941 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -149.17 104.48 3.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.061 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.2 t -79.54 152.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.041 -1.037 . . . . 0.0 108.461 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.757 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.27 128.4 46.35 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.402 0.62 . . . . 0.0 111.022 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.069 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -164.4 146.05 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.184 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.686 ' C ' HG22 ' A' ' 14' ' ' THR . 1.0 OUTLIER -133.26 -48.56 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.72 106.14 0.37 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.48 ' C ' ' O ' ' A' ' 64' ' ' LYS . 1.7 mpp_? -34.83 -55.63 0.57 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.178 0.513 . . . . 0.0 110.265 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -47.95 79.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 62' ' ' TYR . 39.7 tt0 -52.26 -29.4 22.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -68.79 -48.54 63.37 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.978 -1.076 . . . . 0.0 108.45 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -47.41 -32.33 4.89 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 20.4 mm-40 -67.38 -49.32 64.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.731 -0.606 . . . . 0.0 109.484 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -65.73 -13.54 59.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.802 ' HA ' HG21 ' A' ' 89' ' ' VAL . 19.3 mm -81.51 -69.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.012 -1.055 . . . . 0.0 108.596 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -77.48 8.6 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.635 -0.666 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -130.02 -50.53 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.941 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.4 mp -78.91 -32.31 45.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.014 -1.054 . . . . 0.0 108.515 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 40.7 t-20 -55.18 125.06 19.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 4.4 m120 65.97 72.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.7 p -86.81 48.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -154.96 134.16 7.58 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 79' ' ' ILE . 34.7 Cg_endo -46.5 138.16 14.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.774 1.408 . . . . 0.0 109.758 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 80' ' ' PRO . 2.5 mm-40 -42.23 145.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.059 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.02 -29.49 2.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 140.31 -127.59 3.55 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.2 m 70.7 3.46 4.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.323 -1.104 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.425 ' OE1' ' HD3' ' A' ' 22' ' ' PRO . 4.7 mt-30 64.94 122.73 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.055 -1.028 . . . . 0.0 109.203 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -108.12 152.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 110.803 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -70.17 119.62 14.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.578 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -78.59 98.45 6.16 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HA ' ' A' ' 72' ' ' ILE . 33.8 m -78.83 153.47 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.02 0.915 . . . . 0.0 111.671 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 154.32 141.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.799 HD22 ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -59.78 134.68 57.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.53 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -94.1 -31.48 14.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 109.597 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 0.8 OUTLIER 76.23 63.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.187 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.0 -34.8 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.594 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -148.83 -92.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 15' ' ' ASN . . . -176.61 -44.89 0.06 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.236 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 120.954 0.407 . . . . 0.0 111.433 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -131.21 -67.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.943 -1.098 . . . . 0.0 111.596 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -161.53 102.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.523 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 46.8 p30 -98.38 -163.89 1.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.463 -0.773 . . . . 0.0 109.078 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.058 HD21 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -160.34 119.2 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.599 -1.24 . . . . 0.0 112.151 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -79.41 131.47 36.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.8 m -124.16 149.57 28.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.513 -1.367 . . . . 0.0 111.465 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -135.97 -153.32 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.525 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 34.77 16.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.995 . . . . 0.0 110.287 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.869 HD11 ' HB2' ' A' ' 58' ' ' ALA . 2.9 pp -170.49 128.72 0.78 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -102.81 67.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.979 1.515 . . . . 0.0 109.934 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.68 ' CG ' HG21 ' A' ' 45' ' ' ILE . 26.6 mtp180 62.11 54.64 2.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.5 p -79.8 -1.09 37.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -151.4 -160.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.6 p -122.12 151.53 40.84 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 92.6 m-20 -49.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.339 -0.851 . . . . 0.0 109.322 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.0 p30 -42.34 -26.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.095 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.523 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.7 tt0 -63.53 -57.74 9.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 110.143 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.935 HD21 ' CD2' ' A' ' 87' ' ' LEU . 3.0 mp -45.33 -44.44 11.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.867 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.944 ' OD1' HD11 ' A' ' 40' ' ' ILE . 21.2 t0 -59.5 -40.68 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 110.054 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 m -77.85 -10.94 59.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.0 -45.95 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 0.0 109.904 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 1.006 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 39.5 p90 -103.4 -45.89 4.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 109.449 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 34' ' ' PHE . . . 15.21 60.11 0.01 OUTLIER Glycine 0 N--CA 1.505 3.254 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' PHE . 12.4 tttt -133.36 -28.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.256 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -111.68 -100.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 110.31 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 67' ' ' GLU . . . -79.24 152.48 36.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 40' ' ' ILE . 20.6 t -87.05 45.24 1.25 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.122 -1.223 . . . . 0.0 108.258 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.006 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 39.95 110.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.217 1.008 . . . . 0.0 110.598 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 61' ' ' ARG . 4.8 m -77.64 7.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.296 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER 162.46 72.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.068 -1.02 . . . . 0.0 110.29 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 1.8 ptpp? -82.76 117.72 22.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 20.0 p30 -154.73 169.6 23.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.198 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.68 HG21 ' CG ' ' A' ' 23' ' ' ARG . 13.7 mt -114.39 171.01 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.484 -0.76 . . . . 0.0 109.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.547 ' HB2' HG13 ' A' ' 57' ' ' VAL . 1.2 mt -128.8 113.41 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 110.012 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . 23.0 ptt180 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.67 HG23 HG23 ' A' ' 19' ' ' THR . 1.6 p -142.4 138.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.578 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -89.5 175.34 7.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -157.85 104.76 1.95 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.194 -0.941 . . . . 0.0 110.365 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.063 HG21 HD21 ' A' ' 75' ' ' LEU . 3.2 t -90.5 159.67 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.76 ' HB3' HG23 ' A' ' 41' ' ' VAL . 38.2 mmm-85 -139.51 147.3 41.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.586 -1.321 . . . . 0.0 110.169 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 52.3 m-85 -159.42 149.43 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.533 ' ND2' HG11 ' A' ' 41' ' ' VAL . 3.8 p30 -119.79 71.82 0.9 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.292 -1.363 . . . . 0.0 109.875 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.574 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -171.19 96.86 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.511 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -33.4 -51.93 0.37 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.264 0.554 . . . . 0.0 110.359 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.24 -50.05 74.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 108.466 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.629 ' HG2' ' CD2' ' A' ' 37' ' ' TYR . 15.2 tm-20 -52.37 -48.88 65.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.48 -0.762 . . . . 0.0 110.354 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -46.72 -45.2 19.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.647 -1.283 . . . . 0.0 107.981 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.6 -45.78 73.68 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -52.41 -65.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 109.248 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -53.01 -15.65 0.85 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.838 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.824 HD13 HG12 ' A' ' 89' ' ' VAL . 1.1 mm -85.21 -70.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.676 -1.265 . . . . 0.0 108.881 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 t -58.88 -9.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.737 -1.227 . . . . 0.0 110.582 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.14 -53.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.664 -1.273 . . . . 0.0 111.087 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.063 HD21 HG21 ' A' ' 60' ' ' VAL . 7.1 tp -81.72 5.89 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.971 -1.081 . . . . 0.0 110.837 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HA ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -87.3 22.42 2.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.724 -1.235 . . . . 0.0 108.556 178.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 38.5 p-10 177.86 73.83 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.5 p -80.9 68.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.312 -0.867 . . . . 0.0 108.953 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.738 HD13 ' OG ' ' A' ' 84' ' ' SER . 0.1 OUTLIER 163.87 118.74 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -39.29 128.97 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.956 1.503 . . . . 0.0 110.835 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.75 163.98 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.97 -53.68 0.67 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.75 35.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.738 ' OG ' HD13 ' A' ' 79' ' ' ILE . 7.5 t -110.38 -14.19 14.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -1.218 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' SER . 46.7 mt-30 61.93 117.75 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 37.4 Cg_endo -123.61 -160.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 124.075 1.566 . . . . 0.0 109.354 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.935 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.9 115.76 27.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.958 -1.089 . . . . 0.0 110.926 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 5.8 m -79.23 113.63 17.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 72' ' ' ILE . 13.1 t -83.27 162.21 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.318 1.056 . . . . 0.0 113.17 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 161.57 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.558 HD11 ' CA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -44.04 157.53 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.29 170.8 2.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.48 -0.763 . . . . 0.0 109.906 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 43.2 mm-40 -141.01 125.7 17.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.431 -0.793 . . . . 0.0 109.217 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 70.48 6.51 5.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 109.342 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -141.21 -170.09 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.61 134.37 3.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 61' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.163 . . . . 0.0 109.494 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.588 ' CB ' ' HB2' ' A' ' 63' ' ' ASN . 6.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.16 82.81 0.71 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 111.052 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.603 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -161.35 52.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 0.0 109.142 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.58 HD22 HG21 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.16 -169.4 1.83 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.257 -0.902 . . . . 0.0 109.919 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.05 HD21 HG12 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -153.01 127.0 8.99 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.034 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.877 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -77.6 125.56 29.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 58' ' ' ALA . 29.0 m -118.24 124.01 72.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.415 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -123.65 178.11 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER 87.79 15.19 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 111.337 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -154.59 43.17 0.21 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.343 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 21' ' ' LEU . 37.7 Cg_endo -76.14 142.82 24.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.593 1.312 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 61.05 9.76 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 110.691 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 22' ' ' PRO . 43.2 p -99.84 -38.77 8.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.96 -1.088 . . . . 0.0 108.917 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.875 HD11 HD23 ' A' ' 21' ' ' LEU . 1.3 pp -136.79 166.99 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 108.876 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -103.25 144.67 31.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.092 -1.005 . . . . 0.0 109.789 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -53.9 -66.2 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -44.91 -25.19 0.28 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.004 -1.06 . . . . 0.0 109.484 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 26' ' ' THR . 47.6 tt0 -64.75 -62.21 1.71 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 109.636 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 6.1 mp -43.96 -26.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.234 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' OD2' ' NH2' ' A' ' 61' ' ' ARG . 13.0 t70 -57.99 -54.11 50.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.9 m -62.76 -44.46 96.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.53 -17.2 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 108.509 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.912 ' CE2' HD21 ' A' ' 75' ' ' LEU . 20.4 m-30 -100.5 -91.0 0.31 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 36.6 77.42 0.05 OUTLIER Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -173.7 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.296 . . . . 0.0 110.681 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.625 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.16 -80.68 0.31 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.827 -1.171 . . . . 0.0 109.763 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.47 -165.45 11.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -94.32 26.92 3.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.3 -1.118 . . . . 0.0 108.191 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 41.83 -173.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.629 0.728 . . . . 0.0 109.811 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.58 HG21 HD22 ' A' ' 15' ' ' ASN . 0.0 OUTLIER -118.48 -61.78 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.099 -1.001 . . . . 0.0 111.114 -177.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.772 ' H ' ' CB ' ' A' ' 61' ' ' ARG . 1.3 tm0? -176.59 107.19 0.07 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.898 -0.501 . . . . 0.0 109.675 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -97.74 132.47 43.34 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.879 -1.138 . . . . 0.0 107.96 179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -141.58 159.17 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.633 -1.292 . . . . 0.0 110.356 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.31 137.18 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -120.26 123.67 43.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.658 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.444 -0.785 . . . . 0.0 109.085 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.758 ' O ' HG13 ' A' ' 57' ' ' VAL . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -163.12 157.42 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.484 -1.01 . . . . 0.0 109.77 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.641 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -110.32 174.01 6.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HD21 ' A' ' 46' ' ' LEU . 3.1 m-85 -143.47 104.21 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.784 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.064 HG21 HD23 ' A' ' 75' ' ' LEU . 1.1 t -82.47 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.941 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -119.23 135.37 54.72 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.477 -177.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 1.019 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 7.1 m-85 -155.3 137.98 15.18 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' A' ' 12' ' ' LYS . 7.5 p30 -118.78 -50.28 2.41 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.468 -1.395 . . . . 0.0 110.194 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -53.88 137.08 39.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.4 OUTLIER -63.12 -43.07 99.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 0.0 109.043 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.18 -43.19 67.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 108.772 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.602 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -61.76 -25.61 67.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' GLN . . . -72.89 -48.19 39.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.736 -1.227 . . . . 0.0 107.854 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 8.3 tp-100 -49.43 -32.97 12.88 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -58.89 -67.89 0.32 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.019 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -45.8 -22.05 0.16 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.212 0.529 . . . . 0.0 109.641 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 15.6 mm -74.35 -70.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.406 -1.434 . . . . 0.0 108.657 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.11 22.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.53 -0.731 . . . . 0.0 110.334 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -138.66 -50.57 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.064 HD23 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -79.44 -42.09 26.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 8.0 t-20 -39.2 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.347 -0.845 . . . . 0.0 109.139 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.537 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 2.1 m-20 80.9 80.04 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.8 p -85.28 53.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.791 . . . . 0.0 108.951 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' GLN . 4.6 pt -117.22 173.93 2.83 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.213 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -90.62 20.35 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.97 1.51 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 69.54 70.53 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.38 -31.41 0.23 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.59 -140.18 0.82 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.47 38.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 109.375 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.509 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 29.7 mm-40 -130.55 82.86 63.87 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' O ' HD12 ' A' ' 21' ' ' LEU . 36.8 Cg_endo -108.89 164.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.061 1.559 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -112.33 124.4 52.39 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.189 -0.945 . . . . 0.0 110.321 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 12.9 m -79.13 105.68 10.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 22.7 m -77.26 -167.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.986 -0.446 . . . . 0.0 111.611 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 104.27 108.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 93' ' ' GLU . 9.5 tp -36.64 145.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.523 0.677 . . . . 0.0 110.257 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -77.1 -67.68 0.69 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 0.0 109.402 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.654 ' O ' HD23 ' A' ' 91' ' ' LEU . 43.5 mm-40 -116.8 -170.58 1.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.457 -0.777 . . . . 0.0 109.294 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.4 9.37 29.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 109.9 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 96' ' ' GLY . 18.9 p80 -97.6 -30.52 12.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 95' ' ' HIS . . . 49.08 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.405 ' HG3' ' HB2' ' A' ' 42' ' ' GLN . 8.1 tmtm? . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.588 ' CG ' ' O ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.502 ' CB ' ' C ' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -79.2 -2.21 39.91 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.984 -1.072 . . . . 0.0 110.538 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.096 HG21 ' HB2' ' A' ' 68' ' ' ALA . 15.7 m -162.52 93.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.891 -1.131 . . . . 0.0 110.405 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.648 ' N ' HD11 ' A' ' 91' ' ' LEU . 13.9 t-20 -84.68 106.02 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.986 -1.071 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -79.13 103.57 9.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.926 -1.109 . . . . 0.0 109.149 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -93.85 86.86 5.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.015 HG23 ' HB3' ' A' ' 58' ' ' ALA . 2.6 m -89.52 97.43 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.306 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 1.007 HG23 HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -92.01 -165.53 1.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.575 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.68 ' H ' HG22 ' A' ' 19' ' ' THR . 1.7 t30 53.39 84.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.107 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -146.51 132.95 9.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.5 Cg_endo -104.0 39.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.891 1.469 . . . . 0.0 109.897 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 15.2 mtt85 36.52 61.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.294 0.568 . . . . 0.0 110.338 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.997 HG23 HG13 ' A' ' 25' ' ' ILE . 7.4 t -97.48 -16.19 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.248 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.997 HG13 HG23 ' A' ' 24' ' ' THR . 0.2 OUTLIER -127.2 179.25 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.3 p -105.63 158.45 16.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.202 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 43' ' ' LYS . 9.7 t0 -55.75 -62.45 1.68 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.643 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.79 -15.59 4.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.757 ' OE1' HG22 ' A' ' 25' ' ' ILE . 1.7 tt0 -75.27 -51.76 12.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.829 -1.17 . . . . 0.0 110.354 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.629 HD11 HD13 ' A' ' 25' ' ' ILE . 4.6 mp -46.56 -32.16 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.82 -1.175 . . . . 0.0 108.476 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 4.2 t70 -48.66 -52.85 21.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 108.652 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 m -63.22 -41.51 99.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.466 -0.771 . . . . 0.0 109.042 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.54 -13.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 108.864 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 1.047 ' CZ ' HD13 ' A' ' 75' ' ' LEU . 7.4 m-30 -83.91 -74.26 0.38 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' LYS . . . 144.3 -90.88 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 162.99 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.711 -0.876 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -79.81 -81.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.96 166.6 14.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 40' ' ' ILE . 15.5 m -78.58 94.47 5.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.834 -1.391 . . . . 0.0 108.293 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.2 mp -34.67 117.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 61' ' ' ARG . 1.0 OUTLIER -80.1 18.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 111.009 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.659 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 163.65 138.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 177.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -145.96 76.7 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -94.85 174.1 7.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.0 tt -126.58 104.15 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 110.347 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HA ' ' N ' ' A' ' 57' ' ' VAL . 8.4 mp 52.85 -141.62 0.84 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.516 -0.74 . . . . 0.0 110.011 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' N ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.888 0 O-C-N 120.966 -1.084 . . . . 0.0 109.482 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 1.007 HG22 HG23 ' A' ' 19' ' ' THR . 44.6 t -159.02 153.16 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.114 -1.227 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.015 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -75.97 127.0 32.06 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.607 ' CE1' ' O ' ' A' ' 57' ' ' VAL . 91.6 m-85 -103.35 83.17 2.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 112.091 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 16' ' ' LEU . 3.3 t -86.53 77.55 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.66 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.7 ttm180 -76.82 113.21 14.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.594 -1.316 . . . . 0.0 110.695 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.731 ' CE1' HG13 ' A' ' 60' ' ' VAL . 3.6 m-85 -114.36 -173.87 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -131.29 -100.78 0.29 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.097 -1.441 . . . . 0.0 110.337 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 63' ' ' ASN . 26.1 tttp -24.4 136.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.618 0.723 . . . . 0.0 111.795 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' NH2' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -55.95 -52.37 64.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.465 ' O ' ' OE1' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -52.4 -39.65 61.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -49.49 -47.0 48.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.096 ' HB2' HG21 ' A' ' 14' ' ' THR . . . -57.72 -39.32 76.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.389 -0.819 . . . . 0.0 108.813 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -51.1 -37.08 43.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 108.205 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.4 mt-10 -74.8 -62.45 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.852 0.834 . . . . 0.0 109.751 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.706 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -52.76 -16.14 0.91 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.469 0.652 . . . . 0.0 110.931 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 5.0 mt -92.37 -60.33 2.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.418 -1.426 . . . . 0.0 109.465 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -66.69 -5.31 11.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 0.0 109.959 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' C ' HD23 ' A' ' 75' ' ' LEU . . . -112.7 -53.94 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.944 -1.098 . . . . 0.0 109.961 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -81.27 -39.34 25.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.016 -1.053 . . . . 0.0 109.879 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' HG21 ' A' ' 89' ' ' VAL . 61.5 t-20 -43.79 111.68 0.31 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.616 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 74.8 91.03 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.993 0.901 . . . . 0.0 109.207 -178.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.899 HG23 HG12 ' A' ' 33' ' ' ILE . 3.1 p -103.7 38.48 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -148.56 -175.16 0.45 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.926 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -63.58 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 116.966 -1.556 . . . . 0.0 110.239 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 38.7 tt0 179.16 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.062 -1.024 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.16 55.95 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.32 -81.7 0.16 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 1.021 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -79.26 5.14 13.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.162 . . . . 0.0 109.749 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 84' ' ' SER . 36.1 mt-30 70.35 86.36 0.12 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.149 -0.969 . . . . 0.0 109.152 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.679 ' HA ' HD11 ' A' ' 79' ' ' ILE . 35.0 Cg_endo -58.69 -173.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.363 1.717 . . . . 0.0 111.927 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.793 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.99 152.75 18.05 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -99.69 100.45 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 76' ' ' ASN . 2.5 m -78.11 172.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.734 -0.604 . . . . 0.0 110.715 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 10.8 ttt180 127.5 138.63 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.648 HD11 ' N ' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -65.09 138.16 58.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -93.71 179.51 5.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.65 176.23 5.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' HIS . 4.0 mt-10 61.16 178.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLU . 96.8 m-70 -44.21 154.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.377 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.33 -40.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' A' ' 61' ' ' ARG . 16.0 pttt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 18.6 mmtp . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 120.986 0.422 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.579 ' CB ' ' CB ' ' A' ' 63' ' ' ASN . 23.5 m-20 -162.61 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.964 -1.085 . . . . 0.0 110.251 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.137 ' CG2' HD11 ' A' ' 91' ' ' LEU . 4.4 m -162.75 94.14 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.964 . . . . 0.0 111.134 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.791 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -102.96 165.47 11.01 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.035 -1.041 . . . . 0.0 108.891 178.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HB ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -132.05 122.07 24.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.311 -1.493 . . . . 0.0 110.356 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -79.47 117.88 20.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 89' ' ' VAL . 15.6 m -97.33 146.08 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.477 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -124.03 167.29 14.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.2 m-20 72.4 18.05 4.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.412 -0.805 . . . . 0.0 109.398 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.9 tm? -53.73 109.61 1.6 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 109.998 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.4 Cg_endo -82.08 147.42 14.76 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.044 1.55 . . . . 0.0 109.794 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 19.63 3.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.958 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 22' ' ' PRO . 11.3 t -89.19 -6.05 57.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.395 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.04 -166.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -57.78 -55.99 27.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 108.981 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' GLN . 3.1 p30 -49.36 -24.2 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.257 -0.902 . . . . 0.0 108.869 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 26' ' ' THR . 59.5 tt0 -71.89 -45.07 62.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 109.125 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 87' ' ' LEU . 6.9 mp -46.8 -35.58 6.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.255 -0.903 . . . . 0.0 108.721 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 5.6 t0 -49.2 -50.68 37.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.977 -1.077 . . . . 0.0 109.263 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 m -80.87 -15.34 56.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.647 HG12 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -67.98 -47.73 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 109.805 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.87 ' CD1' HD11 ' A' ' 75' ' ' LEU . 20.1 p90 -92.74 -41.63 10.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.745 -1.222 . . . . 0.0 109.423 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' LYS . . . 127.51 -78.17 0.39 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 1.6 tptp 174.74 78.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -1.088 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.875 ' HE2' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -79.71 -104.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' N ' ' HB3' ' A' ' 67' ' ' GLU . . . -68.89 176.34 29.62 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' VAL . 14.3 t -78.56 81.82 4.86 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.831 -1.394 . . . . 0.0 107.793 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.82 HD13 ' HZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -35.51 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.14 0.972 . . . . 0.0 108.447 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 61' ' ' ARG . 28.4 m -79.25 47.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.286 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.639 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 5.5 tt0 96.81 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.26 0.553 . . . . 0.0 111.449 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.485 ' CD ' ' O ' ' A' ' 27' ' ' ASP . 8.4 ptpp? -92.24 132.17 36.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.525 ' N ' ' OD2' ' A' ' 27' ' ' ASP . 6.3 p30 -129.69 161.62 30.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.59 -1.318 . . . . 0.0 110.789 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.72 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.33 169.0 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.58 117.88 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.414 -0.804 . . . . 0.0 109.067 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' CE1' ' A' ' 59' ' ' PHE . 85.1 t -130.39 145.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.117 . . . . 0.0 109.032 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.89 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -149.15 174.83 11.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.055 . . . . 0.0 109.543 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 33.6 m-85 -154.55 107.65 2.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 75' ' ' LEU . 2.2 t -84.81 102.95 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.776 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.8 mtm180 -83.35 128.66 34.69 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.036 -1.04 . . . . 0.0 110.411 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.825 ' CZ ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -162.52 173.56 13.84 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' CB ' ' A' ' 13' ' ' ASP . 7.7 p30 -112.11 -114.84 0.32 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 117.68 -1.608 . . . . 0.0 110.861 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 10.6 mmtt 16.52 108.74 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.282 0.563 . . . . 0.0 112.343 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.691 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -57.47 -40.87 79.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.983 -1.073 . . . . 0.0 109.58 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -38.97 86.39 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' N ' ' A' ' 38' ' ' GLY . 60.8 mm-40 -59.7 -30.91 69.12 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 62' ' ' TYR . . . -67.17 -37.87 84.47 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -53.52 -35.23 60.46 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.7 mp0 -61.4 -52.48 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.606 ' CA ' ' HB2' ' A' ' 75' ' ' LEU . . . -67.01 -5.21 11.99 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.594 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.608 HD13 HG23 ' A' ' 89' ' ' VAL . 14.0 mm -84.49 -57.42 4.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -79.67 0.84 28.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.946 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.28 -44.16 1.59 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.026 -1.046 . . . . 0.0 109.906 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -89.34 -28.43 19.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.74 ' HA ' HG22 ' A' ' 89' ' ' VAL . 34.3 t-20 -46.67 -27.5 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.217 -1.552 . . . . 0.0 109.453 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -148.53 78.81 1.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 87' ' ' LEU . 1.5 t -85.4 107.28 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.998 -1.064 . . . . 0.0 108.97 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.53 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 174.19 164.6 0.33 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.6 Cg_endo -86.47 37.41 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.703 1.37 . . . . 0.0 110.477 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' PRO . 4.0 mt-10 40.24 44.45 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.498 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.11 -19.95 17.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 84' ' ' SER . . . -141.65 -108.73 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 41.4 t 175.76 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -1.098 . . . . 0.0 109.456 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.6 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.0 pt20 -143.94 32.95 0.13 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.955 . . . . 0.0 110.632 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 37.8 Cg_endo -68.31 -162.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.424 1.223 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -100.19 114.57 28.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.812 -1.155 . . . . 0.0 109.657 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -79.1 116.04 19.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 177.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 18' ' ' VAL . 17.4 m -94.38 171.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.982 0.896 . . . . 0.0 112.003 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER 166.47 116.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.137 HD11 ' CG2' ' A' ' 14' ' ' THR . 2.3 mt -41.94 109.3 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.197 -0.94 . . . . 0.0 109.477 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 17' ' ' TYR . . . -58.55 -156.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.113 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.4 tp10 -171.7 99.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.994 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 78.69 3.51 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.557 -0.714 . . . . 0.0 110.046 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 95' ' ' HIS . 0.3 OUTLIER -73.57 174.18 8.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.47 47.8 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.434 ' OXT' ' NH1' ' A' ' 61' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.239 -1.153 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 1.8 mttt . . . . . 0 N--CA 1.484 1.262 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' N ' ' HB2' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -156.35 98.17 1.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.894 -1.754 . . . . 0.0 112.192 -179.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.595 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 16.5 m -162.71 49.66 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.76 HD21 HG23 ' A' ' 41' ' ' VAL . 2.0 m120 -76.04 -177.46 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.66 0.743 . . . . 0.0 110.498 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.942 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -142.9 129.06 19.77 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.744 0.783 . . . . 0.0 109.741 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.72 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 1.1 t80 -78.86 95.89 5.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.697 -0.627 . . . . 0.0 109.914 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 1.094 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 16.4 m -80.07 106.54 11.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 16.3 p -99.86 166.73 10.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.135 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.431 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 2.0 m120 62.76 75.29 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.429 -0.795 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.67 158.0 68.94 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 109.347 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' HG2' ' CG2' ' A' ' 24' ' ' THR . 36.5 Cg_endo -94.74 -175.4 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.053 1.554 . . . . 0.0 109.994 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 6.83 47.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 25' ' ' ILE . 1.3 t -80.48 -6.25 57.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.678 HG23 HG23 ' A' ' 24' ' ' THR . 1.7 pp -127.96 127.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.556 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.6 p -99.68 170.98 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.809 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.0 -53.46 38.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.57 -11.71 37.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 30' ' ' LEU . 35.7 tt0 -78.36 -56.29 4.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.987 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 mp -44.64 -39.07 4.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 5.3 t70 -58.97 -48.29 82.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.038 -1.039 . . . . 0.0 109.829 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -23.03 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.49 -0.756 . . . . 0.0 110.065 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.44 -26.44 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.741 -1.224 . . . . 0.0 109.731 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 33' ' ' ILE . 4.3 m-85 -111.53 -73.44 0.68 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.11 -0.994 . . . . 0.0 109.153 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 34.11 78.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -171.92 28.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.952 -1.322 . . . . 0.0 111.028 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CE2' ' CZ ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -133.97 -96.72 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.706 -1.246 . . . . 0.0 109.758 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 -167.74 16.52 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.55 ' O ' ' C ' ' A' ' 40' ' ' ILE . 4.5 t -80.16 78.71 6.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.339 -1.095 . . . . 0.0 108.856 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -24.65 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 HD21 ' A' ' 15' ' ' ASN . 5.5 m -100.14 58.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.674 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 2.5 tt0 92.47 117.96 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.101 0.953 . . . . 0.0 113.267 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.788 ' HE3' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -115.95 138.09 51.51 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -151.53 174.31 13.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.286 -1.509 . . . . 0.0 111.282 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 26' ' ' THR . 37.3 mt -145.64 111.08 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 18.3 mt -100.65 143.98 30.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.616 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 17' ' ' TYR . 19.8 m -144.98 165.38 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -1.127 . . . . 0.0 109.655 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.094 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -157.09 175.35 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.838 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -141.27 104.91 4.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 0.0 108.991 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.3 t -78.21 148.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.81 -1.181 . . . . 0.0 108.132 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.874 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -85.37 125.86 33.3 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.447 0.641 . . . . 0.0 110.136 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.857 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -163.63 147.21 10.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.934 -1.104 . . . . 0.0 108.472 179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.668 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.2 t-20 -135.02 -91.28 0.32 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.472 -1.392 . . . . 0.0 109.449 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.668 ' C ' ' O ' ' A' ' 63' ' ' ASN . 11.5 mptt -14.72 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.538 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.99 -47.85 0.08 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.83 -0.544 . . . . 0.0 110.238 -177.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.89 -50.88 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 42.5 mm-40 -46.86 -43.99 19.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . . . -60.14 -41.86 93.59 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.088 -1.632 . . . . 0.0 107.183 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.1 -37.47 6.88 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.776 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -62.83 -49.31 75.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -62.83 -11.92 21.23 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.142 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 68' ' ' ALA . 49.7 mm -84.44 -69.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.865 -1.147 . . . . 0.0 108.35 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.95 3.71 7.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -124.65 -51.87 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.051 . . . . 0.0 109.723 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.017 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -81.21 -35.35 31.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 0.0 110.225 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 1.7 p-10 -53.93 139.09 35.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.68 -1.263 . . . . 0.0 109.262 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER 52.9 50.55 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.23 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 ' CE1' ' A' ' 34' ' ' PHE . 2.5 t -88.56 82.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -141.94 -164.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -92.45 26.73 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.559 1.294 . . . . 0.0 110.448 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.492 ' CG ' ' C ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER 41.54 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 0.0 109.549 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.06 44.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 106.41 -168.86 14.97 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 77.27 -4.0 2.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -1.186 . . . . 0.0 109.864 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' SER . 14.3 mt-30 60.85 145.76 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.66 147.55 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.065 1.561 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.946 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.76 121.53 18.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 17' ' ' TYR . 1.5 t -79.52 104.17 9.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.907 ' HB ' HD12 ' A' ' 16' ' ' LEU . 35.5 m -78.51 -144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 111.458 -177.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 84.79 106.52 0.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 -178.052 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -41.26 141.46 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.291 -0.88 . . . . 0.0 110.089 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -100.89 -165.85 1.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -95.55 119.31 33.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.993 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 164.85 -88.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 24.1 t-80 175.67 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 138.81 -119.45 1.75 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.072 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 120.716 0.293 . . . . 0.0 110.864 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 12' ' ' LYS . 9.9 m-20 -137.43 12.59 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.801 -1.187 . . . . 0.0 110.603 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.589 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -160.29 70.56 0.43 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -77.0 152.71 35.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.771 -1.206 . . . . 0.0 108.869 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.586 HD23 HG11 ' A' ' 60' ' ' VAL . 1.5 tp -97.49 108.8 21.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.336 -0.853 . . . . 0.0 109.957 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 33.3 t80 -79.55 87.07 5.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.525 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 58' ' ' ALA . 16.3 m -79.76 112.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.858 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 4.5 m -117.1 161.33 19.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' THR . 6.0 t-20 78.66 52.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.882 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -160.22 136.75 6.46 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -86.74 -177.48 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.897 1.472 . . . . 0.0 110.108 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 34.65 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.471 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -79.64 -54.98 5.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.915 . . . . 0.0 109.014 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.31 165.82 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.224 -0.922 . . . . 0.0 108.752 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -109.43 136.54 48.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 9.4 t0 -56.15 -60.59 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.037 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 10.0 p-10 -48.61 -21.55 0.61 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' THR . 38.7 tt0 -74.65 -45.91 41.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.979 -1.076 . . . . 0.0 110.2 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.798 HD23 ' CG2' ' A' ' 60' ' ' VAL . 4.4 mp -45.59 -25.3 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.849 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 3.0 t0 -65.97 -51.46 58.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 108.764 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 m -53.49 -52.61 58.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.757 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -63.29 -25.77 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 108.574 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -66.14 -89.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 108.869 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 9.92 58.56 0.01 OUTLIER Glycine 0 N--CA 1.503 3.12 0 C-N-CA 122.941 0.305 . . . . 0.0 112.807 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' PHE . 2.3 tttt -161.68 4.97 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.662 -1.493 . . . . 0.0 112.247 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.746 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.92 -83.81 0.09 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.381 -1.45 . . . . 0.0 110.18 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.04 -177.27 24.48 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' ILE . 56.5 m -92.93 19.6 7.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -1.21 . . . . 0.0 109.647 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.798 HD12 ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 51.33 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.369 0.604 . . . . 0.0 109.738 178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.86 ' O ' HG23 ' A' ' 41' ' ' VAL . 0.9 OUTLIER -133.16 49.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 O-C-N 120.647 -1.283 . . . . 0.0 114.253 -177.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.664 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.4 tm0? 85.23 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.582 -1.324 . . . . 0.0 112.207 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.568 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 pttp -78.5 144.58 35.58 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.128 -0.982 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.74 120.61 3.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 109.813 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.66 ' O ' HD22 ' A' ' 46' ' ' LEU . 22.8 pt -84.51 162.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.062 -1.024 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.6 110.5 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 110.496 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 9.2 tpm_? . . . . . 0 N--CA 1.491 1.578 0 O-C-N 120.495 -1.378 . . . . 0.0 110.41 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 47' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 46' ' ' LEU . 1.9 p -129.04 109.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 108.921 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.579 ' HB1' ' HA ' ' A' ' 45' ' ' ILE . . . -109.34 178.28 4.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.751 -1.218 . . . . 0.0 110.241 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 3.6 m-85 -135.59 110.38 8.71 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.798 ' CG2' HD23 ' A' ' 30' ' ' LEU . 1.1 t -77.95 157.38 5.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.798 ' NH2' HD12 ' A' ' 40' ' ' ILE . 9.2 ptt180 -95.76 108.88 21.24 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.362 0.601 . . . . 0.0 110.302 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.726 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -162.23 71.01 0.32 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.237 -0.915 . . . . 0.0 108.641 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.741 ' ND2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -68.87 -104.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 109.343 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.634 ' C ' ' O ' ' A' ' 63' ' ' ASN . 3.0 mttp 9.05 90.07 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-N 118.18 0.445 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.39 -37.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.947 -0.471 . . . . 0.0 111.102 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 65' ' ' ARG . 43.4 tt0 -64.06 -58.24 7.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 108.235 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 60.1 mt-10 -53.6 -47.61 70.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.843 . . . . 0.0 109.406 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.3 -39.16 29.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 108.725 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 2.9 tt0 -60.94 -41.51 96.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.719 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 mp0 -55.67 -49.21 73.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.47 -0.769 . . . . 0.0 109.956 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -71.21 -13.69 62.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.183 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 89' ' ' VAL . 2.1 mm -74.89 -64.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 108.406 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -3.14 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.578 -0.701 . . . . 0.0 110.438 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -117.36 -50.76 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.828 -1.17 . . . . 0.0 110.249 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.726 HD11 ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -79.4 -26.22 41.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 0.0 109.719 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.3 t-20 -47.37 102.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.653 -1.279 . . . . 0.0 107.978 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 7.2 m-20 72.82 92.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.7 p -85.94 53.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.008 ' O ' HD12 ' A' ' 79' ' ' ILE . 2.1 pp -133.33 140.1 36.12 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 35.9 Cg_endo -40.87 -76.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.936 1.493 . . . . 0.0 110.527 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 11.4 tp10 176.53 152.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.203 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . 115.54 3.27 20.72 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 131.72 -161.96 23.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.663 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.4 m 84.16 -62.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.784 -0.833 . . . . 0.0 109.429 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.534 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.3 pt20 27.05 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 122.12 -0.362 . . . . 0.0 110.732 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.922 ' O ' HD12 ' A' ' 87' ' ' LEU . 37.3 Cg_endo -127.19 65.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.54 1.284 . . . . 0.0 111.428 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 174.5 87.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.5 t -81.17 107.41 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 72' ' ' ILE . 24.7 m -83.77 147.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.528 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 28.4 ptt180 152.96 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 92' ' ' ALA . 8.9 tt -58.63 149.45 25.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.788 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.795 ' N ' HD23 ' A' ' 91' ' ' LEU . . . -123.34 -58.78 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 109.958 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.99 178.13 7.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.782 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -118.22 80.35 1.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 132.28 3.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.5 -175.43 52.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 16.5 p-10 -160.69 92.96 0.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.765 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.697 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 p -144.24 43.38 1.42 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -75.36 155.38 36.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.62 142.83 29.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.477 -1.689 . . . . 0.0 110.223 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 88' ' ' SER . 1.8 t80 -78.52 78.84 4.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.957 HG23 ' HB3' ' A' ' 58' ' ' ALA . 24.6 m -77.89 105.46 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.003 0.906 . . . . 0.0 109.699 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.851 HG22 HG12 ' A' ' 57' ' ' VAL . 53.1 p -116.85 126.1 52.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' THR . 10.0 t-20 159.01 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.632 . . . . 0.0 109.667 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.849 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -39.89 161.56 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.436 -179.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -117.95 50.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.903 1.475 . . . . 0.0 110.131 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.06 21.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.554 -0.717 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.602 HG23 HG23 ' A' ' 25' ' ' ILE . 12.5 t -87.53 -24.34 24.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.29 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.602 HG23 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -107.54 -164.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 108.955 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.688 HG23 ' CB ' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -132.48 130.3 40.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.021 -1.049 . . . . 0.0 109.989 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.504 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -59.58 -50.0 75.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.951 -1.093 . . . . 0.0 108.627 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -49.28 -26.62 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.323 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.688 ' CB ' HG23 ' A' ' 26' ' ' THR . 8.2 tt0 -74.84 -42.4 58.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.7 mp -46.67 -32.98 3.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 109.896 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.605 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -60.34 -62.59 1.75 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.866 -1.146 . . . . 0.0 109.511 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 32' ' ' THR . 12.1 m -62.42 -9.62 8.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.503 -0.748 . . . . 0.0 110.121 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 30' ' ' LEU . 2.6 tt -83.96 -40.24 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.945 -1.097 . . . . 0.0 110.029 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.822 ' CE2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.4 -54.24 2.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.512 -1.368 . . . . 0.0 110.456 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 16.55 67.32 0.01 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -141.49 -25.8 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.278 . . . . 0.0 111.601 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -96.2 -37.58 10.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.606 -1.309 . . . . 0.0 109.242 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.4 -163.96 10.91 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.668 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -109.96 35.94 3.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -1.172 . . . . 0.0 109.217 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.782 HG22 ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 43.27 147.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 CA-C-O 122.125 0.964 . . . . 0.0 111.418 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 63' ' ' ASN . 96.8 t -109.44 -38.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 119.975 -1.703 . . . . 0.0 113.901 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.901 ' C ' ' HG2' ' A' ' 61' ' ' ARG . 1.1 tm0? 177.96 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 O-C-N 120.464 -1.397 . . . . 0.0 110.962 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.798 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -112.57 150.66 31.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.404 -0.81 . . . . 0.0 109.923 -177.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -159.47 172.95 16.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 109.156 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 tt -155.19 146.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.734 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.513 HD21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -152.56 144.66 23.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 109.694 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.845 ' O ' HG13 ' A' ' 57' ' ' VAL . . . . . . . . 0 C--O 1.214 -1.149 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 19' ' ' THR . 1.2 m -165.38 176.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 121.863 -0.786 . . . . 0.0 110.048 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.957 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -147.86 159.73 43.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -131.97 116.73 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.851 HG21 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.52 162.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.357 -1.464 . . . . 0.0 109.864 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.901 ' HG2' ' C ' ' A' ' 42' ' ' GLN . 3.6 mtm180 -79.73 107.49 12.54 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.982 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 44.2 m-85 -163.95 143.99 8.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.695 -1.253 . . . . 0.0 110.089 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.756 ' HB3' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -125.41 -132.69 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.62 ' C ' ' O ' ' A' ' 63' ' ' ASN . 1.8 mtpt 17.59 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.912 0.778 . . . . 0.0 110.386 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.575 ' H ' ' HD3' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -28.87 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.922 -0.486 . . . . 0.0 110.599 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 64' ' ' LYS . 2.3 tt0 -64.0 -56.0 18.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 108.313 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -44.99 -44.68 10.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.005 ' CB ' HD21 ' A' ' 91' ' ' LEU . . . -56.12 -45.96 79.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.6 -1.313 . . . . 0.0 107.715 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 tt0 -45.35 -39.04 6.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 78.5 mm-40 -57.62 -54.93 41.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -61.2 -13.26 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.729 0.776 . . . . 0.0 110.025 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 6.7 mm -82.98 -62.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 O-C-N 120.621 -1.299 . . . . 0.0 108.679 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.58 6.69 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.965 . . . . 0.0 109.797 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -128.9 -52.53 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.851 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.31 -26.23 42.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.171 -0.955 . . . . 0.0 109.97 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.91 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.354 -1.467 . . . . 0.0 107.664 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' LEU . 3.8 m-20 74.21 58.67 0.08 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 108.684 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.973 HG23 HD21 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -79.45 78.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.184 -0.947 . . . . 0.0 108.773 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -133.0 -163.51 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.4 Cg_endo -102.52 38.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.021 1.537 . . . . 0.0 109.984 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 47.68 60.14 3.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.35 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 163.2 -46.28 0.32 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -53.52 -175.61 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -128.75 75.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.262 . . . . 0.0 109.716 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.539 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -165.83 64.41 0.93 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -92.48 -170.65 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.969 1.51 . . . . 0.0 110.581 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.973 HD21 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -149.61 124.69 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 13.9 t -78.03 100.14 6.38 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 16' ' ' LEU . 34.6 m -78.55 146.4 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.928 0.87 . . . . 0.0 111.948 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.9 tmm_? 168.41 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.005 HD21 ' CB ' ' A' ' 68' ' ' ALA . 1.1 mp -36.89 145.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.412 0.625 . . . . 0.0 110.417 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.69 -166.83 1.43 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 109.261 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 71.9 1.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.106 -0.996 . . . . 0.0 109.34 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.59 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -58.08 152.71 16.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.219 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 13' ' ' ASP . . . -130.91 -116.62 1.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 0.0 109.725 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 13' ' ' ASP . 25.3 t0 -145.46 84.59 1.69 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.664 -1.273 . . . . 0.0 111.948 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.051 HG23 ' CB ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER -162.04 38.07 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -174.01 2.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.863 ' CG ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -108.26 123.47 48.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.483 0.659 . . . . 0.0 110.712 -178.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 11.1 t80 -90.59 94.71 9.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.964 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 19.5 m -91.77 130.42 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 110.463 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.75 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.6 p -126.98 -175.67 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 55.04 70.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.624 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.58 ' C ' HD12 ' A' ' 21' ' ' LEU . 3.9 pp 178.8 151.41 0.47 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 36.8 Cg_endo -110.15 -169.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.008 1.53 . . . . 0.0 110.037 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.51 41.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.662 HG23 HG23 ' A' ' 25' ' ' ILE . 2.1 t -80.58 -29.43 37.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 24' ' ' THR . 37.2 pt -108.32 162.46 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.44 136.7 39.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 4.3 p-10 -61.94 -47.49 84.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 25.9 t0 -54.42 -19.8 6.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.182 -0.949 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 26' ' ' THR . 13.8 mt-30 -77.13 -53.14 8.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.67 ' O ' HG22 ' A' ' 33' ' ' ILE . 4.6 mp -44.72 -34.04 2.09 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.634 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.578 ' N ' ' HE3' ' A' ' 43' ' ' LYS . 4.8 t70 -50.52 -63.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.2 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -64.23 -14.75 57.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.909 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -79.66 -23.22 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.973 ' CE2' HD11 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -150.22 35.36 0.65 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.8 -1.188 . . . . 0.0 110.853 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.981 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -88.34 57.54 4.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -131.94 -8.92 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 110.575 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -115.19 47.3 1.31 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.823 -1.173 . . . . 0.0 109.568 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . 122.77 171.9 13.85 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 40' ' ' ILE . 3.3 m -91.47 93.83 9.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.376 -1.073 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.981 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -29.38 143.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-O 121.259 0.552 . . . . 0.0 110.259 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -105.57 50.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -175.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.676 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 85.88 95.58 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 120.553 -1.342 . . . . 0.0 112.839 177.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 1.072 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 3.0 mttm -81.31 117.46 21.82 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.083 -1.011 . . . . 0.0 109.65 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -122.03 153.51 38.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 108.944 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' A' ' 27' ' ' ASP . 11.1 pt -130.5 159.1 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -157.49 130.92 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 19' ' ' THR . 2.3 m -128.53 154.43 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.147 -1.208 . . . . 0.0 110.069 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.84 176.69 4.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.683 ' CD1' HD21 ' A' ' 46' ' ' LEU . 6.8 m-85 -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.072 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -79.18 157.51 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.729 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -103.87 104.75 14.78 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.654 0.74 . . . . 0.0 109.895 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -161.01 80.78 0.63 Allowed 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 1.051 ' CB ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -77.13 -115.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.814 -1.154 . . . . 0.0 108.748 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 27.53 89.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.683 0.674 . . . . 0.0 109.555 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -27.91 -41.95 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.777 -0.577 . . . . 0.0 110.544 -177.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' LYS . 3.8 mm-40 -67.1 -56.3 10.61 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.882 -1.136 . . . . 0.0 108.109 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -46.86 -49.15 20.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -52.91 -45.52 67.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.599 -1.313 . . . . 0.0 107.944 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HA ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.64 -42.82 35.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 1.0 OUTLIER -60.25 -68.81 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.678 . . . . 0.0 109.872 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 75' ' ' LEU . . . -45.91 -20.05 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 110.104 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.81 ' HA ' HG21 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -71.41 -66.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.58 -1.325 . . . . 0.0 108.219 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -78.53 10.47 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.095 -1.003 . . . . 0.0 110.382 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.73 -56.79 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 109.921 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.973 HD11 ' CE2' ' A' ' 34' ' ' PHE . 51.3 mt -77.38 -33.22 55.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.14 133.29 28.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.709 -1.244 . . . . 0.0 108.259 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.642 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 68.54 55.69 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 109.682 -179.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 87' ' ' LEU . 14.9 p -85.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 108.677 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -132.21 176.25 3.05 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -87.61 44.57 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.842 1.443 . . . . 0.0 109.128 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 80' ' ' PRO . 10.8 pt-20 40.9 45.67 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.5 77.51 0.3 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.08 -36.89 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.488 ' H ' HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER 67.51 45.41 1.55 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.661 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 5.6 mm-40 -128.2 49.74 4.79 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 109.091 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 37.9 Cg_endo -88.52 -162.4 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.759 1.4 . . . . 0.0 111.389 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.666 HD23 HG11 ' A' ' 18' ' ' VAL . 4.8 mp -85.94 124.96 32.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.807 -0.558 . . . . 0.0 110.013 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.4 m -79.26 96.67 6.0 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.863 HG23 ' CG ' ' A' ' 16' ' ' LEU . 8.8 p -75.66 143.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.4 1.095 . . . . 0.0 112.012 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER 175.37 -130.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 92' ' ' ALA . 12.3 tp -149.06 152.02 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.395 -1.441 . . . . 0.0 110.113 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.759 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -126.46 -171.05 2.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 109.559 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.86 -174.08 3.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.19 150.08 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.7 -172.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.52 -61.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.268 -1.137 . . . . 0.0 109.444 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.226 0 CA-C-O 121.219 0.533 . . . . 0.0 110.101 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 70.4 m-20 -149.11 -87.4 0.08 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.57 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.033 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -163.26 105.13 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.906 -1.121 . . . . 0.0 109.73 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.843 ' H ' HD21 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -77.85 -178.95 5.71 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.436 -1.415 . . . . 0.0 108.192 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.117 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -137.02 112.24 9.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.842 -1.161 . . . . 0.0 110.119 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 8.8 t80 -93.92 101.62 13.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.922 . . . . 0.0 108.841 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.825 HG11 HD23 ' A' ' 87' ' ' LEU . 2.8 m -100.79 113.88 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 0.0 109.929 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -83.18 166.42 18.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.985 . . . . 0.0 109.613 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER 76.91 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.206 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.972 HD22 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER 49.53 101.24 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 110.103 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 84' ' ' SER . 36.8 Cg_endo -76.5 140.6 21.64 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.061 1.559 . . . . 0.0 109.631 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.8 41.91 1.05 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -0.967 . . . . 0.0 109.401 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -3.19 30.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.78 179.63 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 p -106.64 155.87 19.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 2.9 p30 -62.05 -42.82 99.59 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 2.6 m-20 -53.84 -27.11 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 108.974 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -33.58 31.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -52.44 -33.56 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -60.12 -46.01 91.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.035 . . . . 0.0 108.418 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 5.9 m -61.1 -43.18 99.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 78' ' ' VAL . 3.0 mm -52.71 -30.64 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 1.158 ' CE1' HD13 ' A' ' 75' ' ' LEU . 4.0 m-30 -79.15 -77.57 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.591 -0.693 . . . . 0.0 109.887 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 36' ' ' LYS . . . 141.12 -82.31 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 166.08 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -1.196 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 3.8 m-85 -78.77 -70.13 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.348 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.05 -169.4 15.5 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 40' ' ' ILE . 48.6 p -78.99 77.18 5.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 108.338 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.934 HD12 HH21 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -40.46 146.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.672 ' N ' ' HB2' ' A' ' 61' ' ' ARG . 28.8 m -111.2 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.857 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 50.2 tt0 62.53 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.13 -0.981 . . . . 0.0 112.803 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 3.2 mtmm -75.56 163.27 27.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.369 -0.832 . . . . 0.0 109.506 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 1.1 m-80 -149.3 106.22 3.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.925 . . . . 0.0 109.592 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.497 HD13 ' HD3' ' A' ' 47' ' ' ARG . 12.3 tt -87.53 141.14 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -120.06 110.39 16.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.564 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 23' ' ' ARG . 2.1 ptm180 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 10.1 p -148.42 159.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.134 . . . . 0.0 109.04 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -160.17 -175.11 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -155.18 104.66 2.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 16' ' ' LEU . 2.7 p -79.33 157.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.271 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.934 HH21 HD12 ' A' ' 40' ' ' ILE . 3.8 ptt180 -84.1 142.35 30.45 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.934 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.808 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -161.42 164.94 29.54 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -145.04 -101.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.366 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 5.1 mmtp -22.15 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.647 -0.658 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.54 ' NH2' ' HA ' ' A' ' 13' ' ' ASP . 32.2 mmt-85 -43.39 -50.59 6.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.187 -0.945 . . . . 0.0 108.558 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 67.6 mt-10 -55.06 -44.8 75.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -47.95 -60.78 2.35 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.666 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.033 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -46.31 -37.01 6.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.757 -1.215 . . . . 0.0 108.19 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -51.66 -53.7 36.02 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' ILE . 4.4 mm-40 -51.28 -67.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.117 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -34.12 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.826 ' HA ' HG11 ' A' ' 89' ' ' VAL . 1.5 mm -70.4 -67.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.927 -1.108 . . . . 0.0 108.29 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -85.68 27.98 0.81 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.465 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.71 -53.41 0.49 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.966 . . . . 0.0 108.486 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.158 HD13 ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -78.78 -29.15 44.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 42.0 t30 -58.3 139.84 54.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 108.86 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.462 ' OD1' ' CB ' ' A' ' 86' ' ' PRO . 3.0 m120 58.88 63.5 1.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.053 -1.03 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.068 ' CG1' HD13 ' A' ' 87' ' ' LEU . 1.5 p -85.7 65.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.769 HG21 ' HB3' ' A' ' 84' ' ' SER . 1.0 OUTLIER -165.4 153.24 9.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 33.7 Cg_endo -43.96 -74.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.547 1.288 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 1.1 pt-20 162.38 144.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.6 -63.16 0.29 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . -132.18 -164.65 11.08 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.769 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 79.86 -9.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -1.003 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER 62.25 154.08 0.11 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.073 -1.017 . . . . 0.0 109.462 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.462 ' CB ' ' OD1' ' A' ' 77' ' ' ASN . 36.4 Cg_endo -107.68 157.34 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.011 1.532 . . . . 0.0 110.839 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 1.068 HD13 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mp -78.79 123.94 27.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -79.15 97.24 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 1.106 HG13 HD11 ' A' ' 16' ' ' LEU . 22.3 t -75.95 137.74 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.396 1.093 . . . . 0.0 111.442 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.406 ' H ' ' CD1' ' A' ' 16' ' ' LEU . 1.3 tpt180 -175.49 -135.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.843 HD21 ' H ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.15 135.92 9.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.67 -1.269 . . . . 0.0 109.184 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -107.34 -162.68 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -171.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.96 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 176.8 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.98 138.2 0.25 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.32 -0.862 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.77 123.66 29.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.206 -1.173 . . . . 0.0 109.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.593 0.235 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -130.8 -74.66 0.53 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.651 -1.281 . . . . 0.0 110.707 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 1.132 HG22 ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -160.31 91.59 0.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.01 -1.056 . . . . 0.0 110.245 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 4.4 t30 -79.25 169.24 18.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -0.877 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.906 HD12 HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -143.92 136.02 26.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.67 -1.269 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' ' CZ ' ' A' ' 59' ' ' PHE . 5.1 t80 -85.28 142.73 29.17 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.422 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.893 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 30.2 m -132.94 157.08 42.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -144.12 159.24 42.98 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.714 -179.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.6 t-20 79.51 88.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 110.299 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.741 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -159.99 150.87 15.73 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.543 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.7 Cg_endo -82.5 -176.8 3.1 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.819 1.431 . . . . 0.0 111.013 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -77.0 3.35 12.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.135 -0.978 . . . . 0.0 109.97 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.849 HG22 ' OE1' ' A' ' 29' ' ' GLN . 33.9 m -84.14 -112.94 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.802 ' CG2' HD22 ' A' ' 30' ' ' LEU . 8.8 mm 42.23 23.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.898 -1.126 . . . . 0.0 110.311 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' THR . 49.0 p -35.94 158.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.692 0.758 . . . . 0.0 110.616 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 16.7 m-20 -60.27 -27.38 67.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.88 -13.03 34.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.849 ' OE1' HG22 ' A' ' 24' ' ' THR . 2.4 mt-30 -79.88 -66.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 25' ' ' ILE . 2.1 mp -57.03 -28.77 62.8 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.248 -1.381 . . . . 0.0 107.98 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -62.44 -43.33 99.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 108.672 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 m -55.75 -56.53 19.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 30' ' ' LEU . 8.4 tp -62.13 -18.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.701 ' HZ ' HD21 ' A' ' 75' ' ' LEU . 6.9 m-85 -86.9 -98.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 18.22 62.53 0.01 OUTLIER Glycine 0 N--CA 1.498 2.832 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER 178.15 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 111.074 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -128.19 50.39 2.07 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.416 -1.427 . . . . 0.0 111.179 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' ' CD1' ' A' ' 62' ' ' TYR . . . 26.21 43.47 0.02 OUTLIER Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -88.84 34.61 0.77 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.46 -1.024 . . . . 0.0 109.997 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.008 HG23 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 165.34 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 61' ' ' ARG . 15.3 m -89.97 13.47 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER 165.93 53.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -42.65 144.54 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.123 -0.986 . . . . 0.0 109.98 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -152.86 150.91 29.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.03 . . . . 0.0 109.825 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 46' ' ' LEU . 1.5 mt -101.9 -178.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.567 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -148.78 105.13 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.378 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.503 ' C ' HD11 ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 46' ' ' LEU . 2.7 m -127.12 178.43 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -1.139 . . . . 0.0 109.394 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.893 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -139.7 177.11 8.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.639 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -146.48 111.27 5.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.008 HG13 HG23 ' A' ' 40' ' ' ILE . 16.9 t -95.87 148.14 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 41' ' ' VAL . 68.3 mtt180 -118.18 65.24 0.75 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.287 -1.508 . . . . 0.0 110.187 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -78.64 91.66 4.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.617 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -47.68 -84.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.891 -1.13 . . . . 0.0 110.993 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -24.03 144.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.534 0.683 . . . . 0.0 112.103 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -78.11 -51.66 9.93 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.625 -0.672 . . . . 0.0 110.364 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -67.19 -39.49 86.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.848 -1.157 . . . . 0.0 108.24 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 18.1 mt-10 -69.3 -29.13 66.93 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.979 ' HB1' HD11 ' A' ' 91' ' ' LEU . . . -63.21 -39.8 95.67 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.8 -28.24 69.32 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -57.68 -67.99 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.458 -0.776 . . . . 0.0 108.978 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -55.51 -17.63 5.68 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.315 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.538 HD13 ' CG1' ' A' ' 89' ' ' VAL . 3.0 mm -69.39 -61.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.545 -1.347 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.91 4.34 41.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.604 -0.685 . . . . 0.0 111.11 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . -131.56 -1.28 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.745 -1.222 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.701 HD21 ' HZ ' ' A' ' 34' ' ' PHE . 2.0 tp -127.87 -23.63 3.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.742 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.816 ' CA ' HG23 ' A' ' 89' ' ' VAL . 9.9 t-20 -41.1 -27.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.206 -0.933 . . . . 0.0 108.888 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 75' ' ' LEU . 91.2 m-20 -122.99 76.02 1.33 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.755 -0.59 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.3 p -84.44 48.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.178 -0.951 . . . . 0.0 108.805 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 83' ' ' GLY . 2.0 pt -124.05 -169.58 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.2 Cg_endo -110.92 40.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.983 1.517 . . . . 0.0 110.299 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER 76.97 160.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.48 -50.83 4.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 79' ' ' ILE . . . 155.67 -98.05 0.17 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' GLN . 11.6 m 62.75 10.32 4.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.13 . . . . 0.0 109.425 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 mt-30 53.29 107.7 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 0.0 110.222 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.712 ' HB3' HG23 ' A' ' 79' ' ' ILE . 37.5 Cg_endo -115.61 164.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.939 1.494 . . . . 0.0 109.163 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -72.0 108.94 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.366 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.6 t -76.54 116.46 17.25 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.906 HG11 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -79.09 174.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.519 1.152 . . . . 0.0 113.155 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.629 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.1 OUTLIER 163.7 96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.132 ' CD2' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -51.57 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.082 . . . . 0.0 109.417 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 90' ' ' ARG . . . -54.6 159.71 2.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.512 -0.742 . . . . 0.0 110.02 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -140.61 50.63 1.67 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 109.191 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -152.85 -69.03 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.385 -0.822 . . . . 0.0 109.458 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.459 ' H ' ' CD2' ' A' ' 95' ' ' HIS . 7.4 p80 -119.62 79.99 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.27 -150.68 5.74 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.501 ' OXT' ' CE ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 109.502 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CG ' ' HG2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 63' ' ' ASN . 3.9 p-10 -160.96 94.7 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.63 -1.294 . . . . 0.0 110.281 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -160.16 57.93 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.9 . . . . 0.0 110.036 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 1.1 t30 -78.59 158.06 28.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.874 . . . . 0.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.978 HD21 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -138.07 125.2 21.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.865 -1.147 . . . . 0.0 109.788 178.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 1.1 t80 -77.28 105.67 8.54 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.967 ' CG1' HD23 ' A' ' 87' ' ' LEU . 4.0 m -87.09 103.77 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 88' ' ' SER . 17.2 p -90.44 167.96 12.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.344 -0.847 . . . . 0.0 109.553 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 0.9 OUTLIER 68.15 7.55 5.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 25' ' ' ILE . 9.9 tt -71.08 115.0 32.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.118 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' HD23 ' A' ' 21' ' ' LEU . 36.6 Cg_endo -60.13 142.37 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.859 1.452 . . . . 0.0 110.289 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.71 28.62 1.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 12.11 37.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.928 . . . . 0.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.943 HD11 HD21 ' A' ' 21' ' ' LEU . 2.1 pp -130.33 170.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.498 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.2 p -113.62 153.91 28.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.351 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -49.88 -69.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 109.015 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -42.0 -27.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.498 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -62.97 -62.39 1.74 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.6 mp -52.93 -20.2 3.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.859 -1.15 . . . . 0.0 108.957 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 27.4 t0 -66.43 -47.13 74.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.089 -1.007 . . . . 0.0 108.966 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 m -68.02 -37.55 81.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.451 -0.781 . . . . 0.0 109.072 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -61.75 -27.2 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 108.889 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 10.7 m-85 -88.45 -81.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 38.19 82.83 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -173.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 109.654 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -107.79 -86.08 0.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.877 . . . . 0.0 109.109 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.6 179.29 16.42 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 40' ' ' ILE . 10.7 m -94.13 25.83 3.57 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.077 -1.249 . . . . 0.0 108.773 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.848 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.4 mp 56.91 142.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.887 HG23 ' HD2' ' A' ' 61' ' ' ARG . 33.4 m -79.21 -12.9 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.528 -1.358 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.848 ' H ' HG22 ' A' ' 40' ' ' ILE . 21.4 tt0 157.47 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.79 ' CE ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.24 144.71 44.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 108.656 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 7.0 m120 -132.68 144.46 50.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.1 . . . . 0.0 110.407 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tt -130.11 155.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' VAL . 8.5 tp -168.74 117.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.998 -1.064 . . . . 0.0 109.599 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 109.744 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' LEU . 27.4 m -117.64 160.61 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.679 ' CB ' HD13 ' A' ' 21' ' ' LEU . . . -153.4 164.31 38.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.557 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 11.1 m-85 -128.09 109.08 11.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.978 HG12 HD21 ' A' ' 16' ' ' LEU . 1.6 t -79.89 120.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.887 ' HD2' HG23 ' A' ' 41' ' ' VAL . 13.7 ttm-85 -88.03 99.73 12.39 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.878 -1.139 . . . . 0.0 110.35 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 3.6 m-85 -119.23 74.89 1.01 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.748 ' OD1' HG21 ' A' ' 41' ' ' VAL . 1.4 m-20 -68.38 -4.93 16.33 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.978 -1.076 . . . . 0.0 110.882 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -87.98 146.53 25.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.954 -1.092 . . . . 0.0 109.606 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.561 ' HG2' ' CG ' ' A' ' 12' ' ' LYS . 39.3 mmm-85 -73.07 -58.84 3.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 108.793 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.21 -45.69 79.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.86 . . . . 0.0 108.846 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -52.83 -43.31 65.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.111 -0.993 . . . . 0.0 108.898 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.947 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -61.89 -40.54 95.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.936 -1.103 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -31.31 25.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -80.2 -72.18 0.42 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -36.59 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.526 0.679 . . . . 0.0 110.685 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' GLU . 2.5 mt -81.02 -63.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.498 -1.376 . . . . 0.0 108.827 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 m -84.23 30.46 0.53 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.386 -0.821 . . . . 0.0 109.822 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.11 -52.88 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.877 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.47 -34.39 41.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.151 -0.968 . . . . 0.0 108.657 179.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 6.6 t-20 -42.71 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER 80.87 76.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -89.4 38.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.306 -0.871 . . . . 0.0 109.064 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 ' OG ' ' A' ' 84' ' ' SER . 1.5 mt -151.7 128.32 5.34 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.81 ' HD2' HG23 ' A' ' 79' ' ' ILE . 35.9 Cg_endo -44.06 130.79 8.37 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.741 1.39 . . . . 0.0 110.105 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -46.57 102.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.17 21.08 0.5 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.18 75.76 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.881 ' OG ' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -88.46 16.23 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -1.181 . . . . 0.0 109.218 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.511 ' O ' HD13 ' A' ' 79' ' ' ILE . 28.2 mt-30 69.86 123.32 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.56 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.2 Cg_endo -110.46 -168.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.813 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.967 HD23 ' CG1' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.29 113.46 27.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.642 -0.661 . . . . 0.0 109.927 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -79.73 106.22 11.59 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.776 HG12 HD12 ' A' ' 16' ' ' LEU . 12.5 m -78.21 -167.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 111.322 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.602 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 95.12 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -49.47 168.17 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 91' ' ' LEU . . . -149.16 -156.44 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.14 -169.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.061 -1.025 . . . . 0.0 109.748 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' HIS . 9.7 mt-10 -131.76 124.27 29.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 109.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 57.33 110.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.97 -143.56 3.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.192 -1.181 . . . . 0.0 109.38 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 ttp . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -155.25 110.88 3.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 7.3 m-85 -105.46 90.12 3.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.957 . . . . 0.0 109.471 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 3' ' ' TYR . . . 63.4 162.72 0.11 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.219 -0.925 . . . . 0.0 109.767 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.603 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 5.8 mmt-85 -117.58 -88.36 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 0.0 110.486 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 5' ' ' ARG . 35.6 Cg_endo -43.63 154.36 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.384 1.202 . . . . 0.0 110.951 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.5 ' N ' ' HB3' ' A' ' 65' ' ' ARG . . . -110.27 -111.79 3.37 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.557 ' CA ' ' HB2' ' A' ' 65' ' ' ARG . . . -159.07 144.0 9.81 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' HB2' ' NE ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER 166.47 140.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.323 -1.104 . . . . 0.0 109.486 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 9' ' ' GLU . 1.1 p -38.63 161.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.409 -0.807 . . . . 0.0 110.628 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -41.45 103.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.564 -0.71 . . . . 0.0 109.202 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -125.84 -87.28 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 96' ' ' GLY . 30.5 t0 -161.93 96.31 1.0 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.752 ' HA ' HD11 ' A' ' 91' ' ' LEU . 1.2 m -148.23 54.87 1.03 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.454 -0.779 . . . . 0.0 109.462 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.57 ' O ' HD13 ' A' ' 91' ' ' LEU . 0.2 OUTLIER -78.34 164.09 25.13 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.865 HD11 HG12 ' A' ' 89' ' ' VAL . 1.8 pt? -127.25 141.44 51.72 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.561 -1.256 . . . . 0.0 110.641 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.682 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.3 OUTLIER -83.44 110.92 18.57 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.325 0.583 . . . . 0.0 109.437 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.605 ' HB ' ' CB ' ' A' ' 87' ' ' LEU . 5.3 m -84.78 116.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.212 -0.93 . . . . 0.0 109.248 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.485 ' HA ' HG12 ' A' ' 57' ' ' VAL . 9.8 p -91.11 163.15 14.39 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.082 -1.011 . . . . 0.0 109.713 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 52.69 89.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.558 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 87' ' ' LEU . 9.1 tp -157.22 96.68 2.07 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HG3' ' OE1' ' A' ' 85' ' ' GLN . 36.9 Cg_endo -69.11 168.53 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.989 1.52 . . . . 0.0 110.25 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.87 42.63 1.06 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.987 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.754 HG23 HG23 ' A' ' 25' ' ' ILE . 9.3 t -80.19 -12.0 59.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.786 ' H ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -125.77 -177.73 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 109.434 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.5 p -110.59 153.76 24.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.185 -0.947 . . . . 0.0 109.621 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' HB3' HD11 ' A' ' 45' ' ' ILE . 6.1 p-10 -57.62 -47.35 82.44 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.282 -0.886 . . . . 0.0 109.308 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.1 OUTLIER -65.53 -19.05 65.77 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.319 -0.863 . . . . 0.0 109.436 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 17.5 tt0 -71.15 -48.82 49.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.576 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.9 OUTLIER -45.7 -26.66 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.055 -1.028 . . . . 0.0 108.735 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 10.3 t70 -64.65 -51.14 64.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.842 . . . . 0.0 109.109 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.7 m -54.62 -44.35 73.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.334 -0.854 . . . . 0.0 109.087 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.89 HG21 ' HB ' ' A' ' 78' ' ' VAL . 1.8 mp -57.25 -36.11 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.934 . . . . 0.0 109.197 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.699 ' CD1' HD21 ' A' ' 75' ' ' LEU . 2.0 m-30 -80.28 -83.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.126 -0.984 . . . . 0.0 109.346 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 23.01 67.09 0.02 OUTLIER Glycine 0 N--CA 1.503 3.115 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -172.88 -39.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.081 -1.247 . . . . 0.0 109.922 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.889 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -94.38 -77.52 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.177 -0.952 . . . . 0.0 109.584 -179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.45 -168.15 14.94 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -106.32 32.58 4.36 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -1.232 . . . . 0.0 109.555 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 26.62 101.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.774 179.181 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.818 HG13 HH11 ' A' ' 61' ' ' ARG . 0.7 OUTLIER -76.54 9.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 120.362 -1.461 . . . . 0.0 110.129 -179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 0.2 OUTLIER -168.04 -164.65 0.56 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.638 -1.289 . . . . 0.0 110.776 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.543 ' NZ ' ' HB2' ' A' ' 31' ' ' ASP . 0.4 OUTLIER 159.02 106.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -178.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 0.7 OUTLIER -139.33 -178.5 5.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.62 -1.3 . . . . 0.0 110.905 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD11 ' HB3' ' A' ' 27' ' ' ASP . 5.3 mp -139.25 141.65 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 1.8 mp -127.58 130.38 48.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.95 -1.094 . . . . 0.0 109.479 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -114.35 164.04 14.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 53' ' ' ARG . 10.9 t70 -134.99 69.21 1.45 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.146 -0.971 . . . . 0.0 109.276 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -129.73 1.1 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.566 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.84 15.9 1.09 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.453 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 t -142.14 -39.48 0.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.827 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.81 34.51 59.24 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.582 ' CB ' ' HD3' ' A' ' 54' ' ' PRO . 0.6 OUTLIER -105.64 -56.97 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.2 -1.176 . . . . 0.0 109.584 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 53' ' ' ARG . 37.4 Cg_endo -89.18 -163.31 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.595 1.313 . . . . 0.0 109.904 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -142.56 62.19 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.25 -0.907 . . . . 0.0 109.235 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.498 ' C ' HG13 ' A' ' 57' ' ' VAL . . . 54.75 78.87 0.1 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.498 HG13 ' C ' ' A' ' 56' ' ' GLY . 13.6 m -157.38 143.08 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -1.101 . . . . 0.0 109.704 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -100.47 -176.45 3.21 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.277 -0.889 . . . . 0.0 108.801 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.682 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -133.93 108.02 8.16 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 109.55 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.773 HG11 HD12 ' A' ' 75' ' ' LEU . 1.7 t -85.89 160.85 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.818 HH11 HG13 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -104.71 140.85 37.46 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.791 -0.763 . . . . 0.0 110.675 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.151 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 9.4 m-85 -161.39 68.99 0.32 Allowed 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.671 ' ND2' HG11 ' A' ' 41' ' ' VAL . 18.0 m-20 -46.86 -86.6 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.434 -0.791 . . . . 0.0 109.731 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' HB2' HD12 ' A' ' 11' ' ' ILE . 6.5 ttmm -37.01 118.37 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.326 0.584 . . . . 0.0 109.672 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.698 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.1 OUTLIER -45.74 -47.7 15.39 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.629 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 64' ' ' LYS . 14.6 mt-10 -54.38 -50.02 68.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 70' ' ' GLU . 3.1 tp10 -53.86 -42.78 68.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.226 -0.921 . . . . 0.0 109.349 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' CA ' ' HB3' ' A' ' 62' ' ' TYR . . . -55.43 -39.33 70.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.838 -1.164 . . . . 0.0 108.594 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.507 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.47 -44.73 76.73 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -49.2 -62.24 1.64 Allowed 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.151 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -43.37 -40.09 3.48 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.524 -0.735 . . . . 0.0 109.152 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.548 ' O ' ' HB2' ' A' ' 76' ' ' ASN . 40.8 mm -46.99 -60.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -68.82 0.68 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.185 -0.947 . . . . 0.0 110.269 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.889 ' HB1' ' CZ ' ' A' ' 37' ' ' TYR . . . -45.94 -50.95 14.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.423 -0.798 . . . . 0.0 111.588 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.773 HD12 HG11 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.18 -28.17 42.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.723 -1.235 . . . . 0.0 110.635 -178.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.0 t30 -46.15 115.29 0.96 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.251 -1.53 . . . . 0.0 107.463 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 60.81 78.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -177.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.941 HG13 HD11 ' A' ' 87' ' ' LEU . 1.6 m -85.23 45.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.295 -0.878 . . . . 0.0 109.567 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.781 HD13 ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.97 145.05 25.93 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.42 -0.8 . . . . 0.0 109.234 179.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.458 ' O ' ' C ' ' A' ' 81' ' ' GLU . 36.3 Cg_endo -62.47 139.21 75.19 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.91 1.479 . . . . 0.0 109.328 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -40.33 107.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.781 -179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 164.72 38.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 81.56 -139.47 20.2 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.667 ' OG ' HG21 ' A' ' 79' ' ' ILE . 1.4 t 78.77 -4.82 2.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.598 -0.942 . . . . 0.0 109.391 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.468 ' O ' ' O ' ' A' ' 84' ' ' SER . 24.7 mt-30 57.97 117.22 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.835 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.59 ' HA ' HD11 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -83.75 177.74 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.905 1.476 . . . . 0.0 110.295 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -118.09 138.73 52.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 109.574 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 19' ' ' THR . 19.2 m -79.04 103.81 9.24 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.865 HG12 HD11 ' A' ' 16' ' ' LEU . 1.2 m -83.08 144.23 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.731 0.776 . . . . 0.0 110.886 -178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' H ' ' HB2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER 171.92 132.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 14' ' ' THR . 0.3 OUTLIER -61.29 116.21 4.44 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.376 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.12 162.26 25.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.31 -0.869 . . . . 0.0 109.358 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -95.15 71.45 3.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.205 -0.934 . . . . 0.0 109.396 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 95' ' ' HIS . 0.7 OUTLIER -150.31 -38.13 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 97.8 m-70 62.41 105.67 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.258 -0.901 . . . . 0.0 109.23 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.412 ' N ' ' OD2' ' A' ' 13' ' ' ASP . . . -177.41 96.0 0.1 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.474 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -100.5 177.95 4.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.335 -0.853 . . . . 0.0 109.617 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 47.2 t80 -152.32 20.72 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.842 . . . . 0.0 109.441 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.07 -58.29 2.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.3 mtt-85 -68.03 144.23 96.86 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.681 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 37.0 Cg_endo -94.04 1.05 3.11 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.059 1.558 . . . . 0.0 110.063 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -158.37 14.97 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' OE1' ' A' ' 93' ' ' GLU . . . -127.6 -131.88 3.53 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' O ' ' OG ' ' A' ' 10' ' ' SER . 0.2 OUTLIER 65.07 114.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -1.156 . . . . 0.0 109.915 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -171.95 -162.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.038 HG12 HG21 ' A' ' 41' ' ' VAL . 1.4 pp -68.11 81.72 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.556 -0.715 . . . . 0.0 109.136 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 42.81 19.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.506 -0.746 . . . . 0.0 111.084 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.594 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 12.5 m-20 -157.97 -105.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.615 -1.303 . . . . 0.0 111.012 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.554 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -159.21 92.46 1.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.665 -1.272 . . . . 0.0 110.394 -178.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.751 ' O ' HD22 ' A' ' 91' ' ' LEU . 33.3 p-10 -83.65 168.53 16.23 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.324 -0.86 . . . . 0.0 109.564 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.032 HD21 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -134.89 122.16 21.59 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.459 -1.401 . . . . 0.0 110.43 178.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' CD1' ' CE2' ' A' ' 59' ' ' PHE . 9.4 t80 -78.14 135.75 37.72 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.863 HG21 ' CD2' ' A' ' 87' ' ' LEU . 3.5 m -116.35 148.07 19.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.873 -1.131 . . . . 0.0 110.995 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.693 ' HA ' HG12 ' A' ' 57' ' ' VAL . 28.3 p -131.54 178.34 6.81 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 0.0 109.377 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 57.17 91.27 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 0.0 110.232 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.801 HD13 HG23 ' A' ' 45' ' ' ILE . 23.2 mt -108.99 175.32 2.0 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 109.121 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 36.2 Cg_endo -114.22 6.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.743 1.391 . . . . 0.0 111.173 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.516 ' CB ' ' O ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER 163.4 -97.77 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.648 ' HA ' HG21 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -162.36 -44.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.06 -1.025 . . . . 0.0 109.444 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.759 HG22 ' OE1' ' A' ' 29' ' ' GLN . 1.1 mt 47.99 -174.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.292 -0.88 . . . . 0.0 108.913 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.589 ' H ' HG22 ' A' ' 25' ' ' ILE . 1.1 p -100.28 143.83 30.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.139 -0.976 . . . . 0.0 109.339 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' O ' ' CE ' ' A' ' 43' ' ' LYS . 1.5 m-20 -57.79 -62.02 2.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.349 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -51.06 -18.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.946 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.759 ' OE1' HG22 ' A' ' 25' ' ' ILE . 22.2 mt-30 -75.08 -61.46 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.004 -1.06 . . . . 0.0 110.368 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.826 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 tp -44.5 -25.2 0.24 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.077 -1.014 . . . . 0.0 109.719 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.573 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 1.2 m-20 -64.52 -54.49 31.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.982 -1.074 . . . . 0.0 108.878 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -62.38 -35.94 80.74 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.399 -0.813 . . . . 0.0 109.087 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.826 HG22 ' O ' ' A' ' 30' ' ' LEU . 4.5 tt -61.3 -27.69 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.294 -0.878 . . . . 0.0 108.67 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.891 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 12.3 m-85 -72.79 -69.51 0.41 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' O ' ' CG ' ' A' ' 36' ' ' LYS . . . 155.54 -91.69 0.12 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.534 ' CG ' ' O ' ' A' ' 35' ' ' GLY . 0.5 OUTLIER 169.3 50.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.275 -1.132 . . . . 0.0 109.812 -179.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -93.76 -86.51 0.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.011 -1.056 . . . . 0.0 109.152 179.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.545 ' CA ' ' HG3' ' A' ' 67' ' ' GLU . . . -74.09 157.33 51.14 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 40' ' ' ILE . 28.1 t -79.35 79.57 5.78 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.115 -1.227 . . . . 0.0 107.904 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.545 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -34.83 115.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-O 121.662 0.744 . . . . 0.0 109.574 -178.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.038 HG21 HG12 ' A' ' 11' ' ' ILE . 6.2 m -81.53 38.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.692 -0.63 . . . . 0.0 110.122 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 2.9 tt0 91.65 104.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.602 0.715 . . . . 0.0 111.035 178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -99.95 151.45 21.31 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.637 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -145.65 175.68 10.19 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.59 -1.319 . . . . 0.0 110.992 -179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.801 HG23 HD13 ' A' ' 21' ' ' LEU . 49.9 mt -143.19 134.43 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.1 151.43 31.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.978 -1.076 . . . . 0.0 109.893 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.88 -35.52 0.41 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.165 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -78.7 177.38 8.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.059 -1.025 . . . . 0.0 109.93 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.56 -43.56 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 109.329 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 tp -152.08 -40.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 109.482 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 m -134.05 6.12 3.62 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.14 -0.975 . . . . 0.0 109.62 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.5 59.23 1.03 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 150.76 89.22 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.27 -1.135 . . . . 0.0 109.512 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -85.26 82.94 1.55 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.006 1.53 . . . . 0.0 110.385 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 mtp85 -133.74 -89.62 0.38 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 109.314 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.23 74.66 1.28 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.693 HG12 ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -126.33 140.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -1.171 . . . . 0.0 109.501 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.857 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.79 -174.34 2.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 109.483 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 17' ' ' TYR . 23.2 m-85 -143.57 99.14 3.37 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.285 -0.884 . . . . 0.0 110.057 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.032 HG12 HD21 ' A' ' 16' ' ' LEU . 15.6 t -85.85 148.66 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.945 ' O ' HG22 ' A' ' 41' ' ' VAL . 9.5 mtt180 -137.33 79.25 1.74 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.252 -1.779 . . . . 0.0 111.415 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 11.1 m-85 -78.86 160.04 27.51 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.594 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -103.45 -91.95 0.35 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 117.939 -1.504 . . . . 0.0 111.111 -178.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.522 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER -25.54 136.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.112 0.482 . . . . 0.0 111.188 -177.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.508 ' N ' ' HD3' ' A' ' 65' ' ' ARG . 0.8 OUTLIER -50.93 -51.25 54.04 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' O ' ' CD ' ' A' ' 70' ' ' GLU . 16.5 mt-10 -63.43 -35.33 80.07 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.545 ' HG3' ' CA ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -61.34 -28.12 68.99 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.554 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -75.82 -43.93 43.58 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -60.56 -20.77 61.4 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.542 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 0.6 OUTLIER -70.75 -61.51 1.74 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -68.44 -5.13 17.51 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.561 0.696 . . . . 0.0 109.42 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.059 ' HA ' HG21 ' A' ' 89' ' ' VAL . 1.0 OUTLIER -86.43 -60.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 120.723 -1.236 . . . . 0.0 108.21 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 t -75.29 -1.64 24.5 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.818 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -125.84 -47.51 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 110.357 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.891 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 1.0 OUTLIER -84.09 -21.14 31.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.089 -1.007 . . . . 0.0 110.556 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.683 ' HA ' HG22 ' A' ' 89' ' ' VAL . 23.6 p-10 -46.95 -23.83 0.51 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.55 -1.344 . . . . 0.0 109.128 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 85' ' ' GLN . 3.4 m-80 -143.59 86.63 1.89 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.744 ' HB ' HD12 ' A' ' 87' ' ' LEU . 2.2 p -78.46 88.55 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.153 -0.967 . . . . 0.0 108.838 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.048 HG23 ' HG3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -147.55 -172.61 0.32 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.48 -0.762 . . . . 0.0 109.085 -179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.467 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.7 Cg_endo -102.7 24.06 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.899 1.473 . . . . 0.0 109.424 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.2 OUTLIER 73.24 114.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.446 -0.784 . . . . 0.0 109.693 -179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.83 -18.65 1.11 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 137.44 -148.76 20.0 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.975 ' HB3' HG21 ' A' ' 79' ' ' ILE . 6.2 t 83.83 -28.11 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.799 -0.824 . . . . 0.0 109.837 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER 38.41 92.25 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.245 -0.909 . . . . 0.0 110.755 179.331 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 1.048 ' HG3' HG23 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -121.24 -178.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 O-C-N 123.925 1.487 . . . . 0.0 110.049 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.863 ' CD2' HG21 ' A' ' 18' ' ' VAL . 77.3 mt 25.07 68.02 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 7.4 m -77.25 102.12 6.54 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.059 HG21 ' HA ' ' A' ' 72' ' ' ILE . 14.7 m -77.85 163.87 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 122.313 1.054 . . . . 0.0 113.153 -175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.515 ' O ' ' C ' ' A' ' 91' ' ' LEU . 2.1 ttt180 171.2 105.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.751 HD22 ' O ' ' A' ' 15' ' ' ASN . 1.0 OUTLIER -33.64 141.76 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.622 -0.674 . . . . 0.0 109.386 -179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.79 179.48 6.56 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.86 -1.15 . . . . 0.0 110.279 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.467 ' OE1' ' O ' ' A' ' 8' ' ' GLY . 1.2 mm-40 -123.35 105.22 9.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.443 -0.785 . . . . 0.0 109.176 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.31 -163.55 1.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.153 -0.967 . . . . 0.0 109.309 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -108.38 30.62 6.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.187 -0.946 . . . . 0.0 109.431 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.01 -33.66 0.05 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.643 ' HB3' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.213 -1.169 . . . . 0.0 109.61 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtp . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.272 0.558 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 t -90.01 175.8 7.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.181 -0.95 . . . . 0.0 109.719 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.405 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 10.6 m-30 -57.37 -64.16 0.98 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.872 . . . . 0.0 110.039 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 5' ' ' ARG . . . -146.28 170.84 15.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.183 -0.948 . . . . 0.0 109.736 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 5' ' ' ARG . 4.3 ttp85 65.32 118.73 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.756 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 14' ' ' THR . 36.8 Cg_endo -118.46 159.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.868 1.457 . . . . 0.0 109.874 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.526 ' HA3' ' OG1' ' A' ' 14' ' ' THR . . . 166.73 -174.48 42.12 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.628 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' O ' ' CD ' ' A' ' 65' ' ' ARG . . . -154.53 -90.69 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 10' ' ' SER . 12.6 pt-20 -178.86 -177.05 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -1.23 . . . . 0.0 109.698 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 63' ' ' ASN . 1.5 m 73.95 148.01 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.228 -0.92 . . . . 0.0 109.302 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.771 HD13 HG12 ' A' ' 41' ' ' VAL . 11.1 mm -72.3 81.25 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.23 -0.919 . . . . 0.0 109.875 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.4 OUTLIER 153.02 60.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.59 -88.17 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.48 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.782 ' HA ' HD13 ' A' ' 91' ' ' LEU . 3.2 m -79.22 71.62 5.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.45 0.643 . . . . 0.0 110.03 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -76.89 -177.27 4.29 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.048 HD23 HG12 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -112.28 103.79 11.94 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.702 -1.249 . . . . 0.0 111.407 -178.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' CZ ' ' A' ' 59' ' ' PHE . 2.8 t80 -83.11 81.92 8.48 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.617 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 2.5 m -82.47 129.68 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 111.261 -177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.753 HG23 HG12 ' A' ' 57' ' ' VAL . 19.6 m -131.76 172.18 12.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.562 ' H ' HG22 ' A' ' 19' ' ' THR . 20.3 t-20 79.27 63.29 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.149 -0.969 . . . . 0.0 110.121 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.81 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -170.1 144.98 2.28 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.018 179.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.6 Cg_endo -106.85 69.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.626 1.329 . . . . 0.0 111.003 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 4.2 mtm180 40.1 36.38 0.31 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.0 110.194 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 24' ' ' THR . 89.2 m -79.82 -5.24 55.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.133 -0.98 . . . . 0.0 109.23 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.532 ' CD1' HD12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -152.32 150.27 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 0.0 109.174 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -91.55 155.41 18.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 109.538 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' H ' HD11 ' A' ' 45' ' ' ILE . 5.4 p-10 -62.31 -49.63 74.86 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.166 -0.959 . . . . 0.0 108.488 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 28' ' ' ASP . 6.6 t0 -50.79 -22.5 2.18 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -77.37 -41.48 40.04 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.371 -0.831 . . . . 0.0 109.777 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.985 ' O ' HG22 ' A' ' 33' ' ' ILE . 6.9 mp -47.3 -44.35 23.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.091 -1.006 . . . . 0.0 109.121 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 6.9 t70 -58.03 -41.32 82.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.818 -1.176 . . . . 0.0 108.991 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -36.04 81.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.491 -0.755 . . . . 0.0 110.476 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.988 HD13 HG13 ' A' ' 78' ' ' VAL . 1.2 tt -67.21 -33.94 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.741 -1.224 . . . . 0.0 109.784 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.814 ' CD1' HG23 ' A' ' 33' ' ' ILE . 1.8 m-85 -84.37 -72.03 0.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.934 -1.104 . . . . 0.0 109.075 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' C ' ' CD ' ' A' ' 36' ' ' LYS . . . 104.09 -40.74 2.34 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' CD ' ' C ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -175.22 98.73 0.08 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.057 -1.261 . . . . 0.0 109.437 -179.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.711 ' CE1' ' HB2' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -136.67 -21.7 1.28 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.168 -0.958 . . . . 0.0 110.022 -179.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' HA3' ' HE1' ' A' ' 62' ' ' TYR . . . -178.91 -175.5 46.0 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.53 ' HB3' HD11 ' A' ' 11' ' ' ILE . 1.4 t -88.91 71.99 8.52 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.372 -1.075 . . . . 0.0 109.23 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -37.71 134.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.771 HG12 HD13 ' A' ' 11' ' ' ILE . 3.9 m -102.21 48.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.34 -0.85 . . . . 0.0 111.788 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.755 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 1.1 tm0? 89.28 131.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.592 0.71 . . . . 0.0 110.882 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.3 mtmp? -100.66 169.66 8.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -160.56 163.9 32.39 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.916 -1.115 . . . . 0.0 110.341 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 27' ' ' ASP . 1.8 mt -141.11 107.85 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.336 -0.852 . . . . 0.0 109.011 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.719 ' HB2' HG23 ' A' ' 57' ' ' VAL . 2.0 mm? -93.91 130.9 39.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.335 -0.853 . . . . 0.0 109.145 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 4.9 ptt180 -135.34 -58.66 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.958 . . . . 0.0 109.898 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 47' ' ' ARG . 0.2 OUTLIER -140.42 -174.97 4.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.953 -1.092 . . . . 0.0 109.662 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' C ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -145.35 -81.98 0.15 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -0.92 . . . . 0.0 109.6 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD23 ' C ' ' A' ' 49' ' ' LYS . 2.7 mt -120.6 -12.55 8.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 0.0 109.442 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.536 HG22 ' H ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -116.49 -160.51 0.76 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.441 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' HG22 ' A' ' 51' ' ' THR . . . -103.95 25.7 25.53 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.07 114.83 30.57 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.201 -1.176 . . . . 0.0 109.634 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' O ' ' CB ' ' A' ' 55' ' ' ARG . 36.7 Cg_endo -74.89 -81.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.976 1.514 . . . . 0.0 110.067 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 8.5 ttm180 83.86 -54.98 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.758 -0.589 . . . . 0.0 109.749 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.01 84.09 0.09 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.753 HG12 HG23 ' A' ' 19' ' ' THR . 10.7 m -145.89 139.88 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -1.084 . . . . 0.0 109.075 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -124.55 177.11 6.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.01 . . . . 0.0 110.087 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' LEU . 47.8 m-85 -142.84 107.97 4.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.048 HG12 HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -78.8 177.52 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.012 -1.075 . . . . 0.0 108.14 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.806 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -107.03 123.76 48.66 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.539 -0.864 . . . . 0.0 112.3 -177.194 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.63 ' CE1' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -163.93 158.34 19.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.92 -1.113 . . . . 0.0 109.77 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.558 ' HA ' ' H ' ' A' ' 14' ' ' THR . 5.2 p-10 -148.32 -64.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.889 -1.132 . . . . 0.0 110.962 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -49.55 99.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.63 -1.294 . . . . 0.0 108.977 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.491 ' CD ' ' O ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -30.36 -35.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.748 -0.595 . . . . 0.0 111.379 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 64' ' ' LYS . 56.9 mt-10 -66.71 -64.61 0.82 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.894 -1.129 . . . . 0.0 109.426 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . 26.3 pt-20 -56.02 -24.13 37.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.903 -1.123 . . . . 0.0 108.711 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 14' ' ' THR . . . -65.03 -44.63 88.5 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.474 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 52.8 tt0 -48.19 -33.69 8.89 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -60.13 -53.0 62.92 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -60.97 -11.91 9.6 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.469 -0.892 . . . . 0.0 109.072 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.902 ' HA ' HG21 ' A' ' 89' ' ' VAL . 33.0 mm -80.17 -59.55 2.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.12 4.3 8.83 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.565 -0.709 . . . . 0.0 110.172 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -131.42 -54.31 1.02 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.938 -1.101 . . . . 0.0 109.862 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.037 HD21 HG21 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -79.4 -11.27 59.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.322 -179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.63 ' CB ' HG22 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -82.86 42.42 0.79 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.405 -1.435 . . . . 0.0 109.145 178.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 p30 156.27 49.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.988 HG13 HD13 ' A' ' 33' ' ' ILE . 2.1 t -79.97 87.62 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.021 HD13 ' O ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER 172.58 135.74 0.1 Allowed Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.473 -0.767 . . . . 0.0 109.181 179.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.512 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 36.6 Cg_endo -43.73 117.31 1.13 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.979 1.515 . . . . 0.0 110.552 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -45.37 147.12 0.85 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 120.95 -59.64 0.55 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -60.81 -127.68 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.457 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -179.89 35.38 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 109.554 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 1.021 ' O ' HD13 ' A' ' 79' ' ' ILE . 13.2 mt-30 -129.44 71.3 82.08 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.908 . . . . 0.0 109.391 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.56 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.69 -171.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.896 1.472 . . . . 0.0 110.954 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.96 HD12 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -116.47 113.62 23.08 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.24 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.1 t -78.53 102.65 8.0 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.902 HG21 ' HA ' ' A' ' 72' ' ' ILE . 17.0 m -78.5 153.89 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 CA-C-O 122.008 0.909 . . . . 0.0 111.576 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 4.3 ttm-85 173.99 113.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.782 HD13 ' HA ' ' A' ' 14' ' ' THR . 7.4 tp -52.42 136.82 30.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.938 -1.101 . . . . 0.0 108.978 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.615 ' N ' HD12 ' A' ' 91' ' ' LEU . . . -133.79 145.42 49.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.31 141.47 35.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -179.81 -56.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -0.861 . . . . 0.0 109.607 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 -159.65 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.666 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.55 -117.25 0.76 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.218 -1.166 . . . . 0.0 109.621 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 68.7 m -103.96 73.18 1.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.469 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 2' ' ' SER . 33.9 m-85 73.12 -80.33 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.481 -0.762 . . . . 0.0 109.542 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.83 -67.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.89 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.97 175.28 1.51 Allowed Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.325 -0.86 . . . . 0.0 108.709 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 37.5 Cg_endo -109.73 164.13 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.683 1.359 . . . . 0.0 110.223 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -110.91 -170.34 19.31 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.0 -129.68 1.16 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.56 179.45 5.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.321 -1.105 . . . . 0.0 109.711 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.69 47.89 0.92 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.217 -0.927 . . . . 0.0 109.839 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.856 HD12 HG11 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -99.5 98.91 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.274 -0.891 . . . . 0.0 109.018 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.689 ' HB2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER 79.69 -59.31 0.35 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.891 -0.506 . . . . 0.0 110.833 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB2' ' N ' ' A' ' 64' ' ' LYS . 0.9 OUTLIER -160.95 -99.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.474 -1.391 . . . . 0.0 111.584 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 68' ' ' ALA . 7.7 p -107.75 -133.73 0.33 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.35 -1.469 . . . . 0.0 109.867 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.543 ' CB ' HD11 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -164.56 -167.6 1.31 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.243 -0.911 . . . . 0.0 108.932 -178.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.933 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.8 tp -154.62 121.54 5.54 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.85 ' OH ' HG11 ' A' ' 57' ' ' VAL . 11.4 t80 -110.17 117.26 33.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.808 -1.182 . . . . 0.0 109.726 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 89' ' ' VAL . 18.8 m -112.36 131.77 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.277 -0.89 . . . . 0.0 110.006 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.689 ' OG1' HG12 ' A' ' 57' ' ' VAL . 11.1 t -127.04 -166.53 1.61 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.298 -0.876 . . . . 0.0 108.896 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.4 OUTLIER 81.78 -65.24 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.626 -0.671 . . . . 0.0 110.317 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.585 HD12 ' O ' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -38.3 126.45 1.08 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.592 -0.693 . . . . 0.0 109.954 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -106.37 64.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.971 1.511 . . . . 0.0 110.639 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 52.49 65.08 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.953 . . . . 0.0 109.906 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.7 m -124.0 -24.93 4.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.115 -0.991 . . . . 0.0 109.964 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.726 HD12 ' CD1' ' A' ' 30' ' ' LEU . 1.1 pt -111.35 179.56 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -114.35 153.04 30.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.798 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 1.9 m-20 -63.35 -60.13 3.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.871 . . . . 0.0 108.911 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -43.23 -26.39 0.17 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.305 -0.872 . . . . 0.0 109.382 179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.7 tt0 -72.23 -63.44 1.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.726 ' CD1' HD12 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -45.96 -24.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.259 -0.901 . . . . 0.0 109.124 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 1.6 t70 -64.86 -59.12 4.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.022 . . . . 0.0 109.118 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' THR . 92.8 m -64.28 -12.39 41.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.155 -0.966 . . . . 0.0 109.436 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.639 HG21 HG23 ' A' ' 78' ' ' VAL . 12.8 mm -77.72 -45.78 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.138 -0.977 . . . . 0.0 109.58 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.867 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 7.8 p90 -142.35 49.6 1.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.132 -0.98 . . . . 0.0 110.198 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.49 36.73 4.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -100.28 -44.97 5.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.61 ' CD1' ' OH ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -79.42 -97.73 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.72 131.76 10.61 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 105.674 -2.971 . . . . 0.0 105.674 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.622 ' O ' ' O ' ' A' ' 40' ' ' ILE . 53.4 p -79.03 75.26 5.54 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.915 -1.344 . . . . 0.0 108.48 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 23.59 108.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.883 1.325 . . . . 0.0 110.319 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.926 HG11 HD21 ' A' ' 63' ' ' ASN . 3.1 t -75.61 -4.39 5.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.968 -177.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 170.11 99.67 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.544 -0.722 . . . . 0.0 110.033 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.597 ' HG3' HG21 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -87.16 87.09 7.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.155 -0.965 . . . . 0.0 108.621 178.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.76 147.39 25.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 110.545 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.503 HG13 ' HB2' ' A' ' 58' ' ' ALA . 19.5 tt -161.5 140.1 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.042 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' O ' ' HA2' ' A' ' 56' ' ' GLY . 3.3 pp -161.59 155.07 21.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.08 . . . . 0.0 110.141 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.504 ' HA ' ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -155.63 -163.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.389 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 54.2 p30 -97.88 175.13 6.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.284 -0.885 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -103.59 -59.54 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.7 mt -123.35 -56.66 1.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.924 . . . . 0.0 109.651 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.0 p -140.29 150.11 43.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' C ' ' CG ' ' A' ' 53' ' ' ARG . . . 128.02 -72.99 0.46 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' CG ' ' C ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER 40.49 84.8 0.18 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.513 -0.992 . . . . 0.0 109.69 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.406 ' C ' ' HG3' ' A' ' 55' ' ' ARG . 36.5 Cg_endo -90.68 -37.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.057 1.556 . . . . 0.0 110.43 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.406 ' HG3' ' C ' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -130.85 -60.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.621 -179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 47' ' ' ARG . . . 51.83 86.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.85 HG11 ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -160.95 166.03 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.125 . . . . 0.0 109.999 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -129.53 150.26 50.95 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 93.5 m-85 -126.46 101.67 6.79 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.935 -1.103 . . . . 0.0 110.616 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.933 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -81.8 107.11 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 176.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.801 ' NH2' HG21 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -76.97 87.25 3.5 Favored 'General case' 0 C--N 1.291 -1.943 0 O-C-N 120.138 -1.601 . . . . 0.0 108.618 -178.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.723 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 2.1 t80 -94.7 114.26 26.16 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.926 HD21 HG11 ' A' ' 41' ' ' VAL . 9.1 m120 -71.32 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.817 -1.553 . . . . 0.0 111.148 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER 7.32 127.71 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 14' ' ' THR . 0.1 OUTLIER -62.23 -61.67 2.3 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.937 -1.102 . . . . 0.0 109.051 178.361 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -53.04 62.79 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.407 -0.808 . . . . 0.0 109.618 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.609 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 81.8 mt-10 -67.01 -10.9 54.72 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.015 -1.053 . . . . 0.0 109.885 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 64' ' ' LYS . . . -75.19 -37.89 61.03 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 177.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.574 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -69.71 -20.75 63.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.587 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.8 mt-10 -62.65 -75.45 0.08 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.752 ' HB3' ' CD2' ' A' ' 16' ' ' LEU . . . -50.11 -23.08 1.92 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.612 ' O ' HG21 ' A' ' 89' ' ' VAL . 2.6 mm -58.36 -51.64 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.688 -1.257 . . . . 0.0 107.795 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 t -86.47 -59.46 2.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.083 . . . . 0.0 110.231 179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.52 -44.0 62.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 110.446 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.873 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.5 tp -79.25 -38.8 34.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.026 -1.046 . . . . 0.0 109.062 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.544 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 2.4 t-20 -40.96 116.71 0.75 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.506 ' ND2' ' N ' ' A' ' 77' ' ' ASN . 0.5 OUTLIER 67.29 78.25 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.922 ' O ' HG23 ' A' ' 79' ' ' ILE . 7.4 p -86.18 52.17 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.078 -1.014 . . . . 0.0 109.773 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.08 HG21 ' CB ' ' A' ' 84' ' ' SER . 0.3 OUTLIER -176.35 170.23 1.19 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.385 -0.822 . . . . 0.0 108.908 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -87.96 39.11 0.52 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.758 1.399 . . . . 0.0 109.677 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 46.88 68.77 0.57 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.0 108.771 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.29 27.8 1.97 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.586 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.448 ' O ' ' OE1' ' A' ' 85' ' ' GLN . . . 127.61 -50.96 0.87 Allowed Glycine 0 N--CA 1.492 2.374 0 O-C-N 120.885 -1.362 . . . . 0.0 110.332 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.08 ' CB ' HG21 ' A' ' 79' ' ' ILE . 73.1 m -50.93 -18.9 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 110.316 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' SER . 7.0 mp0 64.53 140.8 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.885 . . . . 0.0 109.236 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.479 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.0 Cg_endo -84.25 -179.86 4.17 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.153 1.607 . . . . 0.0 111.455 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.873 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -122.06 123.87 42.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 109.098 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.626 ' HB3' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -78.5 97.04 5.57 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.82 HG12 HG12 ' A' ' 18' ' ' VAL . 14.5 m -78.27 163.63 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 CA-C-O 122.301 1.048 . . . . 0.0 112.049 -177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 17' ' ' TYR . 5.5 ptp180 173.42 -133.93 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.543 HD11 ' CB ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -146.73 119.46 8.61 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.679 -1.263 . . . . 0.0 108.217 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . . . -145.68 -174.07 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.787 -1.196 . . . . 0.0 109.76 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -172.29 88.2 0.09 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.323 -0.861 . . . . 0.0 109.185 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -46.42 -31.0 2.4 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -168.82 -152.63 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.49 95.27 1.57 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.588 ' CB ' ' HD2' ' A' ' 61' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.416 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.56 155.83 28.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -133.05 26.83 4.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -164.69 168.44 18.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.262 -0.899 . . . . 0.0 109.761 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' CG ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -117.77 175.39 2.06 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 5' ' ' ARG . 35.4 Cg_endo -65.41 -163.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.637 1.335 . . . . 0.0 109.924 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 92' ' ' ALA . . . -143.68 -158.52 7.61 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.408 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.83 -155.58 10.21 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.496 ' HA ' ' HB3' ' A' ' 13' ' ' ASP . 1.7 mt-10 -162.75 -172.11 2.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.154 -1.204 . . . . 0.0 109.949 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.496 ' HB3' ' HA ' ' A' ' 97' ' ' LYS . 1.3 t 64.55 133.65 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.319 -0.863 . . . . 0.0 109.578 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.928 HD12 HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 35.7 71.38 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-O 121.822 0.82 . . . . 0.0 109.011 -179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.577 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 67.28 -173.86 0.19 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -178.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' HB3' ' HA ' ' A' ' 9' ' ' GLU . 3.2 p-10 -155.95 87.16 1.06 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.363 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.746 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.1 OUTLIER -161.44 34.26 0.14 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.619 ' HB3' HG21 ' A' ' 41' ' ' VAL . 39.0 p-10 -76.93 -171.78 2.09 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.038 HD21 HG12 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -156.18 119.69 4.32 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.816 -1.153 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -81.58 134.07 35.45 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.975 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 5.3 m -106.23 150.38 8.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.523 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.491 HG23 ' OG ' ' A' ' 88' ' ' SER . 0.1 OUTLIER -115.42 168.94 9.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.348 -0.845 . . . . 0.0 109.439 179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 19' ' ' THR . 86.1 m-20 61.26 72.95 0.5 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.29 -0.881 . . . . 0.0 109.432 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD13 ' CB ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -136.19 115.27 10.91 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.895 . . . . 0.0 109.408 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.76 -171.27 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.044 1.549 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -114.0 17.38 17.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.305 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -79.76 -56.84 3.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.191 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.848 HD11 HD12 ' A' ' 30' ' ' LEU . 2.0 tt -82.41 167.13 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.098 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.567 ' N ' ' CG1' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -116.12 146.12 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -0.838 . . . . 0.0 109.766 -179.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 2.9 p30 -59.45 -44.31 92.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.295 -0.878 . . . . 0.0 109.085 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 6.9 t0 -58.46 -24.92 61.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 108.998 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.524 ' OE1' HG23 ' A' ' 26' ' ' THR . 7.8 mt-30 -73.76 -40.5 63.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.328 -0.857 . . . . 0.0 109.183 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.055 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.5 mp -42.77 -54.19 4.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.83 . . . . 0.0 109.407 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -41.48 -49.22 3.96 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.412 -0.805 . . . . 0.0 109.875 -179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.0 m -61.26 -43.63 98.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.012 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.055 HG22 ' O ' ' A' ' 30' ' ' LEU . 10.1 tp -57.04 -24.83 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.108 -0.995 . . . . 0.0 109.891 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.803 ' CD1' HG23 ' A' ' 33' ' ' ILE . 3.2 m-85 -97.69 -73.09 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.812 -1.18 . . . . 0.0 109.495 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 142.54 -80.82 0.24 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.98 105.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -1.151 . . . . 0.0 109.333 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.683 ' CE1' ' CE1' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -94.85 -83.4 0.35 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.326 -0.859 . . . . 0.0 108.976 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . -98.87 -93.18 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.571 ' O ' ' C ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -150.47 67.63 0.96 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.771 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -23.75 122.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 CA-C-O 121.718 0.77 . . . . 0.0 109.715 -178.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.928 HG12 HD12 ' A' ' 11' ' ' ILE . 5.3 m -90.04 49.4 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.733 ' H ' ' HD2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 82.6 120.29 0.05 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.415 -0.803 . . . . 0.0 112.191 178.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.889 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -124.02 132.59 53.71 Favored 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 177.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.77 146.0 30.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.638 -1.289 . . . . 0.0 110.503 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.606 ' C ' HD22 ' A' ' 46' ' ' LEU . 1.7 tt -92.02 124.07 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 45' ' ' ILE . 1.7 mm? -106.96 138.53 42.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.102 -0.999 . . . . 0.0 110.215 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.438 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 53.9 mtp180 -117.36 -61.57 1.69 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.491 -0.756 . . . . 0.0 109.029 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 47' ' ' ARG . 1.0 OUTLIER 172.56 142.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.357 -0.839 . . . . 0.0 109.189 179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -120.76 -17.5 7.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.102 -0.999 . . . . 0.0 109.94 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.62 -46.48 5.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.623 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.78 -143.57 0.28 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.481 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -139.25 80.56 0.27 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -74.38 166.49 44.4 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -112.96 -1.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.972 1.511 . . . . 0.0 110.29 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -71.33 0.18 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.646 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.12 91.51 1.8 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 46' ' ' LEU . 2.1 m -96.89 171.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.174 -1.192 . . . . 0.0 109.623 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.975 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -147.68 -179.13 6.65 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.32 -0.863 . . . . 0.0 109.291 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 m-85 -152.15 115.64 4.78 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.414 -0.804 . . . . 0.0 109.669 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.073 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -100.07 153.84 4.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 120.54 -1.35 . . . . 0.0 107.684 178.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.771 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -95.18 132.53 40.03 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 122.084 0.945 . . . . 0.0 111.299 -178.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.166 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -163.26 147.01 10.73 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.63 ' O ' ' C ' ' A' ' 64' ' ' LYS . 13.0 p30 -137.88 -118.82 0.15 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.785 -1.197 . . . . 0.0 107.879 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.63 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 10.43 103.27 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 CA-C-N 118.626 0.648 . . . . 0.0 110.855 179.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.746 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.05 -59.25 0.14 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.611 -0.681 . . . . 0.0 111.069 -178.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -53.9 -50.6 65.99 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.844 -1.16 . . . . 0.0 108.685 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 85.3 mt-10 -49.65 -48.9 49.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.399 -0.813 . . . . 0.0 110.34 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.39 -46.75 47.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.333 -1.479 . . . . 0.0 108.038 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.497 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 5.4 tt0 -52.92 -42.38 65.33 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 7.5 mm-40 -50.04 -66.6 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.073 -1.017 . . . . 0.0 108.585 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.166 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -51.01 -29.62 13.0 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.895 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.59 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 24.6 mm -60.03 -49.35 84.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.465 -1.397 . . . . 0.0 108.407 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.4 m -84.35 -65.49 1.0 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.84 -1.162 . . . . 0.0 110.117 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.01 76.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.464 -0.773 . . . . 0.0 111.303 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.073 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -79.45 -38.96 33.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.62 -1.3 . . . . 0.0 110.597 -178.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.59 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 23.8 t-20 -52.6 131.77 34.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.264 -1.522 . . . . 0.0 108.413 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 8.7 m120 64.56 69.84 0.5 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.122 -0.986 . . . . 0.0 109.601 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 78' ' ' VAL . 3.3 p -86.22 61.28 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -162.73 162.39 18.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.8 Cg_endo -87.14 41.21 0.72 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.656 1.345 . . . . 0.0 109.986 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' PRO . 9.0 mt-10 59.94 147.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.91 -76.37 0.41 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -59.67 -25.32 60.99 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.462 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER 58.27 28.75 17.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -1.115 . . . . 0.0 109.942 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.58 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 2.0 mt-30 -127.57 75.39 77.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.025 -1.047 . . . . 0.0 109.581 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -109.28 -161.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.879 1.463 . . . . 0.0 110.773 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.846 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -103.15 123.06 45.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.575 -0.703 . . . . 0.0 110.356 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.8 OUTLIER -78.47 111.26 14.31 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 176.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.538 ' HB ' HD13 ' A' ' 72' ' ' ILE . 2.9 m -78.19 155.86 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-O 122.428 1.109 . . . . 0.0 112.395 -176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.572 ' HD2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 167.53 126.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.534 ' HA ' ' O ' ' A' ' 15' ' ' ASN . 15.0 mt -41.76 159.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.922 . . . . 0.0 110.01 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' GLY . . . -84.51 167.81 16.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 7' ' ' GLY . 3.1 mt-10 -64.07 -162.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.45 4.55 10.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.222 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -125.22 112.54 16.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.03 -1.044 . . . . 0.0 109.599 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.96 178.51 34.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 17.9 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.287 -1.125 . . . . 0.0 109.43 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HA ' ' CE2' ' A' ' 3' ' ' TYR . 1.6 ttt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.308 0.575 . . . . 0.0 109.561 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.18 61.14 2.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.464 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.49 ' C ' ' CD1' ' A' ' 3' ' ' TYR . 21.6 p90 -165.09 157.02 15.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.95 -88.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.166 -0.959 . . . . 0.0 109.527 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.19 101.15 2.09 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 0.0 109.547 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.593 ' HG2' ' CG ' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -92.37 -165.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.887 1.467 . . . . 0.0 109.993 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' HA3' ' HG3' ' A' ' 65' ' ' ARG . . . -172.26 -145.09 4.8 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.189 -1.481 . . . . 0.0 111.052 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.56 ' N ' ' HB3' ' A' ' 13' ' ' ASP . . . 178.67 -108.35 0.24 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.516 ' N ' ' CG ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -166.72 136.5 3.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.959 -1.318 . . . . 0.0 110.646 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 0.3 OUTLIER 74.85 172.19 0.27 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.49 -0.756 . . . . 0.0 111.176 178.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.837 ' CD1' HG12 ' A' ' 41' ' ' VAL . 13.3 mm -61.18 87.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.597 -0.689 . . . . 0.0 109.237 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 9.6 pttt 147.88 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.56 ' HB3' ' N ' ' A' ' 8' ' ' GLY . 18.9 m-20 -111.27 -92.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.479 -0.763 . . . . 0.0 110.747 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.777 ' HA ' HD21 ' A' ' 91' ' ' LEU . 10.0 t -82.04 64.42 6.71 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.332 -0.855 . . . . 0.0 110.402 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.799 ' O ' HD22 ' A' ' 91' ' ' LEU . 2.2 p-10 -76.76 160.63 29.14 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.061 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.6 OUTLIER -137.57 125.8 23.13 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 117.621 -1.632 . . . . 0.0 111.636 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.762 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -85.12 114.82 22.54 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.067 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 32.5 m -88.89 139.32 17.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -116.99 -179.48 3.71 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.332 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.448 ' H ' HG22 ' A' ' 19' ' ' THR . 0.4 OUTLIER 57.58 86.48 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.143 -0.973 . . . . 0.0 109.269 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' O ' ' HA3' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -163.18 132.75 3.13 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 0.0 109.546 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' OE1' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -108.66 52.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.965 1.508 . . . . 0.0 110.194 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 22' ' ' PRO . 77.3 mtt180 41.7 53.08 4.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.483 -0.761 . . . . 0.0 109.637 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -96.0 -21.5 17.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.925 . . . . 0.0 109.652 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' HD12 ' A' ' 25' ' ' ILE . 1.3 pp -121.81 160.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.389 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.468 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 0.6 OUTLIER -96.66 157.12 16.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.162 -0.961 . . . . 0.0 109.992 -179.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -59.89 -53.67 55.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.418 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.3 -3.0 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.896 -1.127 . . . . 0.0 109.625 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.468 ' HB2' ' OG1' ' A' ' 26' ' ' THR . 1.0 OUTLIER -83.1 -63.92 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.022 -1.049 . . . . 0.0 110.722 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . 3.2 mp -44.3 -37.22 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.52 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.545 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . 30.5 t0 -49.7 -55.82 12.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.662 -1.274 . . . . 0.0 109.228 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 30.6 m -65.18 -21.44 66.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.224 -0.923 . . . . 0.0 109.711 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.515 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -83.01 -15.12 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.148 -0.97 . . . . 0.0 110.718 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.94 ' CG ' HD11 ' A' ' 75' ' ' LEU . 10.5 p90 -153.4 33.86 0.46 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.593 -1.317 . . . . 0.0 111.125 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.914 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -97.57 61.56 1.01 Allowed Glycine 0 N--CA 1.493 2.476 0 O-C-N 120.134 -1.604 . . . . 0.0 109.697 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -138.54 -10.55 1.4 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.058 -1.26 . . . . 0.0 111.183 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.617 ' CD2' ' OH ' ' A' ' 62' ' ' TYR . 0.9 OUTLIER -85.7 -50.14 7.41 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.684 -1.26 . . . . 0.0 109.875 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.49 -160.2 8.63 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.552 ' O ' ' C ' ' A' ' 40' ' ' ILE . 14.5 m -95.35 72.77 3.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.275 -1.132 . . . . 0.0 109.139 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.914 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -25.65 131.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-O 121.153 0.502 . . . . 0.0 110.046 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.837 HG12 ' CD1' ' A' ' 11' ' ' ILE . 3.2 m -98.76 56.04 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 N-CA-C 115.094 1.516 . . . . 0.0 115.094 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 12.2 tt0 94.26 100.91 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.599 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 0.3 OUTLIER -83.05 165.79 19.3 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HA ' ' OD2' ' A' ' 27' ' ' ASP . 1.9 t-20 -158.98 158.1 32.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.838 -1.164 . . . . 0.0 109.892 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 45' ' ' ILE . 0.5 OUTLIER -158.41 117.38 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.343 -0.848 . . . . 0.0 109.316 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.21 158.98 43.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.766 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -122.36 -81.8 0.64 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.38 -0.825 . . . . 0.0 109.629 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.423 ' O ' ' HD2' ' A' ' 49' ' ' LYS . 2.6 p30 -99.3 -171.72 2.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.632 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -171.97 -44.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 0.0 109.298 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.61 -75.5 0.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.7 p -149.68 19.2 0.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' O ' ' HG3' ' A' ' 53' ' ' ARG . . . -87.77 -35.35 9.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 20.5 ptt180 37.88 55.45 4.19 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.611 -0.934 . . . . 0.0 109.934 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.31 -169.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.868 1.457 . . . . 0.0 110.358 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.36 -5.71 58.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.395 -0.816 . . . . 0.0 109.619 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . 107.27 112.03 3.61 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.8 m -125.71 163.61 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -1.145 . . . . 0.0 109.431 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -134.26 -174.1 3.46 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.463 -0.773 . . . . 0.0 108.941 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE2' ' CD2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -149.17 104.48 3.41 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.269 -0.894 . . . . 0.0 109.296 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.061 ' CG1' HD21 ' A' ' 16' ' ' LEU . 2.2 t -79.54 152.87 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.041 -1.037 . . . . 0.0 108.461 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.757 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -100.27 128.4 46.35 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-O 121.402 0.62 . . . . 0.0 111.022 -178.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.069 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -164.4 146.05 8.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.032 -1.042 . . . . 0.0 110.184 178.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.686 ' C ' HG22 ' A' ' 14' ' ' THR . 1.0 OUTLIER -133.26 -48.56 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.255 -0.903 . . . . 0.0 109.665 179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -58.72 106.14 0.37 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.847 -1.158 . . . . 0.0 109.191 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HG3' ' HA3' ' A' ' 7' ' ' GLY . 1.7 mpp_? -34.83 -55.63 0.57 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.178 0.513 . . . . 0.0 110.265 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.14 -47.95 79.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 108.856 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 62' ' ' TYR . 39.7 tt0 -52.26 -29.4 22.79 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.395 -0.816 . . . . 0.0 109.236 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.76 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -68.79 -48.54 63.37 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.978 -1.076 . . . . 0.0 108.45 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -47.41 -32.33 4.89 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.831 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 20.4 mm-40 -67.38 -49.32 64.41 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.731 -0.606 . . . . 0.0 109.484 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.069 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -65.73 -13.54 59.54 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.303 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.802 ' HA ' HG21 ' A' ' 89' ' ' VAL . 19.3 mm -81.51 -69.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.012 -1.055 . . . . 0.0 108.596 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.2 m -77.48 8.6 4.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.635 -0.666 . . . . 0.0 110.551 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.831 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -130.02 -50.53 1.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.941 ' O ' HD11 ' A' ' 87' ' ' LEU . 5.4 mp -78.91 -32.31 45.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.014 -1.054 . . . . 0.0 108.515 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 40.7 t-20 -55.18 125.06 19.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.576 ' HA ' ' HB3' ' A' ' 86' ' ' PRO . 4.4 m120 65.97 72.4 0.4 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.505 -0.747 . . . . 0.0 110.508 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.7 p -86.81 48.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.914 HG21 ' CB ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -154.96 134.16 7.58 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.845 ' HD2' HG23 ' A' ' 79' ' ' ILE . 34.7 Cg_endo -46.5 138.16 14.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.774 1.408 . . . . 0.0 109.758 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 80' ' ' PRO . 2.5 mm-40 -42.23 145.98 0.34 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 0.0 110.059 -179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 141.02 -29.49 2.32 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 140.31 -127.59 3.55 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.914 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.2 m 70.7 3.46 4.57 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.323 -1.104 . . . . 0.0 109.536 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.425 ' OE1' ' HD3' ' A' ' 22' ' ' PRO . 4.7 mt-30 64.94 122.73 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.055 -1.028 . . . . 0.0 109.203 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.576 ' HB3' ' HA ' ' A' ' 77' ' ' ASN . 37.8 Cg_endo -108.12 152.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 124.077 1.567 . . . . 0.0 110.803 -178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.941 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -70.17 119.62 14.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.578 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -78.59 98.45 6.16 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.802 HG21 ' HA ' ' A' ' 72' ' ' ILE . 33.8 m -78.83 153.47 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 122.02 0.915 . . . . 0.0 111.671 -177.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.537 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 154.32 141.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.594 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.799 HD22 ' O ' ' A' ' 15' ' ' ASN . 0.1 OUTLIER -59.78 134.68 57.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.38 -0.825 . . . . 0.0 109.53 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -94.1 -31.48 14.17 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.272 -0.893 . . . . 0.0 109.597 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 92' ' ' ALA . 0.8 OUTLIER 76.23 63.53 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.411 -0.806 . . . . 0.0 109.187 -179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -131.0 -34.8 1.44 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.399 -0.813 . . . . 0.0 109.594 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -148.83 -92.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.467 ' O ' ' OD1' ' A' ' 15' ' ' ASN . . . -176.61 -44.89 0.06 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.506 ' CA ' ' HA ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.098 -1.236 . . . . 0.0 109.597 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -103.46 96.17 6.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.199 -0.938 . . . . 0.0 109.512 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -65.68 -30.13 70.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.294 -0.879 . . . . 0.0 109.568 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.37 118.61 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 109.729 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.5 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . 12.5 ptt180 -58.47 142.78 81.93 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 108.689 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 91' ' ' LEU . 35.6 Cg_endo -41.3 133.77 3.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.857 1.451 . . . . 0.0 111.042 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.78 92.05 0.12 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.84 -163.2 33.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -65.19 123.35 19.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -1.106 . . . . 0.0 109.727 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 11' ' ' ILE . 2.1 t -179.01 -157.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.155 ' CD1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -36.67 158.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -25.76 -41.62 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 120.954 0.407 . . . . 0.0 111.433 -179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -131.21 -67.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.943 -1.098 . . . . 0.0 111.596 -179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -161.53 102.74 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.789 -1.194 . . . . 0.0 109.967 -178.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.574 ' N ' ' CG2' ' A' ' 11' ' ' ILE . 46.8 p30 -98.38 -163.89 1.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.463 -0.773 . . . . 0.0 109.078 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.058 HD21 HG12 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -160.34 119.2 2.68 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.599 -1.24 . . . . 0.0 112.151 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.661 ' CE2' ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -79.41 131.47 36.1 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.8 m -124.16 149.57 28.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.513 -1.367 . . . . 0.0 111.465 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.67 HG23 HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -135.97 -153.32 0.5 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.525 179.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.92 34.77 16.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.995 . . . . 0.0 110.287 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.869 HD11 ' HB2' ' A' ' 58' ' ' ALA . 2.9 pp -170.49 128.72 0.78 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.995 -1.065 . . . . 0.0 109.858 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 36.9 Cg_endo -102.81 67.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.979 1.515 . . . . 0.0 109.934 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.68 ' CG ' HG21 ' A' ' 45' ' ' ILE . 26.6 mtp180 62.11 54.64 2.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.453 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.5 p -79.8 -1.09 37.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.17 -0.956 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.837 HD13 ' N ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -151.4 -160.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.167 -0.958 . . . . 0.0 109.33 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.523 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.6 p -122.12 151.53 40.84 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 92.6 m-20 -49.06 -73.24 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.339 -0.851 . . . . 0.0 109.322 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' ASP . 4.0 p30 -42.34 -26.36 0.11 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.095 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.523 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.7 tt0 -63.53 -57.74 9.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 110.143 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.935 HD21 ' CD2' ' A' ' 87' ' ' LEU . 3.0 mp -45.33 -44.44 11.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.199 -0.938 . . . . 0.0 109.867 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.944 ' OD1' HD11 ' A' ' 40' ' ' ILE . 21.2 t0 -59.5 -40.68 87.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.014 -1.054 . . . . 0.0 110.054 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.1 m -77.85 -10.94 59.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER -84.0 -45.95 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 0.0 109.904 -179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 1.006 ' CZ ' HD12 ' A' ' 40' ' ' ILE . 39.5 p90 -103.4 -45.89 4.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.004 -1.06 . . . . 0.0 109.449 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.639 ' N ' ' CD1' ' A' ' 34' ' ' PHE . . . 15.21 60.11 0.01 OUTLIER Glycine 0 N--CA 1.505 3.254 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' PHE . 12.4 tttt -133.36 -28.49 1.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.065 -1.256 . . . . 0.0 110.493 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.629 ' CD2' ' HG2' ' A' ' 67' ' ' GLU . 0.1 OUTLIER -111.68 -100.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.847 -1.158 . . . . 0.0 110.31 -179.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.425 ' H ' ' HG3' ' A' ' 67' ' ' GLU . . . -79.24 152.48 36.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 40' ' ' ILE . 20.6 t -87.05 45.24 1.25 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.122 -1.223 . . . . 0.0 108.258 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.006 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER 39.95 110.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 122.217 1.008 . . . . 0.0 110.598 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.155 HG21 ' CD1' ' A' ' 11' ' ' ILE . 4.8 m -77.64 7.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.325 -0.859 . . . . 0.0 110.296 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER 162.46 72.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.068 -1.02 . . . . 0.0 110.29 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 1.8 ptpp? -82.76 117.72 22.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.893 -1.13 . . . . 0.0 109.014 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HA ' ' CG ' ' A' ' 27' ' ' ASP . 20.0 p30 -154.73 169.6 23.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 110.198 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.68 HG21 ' CG ' ' A' ' 23' ' ' ARG . 13.7 mt -114.39 171.01 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.484 -0.76 . . . . 0.0 109.117 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.547 ' HB2' HG13 ' A' ' 57' ' ' VAL . 1.2 mt -128.8 113.41 15.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.078 -1.014 . . . . 0.0 110.012 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.454 ' HB3' ' HD2' ' A' ' 23' ' ' ARG . 23.0 ptt180 -133.38 -160.64 1.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 0.2 OUTLIER -124.26 -171.7 2.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.988 -1.07 . . . . 0.0 109.719 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 mmmt -47.63 -76.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.993 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -137.77 -78.57 0.38 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.076 -1.015 . . . . 0.0 110.007 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.4 p -105.95 33.37 3.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.028 -1.045 . . . . 0.0 109.905 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 48' ' ' ASP . . . -126.31 63.19 0.6 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -121.27 116.24 31.05 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.352 -1.087 . . . . 0.0 109.456 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -114.28 32.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.976 1.514 . . . . 0.0 110.468 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -154.2 -62.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.294 -0.879 . . . . 0.0 109.786 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.32 95.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.67 HG23 HG23 ' A' ' 19' ' ' THR . 1.6 p -142.4 138.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.578 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 21' ' ' LEU . . . -89.5 175.34 7.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.661 ' CE2' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -157.85 104.76 1.95 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.194 -0.941 . . . . 0.0 110.365 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.063 HG21 HD21 ' A' ' 75' ' ' LEU . 3.2 t -90.5 159.67 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.76 ' HB3' HG23 ' A' ' 41' ' ' VAL . 38.2 mmm-85 -139.51 147.3 41.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.586 -1.321 . . . . 0.0 110.169 -179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.665 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 52.3 m-85 -159.42 149.43 18.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.599 ' HB3' HD13 ' A' ' 11' ' ' ILE . 3.8 p30 -119.79 71.82 0.9 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.292 -1.363 . . . . 0.0 109.875 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.574 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -171.19 96.86 0.2 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.511 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -33.4 -51.93 0.37 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.264 0.554 . . . . 0.0 110.359 -179.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -57.24 -50.05 74.11 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.91 -1.119 . . . . 0.0 108.466 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.629 ' HG2' ' CD2' ' A' ' 37' ' ' TYR . 15.2 tm-20 -52.37 -48.88 65.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.48 -0.762 . . . . 0.0 110.354 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.563 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -46.72 -45.2 19.4 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.647 -1.283 . . . . 0.0 107.981 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -54.6 -45.78 73.68 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.601 ' HB3' ' CE1' ' A' ' 37' ' ' TYR . 0.5 OUTLIER -52.41 -65.77 0.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.875 0.845 . . . . 0.0 109.248 179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.665 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -53.01 -15.65 0.85 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.209 0.528 . . . . 0.0 110.838 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.824 HD13 HG12 ' A' ' 89' ' ' VAL . 1.1 mm -85.21 -70.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 O-C-N 120.676 -1.265 . . . . 0.0 108.881 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.8 t -58.88 -9.3 1.74 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.737 -1.227 . . . . 0.0 110.582 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -129.14 -53.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.664 -1.273 . . . . 0.0 111.087 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.063 HD21 HG21 ' A' ' 60' ' ' VAL . 7.1 tp -81.72 5.89 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.971 -1.081 . . . . 0.0 110.837 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' HA ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -87.3 22.42 2.14 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.724 -1.235 . . . . 0.0 108.556 178.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.546 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 38.5 p-10 177.86 73.83 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 78' ' ' VAL . 11.5 p -80.9 68.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.312 -0.867 . . . . 0.0 108.953 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.738 HD13 ' OG ' ' A' ' 84' ' ' SER . 0.1 OUTLIER 163.87 118.74 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -39.29 128.97 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.956 1.503 . . . . 0.0 110.835 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -56.75 163.98 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.305 -0.872 . . . . 0.0 109.52 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.97 -53.68 0.67 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.75 35.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.738 ' OG ' HD13 ' A' ' 79' ' ' ILE . 7.5 t -110.38 -14.19 14.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.129 -1.218 . . . . 0.0 109.529 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 84' ' ' SER . 46.7 mt-30 61.93 117.75 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.278 -0.889 . . . . 0.0 110.882 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HB2' ' HA ' ' A' ' 77' ' ' ASN . 37.4 Cg_endo -123.61 -160.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 124.075 1.566 . . . . 0.0 109.354 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.935 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -94.9 115.76 27.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.958 -1.089 . . . . 0.0 110.926 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 5.8 m -79.23 113.63 17.51 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.824 HG12 HD13 ' A' ' 72' ' ' ILE . 13.1 t -83.27 162.21 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-O 122.318 1.056 . . . . 0.0 113.17 -175.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 161.57 115.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.558 HD11 ' CA ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -44.04 157.53 0.05 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.958 -1.089 . . . . 0.0 109.894 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.29 170.8 2.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.48 -0.763 . . . . 0.0 109.906 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 43.2 mm-40 -141.01 125.7 17.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.431 -0.793 . . . . 0.0 109.217 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 70.48 6.51 5.84 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 0.0 109.342 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -141.21 -170.09 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.449 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.61 134.37 3.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 61' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.222 -1.163 . . . . 0.0 109.494 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mmt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -54.68 99.56 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.099 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER -175.42 75.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.512 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ARG . . . -158.77 86.79 0.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 109.809 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER 58.91 152.82 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.571 ' CG ' ' HB3' ' A' ' 91' ' ' LEU . 37.6 Cg_endo -120.88 -160.12 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.741 1.39 . . . . 0.0 110.27 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.75 -131.74 3.72 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.548 ' N ' ' HB2' ' A' ' 13' ' ' ASP . . . 159.71 -133.08 3.19 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.533 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 1.4 mm-40 -169.43 179.93 3.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.161 . . . . 0.0 109.376 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.582 ' CB ' ' HD3' ' A' ' 97' ' ' LYS . 0.8 OUTLIER 71.5 -163.05 0.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.1 -1.0 . . . . 0.0 109.474 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.949 HG23 ' CG1' ' A' ' 41' ' ' VAL . 0.5 OUTLIER -41.05 95.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.588 ' CB ' ' HB2' ' A' ' 63' ' ' ASN . 6.9 mmtt 57.93 -167.92 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.548 ' HB2' ' N ' ' A' ' 8' ' ' GLY . 0.0 OUTLIER -160.16 82.81 0.71 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.623 -1.298 . . . . 0.0 111.052 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.603 HG21 ' HA ' ' A' ' 65' ' ' ARG . 0.7 OUTLIER -161.35 52.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 0.0 109.142 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.58 HD22 HG21 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -79.16 -169.4 1.83 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.257 -0.902 . . . . 0.0 109.919 -179.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.05 HD21 HG12 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -153.01 127.0 8.99 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.034 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.877 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.1 OUTLIER -77.6 125.56 29.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.628 HG23 ' HB3' ' A' ' 58' ' ' ALA . 29.0 m -118.24 124.01 72.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.415 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.582 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -123.65 178.11 5.37 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.582 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.2 OUTLIER 87.79 15.19 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.575 -0.703 . . . . 0.0 111.337 179.089 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -154.59 43.17 0.21 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.716 -1.24 . . . . 0.0 110.343 179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 21' ' ' LEU . 37.7 Cg_endo -76.14 142.82 24.93 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.593 1.312 . . . . 0.0 110.895 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 61.05 9.76 2.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 110.691 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 22' ' ' PRO . 43.2 p -99.84 -38.77 8.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.96 -1.088 . . . . 0.0 108.917 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.875 HD11 HD23 ' A' ' 21' ' ' LEU . 1.3 pp -136.79 166.99 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 108.876 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -103.25 144.67 31.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.092 -1.005 . . . . 0.0 109.789 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.545 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -53.9 -66.2 0.44 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.241 -0.912 . . . . 0.0 109.214 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.9 OUTLIER -44.91 -25.19 0.28 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.004 -1.06 . . . . 0.0 109.484 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 26' ' ' THR . 47.6 tt0 -64.75 -62.21 1.71 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.113 -0.992 . . . . 0.0 109.636 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . 6.1 mp -43.96 -26.41 0.28 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.187 -0.946 . . . . 0.0 109.234 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' OD2' ' NH2' ' A' ' 61' ' ' ARG . 13.0 t70 -57.99 -54.11 50.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.9 m -62.76 -44.46 96.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.641 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -57.53 -17.2 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 0.0 108.509 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.912 ' CE2' HD21 ' A' ' 75' ' ' LEU . 20.4 m-30 -100.5 -91.0 0.31 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.359 -0.838 . . . . 0.0 110.233 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 36.6 77.42 0.05 OUTLIER Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.106 -1.197 . . . . 0.0 110.106 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -173.7 -38.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.296 . . . . 0.0 110.681 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.625 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -90.16 -80.68 0.31 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.827 -1.171 . . . . 0.0 109.763 -179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.47 -165.45 11.98 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.506 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.5 OUTLIER -94.32 26.92 3.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.3 -1.118 . . . . 0.0 108.191 179.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.941 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 41.83 -173.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-O 121.629 0.728 . . . . 0.0 109.811 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.949 ' CG1' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -118.48 -61.78 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.099 -1.001 . . . . 0.0 111.114 -177.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.772 ' H ' ' CB ' ' A' ' 61' ' ' ARG . 1.3 tm0? -176.59 107.19 0.07 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.898 -0.501 . . . . 0.0 109.675 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' CB ' ' HG2' ' A' ' 61' ' ' ARG . 0.1 OUTLIER -97.74 132.47 43.34 Favored 'General case' 0 N--CA 1.511 2.576 0 O-C-N 120.879 -1.138 . . . . 0.0 107.96 179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -141.58 159.17 42.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.633 -1.292 . . . . 0.0 110.356 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -123.31 137.18 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.822 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -120.26 123.67 43.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.067 -1.02 . . . . 0.0 109.658 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -87.71 -130.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.444 -0.785 . . . . 0.0 109.085 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 53' ' ' ARG . 2.6 m-20 -141.01 125.4 17.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.758 -1.214 . . . . 0.0 109.678 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.769 ' C ' HD23 ' A' ' 50' ' ' LEU . 5.5 mtmp? -121.48 33.86 5.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -0.895 . . . . 0.0 109.464 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.769 HD23 ' C ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -138.88 -53.14 0.58 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.208 -0.932 . . . . 0.0 109.205 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.5 p -105.6 -34.75 7.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.246 -0.909 . . . . 0.0 109.538 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.14 45.35 2.22 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 48' ' ' ASP . 5.3 ttt180 -64.9 157.99 72.54 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.321 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CG ' ' A' ' 55' ' ' ARG . 36.4 Cg_endo -102.45 11.59 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.956 1.503 . . . . 0.0 110.397 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 54' ' ' PRO . 40.4 mtm-85 -161.19 85.04 0.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.758 ' O ' HG13 ' A' ' 57' ' ' VAL . . . -73.13 -111.61 0.06 OUTLIER Glycine 0 N--CA 1.477 1.393 0 N-CA-C 109.106 -1.597 . . . . 0.0 109.106 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -163.12 157.42 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 O-C-N 121.484 -1.01 . . . . 0.0 109.77 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.641 ' CB ' HD21 ' A' ' 21' ' ' LEU . . . -110.32 174.01 6.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.769 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HD21 ' A' ' 46' ' ' LEU . 3.1 m-85 -143.47 104.21 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.784 -179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.064 HG21 HD23 ' A' ' 75' ' ' LEU . 1.1 t -82.47 158.71 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.941 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -119.23 135.37 54.72 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 119.118 -1.033 . . . . 0.0 112.477 -177.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 1.019 ' CE1' ' HB2' ' A' ' 71' ' ' ALA . 7.1 m-85 -155.3 137.98 15.18 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.588 ' HB2' ' CB ' ' A' ' 12' ' ' LYS . 7.5 p30 -118.78 -50.28 2.41 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 120.468 -1.395 . . . . 0.0 110.194 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -53.88 137.08 39.58 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.603 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.4 OUTLIER -63.12 -43.07 99.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 0.0 109.043 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.18 -43.19 67.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.93 . . . . 0.0 108.772 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.602 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -61.76 -25.61 67.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.261 -0.899 . . . . 0.0 109.35 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' GLN . . . -72.89 -48.19 39.4 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.736 -1.227 . . . . 0.0 107.854 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.472 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 8.3 tp-100 -49.43 -32.97 12.88 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -58.89 -67.89 0.32 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.019 ' HB2' ' CE1' ' A' ' 62' ' ' TYR . . . -45.8 -22.05 0.16 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.212 0.529 . . . . 0.0 109.641 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.534 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 15.6 mm -74.35 -70.12 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.406 -1.434 . . . . 0.0 108.657 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.11 22.61 0.95 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.53 -0.731 . . . . 0.0 110.334 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -138.66 -50.57 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.064 HD23 HG21 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -79.44 -42.09 26.14 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 8.0 t-20 -39.2 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.347 -0.845 . . . . 0.0 109.139 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.537 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 2.1 m-20 80.9 80.04 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.8 p -85.28 53.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.435 -0.791 . . . . 0.0 108.951 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 85' ' ' GLN . 4.6 pt -117.22 173.93 2.83 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.149 -0.969 . . . . 0.0 109.213 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 36.5 Cg_endo -90.62 20.35 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.97 1.51 . . . . 0.0 110.098 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 69.54 70.53 0.25 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.526 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 165.38 -31.41 0.23 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -75.59 -140.18 0.82 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.47 38.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -1.164 . . . . 0.0 109.375 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.509 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 29.7 mm-40 -130.55 82.86 63.87 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' O ' HD12 ' A' ' 21' ' ' LEU . 36.8 Cg_endo -108.89 164.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.061 1.559 . . . . 0.0 110.125 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -112.33 124.4 52.39 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.189 -0.945 . . . . 0.0 110.321 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 12.9 m -79.13 105.68 10.63 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.618 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 22.7 m -77.26 -167.57 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.986 -0.446 . . . . 0.0 111.611 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.618 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 104.27 108.04 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -177.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 93' ' ' GLU . 9.5 tp -36.64 145.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.523 0.677 . . . . 0.0 110.257 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.877 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -77.1 -67.68 0.69 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.527 -0.733 . . . . 0.0 109.402 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.654 ' O ' HD23 ' A' ' 91' ' ' LEU . 43.5 mm-40 -116.8 -170.58 1.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.457 -0.777 . . . . 0.0 109.294 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -90.4 9.37 29.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.339 -0.851 . . . . 0.0 109.9 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' CE1' ' O ' ' A' ' 96' ' ' GLY . 18.9 p80 -97.6 -30.52 12.8 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' CE1' ' A' ' 95' ' ' HIS . . . 49.08 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.582 ' HD3' ' CB ' ' A' ' 10' ' ' SER . 8.1 tmtm? . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.257 -1.143 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 3' ' ' TYR . 33.3 t -77.87 149.79 34.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 109.554 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 1.4 m-85 -45.11 -89.42 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.297 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 3' ' ' TYR . . . 178.78 139.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.868 . . . . 0.0 109.345 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 1.0 OUTLIER -165.05 80.16 1.26 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.988 . . . . 0.0 110.057 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.953 ' O ' HD22 ' A' ' 91' ' ' LEU . 36.0 Cg_endo -111.01 166.7 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.752 1.396 . . . . 0.0 110.26 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.58 176.39 21.94 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.545 ' O ' ' CB ' ' A' ' 9' ' ' GLU . . . 171.96 172.66 38.1 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.545 ' CB ' ' O ' ' A' ' 8' ' ' GLY . 1.3 tp10 81.98 172.34 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.581 -0.952 . . . . 0.0 110.105 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -86.19 151.31 23.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.854 . . . . 0.0 109.857 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.677 HD11 HG12 ' A' ' 41' ' ' VAL . 5.8 tp 38.4 33.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 122.248 1.023 . . . . 0.0 109.605 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.588 ' O ' ' CG ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -164.16 26.73 0.07 Allowed 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.502 ' CB ' ' C ' ' A' ' 63' ' ' ASN . 0.3 OUTLIER -79.2 -2.21 39.91 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.984 -1.072 . . . . 0.0 110.538 -179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.096 HG21 ' HB2' ' A' ' 68' ' ' ALA . 15.7 m -162.52 93.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.891 -1.131 . . . . 0.0 110.405 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.648 ' N ' HD11 ' A' ' 91' ' ' LEU . 13.9 t-20 -84.68 106.02 15.91 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.986 -1.071 . . . . 0.0 108.715 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.736 HD23 HG11 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -79.13 103.57 9.16 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.926 -1.109 . . . . 0.0 109.149 -179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -93.85 86.86 5.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.359 -0.838 . . . . 0.0 108.949 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.015 HG23 ' HB3' ' A' ' 58' ' ' ALA . 2.6 m -89.52 97.43 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.099 -1.001 . . . . 0.0 109.306 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 1.007 HG23 HG22 ' A' ' 57' ' ' VAL . 0.7 OUTLIER -92.01 -165.53 1.37 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.439 -0.788 . . . . 0.0 109.575 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.68 ' H ' HG22 ' A' ' 19' ' ' THR . 1.7 t30 53.39 84.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -0.917 . . . . 0.0 109.107 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -146.51 132.95 9.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 0.0 109.594 -179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 23' ' ' ARG . 36.5 Cg_endo -104.0 39.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.891 1.469 . . . . 0.0 109.897 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' A' ' 22' ' ' PRO . 15.2 mtt85 36.52 61.35 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.294 0.568 . . . . 0.0 110.338 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.997 HG23 HG13 ' A' ' 25' ' ' ILE . 7.4 t -97.48 -16.19 20.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.248 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.997 HG13 HG23 ' A' ' 24' ' ' THR . 0.2 OUTLIER -127.2 179.25 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.373 -0.829 . . . . 0.0 109.051 179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 29' ' ' GLN . 1.3 p -105.63 158.45 16.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.0 109.202 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 43' ' ' LYS . 9.7 t0 -55.75 -62.45 1.68 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.643 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -56.79 -15.59 4.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -0.885 . . . . 0.0 110.278 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.757 ' OE1' HG22 ' A' ' 25' ' ' ILE . 1.7 tt0 -75.27 -51.76 12.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.829 -1.17 . . . . 0.0 110.354 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.629 HD11 HD13 ' A' ' 25' ' ' ILE . 4.6 mp -46.56 -32.16 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.82 -1.175 . . . . 0.0 108.476 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 34' ' ' PHE . 4.2 t70 -48.66 -52.85 21.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.064 -1.023 . . . . 0.0 108.652 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.6 m -63.22 -41.51 99.14 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.466 -0.771 . . . . 0.0 109.042 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.899 HG12 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -64.54 -13.48 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 0.0 108.864 179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 1.047 ' CZ ' HD13 ' A' ' 75' ' ' LEU . 7.4 m-30 -83.91 -74.26 0.38 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 36' ' ' LYS . . . 144.3 -90.88 0.16 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 162.99 47.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.711 -0.876 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' ' HB3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -79.81 -81.12 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.96 166.6 14.73 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 107.52 -2.232 . . . . 0.0 107.52 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 40' ' ' ILE . 15.5 m -78.58 94.47 5.01 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.834 -1.391 . . . . 0.0 108.293 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.2 mp -34.67 117.07 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -80.1 18.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 111.009 -177.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.659 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER 163.65 138.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.307 -0.871 . . . . 0.0 110.18 177.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -145.96 76.7 1.47 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -94.85 174.1 7.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.676 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 45' ' ' ILE . 3.0 tt -126.58 104.15 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.1 -1.0 . . . . 0.0 110.347 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.813 ' HA ' ' N ' ' A' ' 57' ' ' VAL . 8.4 mp 52.85 -141.62 0.84 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.516 -0.74 . . . . 0.0 110.011 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.578 ' NE ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -163.32 120.74 1.88 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 120.966 -1.084 . . . . 0.0 109.482 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 61.35 136.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.132 -179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.58 3.29 24.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.968 . . . . 0.0 109.693 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.83 -46.71 1.69 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.0 109.543 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.2 OUTLIER -118.66 146.43 44.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.913 . . . . 0.0 109.795 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 53' ' ' ARG . . . -87.19 51.91 4.29 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.625 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -40.9 -60.52 1.62 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.617 -0.931 . . . . 0.0 109.928 -179.307 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' A' ' 53' ' ' ARG . 35.9 Cg_endo -94.38 -90.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 117.171 -1.419 . . . . 0.0 110.831 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -141.58 -37.58 0.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.935 . . . . 0.0 109.964 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 47' ' ' ARG . . . 85.68 96.78 0.75 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.007 HG22 HG23 ' A' ' 19' ' ' THR . 44.6 t -159.02 153.16 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.114 -1.227 . . . . 0.0 110.11 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.015 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -75.97 127.0 32.06 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.607 ' CE1' ' O ' ' A' ' 57' ' ' VAL . 91.6 m-85 -103.35 83.17 2.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 112.091 -176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.736 HG11 HD23 ' A' ' 16' ' ' LEU . 3.3 t -86.53 77.55 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.66 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.7 ttm180 -76.82 113.21 14.24 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.594 -1.316 . . . . 0.0 110.695 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.731 ' CE1' HG13 ' A' ' 60' ' ' VAL . 3.6 m-85 -114.36 -173.87 2.37 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.535 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.4 OUTLIER -131.29 -100.78 0.29 Allowed 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.097 -1.441 . . . . 0.0 110.337 178.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 63' ' ' ASN . 26.1 tttp -24.4 136.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 CA-C-O 121.618 0.723 . . . . 0.0 111.795 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' NH2' ' HG3' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -55.95 -52.37 64.37 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -52.4 -39.65 61.17 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -49.49 -47.0 48.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.096 ' HB2' HG21 ' A' ' 14' ' ' THR . . . -57.72 -39.32 76.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.389 -0.819 . . . . 0.0 108.813 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -51.1 -37.08 43.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 108.205 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 4.4 mt-10 -74.8 -62.45 1.54 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.852 0.834 . . . . 0.0 109.751 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.706 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -52.76 -16.14 0.91 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.469 0.652 . . . . 0.0 110.931 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.557 ' O ' ' CB ' ' A' ' 76' ' ' ASN . 5.0 mt -92.37 -60.33 2.52 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.418 -1.426 . . . . 0.0 109.465 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.1 t -66.69 -5.31 11.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 0.0 109.959 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' C ' HD23 ' A' ' 75' ' ' LEU . . . -112.7 -53.94 2.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.944 -1.098 . . . . 0.0 109.961 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -81.27 -39.34 25.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.016 -1.053 . . . . 0.0 109.879 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.689 ' HB2' HG21 ' A' ' 89' ' ' VAL . 61.5 t-20 -43.79 111.68 0.31 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.616 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER 74.8 91.03 0.08 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.993 0.901 . . . . 0.0 109.207 -178.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.899 HG23 HG12 ' A' ' 33' ' ' ILE . 3.1 p -103.7 38.48 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.021 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -148.56 -175.16 0.45 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.926 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.2 Cg_endo -63.58 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 116.966 -1.556 . . . . 0.0 110.239 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 38.7 tt0 179.16 107.0 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.062 -1.024 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.95 48.16 55.95 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -134.32 -81.7 0.16 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 1.021 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -79.26 5.14 13.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.224 -1.162 . . . . 0.0 109.749 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 84' ' ' SER . 36.1 mt-30 70.35 86.36 0.12 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.149 -0.969 . . . . 0.0 109.152 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.679 ' HA ' HD11 ' A' ' 79' ' ' ILE . 35.0 Cg_endo -58.69 -173.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.363 1.717 . . . . 0.0 111.927 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.793 HD23 HD21 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -94.99 152.75 18.05 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -99.69 100.45 11.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 76' ' ' ASN . 2.5 m -78.11 172.87 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.734 -0.604 . . . . 0.0 110.715 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.647 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 10.8 ttt180 127.5 138.63 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.953 HD22 ' O ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -65.09 138.16 58.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.936 -1.102 . . . . 0.0 109.988 -179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.436 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -93.71 179.51 5.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.585 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.65 176.23 5.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' HIS . 4.0 mt-10 61.16 178.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.372 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLU . 96.8 m-70 -44.21 154.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.156 -0.965 . . . . 0.0 109.377 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.33 -40.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' A' ' 61' ' ' ARG . 16.0 pttt . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 0.0 109.376 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.5 t -126.5 43.14 3.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.128 -0.982 . . . . 0.0 109.542 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.707 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -137.14 -170.68 2.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 0.0 109.523 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 3' ' ' TYR . . . 79.39 -73.47 0.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.474 -0.766 . . . . 0.0 109.907 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 -148.02 97.33 3.9 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.384 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -84.29 120.12 2.48 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.895 1.471 . . . . 0.0 110.228 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 170.55 20.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.42 -148.02 18.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' C ' ' OG ' ' A' ' 10' ' ' SER . 3.4 tt0 -70.87 125.35 26.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -1.171 . . . . 0.0 109.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.566 ' CB ' ' OD1' ' A' ' 15' ' ' ASN . 0.0 OUTLIER 176.97 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.58 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.7 HD13 ' HB2' ' A' ' 13' ' ' ASP . 0.0 OUTLIER 44.58 50.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.314 -0.866 . . . . 0.0 109.497 -179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 11' ' ' ILE . 18.6 mmtp 31.39 34.78 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.966 -0.459 . . . . 0.0 111.396 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.7 ' HB2' HD13 ' A' ' 11' ' ' ILE . 23.5 m-20 -162.61 -93.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.964 -1.085 . . . . 0.0 110.251 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.137 ' CG2' HD11 ' A' ' 91' ' ' LEU . 4.4 m -162.75 94.14 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.964 . . . . 0.0 111.134 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.791 ' O ' HD23 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -102.96 165.47 11.01 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.035 -1.041 . . . . 0.0 108.891 178.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.885 HD12 ' HB ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -132.05 122.07 24.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.311 -1.493 . . . . 0.0 110.356 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' OH ' ' HB ' ' A' ' 19' ' ' THR . 0.1 OUTLIER -79.47 117.88 20.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 89' ' ' VAL . 15.6 m -97.33 146.08 8.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.446 -0.783 . . . . 0.0 109.7 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.477 ' HB ' ' OH ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -124.03 167.29 14.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.39 -0.819 . . . . 0.0 109.438 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.2 m-20 72.4 18.05 4.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.412 -0.805 . . . . 0.0 109.398 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 21' ' ' LEU . 2.9 tm? -53.73 109.61 1.6 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.91 . . . . 0.0 109.998 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.717 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.4 Cg_endo -82.08 147.42 14.76 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.044 1.55 . . . . 0.0 109.794 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.36 19.63 3.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.139 -0.975 . . . . 0.0 109.958 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 22' ' ' PRO . 11.3 t -89.19 -6.05 57.21 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 109.395 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.04 -166.87 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.202 -0.936 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -137.2 149.94 47.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 109.916 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' N ' ' A' ' 44' ' ' ASN . 0.3 OUTLIER -57.78 -55.99 27.8 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.361 -0.837 . . . . 0.0 108.981 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' GLN . 3.1 p30 -49.36 -24.2 1.8 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.257 -0.902 . . . . 0.0 108.869 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HB3' ' O ' ' A' ' 26' ' ' THR . 59.5 tt0 -71.89 -45.07 62.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.295 -0.878 . . . . 0.0 109.125 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.11 HD21 ' CD2' ' A' ' 87' ' ' LEU . 6.9 mp -46.8 -35.58 6.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.255 -0.903 . . . . 0.0 108.721 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.612 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 5.6 t0 -49.2 -50.68 37.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.977 -1.077 . . . . 0.0 109.263 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 4.0 m -80.87 -15.34 56.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.863 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.647 HG12 HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -67.98 -47.73 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.949 -1.094 . . . . 0.0 109.805 -179.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.87 ' CD1' HD11 ' A' ' 75' ' ' LEU . 20.1 p90 -92.74 -41.63 10.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.745 -1.222 . . . . 0.0 109.423 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' LYS . . . 127.51 -78.17 0.39 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 1.6 tptp 174.74 78.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.351 -1.088 . . . . 0.0 109.858 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.875 ' HE2' HD13 ' A' ' 75' ' ' LEU . 0.1 OUTLIER -79.71 -104.1 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' N ' ' HB3' ' A' ' 67' ' ' GLU . . . -68.89 176.34 29.62 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 107.068 -2.413 . . . . 0.0 107.068 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 41' ' ' VAL . 14.3 t -78.56 81.82 4.86 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.831 -1.394 . . . . 0.0 107.793 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.82 HD13 ' HZ ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -35.51 96.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 CA-C-O 122.14 0.972 . . . . 0.0 108.447 -178.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.776 HG23 ' HB3' ' A' ' 61' ' ' ARG . 28.4 m -79.25 47.92 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.286 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.639 ' CB ' ' O ' ' A' ' 41' ' ' VAL . 5.5 tt0 96.81 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.26 0.553 . . . . 0.0 111.449 178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' CD ' ' O ' ' A' ' 27' ' ' ASP . 8.4 ptpp? -92.24 132.17 36.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.525 ' N ' ' OD2' ' A' ' 27' ' ' ASP . 6.3 p30 -129.69 161.62 30.23 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.59 -1.318 . . . . 0.0 110.789 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.72 ' O ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -108.33 169.0 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.72 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.58 117.88 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 109.454 -179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ptp85 -96.23 -163.76 1.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.414 -0.804 . . . . 0.0 109.067 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.51 ' HB3' ' HA ' ' A' ' 53' ' ' ARG . 9.9 p30 -72.21 164.25 26.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.024 -1.047 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 49' ' ' LYS . 2.5 tptp 176.83 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.487 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.21 -40.02 4.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -161.82 0.54 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.304 -0.872 . . . . 0.0 109.601 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' C ' ' CG ' ' A' ' 53' ' ' ARG . . . -67.88 -79.85 0.23 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.57 ' CB ' ' CD ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -167.78 -81.97 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.181 -1.188 . . . . 0.0 109.371 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.57 ' CD ' ' CB ' ' A' ' 53' ' ' ARG . 35.8 Cg_endo -48.29 97.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.861 1.453 . . . . 0.0 110.256 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.424 ' N ' ' O ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -142.89 -50.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.257 -0.902 . . . . 0.0 109.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 21' ' ' LEU . . . 66.77 99.06 0.02 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' CE1' ' A' ' 59' ' ' PHE . 85.1 t -130.39 145.36 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.117 . . . . 0.0 109.032 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.89 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -149.15 174.83 11.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.011 -1.055 . . . . 0.0 109.543 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 33.6 m-85 -154.55 107.65 2.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 75' ' ' LEU . 2.2 t -84.81 102.95 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.776 ' HB3' HG23 ' A' ' 41' ' ' VAL . 4.8 mtm180 -83.35 128.66 34.69 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.036 -1.04 . . . . 0.0 110.411 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.825 ' CZ ' HD22 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -162.52 173.56 13.84 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.579 ' CB ' ' CB ' ' A' ' 13' ' ' ASP . 7.7 p30 -112.11 -114.84 0.32 Allowed 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 117.68 -1.608 . . . . 0.0 110.861 -178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 10.6 mmtt 16.52 108.74 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.282 0.563 . . . . 0.0 112.343 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.691 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -57.47 -40.87 79.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.983 -1.073 . . . . 0.0 109.58 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -38.97 86.39 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HB3' ' N ' ' A' ' 38' ' ' GLY . 60.8 mm-40 -59.7 -30.91 69.12 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.671 ' HA ' ' CZ ' ' A' ' 62' ' ' TYR . . . -67.17 -37.87 84.47 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -53.52 -35.23 60.46 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 2.7 mp0 -61.4 -52.48 64.42 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.606 ' CA ' ' HB2' ' A' ' 75' ' ' LEU . . . -67.01 -5.21 11.99 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.796 -0.761 . . . . 0.0 109.594 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.608 HD13 HG23 ' A' ' 89' ' ' VAL . 14.0 mm -84.49 -57.42 4.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 t -79.67 0.84 28.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.946 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -127.28 -44.16 1.59 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.026 -1.046 . . . . 0.0 109.906 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 60' ' ' VAL . 0.8 OUTLIER -89.34 -28.43 19.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.312 -0.867 . . . . 0.0 110.185 -179.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.74 ' HA ' HG22 ' A' ' 89' ' ' VAL . 34.3 t-20 -46.67 -27.5 1.19 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.217 -1.552 . . . . 0.0 109.453 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -148.53 78.81 1.43 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.785 ' HB ' HD11 ' A' ' 87' ' ' LEU . 1.5 t -85.4 107.28 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.998 -1.064 . . . . 0.0 108.97 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.53 HG12 ' HD2' ' A' ' 80' ' ' PRO . 0.1 OUTLIER 174.19 164.6 0.33 Allowed Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.53 ' HD2' HG12 ' A' ' 79' ' ' ILE . 36.6 Cg_endo -86.47 37.41 0.53 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.703 1.37 . . . . 0.0 110.477 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 80' ' ' PRO . 4.0 mt-10 40.24 44.45 1.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.489 -0.757 . . . . 0.0 109.498 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.11 -19.95 17.52 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 84' ' ' SER . . . -141.65 -108.73 0.72 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' GLY . 41.4 t 175.76 55.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.334 -1.098 . . . . 0.0 109.456 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.6 ' N ' ' CD ' ' A' ' 86' ' ' PRO . 3.0 pt20 -143.94 32.95 0.13 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.171 -0.955 . . . . 0.0 110.632 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 85' ' ' GLN . 37.8 Cg_endo -68.31 -162.45 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.424 1.223 . . . . 0.0 109.191 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.11 ' CD2' HD21 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -100.19 114.57 28.08 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 118.812 -1.155 . . . . 0.0 109.657 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -79.1 116.04 19.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 177.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.081 HG12 HG12 ' A' ' 18' ' ' VAL . 17.4 m -94.38 171.44 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.982 0.896 . . . . 0.0 112.003 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER 166.47 116.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.137 HD11 ' CG2' ' A' ' 14' ' ' THR . 2.3 mt -41.94 109.3 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.197 -0.94 . . . . 0.0 109.477 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 17' ' ' TYR . . . -58.55 -156.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.113 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.529 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 1.4 tp10 -171.7 99.56 0.18 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.994 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 78.69 3.51 2.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.557 -0.714 . . . . 0.0 110.046 179.472 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' C ' ' CD2' ' A' ' 95' ' ' HIS . 0.3 OUTLIER -73.57 174.18 8.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.157 -0.964 . . . . 0.0 109.385 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.47 47.8 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.434 ' OXT' ' NH1' ' A' ' 61' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.239 -1.153 . . . . 0.0 109.435 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmm? . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.6 p -102.33 -149.83 0.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.301 -0.875 . . . . 0.0 109.348 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -90.81 22.73 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 109.254 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.97 133.45 41.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.216 -0.928 . . . . 0.0 109.736 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HB3' ' NH1' ' A' ' 5' ' ' ARG . 0.0 OUTLIER -148.75 176.2 2.36 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.25 -0.906 . . . . 0.0 109.228 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.59 ' HG2' ' CB ' ' A' ' 91' ' ' LEU . 36.0 Cg_endo -111.16 166.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.739 1.389 . . . . 0.0 110.967 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.74 -157.55 7.5 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' OD2' ' A' ' 13' ' ' ASP . . . -177.46 -134.01 1.95 Allowed Glycine 0 N--CA 1.496 2.656 0 O-C-N 121.051 -1.264 . . . . 0.0 110.295 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -152.6 -169.0 3.22 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.107 -1.231 . . . . 0.0 110.289 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 1.4 p 79.6 -172.44 0.05 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.304 -0.872 . . . . 0.0 110.092 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.788 ' O ' HG23 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -51.92 90.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.246 -0.909 . . . . 0.0 108.928 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HB3' ' HB2' ' A' ' 63' ' ' ASN . 1.8 mttt 61.64 142.7 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.549 -1.344 . . . . 0.0 108.303 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.496 ' OD2' ' HA3' ' A' ' 8' ' ' GLY . 0.4 OUTLIER -156.35 98.17 1.82 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 119.894 -1.754 . . . . 0.0 112.192 -179.03 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.595 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 16.5 m -162.71 49.66 0.17 Allowed 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 177.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.76 HD21 HG23 ' A' ' 41' ' ' VAL . 2.0 m120 -76.04 -177.46 3.93 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.66 0.743 . . . . 0.0 110.498 -177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.942 HD21 ' CG1' ' A' ' 60' ' ' VAL . 0.2 OUTLIER -142.9 129.06 19.77 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.744 0.783 . . . . 0.0 109.741 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.72 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 1.1 t80 -78.86 95.89 5.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.697 -0.627 . . . . 0.0 109.914 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 1.094 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 16.4 m -80.07 106.54 11.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 16.3 p -99.86 166.73 10.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.88 . . . . 0.0 110.135 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.431 ' C ' ' HG ' ' A' ' 21' ' ' LEU . 2.0 m120 62.76 75.29 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.429 -0.795 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -139.67 158.0 68.94 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.918 . . . . 0.0 109.347 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' HG2' ' CG2' ' A' ' 24' ' ' THR . 36.5 Cg_endo -94.74 -175.4 0.38 Allowed 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.053 1.554 . . . . 0.0 109.994 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.76 6.83 47.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.207 -0.933 . . . . 0.0 109.572 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.678 HG23 HG23 ' A' ' 25' ' ' ILE . 1.3 t -80.48 -6.25 57.87 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.678 HG23 HG23 ' A' ' 24' ' ' THR . 1.7 pp -127.96 127.54 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.204 -0.935 . . . . 0.0 109.337 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.556 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.6 p -99.68 170.98 8.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.809 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -66.0 -53.46 38.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.342 -0.849 . . . . 0.0 109.295 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -64.57 -11.71 37.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.344 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 30' ' ' LEU . 35.7 tt0 -78.36 -56.29 4.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -0.879 . . . . 0.0 109.7 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.987 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.3 mp -44.64 -39.07 4.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.923 . . . . 0.0 109.509 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' N ' ' HE2' ' A' ' 43' ' ' LYS . 5.3 t70 -58.97 -48.29 82.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.038 -1.039 . . . . 0.0 109.829 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.12 -23.03 67.25 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.49 -0.756 . . . . 0.0 110.065 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -80.44 -26.44 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.741 -1.224 . . . . 0.0 109.731 -179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.816 ' CD1' HG23 ' A' ' 33' ' ' ILE . 4.3 m-85 -111.53 -73.44 0.68 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.11 -0.994 . . . . 0.0 109.153 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 34.11 78.7 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HD3' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -171.92 28.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.952 -1.322 . . . . 0.0 111.028 -179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.707 ' CE2' ' CZ ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -133.97 -96.72 0.28 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.706 -1.246 . . . . 0.0 109.758 179.305 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.64 -167.74 16.52 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.55 ' O ' ' C ' ' A' ' 40' ' ' ILE . 4.5 t -80.16 78.71 6.79 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.339 -1.095 . . . . 0.0 108.856 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.874 HG22 ' O ' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -24.65 130.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.76 HG23 HD21 ' A' ' 15' ' ' ASN . 5.5 m -100.14 58.82 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.674 ' N ' ' HB3' ' A' ' 61' ' ' ARG . 2.5 tt0 92.47 117.96 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.553 0 CA-C-O 122.101 0.953 . . . . 0.0 113.267 177.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.788 ' HE3' HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -115.95 138.09 51.51 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 177.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . 0.8 OUTLIER -151.53 174.31 13.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.286 -1.509 . . . . 0.0 111.282 -179.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 26' ' ' THR . 37.3 mt -145.64 111.08 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.487 ' HB2' ' CG2' ' A' ' 57' ' ' VAL . 18.3 mt -100.65 143.98 30.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.616 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.41 -90.34 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.956 . . . . 0.0 109.391 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 1.0 OUTLIER -97.44 132.58 43.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 109.724 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -144.76 32.06 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.734 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -152.42 -65.6 0.17 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.144 -0.972 . . . . 0.0 109.453 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 51' ' ' THR . 29.2 m -150.75 30.19 0.66 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.492 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 48' ' ' ASP . . . 74.43 57.09 4.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -100.98 179.32 1.03 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.134 -1.215 . . . . 0.0 109.336 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -108.1 117.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.934 1.492 . . . . 0.0 110.471 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.93 -64.53 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.76 103.5 0.18 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.504 ' HB ' ' CE2' ' A' ' 17' ' ' TYR . 19.8 m -144.98 165.38 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -1.127 . . . . 0.0 109.655 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.094 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -157.09 175.35 14.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.838 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 15' ' ' ASN . 0.8 OUTLIER -141.27 104.91 4.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 0.0 108.991 -179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.017 HG21 ' CD2' ' A' ' 75' ' ' LEU . 1.3 t -78.21 148.47 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.81 -1.181 . . . . 0.0 108.132 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.874 ' O ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -85.37 125.86 33.3 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 121.447 0.641 . . . . 0.0 110.136 -179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.857 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -163.63 147.21 10.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.934 -1.104 . . . . 0.0 108.472 179.149 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.668 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.2 t-20 -135.02 -91.28 0.32 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.472 -1.392 . . . . 0.0 109.449 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.668 ' C ' ' O ' ' A' ' 63' ' ' ASN . 11.5 mptt -14.72 97.21 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.538 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -29.99 -47.85 0.08 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.83 -0.544 . . . . 0.0 110.238 -177.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.89 -50.88 64.82 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 42.5 mm-40 -46.86 -43.99 19.12 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.476 -0.765 . . . . 0.0 109.536 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 62' ' ' TYR . . . -60.14 -41.86 93.59 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.088 -1.632 . . . . 0.0 107.183 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -46.1 -37.47 6.88 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.776 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -62.83 -49.31 75.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.016 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.857 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -62.83 -11.92 21.23 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.142 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 68' ' ' ALA . 49.7 mm -84.44 -69.1 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.865 -1.147 . . . . 0.0 108.35 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.95 3.71 7.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.274 -0.891 . . . . 0.0 110.29 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.776 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -124.65 -51.87 1.71 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.018 -1.051 . . . . 0.0 109.723 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.017 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -81.21 -35.35 31.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.06 -1.025 . . . . 0.0 110.225 -179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 1.7 p-10 -53.93 139.09 35.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.68 -1.263 . . . . 0.0 109.262 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER 52.9 50.55 17.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.23 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.805 HG21 ' CE1' ' A' ' 34' ' ' PHE . 2.5 t -88.56 82.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.804 -1.185 . . . . 0.0 109.734 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.915 HG21 ' HB3' ' A' ' 84' ' ' SER . 0.1 OUTLIER -141.94 -164.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.18 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.856 ' HD3' HG22 ' A' ' 79' ' ' ILE . 36.5 Cg_endo -92.45 26.73 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.559 1.294 . . . . 0.0 110.448 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.492 ' CG ' ' C ' ' A' ' 80' ' ' PRO . 0.6 OUTLIER 41.54 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 0.0 109.549 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 150.06 44.24 0.03 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 106.41 -168.86 14.97 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.915 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER 77.27 -4.0 2.38 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -1.186 . . . . 0.0 109.864 179.861 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 84' ' ' SER . 14.3 mt-30 60.85 145.76 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.126 -0.984 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.514 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.6 Cg_endo -100.66 147.55 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.065 1.561 . . . . 0.0 110.178 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.946 HD11 ' O ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -70.76 121.53 18.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.695 -179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 17' ' ' TYR . 1.5 t -79.52 104.17 9.94 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.907 ' HB ' HD12 ' A' ' 16' ' ' LEU . 35.5 m -78.51 -144.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.354 -0.841 . . . . 0.0 111.458 -177.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 84.79 106.52 0.05 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.262 -0.899 . . . . 0.0 108.862 -178.052 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.59 ' CB ' ' HG2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -41.26 141.46 0.68 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.291 -0.88 . . . . 0.0 110.089 -179.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 17' ' ' TYR . . . -100.89 -165.85 1.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 94' ' ' GLU . 0.2 OUTLIER -95.55 119.31 33.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.993 . . . . 0.0 109.599 179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 93' ' ' GLU . 0.4 OUTLIER 164.85 -88.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.495 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.472 ' NE2' ' HB3' ' A' ' 10' ' ' SER . 24.1 t-80 175.67 -82.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.911 . . . . 0.0 109.537 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 138.81 -119.45 1.75 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.178 -1.189 . . . . 0.0 109.072 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.49 162.31 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.918 . . . . 0.0 109.524 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -170.08 116.18 0.53 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.225 -0.922 . . . . 0.0 109.43 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' TYR . . . 177.93 121.02 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.0 109.114 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.1 ttm180 -139.5 41.2 0.45 Allowed Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.793 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.579 ' HB2' ' CG2' ' A' ' 14' ' ' THR . 32.2 Cg_endo -45.53 149.83 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.976 1.514 . . . . 0.0 111.039 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.537 ' HA2' ' HB3' ' A' ' 65' ' ' ARG . . . -161.57 142.02 7.72 Favored Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' O ' ' HD2' ' A' ' 65' ' ' ARG . . . 142.9 141.69 3.89 Favored Glycine 0 N--CA 1.498 2.811 0 O-C-N 121.063 -1.257 . . . . 0.0 110.131 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 10' ' ' SER . 3.5 pm0 -120.2 98.43 6.06 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.898 -1.354 . . . . 0.0 110.079 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.501 ' CB ' ' O ' ' A' ' 9' ' ' GLU . 0.4 OUTLIER 161.37 178.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.868 HG23 ' HB ' ' A' ' 41' ' ' VAL . 23.6 mm -90.56 55.22 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.853 -1.154 . . . . 0.0 109.77 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' O ' ' OD1' ' A' ' 13' ' ' ASP . 0.1 OUTLIER 169.9 38.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.926 -1.109 . . . . 0.0 110.864 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.49 ' OD2' ' HB2' ' A' ' 10' ' ' SER . 9.9 m-20 -137.43 12.59 3.0 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.801 -1.187 . . . . 0.0 110.603 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.589 ' CB ' ' HA ' ' A' ' 63' ' ' ASN . 0.1 OUTLIER -160.29 70.56 0.43 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -77.0 152.71 35.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.771 -1.206 . . . . 0.0 108.869 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.586 HD23 HG11 ' A' ' 60' ' ' VAL . 1.5 tp -97.49 108.8 21.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.336 -0.853 . . . . 0.0 109.957 -178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 33.3 t80 -79.55 87.07 5.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.525 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 58' ' ' ALA . 16.3 m -79.76 112.92 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.241 -0.912 . . . . 0.0 109.858 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 4.5 m -117.1 161.33 19.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.267 -0.895 . . . . 0.0 109.649 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 19' ' ' THR . 6.0 t-20 78.66 52.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.288 -0.882 . . . . 0.0 109.755 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD21 ' O ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -160.22 136.75 6.46 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.116 -0.99 . . . . 0.0 109.782 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -86.74 -177.48 2.3 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.897 1.472 . . . . 0.0 110.108 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.16 34.65 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.471 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.4 m -79.64 -54.98 5.35 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.235 -0.915 . . . . 0.0 109.014 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -62.31 165.82 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.224 -0.922 . . . . 0.0 108.752 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -109.43 136.54 48.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.951 -1.093 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.499 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 9.4 t0 -56.15 -60.59 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.037 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HA ' ' NZ ' ' A' ' 43' ' ' LYS . 10.0 p-10 -48.61 -21.55 0.61 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.401 -0.812 . . . . 0.0 109.721 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.507 ' HB3' ' O ' ' A' ' 26' ' ' THR . 38.7 tt0 -74.65 -45.91 41.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.979 -1.076 . . . . 0.0 110.2 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.798 HD23 ' CG2' ' A' ' 60' ' ' VAL . 4.4 mp -45.59 -25.3 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.849 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 3.0 t0 -65.97 -51.46 58.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.105 -0.997 . . . . 0.0 108.764 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.2 m -53.49 -52.61 58.99 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.51 -0.744 . . . . 0.0 109.073 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.757 ' O ' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -63.29 -25.77 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.228 -0.92 . . . . 0.0 108.574 179.483 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -66.14 -89.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 108.869 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.539 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 9.92 58.56 0.01 OUTLIER Glycine 0 N--CA 1.503 3.12 0 C-N-CA 122.941 0.305 . . . . 0.0 112.807 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.526 ' N ' ' O ' ' A' ' 34' ' ' PHE . 2.3 tttt -161.68 4.97 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.662 -1.493 . . . . 0.0 112.247 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.746 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -150.92 -83.81 0.09 Allowed 'General case' 0 N--CA 1.505 2.281 0 O-C-N 120.381 -1.45 . . . . 0.0 110.18 -178.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.04 -177.27 24.48 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.519 ' O ' ' O ' ' A' ' 40' ' ' ILE . 56.5 m -92.93 19.6 7.55 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -1.21 . . . . 0.0 109.647 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.798 HD12 ' NH2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 51.33 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.369 0.604 . . . . 0.0 109.738 178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.868 ' HB ' HG23 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -133.16 49.32 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 O-C-N 120.647 -1.283 . . . . 0.0 114.253 -177.131 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.664 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 1.4 tm0? 85.23 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.519 2.981 0 O-C-N 120.582 -1.324 . . . . 0.0 112.207 178.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.568 ' CA ' ' HG2' ' A' ' 61' ' ' ARG . 11.1 pttp -78.5 144.58 35.58 Favored 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.128 -0.982 . . . . 0.0 109.414 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -158.74 120.61 3.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.141 -0.974 . . . . 0.0 109.813 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.66 ' O ' HD22 ' A' ' 46' ' ' LEU . 22.8 pt -84.51 162.29 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.062 -1.024 . . . . 0.0 109.992 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.66 HD22 ' O ' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -144.6 110.5 5.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.233 -0.917 . . . . 0.0 110.496 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 47' ' ' ARG . 9.2 tpm_? -160.84 -95.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.495 -1.378 . . . . 0.0 110.41 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -111.93 -170.6 1.68 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.878 -1.139 . . . . 0.0 109.906 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -132.98 -60.73 0.85 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.412 -0.805 . . . . 0.0 109.501 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -64.18 1.1 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.5 p -152.03 178.68 9.19 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.171 -0.955 . . . . 0.0 109.599 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.74 28.24 29.8 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -58.5 135.95 85.77 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.271 -1.135 . . . . 0.0 109.396 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -105.83 -50.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.915 1.482 . . . . 0.0 110.454 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.2 mtm180 -140.97 -93.37 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.855 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 47' ' ' ARG . . . 148.64 103.65 0.31 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' O ' ' O ' ' A' ' 46' ' ' LEU . 1.9 p -129.04 109.38 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 0.0 108.921 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.579 ' HB1' ' HA ' ' A' ' 45' ' ' ILE . . . -109.34 178.28 4.49 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.751 -1.218 . . . . 0.0 110.241 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.541 ' CD1' ' C ' ' A' ' 58' ' ' ALA . 3.6 m-85 -135.59 110.38 8.71 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.798 ' CG2' HD23 ' A' ' 30' ' ' LEU . 1.1 t -77.95 157.38 5.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.798 ' NH2' HD12 ' A' ' 40' ' ' ILE . 9.2 ptt180 -95.76 108.88 21.24 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-O 121.362 0.601 . . . . 0.0 110.302 -178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.726 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -162.23 71.01 0.32 Allowed 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.237 -0.915 . . . . 0.0 108.641 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.741 ' ND2' HG21 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -68.87 -104.92 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.004 -1.478 . . . . 0.0 109.343 -179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.634 ' C ' ' O ' ' A' ' 63' ' ' ASN . 3.0 mttp 9.05 90.07 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.514 0 CA-C-N 118.18 0.445 . . . . 0.0 110.4 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.556 ' HA ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -29.39 -37.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.947 -0.471 . . . . 0.0 111.102 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' N ' ' HG2' ' A' ' 65' ' ' ARG . 43.4 tt0 -64.06 -58.24 7.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 108.235 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 60.1 mt-10 -53.6 -47.61 70.01 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.35 -0.843 . . . . 0.0 109.406 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 72' ' ' ILE . . . -49.3 -39.16 29.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.869 -1.144 . . . . 0.0 108.725 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.487 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 2.9 tt0 -60.94 -41.51 96.39 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.719 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 mp0 -55.67 -49.21 73.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.47 -0.769 . . . . 0.0 109.956 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.726 ' HB2' ' CD2' ' A' ' 62' ' ' TYR . . . -71.21 -13.69 62.0 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.183 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 89' ' ' VAL . 2.1 mm -74.89 -64.75 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.029 -1.044 . . . . 0.0 108.406 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.5 -3.14 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.578 -0.701 . . . . 0.0 110.438 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -117.36 -50.76 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.828 -1.17 . . . . 0.0 110.249 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.726 HD11 ' CE1' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -79.4 -26.22 41.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.099 -1.001 . . . . 0.0 109.719 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 24.3 t-20 -47.37 102.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.653 -1.279 . . . . 0.0 107.978 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 76' ' ' ASN . 7.2 m-20 72.82 92.27 0.08 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 78' ' ' VAL . 2.7 p -85.94 53.28 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.008 ' O ' HD12 ' A' ' 79' ' ' ILE . 2.1 pp -133.33 140.1 36.12 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 35.9 Cg_endo -40.87 -76.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.936 1.493 . . . . 0.0 110.527 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 80' ' ' PRO . 11.4 tp10 176.53 152.86 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 0.0 109.203 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 81' ' ' GLU . . . 115.54 3.27 20.72 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . 131.72 -161.96 23.76 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.663 ' CB ' HG21 ' A' ' 79' ' ' ILE . 1.4 m 84.16 -62.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.784 -0.833 . . . . 0.0 109.429 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.534 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 1.3 pt20 27.05 94.33 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 122.12 -0.362 . . . . 0.0 110.732 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.922 ' O ' HD12 ' A' ' 87' ' ' LEU . 37.3 Cg_endo -127.19 65.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.54 1.284 . . . . 0.0 111.428 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 174.5 87.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 178.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 3.5 t -81.17 107.41 13.95 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.775 ' HB ' HD13 ' A' ' 72' ' ' ILE . 24.7 m -83.77 147.8 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.663 0.744 . . . . 0.0 111.528 -177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 28.4 ptt180 152.96 129.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 92' ' ' ALA . 8.9 tt -58.63 149.45 25.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.986 -1.071 . . . . 0.0 109.788 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.795 ' N ' HD23 ' A' ' 91' ' ' LEU . . . -123.34 -58.78 1.6 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.368 -0.833 . . . . 0.0 109.958 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.99 178.13 7.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.31 -0.869 . . . . 0.0 109.782 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -118.22 80.35 1.51 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.327 -0.858 . . . . 0.0 109.355 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -163.92 132.28 3.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.197 -0.939 . . . . 0.0 109.443 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.5 -175.43 52.34 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 mttt . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.222 0.534 . . . . 0.0 109.582 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.486 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 38.1 m -46.85 -67.15 0.31 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.982 . . . . 0.0 109.149 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 2' ' ' SER . 3.0 m-85 -158.67 -57.65 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.843 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.96 -78.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.119 -0.988 . . . . 0.0 109.592 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -48.43 137.68 11.81 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 109.2 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -123.86 164.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.707 1.372 . . . . 0.0 110.397 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 13' ' ' ASP . . . 141.06 150.2 5.36 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.876 -1.289 . . . . 0.0 109.876 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' O ' ' HD2' ' A' ' 65' ' ' ARG . . . -96.53 -169.24 34.21 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 10' ' ' SER . 13.0 mt-10 -101.05 165.25 11.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.113 -1.228 . . . . 0.0 109.957 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' LYS . 0.9 OUTLIER 52.05 173.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 41' ' ' VAL . 12.2 mm -58.51 88.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.93 -1.106 . . . . 0.0 108.13 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -128.02 -79.63 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.059 -179.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.539 ' CB ' ' HA2' ' A' ' 96' ' ' GLY . 16.5 p-10 -160.69 92.96 0.98 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.569 -1.252 . . . . 0.0 111.765 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.697 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 p -144.24 43.38 1.42 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -75.36 155.38 36.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 179.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.964 HD23 ' N ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -98.62 142.83 29.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 117.477 -1.689 . . . . 0.0 110.223 -178.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' O ' ' O ' ' A' ' 88' ' ' SER . 1.8 t80 -78.52 78.84 4.97 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.957 HG23 ' HB3' ' A' ' 58' ' ' ALA . 24.6 m -77.89 105.46 6.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-O 122.003 0.906 . . . . 0.0 109.699 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.851 HG22 HG12 ' A' ' 57' ' ' VAL . 53.1 p -116.85 126.1 52.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 19' ' ' THR . 10.0 t-20 159.01 -65.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.688 -0.632 . . . . 0.0 109.667 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.849 ' H ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -39.89 161.56 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.427 -0.796 . . . . 0.0 110.436 -179.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -117.95 50.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.903 1.475 . . . . 0.0 110.131 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.06 21.83 1.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.554 -0.717 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.602 HG23 HG23 ' A' ' 25' ' ' ILE . 12.5 t -87.53 -24.34 24.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.29 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.602 HG23 HG23 ' A' ' 24' ' ' THR . 1.0 OUTLIER -107.54 -164.32 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 108.955 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.688 HG23 ' CB ' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -132.48 130.3 40.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.021 -1.049 . . . . 0.0 109.989 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.504 ' C ' ' HD2' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -59.58 -50.0 75.59 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.951 -1.093 . . . . 0.0 108.627 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 0.6 OUTLIER -49.28 -26.62 3.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.42 -0.8 . . . . 0.0 109.323 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.688 ' CB ' HG23 ' A' ' 26' ' ' THR . 8.2 tt0 -74.84 -42.4 58.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.382 -0.824 . . . . 0.0 109.446 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.723 ' O ' HG22 ' A' ' 33' ' ' ILE . 5.7 mp -46.67 -32.98 3.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.084 -1.01 . . . . 0.0 109.896 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.605 ' HB2' ' CE ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -60.34 -62.59 1.75 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.866 -1.146 . . . . 0.0 109.511 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 32' ' ' THR . 12.1 m -62.42 -9.62 8.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.503 -0.748 . . . . 0.0 110.121 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 30' ' ' LEU . 2.6 tt -83.96 -40.24 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.945 -1.097 . . . . 0.0 110.029 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.822 ' CE2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -108.4 -54.24 2.53 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.512 -1.368 . . . . 0.0 110.456 179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.567 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 16.55 67.32 0.01 OUTLIER Glycine 0 N--CA 1.507 3.414 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.7 tptt -141.49 -25.8 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.027 -1.278 . . . . 0.0 111.601 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -96.2 -37.58 10.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.606 -1.309 . . . . 0.0 109.242 -179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.4 -163.96 10.91 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.668 ' O ' ' O ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -109.96 35.94 3.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.208 -1.172 . . . . 0.0 109.217 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.782 HG22 ' HB2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 43.27 147.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.499 0 CA-C-O 122.125 0.964 . . . . 0.0 111.418 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.756 HG21 ' HB3' ' A' ' 63' ' ' ASN . 96.8 t -109.44 -38.18 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 119.975 -1.703 . . . . 0.0 113.901 -176.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.901 ' C ' ' HG2' ' A' ' 61' ' ' ARG . 1.1 tm0? 177.96 103.72 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 O-C-N 120.464 -1.397 . . . . 0.0 110.962 -179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.798 ' N ' ' HG2' ' A' ' 61' ' ' ARG . 0.0 OUTLIER -112.57 150.66 31.05 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.404 -0.81 . . . . 0.0 109.923 -177.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -159.47 172.95 16.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.33 -0.856 . . . . 0.0 109.156 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.7 tt -155.19 146.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.734 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.513 HD21 ' CZ ' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -152.56 144.66 23.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.965 . . . . 0.0 109.694 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -141.06 -83.32 0.22 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.253 -0.904 . . . . 0.0 109.642 179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 0.2 OUTLIER 158.3 -176.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.351 -0.843 . . . . 0.0 109.214 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.403 ' HB3' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -174.42 -62.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -97.54 48.3 1.03 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.137 -0.977 . . . . 0.0 109.638 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.456 ' HB ' ' OD1' ' A' ' 48' ' ' ASP . 29.0 m -160.74 -59.25 0.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.106 -0.996 . . . . 0.0 109.704 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' ' 54' ' ' PRO . . . 166.08 106.78 0.2 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.08 96.29 33.72 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.267 -1.137 . . . . 0.0 109.68 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.525 ' O ' ' CB ' ' A' ' 55' ' ' ARG . 36.9 Cg_endo -101.73 -16.79 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.025 1.54 . . . . 0.0 109.472 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 54' ' ' PRO . 5.3 mtm-85 160.04 107.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.845 ' O ' HG13 ' A' ' 57' ' ' VAL . . . -92.45 -131.78 5.68 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 108.253 -1.939 . . . . 0.0 108.253 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 19' ' ' THR . 1.2 m -165.38 176.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 O-C-N 121.863 -0.786 . . . . 0.0 110.048 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.957 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -147.86 159.73 43.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.3 OUTLIER -131.97 116.73 17.5 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.851 HG21 ' CD2' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -86.52 162.07 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 120.357 -1.464 . . . . 0.0 109.864 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.901 ' HG2' ' C ' ' A' ' 42' ' ' GLN . 3.6 mtm180 -79.73 107.49 12.54 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.982 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 44.2 m-85 -163.95 143.99 8.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.695 -1.253 . . . . 0.0 110.089 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.756 ' HB3' HG21 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -125.41 -132.69 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.62 ' C ' ' O ' ' A' ' 63' ' ' ASN . 1.8 mtpt 17.59 94.13 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-N 118.912 0.778 . . . . 0.0 110.386 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.575 ' H ' ' HD3' ' A' ' 65' ' ' ARG . 0.5 OUTLIER -28.87 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.922 -0.486 . . . . 0.0 110.599 -178.425 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 64' ' ' LYS . 2.3 tt0 -64.0 -56.0 18.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.977 -1.077 . . . . 0.0 108.313 178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 64' ' ' LYS . 0.8 OUTLIER -44.99 -44.68 10.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.0 109.413 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.005 ' CB ' HD21 ' A' ' 91' ' ' LEU . . . -56.12 -45.96 79.32 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.6 -1.313 . . . . 0.0 107.715 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 68' ' ' ALA . 1.5 tt0 -45.35 -39.04 6.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 78.5 mm-40 -57.62 -54.93 41.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.982 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -61.2 -13.26 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.729 0.776 . . . . 0.0 110.025 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' A' ' 76' ' ' ASN . 6.7 mm -82.98 -62.51 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 O-C-N 120.621 -1.299 . . . . 0.0 108.679 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.58 6.69 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.965 . . . . 0.0 109.797 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 70' ' ' GLU . . . -128.9 -52.53 1.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.971 -1.08 . . . . 0.0 109.995 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.851 ' CD2' HG21 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -79.31 -26.23 42.25 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.171 -0.955 . . . . 0.0 109.97 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.91 96.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.354 -1.467 . . . . 0.0 107.664 179.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.586 ' N ' ' O ' ' A' ' 75' ' ' LEU . 3.8 m-20 74.21 58.67 0.08 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 108.684 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.973 HG23 HD21 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -79.45 78.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.184 -0.947 . . . . 0.0 108.773 179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.556 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -133.0 -163.51 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.45 -0.781 . . . . 0.0 108.901 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 36.4 Cg_endo -102.52 38.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.021 1.537 . . . . 0.0 109.984 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER 47.68 60.14 3.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 109.35 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 83' ' ' GLY . . . 163.2 -46.28 0.32 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 82' ' ' GLY . . . -53.52 -175.61 0.07 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.9 p -128.75 75.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.262 . . . . 0.0 109.716 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -165.83 64.41 0.93 Allowed Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.0 109.78 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 36.4 Cg_endo -92.48 -170.65 0.3 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.969 1.51 . . . . 0.0 110.581 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.973 HD21 HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -149.61 124.69 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.06 -179.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 13.9 t -78.03 100.14 6.38 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.63 HG12 HD12 ' A' ' 16' ' ' LEU . 34.6 m -78.55 146.4 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.928 0.87 . . . . 0.0 111.948 -176.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.9 tmm_? 168.41 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.005 HD21 ' CB ' ' A' ' 68' ' ' ALA . 1.1 mp -36.89 145.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.412 0.625 . . . . 0.0 110.417 -179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -97.69 -166.83 1.43 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 109.261 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 71.9 1.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.106 -0.996 . . . . 0.0 109.34 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 177.59 -78.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.365 -0.834 . . . . 0.0 109.527 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -58.08 152.71 16.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.219 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.539 ' HA2' ' CB ' ' A' ' 13' ' ' ASP . . . -130.91 -116.62 1.83 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.731 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.183 -1.186 . . . . 0.0 109.725 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.9 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.2 t -116.7 130.63 56.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 109.32 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 7.8 p90 -151.8 174.58 13.38 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.562 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.52 152.99 18.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.854 . . . . 0.0 109.217 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.592 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.9 OUTLIER -85.95 -28.18 0.39 Allowed Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.204 -0.935 . . . . 0.0 110.052 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.64 ' CB ' HD22 ' A' ' 91' ' ' LEU . 37.1 Cg_endo -102.94 172.56 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.567 1.298 . . . . 0.0 111.48 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.8 -165.22 25.83 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 65' ' ' ARG . . . 160.45 -151.98 22.63 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -168.04 138.5 2.7 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.045 -1.268 . . . . 0.0 110.358 -179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 9' ' ' GLU . 0.2 OUTLIER 45.64 -172.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.32 -0.862 . . . . 0.0 109.974 179.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.673 ' HA ' ' CG ' ' A' ' 63' ' ' ASN . 0.5 OUTLIER -76.71 82.41 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.114 -0.991 . . . . 0.0 108.739 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' CD ' ' O ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -140.02 -74.18 0.36 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.737 . . . . 0.0 110.853 -179.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 13' ' ' ASP . 25.3 t0 -145.46 84.59 1.69 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.664 -1.273 . . . . 0.0 111.948 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.051 HG23 ' CB ' ' A' ' 63' ' ' ASN . 0.6 OUTLIER -162.04 38.07 0.12 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.311 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.09 -174.01 2.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.377 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.863 ' CG ' HG23 ' A' ' 89' ' ' VAL . 0.7 OUTLIER -108.26 123.47 48.82 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.483 0.659 . . . . 0.0 110.712 -178.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.759 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 11.1 t80 -90.59 94.71 9.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.964 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 19.5 m -91.77 130.42 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.105 -0.997 . . . . 0.0 110.463 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.75 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.6 p -126.98 -175.67 3.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER 55.04 70.12 0.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.624 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 21' ' ' LEU . 3.9 pp 178.8 151.41 0.47 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 36.8 Cg_endo -110.15 -169.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 124.008 1.53 . . . . 0.0 110.037 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -87.51 41.59 0.99 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.662 HG23 HG23 ' A' ' 25' ' ' ILE . 2.1 t -80.58 -29.43 37.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.662 HG23 HG23 ' A' ' 24' ' ' THR . 37.2 pt -108.32 162.46 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.386 -0.821 . . . . 0.0 109.312 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 1.1 p -100.44 136.7 39.91 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.174 -0.954 . . . . 0.0 109.761 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.54 ' O ' ' CD ' ' A' ' 43' ' ' LYS . 4.3 p-10 -61.94 -47.49 84.65 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' N ' ' CG ' ' A' ' 27' ' ' ASP . 25.9 t0 -54.42 -19.8 6.31 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.182 -0.949 . . . . 0.0 109.37 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 26' ' ' THR . 13.8 mt-30 -77.13 -53.14 8.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.553 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.67 ' O ' HG22 ' A' ' 33' ' ' ILE . 4.6 mp -44.72 -34.04 2.09 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.634 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.578 ' N ' ' HE3' ' A' ' 43' ' ' LYS . 4.8 t70 -50.52 -63.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.231 -0.918 . . . . 0.0 109.2 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 m -64.23 -14.75 57.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.243 -0.91 . . . . 0.0 108.909 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.67 HG22 ' O ' ' A' ' 30' ' ' LEU . 0.2 OUTLIER -79.66 -23.22 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.426 -0.796 . . . . 0.0 110.09 -179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.973 ' CE2' HD11 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -150.22 35.36 0.65 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.8 -1.188 . . . . 0.0 110.853 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.981 ' HA2' HD11 ' A' ' 40' ' ' ILE . . . -88.34 57.54 4.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtp -131.94 -8.92 3.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.187 -1.184 . . . . 0.0 110.575 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.644 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -115.19 47.3 1.31 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.823 -1.173 . . . . 0.0 109.568 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' HA3' ' OE2' ' A' ' 67' ' ' GLU . . . 122.77 171.9 13.85 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.507 ' O ' ' C ' ' A' ' 40' ' ' ILE . 3.3 m -91.47 93.83 9.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.376 -1.073 . . . . 0.0 109.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.981 HD11 ' HA2' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -29.38 143.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 CA-C-O 121.259 0.552 . . . . 0.0 110.259 -179.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.84 ' O ' HG23 ' A' ' 41' ' ' VAL . 1.0 OUTLIER -105.57 50.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.864 0 N-CA-C 116.218 1.933 . . . . 0.0 116.218 -175.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.676 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 0.0 OUTLIER 85.88 95.58 0.03 OUTLIER 'General case' 0 N--CA 1.52 3.044 0 O-C-N 120.553 -1.342 . . . . 0.0 112.839 177.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 1.072 ' NZ ' HG22 ' A' ' 60' ' ' VAL . 3.0 mttm -81.31 117.46 21.82 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.083 -1.011 . . . . 0.0 109.65 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -122.03 153.51 38.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.02 -1.05 . . . . 0.0 108.944 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' A' ' 27' ' ' ASP . 11.1 pt -130.5 159.1 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.065 -1.022 . . . . 0.0 109.818 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.683 HD21 ' CD1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -157.49 130.92 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.953 . . . . 0.0 109.849 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.05 -23.47 15.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -153.28 168.54 25.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 0.0 109.068 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -175.45 34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.0 109.861 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.428 ' HA ' HD12 ' A' ' 50' ' ' LEU . 18.0 tp -160.02 -72.65 0.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.25 -60.11 0.77 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.313 -0.867 . . . . 0.0 109.364 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 168.14 86.5 0.06 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -113.0 177.05 1.27 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.301 -1.117 . . . . 0.0 109.456 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -107.94 25.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.094 1.576 . . . . 0.0 109.967 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.35 -54.63 11.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.489 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.13 93.82 0.01 OUTLIER Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.75 HG12 ' HA ' ' A' ' 19' ' ' THR . 2.3 m -128.53 154.43 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.147 -1.208 . . . . 0.0 110.069 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.964 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -113.84 176.69 4.93 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.277 -0.889 . . . . 0.0 109.358 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.683 ' CD1' HD21 ' A' ' 46' ' ' LEU . 6.8 m-85 -138.76 105.25 5.3 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.247 -0.908 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.072 HG22 ' NZ ' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -79.18 157.51 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.729 ' HB2' ' N ' ' A' ' 41' ' ' VAL . 0.1 OUTLIER -103.87 104.75 14.78 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.654 0.74 . . . . 0.0 109.895 -179.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CD2' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -161.01 80.78 0.63 Allowed 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 1.051 ' CB ' HG23 ' A' ' 14' ' ' THR . 0.2 OUTLIER -77.13 -115.49 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.814 -1.154 . . . . 0.0 108.748 -178.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.57 ' C ' ' O ' ' A' ' 63' ' ' ASN . 0.0 OUTLIER 27.53 89.97 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 CA-C-N 118.683 0.674 . . . . 0.0 109.555 -179.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.558 ' C ' ' O ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -27.91 -41.95 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.777 -0.577 . . . . 0.0 110.544 -177.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 64' ' ' LYS . 3.8 mm-40 -67.1 -56.3 10.61 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 120.882 -1.136 . . . . 0.0 108.109 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 0.8 OUTLIER -46.86 -49.15 20.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.503 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.537 ' O ' ' CG1' ' A' ' 72' ' ' ILE . . . -52.91 -45.52 67.62 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.599 -1.313 . . . . 0.0 107.944 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' HA ' HG13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -48.64 -42.82 35.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.514 ' HB3' ' CD2' ' A' ' 37' ' ' TYR . 1.0 OUTLIER -60.25 -68.81 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.614 -0.678 . . . . 0.0 109.872 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 75' ' ' LEU . . . -45.91 -20.05 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.515 -0.74 . . . . 0.0 110.104 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.81 ' HA ' HG21 ' A' ' 89' ' ' VAL . 0.9 OUTLIER -71.41 -66.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.58 -1.325 . . . . 0.0 108.219 179.287 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -78.53 10.47 3.15 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.095 -1.003 . . . . 0.0 110.382 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.73 -56.79 1.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.846 -1.159 . . . . 0.0 109.921 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.973 HD11 ' CE2' ' A' ' 34' ' ' PHE . 51.3 mt -77.38 -33.22 55.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -51.14 133.29 28.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.709 -1.244 . . . . 0.0 108.259 178.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.642 ' HA ' ' CB ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 68.54 55.69 0.48 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.039 -1.038 . . . . 0.0 109.682 -179.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.637 HG12 HD12 ' A' ' 87' ' ' LEU . 14.9 p -85.91 44.29 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.929 -1.107 . . . . 0.0 108.677 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -132.21 176.25 3.05 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.531 ' O ' ' CG ' ' A' ' 81' ' ' GLU . 36.6 Cg_endo -87.61 44.57 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.842 1.443 . . . . 0.0 109.128 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 80' ' ' PRO . 10.8 pt-20 40.9 45.67 2.22 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.5 77.51 0.3 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.08 -36.89 1.55 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.488 ' H ' HD11 ' A' ' 79' ' ' ILE . 0.3 OUTLIER 67.51 45.41 1.55 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.485 -1.009 . . . . 0.0 110.441 179.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.661 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 5.6 mm-40 -128.2 49.74 4.79 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 109.091 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 85' ' ' GLN . 37.9 Cg_endo -88.52 -162.4 0.13 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.759 1.4 . . . . 0.0 111.389 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.666 HD23 HG11 ' A' ' 18' ' ' VAL . 4.8 mp -85.94 124.96 32.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.807 -0.558 . . . . 0.0 110.013 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.4 m -79.26 96.67 6.0 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 176.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.863 HG23 ' CG ' ' A' ' 16' ' ' LEU . 8.8 p -75.66 143.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 122.4 1.095 . . . . 0.0 112.012 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.0 OUTLIER 175.37 -130.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.64 HD22 ' CB ' ' A' ' 6' ' ' PRO . 12.3 tp -149.06 152.02 35.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.395 -1.441 . . . . 0.0 110.113 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.759 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -126.46 -171.05 2.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.466 -0.771 . . . . 0.0 109.559 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -95.86 -174.08 3.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 66.19 150.08 0.05 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -74.7 -172.22 1.49 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.52 -61.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.749 -1.341 . . . . 0.0 109.749 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' C ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.268 -1.137 . . . . 0.0 109.444 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -115.61 17.02 16.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.376 -0.828 . . . . 0.0 109.523 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -74.66 -174.1 2.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ARG . . . -135.61 155.63 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 2.8 mtt180 61.05 80.84 0.25 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.744 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 91' ' ' LEU . 36.3 Cg_endo -72.01 -172.65 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.834 1.439 . . . . 0.0 110.048 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.935 ' HA2' HD22 ' A' ' 91' ' ' LEU . . . -160.72 168.55 36.18 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.53 -105.47 1.03 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -166.93 43.99 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.182 -1.187 . . . . 0.0 109.937 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 12' ' ' LYS . 1.4 m -117.67 145.44 44.39 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 1.157 ' CG2' HG11 ' A' ' 41' ' ' VAL . 0.3 OUTLIER 32.63 37.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 CA-C-O 122.375 1.083 . . . . 0.0 108.465 -178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.575 ' C ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER 21.48 58.91 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.101 -179.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.635 ' HB3' ' C ' ' A' ' 63' ' ' ASN . 70.4 m-20 -149.11 -87.4 0.08 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.57 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.033 ' CG2' ' HB2' ' A' ' 68' ' ' ALA . 0.7 OUTLIER -163.26 105.13 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.906 -1.121 . . . . 0.0 109.73 -179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.843 ' H ' HD21 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -77.85 -178.95 5.71 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.436 -1.415 . . . . 0.0 108.192 179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.117 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 0.6 OUTLIER -137.02 112.24 9.12 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.842 -1.161 . . . . 0.0 110.119 -179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' CG ' ' HB2' ' A' ' 92' ' ' ALA . 8.8 t80 -93.92 101.62 13.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -0.922 . . . . 0.0 108.841 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.825 HG11 HD23 ' A' ' 87' ' ' LEU . 2.8 m -100.79 113.88 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 0.0 109.929 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -83.18 166.42 18.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.985 . . . . 0.0 109.613 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 19' ' ' THR . 0.1 OUTLIER 76.91 -79.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.206 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.972 HD22 HD11 ' A' ' 87' ' ' LEU . 0.2 OUTLIER 49.53 101.24 0.03 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.433 -0.792 . . . . 0.0 110.103 179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' A' ' 84' ' ' SER . 36.8 Cg_endo -76.5 140.6 21.64 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.061 1.559 . . . . 0.0 109.631 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -88.8 41.91 1.05 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -0.967 . . . . 0.0 109.401 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.62 -3.19 30.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.424 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.78 179.63 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.192 -0.943 . . . . 0.0 109.533 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.4 p -106.64 155.87 19.2 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 2.9 p30 -62.05 -42.82 99.59 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 2.6 m-20 -53.84 -27.11 27.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.391 -0.818 . . . . 0.0 108.974 179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -33.58 31.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.257 -0.902 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -52.44 -33.56 44.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -60.12 -46.01 91.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.035 . . . . 0.0 108.418 179.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 5.9 m -61.1 -43.18 99.28 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 78' ' ' VAL . 3.0 mm -52.71 -30.64 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 1.158 ' CE1' HD13 ' A' ' 75' ' ' LEU . 4.0 m-30 -79.15 -77.57 0.17 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.591 -0.693 . . . . 0.0 109.887 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 36' ' ' LYS . . . 141.12 -82.31 0.24 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER 166.08 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -1.196 . . . . 0.0 110.523 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' CE2' ' OH ' ' A' ' 62' ' ' TYR . 3.8 m-85 -78.77 -70.13 0.52 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.348 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.05 -169.4 15.5 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 40' ' ' ILE . 48.6 p -78.99 77.18 5.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -1.149 . . . . 0.0 108.338 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.934 HD12 HH21 ' A' ' 61' ' ' ARG . 0.2 OUTLIER -40.46 146.45 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.157 HG11 ' CG2' ' A' ' 11' ' ' ILE . 28.8 m -111.2 62.12 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.857 ' N ' ' HD3' ' A' ' 61' ' ' ARG . 50.2 tt0 62.53 109.08 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.13 -0.981 . . . . 0.0 112.803 176.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 61' ' ' ARG . 3.2 mtmm -75.56 163.27 27.53 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.369 -0.832 . . . . 0.0 109.506 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 59' ' ' PHE . 1.1 m-80 -149.3 106.22 3.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.925 . . . . 0.0 109.592 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.497 HD13 ' HD3' ' A' ' 47' ' ' ARG . 12.3 tt -87.53 141.14 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -120.06 110.39 16.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.564 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' CZ ' ' HB3' ' A' ' 23' ' ' ARG . 2.1 ptm180 -157.03 24.62 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.435 -0.791 . . . . 0.0 109.47 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 57.86 164.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.575 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -110.61 -88.08 0.51 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.193 -0.942 . . . . 0.0 109.516 -179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -120.31 45.08 2.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 m -109.73 -21.06 12.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.478 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.99 55.01 4.58 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 0.2 OUTLIER -114.24 172.43 3.6 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.156 -1.202 . . . . 0.0 109.446 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 53' ' ' ARG . 36.7 Cg_endo -110.46 109.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.015 1.534 . . . . 0.0 110.431 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.91 -84.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.2 -0.937 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.15 45.78 47.43 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 10.1 p -148.42 159.9 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.134 . . . . 0.0 109.04 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' HB2' ' HG ' ' A' ' 21' ' ' LEU . . . -160.17 -175.11 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.882 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -155.18 104.66 2.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 16' ' ' LEU . 2.7 p -79.33 157.6 4.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.775 -1.17 . . . . 0.0 109.271 -179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.934 HH21 HD12 ' A' ' 40' ' ' ILE . 3.8 ptt180 -84.1 142.35 30.45 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.934 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.808 ' CZ ' ' HB2' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -161.42 164.94 29.54 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.635 ' C ' ' HB3' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -145.04 -101.48 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.366 179.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 5.1 mmtp -22.15 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.481 0 O-C-N 121.647 -0.658 . . . . 0.0 110.45 -176.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.54 ' NH2' ' HA ' ' A' ' 13' ' ' ASP . 32.2 mmt-85 -43.39 -50.59 6.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.187 -0.945 . . . . 0.0 108.558 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 67.6 mt-10 -55.06 -44.8 75.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -47.95 -60.78 2.35 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.601 -0.687 . . . . 0.0 109.666 179.255 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.033 ' HB2' ' CG2' ' A' ' 14' ' ' THR . . . -46.31 -37.01 6.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.757 -1.215 . . . . 0.0 108.19 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -51.66 -53.7 36.02 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' ILE . 4.4 mm-40 -51.28 -67.72 0.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.117 ' HB1' ' CD2' ' A' ' 16' ' ' LEU . . . -34.12 -31.5 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.826 ' HA ' HG11 ' A' ' 89' ' ' VAL . 1.5 mm -70.4 -67.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 120.927 -1.108 . . . . 0.0 108.29 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.7 m -85.68 27.98 0.81 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.465 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -140.71 -53.41 0.49 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.155 -0.966 . . . . 0.0 108.486 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.158 HD13 ' CE1' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -78.78 -29.15 44.85 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' CB ' ' O ' ' A' ' 72' ' ' ILE . 42.0 t30 -58.3 139.84 54.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 108.86 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.462 ' OD1' ' CB ' ' A' ' 86' ' ' PRO . 3.0 m120 58.88 63.5 1.63 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.053 -1.03 . . . . 0.0 110.064 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.068 ' CG1' HD13 ' A' ' 87' ' ' LEU . 1.5 p -85.7 65.16 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.769 HG21 ' HB3' ' A' ' 84' ' ' SER . 1.0 OUTLIER -165.4 153.24 9.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 79' ' ' ILE . 33.7 Cg_endo -43.96 -74.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.547 1.288 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 1.1 pt-20 162.38 144.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.6 -63.16 0.29 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' SER . . . -132.18 -164.65 11.08 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.769 ' HB3' HG21 ' A' ' 79' ' ' ILE . 0.2 OUTLIER 79.86 -9.04 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -1.003 . . . . 0.0 109.675 -179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER 62.25 154.08 0.11 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.073 -1.017 . . . . 0.0 109.462 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.462 ' CB ' ' OD1' ' A' ' 77' ' ' ASN . 36.4 Cg_endo -107.68 157.34 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.011 1.532 . . . . 0.0 110.839 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 1.068 HD13 ' CG1' ' A' ' 78' ' ' VAL . 2.9 mp -78.79 123.94 27.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.582 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -79.15 97.24 6.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 178.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 1.106 HG13 HD11 ' A' ' 16' ' ' LEU . 22.3 t -75.95 137.74 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 122.396 1.093 . . . . 0.0 111.442 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.406 ' H ' ' CD1' ' A' ' 16' ' ' LEU . 1.3 tpt180 -175.49 -135.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.935 HD22 ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -159.15 135.92 9.45 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.67 -1.269 . . . . 0.0 109.184 178.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.451 ' HB2' ' CG ' ' A' ' 17' ' ' TYR . . . -107.34 -162.68 0.85 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.194 -0.941 . . . . 0.0 110.106 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.74 -171.13 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.96 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 176.8 0.8 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -176.98 138.2 0.25 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.32 -0.862 . . . . 0.0 109.367 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -63.77 123.66 29.17 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.206 -1.173 . . . . 0.0 109.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.28 0.562 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 171.61 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.475 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.667 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 15.1 p90 -107.24 77.46 1.15 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.189 -0.944 . . . . 0.0 109.358 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.667 ' HB3' ' O ' ' A' ' 3' ' ' TYR . . . 73.25 149.78 0.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.367 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -126.54 45.42 1.52 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.574 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 4' ' ' ALA . 36.2 Cg_endo -58.39 112.84 1.3 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.856 1.451 . . . . 0.0 110.233 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 93' ' ' GLU . . . 177.12 59.09 0.06 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 92' ' ' ALA . . . -127.66 -146.7 6.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 9' ' ' GLU . 5.4 pm0 -170.88 113.21 0.41 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 109.334 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 11' ' ' ILE . 0.3 OUTLIER -166.02 -167.32 1.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.817 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.684 ' CG1' HG21 ' A' ' 41' ' ' VAL . 0.0 OUTLIER 41.24 32.95 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 121.512 0.672 . . . . 0.0 110.121 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER 76.69 -28.23 0.18 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.588 -0.695 . . . . 0.0 110.987 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.617 ' HB2' ' CB ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -130.8 -74.66 0.53 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.651 -1.281 . . . . 0.0 110.707 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.132 HG22 ' CD2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -160.31 91.59 0.94 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.01 -1.056 . . . . 0.0 110.245 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.568 ' O ' ' CD2' ' A' ' 91' ' ' LEU . 4.4 t30 -79.25 169.24 18.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -0.877 . . . . 0.0 109.145 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.906 HD12 HG11 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -143.92 136.02 26.55 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.67 -1.269 . . . . 0.0 110.986 -179.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' CD2' ' CZ ' ' A' ' 59' ' ' PHE . 5.1 t80 -85.28 142.73 29.17 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.422 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.893 ' CG2' ' HB3' ' A' ' 58' ' ' ALA . 30.2 m -132.94 157.08 42.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.052 -1.03 . . . . 0.0 109.561 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' ' CB ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -144.12 159.24 42.98 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.714 -179.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 19' ' ' THR . 1.6 t-20 79.51 88.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.601 -0.687 . . . . 0.0 110.299 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.741 HD22 ' C ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -159.99 150.87 15.73 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.105 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.543 ' O ' HD22 ' A' ' 21' ' ' LEU . 36.7 Cg_endo -82.5 -176.8 3.1 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.819 1.431 . . . . 0.0 111.013 -178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -77.0 3.35 12.47 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.135 -0.978 . . . . 0.0 109.97 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.849 HG22 ' OE1' ' A' ' 29' ' ' GLN . 33.9 m -84.14 -112.94 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.802 ' CG2' HD22 ' A' ' 30' ' ' LEU . 8.8 mm 42.23 23.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.898 -1.126 . . . . 0.0 110.311 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 24' ' ' THR . 49.0 p -35.94 158.1 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.692 0.758 . . . . 0.0 110.616 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 31' ' ' ASP . 16.7 m-20 -60.27 -27.38 67.21 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.691 -0.631 . . . . 0.0 109.523 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -90.88 -13.03 34.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.202 -0.936 . . . . 0.0 109.612 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.849 ' OE1' HG22 ' A' ' 24' ' ' THR . 2.4 mt-30 -79.88 -66.56 0.86 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.149 -0.97 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.802 HD22 ' CG2' ' A' ' 25' ' ' ILE . 2.1 mp -57.03 -28.77 62.8 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.248 -1.381 . . . . 0.0 107.98 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER -62.44 -43.33 99.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 108.672 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 m -55.75 -56.53 19.45 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 30' ' ' LEU . 8.4 tp -62.13 -18.55 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.701 ' HZ ' HD21 ' A' ' 75' ' ' LEU . 6.9 m-85 -86.9 -98.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 18.22 62.53 0.01 OUTLIER Glycine 0 N--CA 1.498 2.832 0 N-CA-C 112.141 -0.384 . . . . 0.0 112.141 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 35' ' ' GLY . 0.6 OUTLIER 178.15 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.904 -1.351 . . . . 0.0 111.074 179.069 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -128.19 50.39 2.07 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.416 -1.427 . . . . 0.0 111.179 -179.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' O ' ' CD1' ' A' ' 62' ' ' TYR . . . 26.21 43.47 0.02 OUTLIER Glycine 0 N--CA 1.508 3.493 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.898 ' O ' HG23 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -88.84 34.61 0.77 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.46 -1.024 . . . . 0.0 109.997 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.008 HG23 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER 165.34 109.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 61' ' ' ARG . 15.3 m -89.97 13.47 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 41' ' ' VAL . 1.0 OUTLIER 165.93 53.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HB3' HG21 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -42.65 144.54 0.54 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.123 -0.986 . . . . 0.0 109.98 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -152.86 150.91 29.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.03 . . . . 0.0 109.825 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.567 HG22 ' H ' ' A' ' 46' ' ' LEU . 1.5 mt -101.9 -178.66 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.567 ' H ' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -148.78 105.13 3.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.378 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.8 ptt180 -111.59 -172.69 2.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.179 -0.951 . . . . 0.0 109.598 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -72.63 175.2 6.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.662 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -106.09 -65.96 1.03 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -129.11 -41.36 1.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.486 -179.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 50' ' ' LEU . 34.0 p -158.15 175.74 13.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.419 ' C ' ' HG3' ' A' ' 53' ' ' ARG . . . 94.4 -57.59 1.99 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 52' ' ' GLY . 0.9 OUTLIER 54.88 87.49 0.14 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.201 -1.176 . . . . 0.0 109.518 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' O ' ' HD2' ' A' ' 55' ' ' ARG . 36.6 Cg_endo -61.16 -54.34 1.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.042 1.548 . . . . 0.0 110.069 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.467 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 0.0 OUTLIER 175.39 -37.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.166 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' C ' HD11 ' A' ' 21' ' ' LEU . . . 108.28 111.56 3.5 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 46' ' ' LEU . 2.7 m -127.12 178.43 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.264 -1.139 . . . . 0.0 109.394 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.893 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -139.7 177.11 8.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 0.0 109.639 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.625 ' CZ ' ' CD2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -146.48 111.27 5.27 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.008 HG13 HG23 ' A' ' 40' ' ' ILE . 16.9 t -95.87 148.14 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 178.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 41' ' ' VAL . 68.3 mtt180 -118.18 65.24 0.75 Allowed 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.287 -1.508 . . . . 0.0 110.187 -178.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.683 ' CZ ' ' HB3' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -78.64 91.66 4.65 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.617 ' CB ' ' HB2' ' A' ' 13' ' ' ASP . 0.1 OUTLIER -47.68 -84.76 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.891 -1.13 . . . . 0.0 110.993 -178.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -24.03 144.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 CA-C-O 121.534 0.683 . . . . 0.0 112.103 -178.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -78.11 -51.66 9.93 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.625 -0.672 . . . . 0.0 110.364 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -67.19 -39.49 86.39 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.848 -1.157 . . . . 0.0 108.24 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HB3' ' CZ ' ' A' ' 62' ' ' TYR . 18.1 mt-10 -69.3 -29.13 66.93 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.979 ' HB1' HD11 ' A' ' 91' ' ' LEU . . . -63.21 -39.8 95.67 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.512 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 0.6 OUTLIER -61.8 -28.24 69.32 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.647 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 0.9 OUTLIER -57.68 -67.99 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.458 -0.776 . . . . 0.0 108.978 179.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.765 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -55.51 -17.63 5.68 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.315 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.538 HD13 ' CG1' ' A' ' 89' ' ' VAL . 3.0 mm -69.39 -61.06 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.545 -1.347 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.91 4.34 41.92 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.604 -0.685 . . . . 0.0 111.11 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . . . -131.56 -1.28 3.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.745 -1.222 . . . . 0.0 109.952 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.701 HD21 ' HZ ' ' A' ' 34' ' ' PHE . 2.0 tp -127.87 -23.63 3.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.742 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.816 ' CA ' HG23 ' A' ' 89' ' ' VAL . 9.9 t-20 -41.1 -27.97 0.08 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.206 -0.933 . . . . 0.0 108.888 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 75' ' ' LEU . 91.2 m-20 -122.99 76.02 1.33 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.755 -0.59 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 78' ' ' VAL . 7.3 p -84.44 48.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.178 -0.951 . . . . 0.0 108.805 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.945 HD13 ' O ' ' A' ' 83' ' ' GLY . 2.0 pt -124.05 -169.58 0.17 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.343 -0.848 . . . . 0.0 109.376 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.518 ' O ' ' CB ' ' A' ' 81' ' ' GLU . 36.2 Cg_endo -110.92 40.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.983 1.517 . . . . 0.0 110.299 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' CB ' ' O ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER 76.97 160.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.391 -0.818 . . . . 0.0 109.963 179.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 87.48 -50.83 4.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.945 ' O ' HD13 ' A' ' 79' ' ' ILE . . . 155.67 -98.05 0.17 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 85' ' ' GLN . 11.6 m 62.75 10.32 4.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.28 -1.13 . . . . 0.0 109.425 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 mt-30 53.29 107.7 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.387 -0.821 . . . . 0.0 110.222 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.712 ' HB3' HG23 ' A' ' 79' ' ' ILE . 37.5 Cg_endo -115.61 164.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.939 1.494 . . . . 0.0 109.163 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -72.0 108.94 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.482 -1.287 . . . . 0.0 109.366 179.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 1.6 t -76.54 116.46 17.25 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 177.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.906 HG11 HD12 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -79.09 174.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-O 122.519 1.152 . . . . 0.0 113.155 -175.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.629 ' H ' HG12 ' A' ' 89' ' ' VAL . 0.1 OUTLIER 163.7 96.38 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.132 ' CD2' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -51.57 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.969 -1.082 . . . . 0.0 109.417 -178.716 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.449 ' O ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.6 159.71 2.05 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.512 -0.742 . . . . 0.0 110.02 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 3.6 pt-20 -140.61 50.63 1.67 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.352 -0.842 . . . . 0.0 109.191 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -152.85 -69.03 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.385 -0.822 . . . . 0.0 109.458 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.459 ' H ' ' CD2' ' A' ' 95' ' ' HIS . 7.4 p80 -119.62 79.99 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.883 . . . . 0.0 109.546 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -79.27 -150.68 5.74 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.501 ' OXT' ' CE ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 109.502 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.268 0.556 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 3' ' ' TYR . 67.8 m -92.87 -32.4 14.62 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.395 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER 68.5 160.09 0.17 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.565 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ARG . . . -179.44 162.06 1.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.096 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' ALA . 7.3 mtm180 61.54 116.16 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.325 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.574 ' CG ' ' HB3' ' A' ' 91' ' ' LEU . 36.5 Cg_endo -91.54 -176.76 0.89 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.993 1.523 . . . . 0.0 110.609 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.534 ' CA ' ' OD2' ' A' ' 13' ' ' ASP . . . -120.99 -149.75 8.24 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.549 ' N ' ' HB2' ' A' ' 13' ' ' ASP . . . 160.6 -132.89 3.05 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' HB3' ' A' ' 13' ' ' ASP . 12.9 pt-20 -161.99 -171.27 2.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.274 -1.133 . . . . 0.0 109.519 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.483 ' O ' ' C ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER 66.61 111.9 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.96 . . . . 0.0 109.009 -179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.567 HG23 ' CB ' ' A' ' 63' ' ' ASN . 0.5 OUTLIER 38.17 67.63 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.561 ' CG ' ' HG2' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 63.9 -162.89 0.27 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 108.516 -178.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' HB2' ' N ' ' A' ' 8' ' ' GLY . 3.9 p-10 -160.96 94.7 1.03 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.63 -1.294 . . . . 0.0 110.281 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.947 ' HB ' ' HB2' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -160.16 57.93 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.261 -0.9 . . . . 0.0 110.036 179.732 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 61' ' ' ARG . 1.1 t30 -78.59 158.06 28.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.302 -0.874 . . . . 0.0 109.106 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.978 HD21 HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -138.07 125.2 21.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.865 -1.147 . . . . 0.0 109.788 178.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' CE1' ' CE2' ' A' ' 59' ' ' PHE . 1.1 t80 -77.28 105.67 8.54 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.967 ' CG1' HD23 ' A' ' 87' ' ' LEU . 4.0 m -87.09 103.77 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 88' ' ' SER . 17.2 p -90.44 167.96 12.21 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.344 -0.847 . . . . 0.0 109.553 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 20' ' ' ASN . 0.9 OUTLIER 68.15 7.55 5.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.943 HD21 HD11 ' A' ' 25' ' ' ILE . 9.9 tt -71.08 115.0 32.05 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.118 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.579 ' O ' HD23 ' A' ' 21' ' ' LEU . 36.6 Cg_endo -60.13 142.37 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.859 1.452 . . . . 0.0 110.289 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.71 28.62 1.29 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 12.11 37.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.928 . . . . 0.0 109.402 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.943 HD11 HD21 ' A' ' 21' ' ' LEU . 2.1 pp -130.33 170.25 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.895 . . . . 0.0 109.254 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.498 HG23 ' OE1' ' A' ' 29' ' ' GLN . 1.2 p -113.62 153.91 28.08 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.272 -0.892 . . . . 0.0 109.351 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' O ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -49.88 -69.3 0.12 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.321 -0.862 . . . . 0.0 109.015 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -42.0 -27.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.498 ' OE1' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -62.97 -62.39 1.74 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.052 -1.03 . . . . 0.0 109.432 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.6 mp -52.93 -20.2 3.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.859 -1.15 . . . . 0.0 108.957 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' CA ' ' HE2' ' A' ' 43' ' ' LYS . 27.4 t0 -66.43 -47.13 74.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.089 -1.007 . . . . 0.0 108.966 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.9 m -68.02 -37.55 81.53 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.451 -0.781 . . . . 0.0 109.072 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 ' CG2' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -61.75 -27.2 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.335 -0.853 . . . . 0.0 108.889 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CZ ' HD21 ' A' ' 75' ' ' LEU . 10.7 m-85 -88.45 -81.21 0.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 108.882 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 34' ' ' PHE . . . 38.19 82.83 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HB3' ' CD1' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -173.42 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 109.654 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.639 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -107.79 -86.08 0.51 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.877 . . . . 0.0 109.109 -179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.6 179.29 16.42 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.528 ' O ' ' O ' ' A' ' 40' ' ' ILE . 10.7 m -94.13 25.83 3.57 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.077 -1.249 . . . . 0.0 108.773 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.848 HG22 ' H ' ' A' ' 42' ' ' GLN . 3.4 mp 56.91 142.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.887 HG23 ' HD2' ' A' ' 61' ' ' ARG . 33.4 m -79.21 -12.9 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.528 -1.358 . . . . 0.0 108.823 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.848 ' H ' HG22 ' A' ' 40' ' ' ILE . 21.4 tt0 157.47 112.46 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.63 -0.669 . . . . 0.0 110.17 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.79 ' CE ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -74.24 144.71 44.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.267 -0.896 . . . . 0.0 108.656 178.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' PHE . 7.0 m120 -132.68 144.46 50.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.941 -1.1 . . . . 0.0 110.407 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 tt -130.11 155.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 57' ' ' VAL . 8.5 tp -168.74 117.11 0.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.998 -1.064 . . . . 0.0 109.599 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -86.79 -39.25 16.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.184 -0.948 . . . . 0.0 109.744 179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 4.7 p30 165.98 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.307 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -148.71 31.03 0.8 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.499 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -152.66 -47.6 0.1 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.16 -0.962 . . . . 0.0 109.438 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.94 -79.49 0.53 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.34 72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' CD ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -132.21 150.17 75.26 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.163 . . . . 0.0 109.461 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -119.3 86.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.777 1.409 . . . . 0.0 110.611 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.576 ' NH2' ' CD ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -159.69 -36.25 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.17 -0.956 . . . . 0.0 109.807 179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' N ' ' HG3' ' A' ' 55' ' ' ARG . . . 107.47 98.45 2.56 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 46' ' ' LEU . 27.4 m -117.64 160.61 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -1.181 . . . . 0.0 109.459 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.679 ' CB ' HD13 ' A' ' 21' ' ' LEU . . . -153.4 164.31 38.38 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 0.0 109.557 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.616 ' CE2' ' CE1' ' A' ' 17' ' ' TYR . 11.1 m-85 -128.09 109.08 11.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.339 -0.851 . . . . 0.0 109.615 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.978 HG12 HD21 ' A' ' 16' ' ' LEU . 1.6 t -79.89 120.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.887 ' HD2' HG23 ' A' ' 41' ' ' VAL . 13.7 ttm-85 -88.03 99.73 12.39 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.878 -1.139 . . . . 0.0 110.35 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 3.6 m-85 -119.23 74.89 1.01 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.748 ' OD1' HG21 ' A' ' 41' ' ' VAL . 1.4 m-20 -68.38 -4.93 16.33 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.978 -1.076 . . . . 0.0 110.882 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' CB ' ' HB2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -87.98 146.53 25.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.954 -1.092 . . . . 0.0 109.606 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.561 ' HG2' ' CG ' ' A' ' 12' ' ' LYS . 39.3 mmm-85 -73.07 -58.84 3.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.0 108.793 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -56.21 -45.69 79.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -0.86 . . . . 0.0 108.846 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HB2' ' CB ' ' A' ' 64' ' ' LYS . 0.3 OUTLIER -52.83 -43.31 65.89 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.111 -0.993 . . . . 0.0 108.898 179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.947 ' HB2' ' HB ' ' A' ' 14' ' ' THR . . . -61.89 -40.54 95.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.936 -1.103 . . . . 0.0 108.751 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.72 -31.31 25.8 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.606 ' HG2' ' CD1' ' A' ' 37' ' ' TYR . 0.4 OUTLIER -80.2 -72.18 0.42 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.658 ' HB2' ' CE2' ' A' ' 62' ' ' TYR . . . -36.59 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.526 0.679 . . . . 0.0 110.685 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' GLU . 2.5 mt -81.02 -63.38 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 120.498 -1.376 . . . . 0.0 108.827 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.3 m -84.23 30.46 0.53 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.386 -0.821 . . . . 0.0 109.822 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.11 -52.88 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.877 HD21 ' CZ ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -79.47 -34.39 41.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.151 -0.968 . . . . 0.0 108.657 179.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 77' ' ' ASN . 6.6 t-20 -42.71 95.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.566 ' N ' ' O ' ' A' ' 75' ' ' LEU . 0.9 OUTLIER 80.87 76.93 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.792 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -89.4 38.46 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.306 -0.871 . . . . 0.0 109.064 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.881 HG21 ' OG ' ' A' ' 84' ' ' SER . 1.5 mt -151.7 128.32 5.34 Favored Pre-proline 0 N--CA 1.492 1.666 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.81 ' HD2' HG23 ' A' ' 79' ' ' ILE . 35.9 Cg_endo -44.06 130.79 8.37 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.741 1.39 . . . . 0.0 110.105 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -46.57 102.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.518 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.17 21.08 0.5 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.18 75.76 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.881 ' OG ' HG21 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -88.46 16.23 6.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -1.181 . . . . 0.0 109.218 179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.511 ' O ' HD13 ' A' ' 79' ' ' ILE . 28.2 mt-30 69.86 123.32 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.325 -0.859 . . . . 0.0 109.12 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.56 ' CB ' ' HA ' ' A' ' 77' ' ' ASN . 36.2 Cg_endo -110.46 -168.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.935 1.492 . . . . 0.0 111.813 -178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.967 HD23 ' CG1' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.29 113.46 27.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.642 -0.661 . . . . 0.0 109.927 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' A' ' 18' ' ' VAL . 0.4 OUTLIER -79.73 106.22 11.59 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.776 HG12 HD12 ' A' ' 16' ' ' LEU . 12.5 m -78.21 -167.72 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 0.0 111.322 -177.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.602 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 95.12 119.07 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -178.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.574 ' HB3' ' CG ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -49.47 168.17 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.319 -0.863 . . . . 0.0 110.369 -179.234 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.55 ' H ' HD23 ' A' ' 91' ' ' LEU . . . -149.16 -156.44 0.72 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.14 -169.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.061 -1.025 . . . . 0.0 109.748 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 95' ' ' HIS . 9.7 mt-10 -131.76 124.27 29.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.865 . . . . 0.0 109.538 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER 57.33 110.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.548 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -164.97 -143.56 3.76 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.192 -1.181 . . . . 0.0 109.38 179.973 . . . . . . . . 0 0 . 1 stop_ save_